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Overview 
 
Women with absolute uterine factor infertility (AUFI) are considered as being ‘unconditionally 
infertile’. Uterine transplantation (UTx) may be a possible treatment option in the future for such 
women. This thesis describes a number of key areas of research that are important in order to move 
closer to a successful and crucially, safe transplant in the human setting.  
 
Nine allogeneic transplants were carried out in a rabbit model to investigate anatomical and surgical 
aspects necessary for a successful UTx. An attempt to characterise and quantify the immunological 
mechanisms involved in allogeneic UTx (rejection patterns) was made. Out of the nine recipients, one 
was a long-term survivor. Embryo transfer was performed in this one doe with the aim of establishing 
pregnancy.  
 
Performing UTx in a large-animal model is necessary as the pelvis resembles a woman’s reproductive 
system more closely. In addition, the anastomotic technique is similar. Five sheep autotransplants 
were performed to further define surgical techniques. The anastomotic model was internal to external 
iliac vessel. Out of the five transplants, three sheep demonstrated adequate perfusion in the immediate 
post-operative period.  
 
Furthermore, the suitability of two different imaging modalities, pulse oximetry and multispectral 
imaging, for assessing uterine perfusion and extent of ischaemia were been studied in both the rabbit 
and sheep models. Biophotonics was also applied in the form of Endoscopic Laser Speckle Contrast 
Analysis to characterize blood flow in the two models. Both Multispectral Imaging and Endoscopic 
Laser Speckle Contrast Analysis have never been assessed before in a gynecological context. 
 
In order to transfer the concept of UTx to the human, we carried out a retrospective study of 
abdominal radical trachelectomy (ART) as a potential replacement for radical hysterectomy in 
patients with early stage cervical cancer desiring a fertility-sparing procedure. ART forms the 
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foundation of the original work into aspects of UTx. This original body of research revolved around 
the potential blood supply to a uterus.  
 
Furthermore, an attempt has been made to analyse the motivations, aims and feelings of patients 
diagnosed with AUFI towards UTx. Forty patients were interviewed.  
 
The final study involved the evaluation of the perceptions of health care professionals towards UTx, 
with 528 participants surveyed. 
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Aims 
 
The aims of this thesis were to explore a set of important topics thought to be crucial in the process of 
moving UTx a step closer from the animal to the human setting. 
 
Animal Studies 
 
In order to achieve the aims below, both small (rabbit) and large animal (sheep) models were used. 
 
1) To investigate anatomical, surgical and physiological aspects necessary for a successful UTx. 
2) To establish pregnancy (rabbit model only) following allogeneic UTx and if successful to evaluate 
fetal growth and well-being using Doppler ultrasound. 
3) To explore and compare the suitability of three different imaging modalities, pulse oximetry, 
optical spectroscopy, and enhanced laser speckle contrast analysis, for assessing uterine perfusion and 
extent of ischaemia and blood flow analysis. 
 
Human Studies 
 
1) To report the experience of ART as a potential replacement for radical hysterectomy in patients 
with early stage cervical cancer and who desire a fertility-sparing procedure. 
2) To analyse the motivations, aims and feelings of patients diagnosed with AUFI and the perceptions 
of health care professionals towards UTx. 
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History and Evolution of Uterine Transplantation 
 
Solid-organ Transplantation  
 
Organ transplantation and the underlying processes have fascinated mankind throughout history. The 
idea of removing a part of an individual’s body and grafting it onto a completely different entity 
transgresses beyond the scientific realm and into the philosophical and religious spheres. In the BC 
era, the Sushruta Samhita, a Sanskrit redaction text which contains all major concepts of ayurvedic 
medicine, had an innovative passage describing methods used by Sushruta to transplant a skin 
autograft during a nasal reconstruction. In the Far East, ca. 500BC, a legend describes how the first 
official Chinese physician, Bian Que used anaesthesia to perform a double heart transplantation in 
order to achieve balance between spirit and will in two men.1 
 
In the modern era, the first successful human transplant was performed by Dr Eduard Zirm in 
Moravia, a province of Czech Republic, at the beginning of the 20th century, who transplanted a 
cornea. In the early 1900s, the French surgeon Alexis Carrel was awarded the Nobel Prize in 
Medicine for furthering the field of transplantation by developing successful and creative vascular 
anastomotic techniques.  
 
Kidney and heart transplants represent two important milestones in solid-organ transplantation. On 
23rd December 1954, Dr Joseph Murray, a plastic surgeon, led the team (including John Merrill 
(nephrologist), J. Hartwell Harrison (urologist), and Gustave Dammin (pathologist)) which performed 
the first successful solid-organ transplant. A kidney was transferred between genetically identical 
twins (Richard who suffered from chronic nephritis and Ronald Herrick), a process that inevitably 
removed the threat of rejection. Thirteen years later, on 3rd December 1967, in Groote Schuur 
Hospital, Cape Town, Professor Christiaan Barnard transplanted a heart from a brain-dead 24 year old 
donor into Mr Louis Washkansky who was suffering from chronic heart failure. He died 18 days later, 
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having been diagnosed with pneumonia. This possibly gave an early insight into the unique immune 
suppression requirements of each type of organ transplantation. 
 
The idea of using organs to solve quality-of life issues was first introduced to the general public in 
1998 following a controversial hand transplant. This case highlighted the important issue of 
psychologically assessing the recipient as would be required in uterine transplantation (UTx). The 
patient, a convicted con-man, failed to follow the post-operative drug and physiotherapy program and 
as a result the donated hand was rejected. In 2010, the first facial transplant was successfully 
performed confirming that quality of life issues can be successfully treated through organ 
transplantation (Table A). 
 
Year Organ 
Surgeon 
(Place of Transplantation) 
1905 Cornea 
Eduard Zirm 
(Czech Republic) 
1954 Kidney 
Joseph Murray 
(USA) 
1966 Pancreas 
Richard Lillehei (USA) 
William Kelly (USA) 
1967 Heart 
Christiaan Barnard 
(South Africa) 
1967 Liver 
Thomas Starzl 
(USA) 
1981 Heart-Lung 
Bruce Reitz 
(USA) 
1998 Hand 
Jean-Michael Dubernard 
Nadey Hakim 
(France) 
2010 Face (full) 
Joan Pere Barret 
(Spain) 
2011 Uterus 
Omer Ozkan 
(Turkey) 
 
Table A Timeline of successful solid-organ transplants2 
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Background to Uterine Transplantation 
 
Women with absolute uterine factor infertility (AUFI) are considered as being ‘unconditionally 
infertile’. Currently, the only two options that women diagnosed with AUFI have with regards to 
managing their infertility are surrogacy or adoption. Potentially, these women may also benefit from a 
possible future third option: UTx.3 Causes of AUFI are congenital, mainly Mullerian duct anomalies, 
or acquired (for example, a hysterectomy performed secondary to obstetric haemorrhage, myoma, 
endometrial or cervical malignancy).4 Other uterine related causes albeit not absolute are secondary to 
pathology such as fibroids and severe endometriosis and adenomyosis (Figure A). Currently, it is 
estimated that even when restricted to women aged 15-34 years, there are around 7 million women in 
USA who have lost their uteri to benign causes or obstetric complications. Based on known fecundity 
rates, thousands of these women therefore require a resolution for their infertility. UTx has been 
proposed as a solution and thus, treatment for AUFI.5,6  
 
Causes of AUFI - Mayer-Rokitansky-Kuster-Hauser 
 
Women who present without a uterus are the most obvious group that may benefit from UTx in the 
future. These are women with either diagnosed uterine agenesis or who underwent hysterectomy. 
Uterine agenesis is the least common uterine anomaly and constitutes 3% of all Müllerian variances.7 
The syndrome is today referred to as Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome based on 
the work of four people who at various times over the 19th and 20th centuries described in the 
syndrome.4,8 MRKH is a congenital condition, with an incidence of 1 in 5000, whereby the Müllerian 
duct fails to develop.7,9,10 Therefore, as it is a congenital condition, the woman is born without a fully 
formed uterus (usually a rudimentary, solid bipartite uterus is seen) and Fallopian tubes. The 
morphology of the vagina is variable, from non-existent to only the upper third missing. Ovaries are 
usually present, and do ovulate normally. After pregnancy and Turner syndrome, it is the third most 
common cause of primary amenorrhoea.7,11,12 The karyotype (46, XX) and hormone profile are 
normal, with no transgender issues and a usual development of a MRKH teenager into a female adult 
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following telarche and adrenarche. In those cases where vaginal agenesis is also present, normal 
sexual function is resumed after the creation of a neovagina.11,13 Inheritance tends to be sporadic, with 
the syndrome appearing most likely to be inherited as a polygenic, multifactorial trait. Three MRKH-
subtypes have been defined to date: (a) typical: described above, an isolated uterovaginal aplasia or 
hypoplasia - prevalence is around 50-60%; (b) atypical: uterovaginal aplasia or hypoplasia with 
associated renal and/or ovarian malformation – prevalence is around 20-25%; and (c) MURCS 
(Müllerian duct aplasia, Renal aplasia and Cervicothoracic Somite dysplasia) syndrome - prevalence 
is around 10-15%. 
 
 
Figure A Causes of Uterine Factor Infertility (adapted from Brannstrom et al) 4 
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Petrozza et al carried out a study on whether MRKH is inherited in an autosomal dominant fashion. 
As currently the only way for MRKH women to have their own genetic child is via surrogacy, 
questionnaires were sent to all infertility treatment centres performing surrogacy in-vitro fertilization 
(IVF) in the US.14 32 programmes responded (60%). 58 MRKH women underwent a total of 162 IVF 
cycles, and 34 live-born children were delivered (female: n=17). No congenital malformations were 
found in the female neonates. One male child had a middle ear defect and hearing loss.14 
 
Causes of AUFI - Hysterectomy 
 
The other group of women who present with an absence of the uterus - women who underwent 
hysterectomy - represent the largest group of AUFI patients.4,15 These women also tend to be young 
and therefore seek surrogacy services to find a solution to their infertility. Goldfarb et al reviewed and 
evaluated retrospectively the experience of an IVF surrogate gestational programme in a tertiary care 
and academic centre during a 15 year period.16 50% of the women enrolled underwent a hysterectomy 
previously. The overall pregnancy rate per cycle after IVF surrogacy was 24% (38 of 158), with a live 
birth rate of 15.8% (25 of 158). Interestingly, their conclusion that ovulation induction had a better 
effect in patients with congenital absence of the uterus rather than in patients who had a hysterectomy, 
most likely secondary to ovarian compromise brought on by the actual hysterectomy, is of value to 
future UTx patients.16 Hysterectomy is carried out either as an emergency or an elective procedure. 
An emergency hysterectomy is a last-line, life-saving treatment for uncontrolled, severe post-partum 
haemorrhage where the patient is haemodynamically unstable. PPH that warrants a hysterectomy is 
usually caused by a Caesarean section, uterine atony or rupture, or placental adherence to the uterine 
wall. As the rate of Caesarean section rate continues to steadily increase, so one would expect the 
PPH hysterectomy rate to also increase from the present 1:2000.4,17-19 
 
Elective hysterectomies are performed for either benign or malignant uterine pathologies. The most 
obvious malignant pathology is gynaecological cancer. The surgical treatment for endometrial cancer 
and uterine sarcoma is a radical hysterectomy. However, the incidence of these cancers (uterine 
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cancers not involving the cervix) is 2.5% in women under the age of 40.20,21 Worldwide, cervical 
cancer remains the most common malignancy, with hysterectomy continuing as the most widespread 
surgical treatment method. This leads to good results with respect to survival and minimal morbidity 
but importantly a loss of a future fertility potential. This has led gynaecologic oncology surgeons to 
consider more carefully possible fertility sparing options in order to improve quality of life outcomes. 
Early stage (IA2-IB) cervical cancer, measuring less than 2cm in diameter can be treated with a 
fertility preserving operation, known as trachelectomy. However large tumours and those more 
serious than stage IB still require a radical hysterectomy.4 Sonoda et al found that 89/186 (48%) 
patients under the age of 40 who underwent a radical hysterectomy for early-stage cervical cancer, 
were eligible for a fertility preserving surgery i.e. trachelectomy.22 It is precisely this group of 
patients, women under the age of 40 who underwent a hysterectomy for cancer treatment who may 
benefit the most from UTx.4  
 
Causes of AUFI – Asherman’s Syndrome 
 
Another cause of AUFI that may lead to a uterus which is not compatible with pregnancy is 
Asherman’s Syndrome or intrauterine adhesion. Prevalence is around 1-2%, with a higher prevalence 
in the developing world secondary to genital tuberculosis.23,24 Genital tuberculosis can have quite 
deleterious effects - it may obliterate 50% of the uterine cavity.25 Asherman’s Syndrome may also be 
caused by an inflammation of the endometrium secondary to viral or bacterial exposure or even 
surgical trauma; for example aggressive uterine curettage when evacuating retained products of 
conception.26 Infertility rates are around 50% of affected women, with also a high rate of miscarriage, 
~40%, in those patients that do fall pregnant.27 A solution may be hysteroscopic adhesiolysis which 
can cure infertility in 90%, 70%, and 30% of cases of mild, moderate and severe Asherman’s 
Syndrome.4,28 However the treatment is not absolute. If infertility is not resolved, hysterectomy 
followed by UTx may be an option for this group of women.4 
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Causes of Uterine-Factor Infertility 
 
Below are described causes of infertility that are uterine-related. They are however not absolute i.e. 
treatment may be possible for each one of them. Described above was the most severe congenital 
malformation which leads to AUFI, that of uterine agenesis. More common however are congenital 
uterine malformations where the uterus is present. Apart from infertility, this type of pathology also 
leads to a multitude of other gynaecological and obstetric complications such as pregnancy loss, pre-
term delivery and difficulty during labour.29 Uterine malformations are found in 6-8% of the general 
as well as infertile female population and around 16-18% of those women that suffer from recurrent 
miscarriage.4,30 It is important to note that despite a relatively high prevalence, majority of women 
with congenital uterine malformations are in fact fertile. The most common type of uterine anomaly 
(35% of cases) in women considered infertile is a septate uterus, with the second most common type 
(25% of cases) being a bicornuate uterus.4,7,30 Spontaneous miscarriage occurs in 80% and 35% of 
pregnancies respectively, following conception in the above two types.31 Hysteroscopic metroplasty 
can decrease the rate considerably but many still cannot carry a pregnancy to 24 weeks.4,32,33 Other 
common uterine anomalies are unicornuate and didelphic uteri, which have a live birth rate following 
conception of 50%.7 The solution in future for those women permanently infertile may be a 
hysterectomy followed by UTx.4 
 
Treatment of non-gynaecological cancers during childhood, puberty or early adulthood (under the age 
of 40) may lead to a non-functioning uterus. Survival into adulthood from a childhood cancer is now 
at 70-80% so cancer treatment is important with respect to future fertility.34 Chemotherapy does not 
seem to affect the uterus with respect to morphology or size. Larsen et al assessed uterine volume 
using a transvaginal ultrasound in 100 childhood female cancer survivors.35 Their results showed that 
cytotoxic therapy did not affect uterine volume, endometrial thickness or uterine artery blood flow. 
Radiotherapy however has an irreversible and damaging effect on both the uterus and the ovaries.4 
Uterine size is reduced in size as demonstrated by a number of studies.35,36 Holm et al assessed the 
internal genitalia and uterine blood flow by ultrasound in 12 females 4-10.9 years after total body 
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irradiation and allogeneic bone marrow transplantation for childhood leukaemia or lymphoma.37 
Median uterine (around 60%) and ovarian volumes were significantly reduced compared with normal 
controls. Follicle growth and uterine blood flow were impaired. Significantly hormone replacement 
therapy could not generate normal uterine growth despite inducing bleeding and suppressing other 
signs of premature menopause.37 Wallace et al presented the first model to reliably predict the age of 
ovarian failure after treatment with a known dose of radiotherapy. Gonadotoxicity is brought on by 
radiation doses as low as 5-20Gy which leads to immediate menopause in 90% of post-pubertal 
females.38 
 
Benign pathologies that may may render a uterus incapable of carrying a healthy pregnancy to term 
include leiomyomas. The incidence of uterine leiomyomas varies anywhere between 8-16%, with the 
incidence increasing in older and Afro-Caribbean women.4,39-41 Marshall et al quantified the incidence 
of uterine leiomyoma according to age and race among 95,061 premenopausal nurses aged 25-44 with 
intact uteri and no history of uterine leiomyoma.39 3.5% of those surveyed aged 30-39 were found to 
have undergone a hysterectomy. Submucosal and intramural leiomyomas are most commonly 
associated with infertility, especially if above 4cm in diameter.42,43 Hysteroscopic resection and 
laparoscopic or open myomectomy are commonly used procedures to increase the probability of a 
successful pregnancy.4,44,45 
 
History of Uterine Transplantation 
 
In-vitro fertilization 
 
It is worth summarising in brief the arrival of IVF, because of its crossover with UTx research with 
respect to the ethical arguments of whether it should be permitted. The first major piece of work that 
proved that the transfer of a normal embryo into a mammalian uterus could lead to a birth of a healthy 
offspring was performed in 1959 by Dr Min Chueh Chang at the Worcester Foundation for 
Experimental Biology based in Massachusetts, USA.46 With regards to human IVF, the majority of 
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the ground-breaking work and a series of ‘world’s firsts’ in the 1970s and 1980s had been done in 
Australia by Professor Carl Wood’s team at the Monash Medical Centre in Melbourne. Their work 
included the world’s first IVF pregnancy, albeit only confirmed biochemically and not via an 
ultrasound scan, the world’s first birth of a healthy IVF baby conceived via frozen embryos (1978), 
the world’s first IVF baby conceived using a donor egg (1983), and the world’s first IVF baby 
following the use of novel sperm retrieval surgical techniques (1986).  
 
What changed IVF from an experimental technique to a successful international practice was their 
introduction of hormonal medication (clomiphene citrate and human chorionic gonadotrophin) to 
stimulate ovarian follicle production in order to achieve better control of oocyte maturation and 
collection. The first team to achieve a ‘real’, non-biochemical pregnancy as well as live birth was 
headed by Professors Patrick Steptoe and Robert Edwards, based in the UK. In 1976, they reported a 
re-introduction of a human embryo in transition between a morula and blastocyst after culture in vitro 
into the mother's uterus via the cervix. The resulting pregnancy was found to be located in the 
Fallopian tube. The ectopic embryo was removed at 13 weeks gestation. However, on 25th July 1978, 
the world’s first baby to be conceived by IVF, Louise Brown, was born in Oldham General Hospital, 
Greater Manchester, UK.47,48 The second such baby, also their work, Alastair MacDonald, was born 
on 14th January 1979 in Glasgow. Professor Carl Wood’s team in Australia then achieved a total of 
nine births from 14 pregnancies, although theirs was not the first IVF baby in that country. That 
honour went to a team led by Ian Johnston and Alex Lopata whose work led to the birth of the world’s 
third live IVF baby, Candice Reed, born on 23rd June 1980 in Melbourne.49 The pioneers of IVF in 
USA were Drs Georgeanna Seegar Jones and her husband, Howard Wilbur Jones II, based in Eastern 
Virginia Medical School in Norfolk, Virginia.50 On 28th December 1981, their work on IVF gave birth 
to Elizabeth Jordan Carr, the first American test tube baby. 
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Uterine transplantation research - The beginning 
 
Below is a review of UTx research before 1985, a cut-off chosen as it came in the middle of a decade 
when the current immunosuppressant medication as well as IVF had reached the clinical stage in 
many parts of the world. The post-1985 research is of a much greater relevance to this thesis and is 
described separately in the coming chapters. The majority of UTx research published in the 1960s 
through to the 1980s, involved transplantation of the entire female genital tract rather than the uterus 
specifically. Aims were to cure infertility but also offer a novel treatment option for various 
pathological conditions of the female genital tract. Furthermore, the transplantation process was 
autogeneic, rather than allogeneic. The first study to report a UTx attempt was by Zhordania et al.51 
Both small and large animals were used: 20 dogs, 10 rabbits and 18 ewes. The uterus, Fallopian tubes 
and ovaries were all excised and placed within the omentum, thus resulting in a heterotopic 
autotransplant. This was an original idea, which introduced the concept of omentopexy, whereby the 
omentum is wrapped and sutured around the graft in order to bring about revascularization of the 
chosen graft. The follow-up data for the ewes was reported in detail. Revascularisation had been 
achieved with a week, demonstrated neatly by methylene blue dye coursing through the descending 
aorta, then into the vessels of the omentum and finally into the uterus, Fallopian tubes and ovaries. 
The morphology of the grafted genital organs was completely normal by two weeks. Histology at one 
month showed normal and viable tissue. The authors did not report any complications with any of the 
animals, although it is unclear whether this is an omission or an actual fact. The most impressive 
result was that 10 out of 16 ewes achieved pregnancies after mating, all of which resulted in normal 
deliveries. The study used a significant number of animals, introduced a novel technique and reported 
surprisingly impressive results, with respect to preservation of both morphology and function. Their 
conclusion supporting the concept of revascularization of autotransplanted internal reproductive 
organs via omentopexy is appropriate given the results. However, it is worth noting that the 
omentopexy technique did not demonstrate such a high success rate in subsequent studies (viability: 
16/18=89%; functionality: 10/16=62.5%).51 
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O’Leary et al performed a similar experiment in a dog model, whereby an omental pedicle graft was 
used as a source of uterine revascularization.52 Specifically, the omentum was divided, with one 
pedicle sutured into the back of the uterus and Fallopian tubes, and the other across the top of the 
uterus, thus encasing the uterus and tube within itself. The number of animals used was appropriate 
(n=32). 23 out of 32 dogs were adequately re-vascularised at 4-6 weeks, with the appearance of the 
graft resembling its original morphology. De novo anastomotic channels were established even after 
two weeks post-operatively. However conception and pregnancy were not attempted so one cannot 
make a conclusion related to graft functionality. Even though the myometrium and cervix appeared 
normal histologically, the endometrium is not commented upon, most likely as the ovaries were 
removed so hormonally there would have been no effect upon the endometrium.52 
 
Scott et al also applied the principle of omentopexy in a dog model but this time specifically for auto-
UTx in order to see whether women with AUFI could be helped in the future.53 This was a study 
looking at both auto-UTx and allo-UTx. Eight auto-UTx involved the application of an omentopexy 
whereas 10 allo-UTx involved the use of an omental pedicle. Two autotransplants were performed 
without the use of an omentopexy. The uterine graft was obtained via a subtotal hysterectomy, with 
the rest of the genital tract left untouched. Both the auto-transplants and homotransplants were 
performed immediately. Immunosuppression, azathioprine and prednisolone, was provided to five of 
the allotransplants. By 12 weeks, the two non-omentopexy transplants fibrosed completely, whereas 
viability was normal in seven out of the eight omentopexy transplants. Normal uterine functionality 
involving conception or pregnancy was not demonstrated. Acute rejection was grossly visible in all 
grafts that underwent allo-UTx. Progressive oedema, necrosis and atrophy were seen within the first 
two weeks. This continued until at first the endometrial layer was completely necrosed, and at four 
weeks, complete non-viability of all uterine layers was seen. Interestingly, administration of 
immunosuppressive drugs did not alter the rate of rejection or appearance of the graft, suggesting that 
mostly likely that the drugs were poorly administered or at a too low a dose. The study demonstrates 
the potential efficacy of the omentopexy technique with a high percentage viability of the auto-
transplanted grafts. However, a similar conclusion regarding allo-UTx, which has a direct bearing on 
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human UTx, could not be made. The early demise of the grafts was most likely because of rejection 
but no attempt was made to differentiate those signs caused by rejection and those signs that may have 
been caused by a poor blood supply. Furthermore, acute rejection was simply noted and described 
using only macroscopic and histopathological features, but no attempt was made to characterise the 
response itself using imaging or biochemical markers. Their statement that histocompatibility testing 
between the donor and recipient, as well as an appropriate immunosuppressive regimen are required 
to ensure long-term allo-graft survival was correct, albeit obvious.53 
 
Both Barzilai et al and Paldi et al also performed an omentopexy-autoUTx type of study in a dog 
model.54,55 However, the results contradicted the favourable conclusions towards omentopexy of the 
above studies. The studies offered an original methodology of comparing two different perfusion 
techniques; one group underwent utero-ovarian autotransplantation and omentopexy and the other 
group underwent the same type of transplant but with a vascular re-anastomotic technique. In order to 
avoid problems related to rejection which would have made comparison more difficult, an 
autotransplant model was selected on purpose. In the first study, 12 dogs were used in each group.54 In 
the omentopexy group, all 12 grafts showed massive necrotic degeneration, with no viable tissue 
present. The re-anastomosis group (common iliacs), however, revealed autografts (10/10; two dogs 
died immediately post-operation) to be viable, with normal uterine and ovarian tissue. Imaging using 
a hystero-salpingogram demonstrated patent tubes and cervico-vaginal anastomosis. Uterine function 
was normal in one dog; pregnancy was achieved with delivery of three healthy pups. The conclusions 
here changed somewhat the perception of the omentopexy technique being a viable perfusion 
technique for a transplanted graft. Follow-up was appropriate, as was the number of dogs in each arm 
of the two groups. The authors also demonstrated that they understood which variables would be key 
in future human attempts by reporting related data: warm ischaemic time, maintenance of a patent 
vascular tree and sound re-anastomosis. The vascular re-anastomotic technique demonstrated 
encouraging results and added to results from number of other studies employing the same technique 
which together highlight the way forward with regards to uterine graft perfusion.54 Paldi et al also 
reported a 100% uterine viability rate three months post-transplant in the group which underwent 
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uterine auto-UTx with vascular re-anastomosis. The graft proved their functionality with subsequent 
implantation of embryos, pregnancy and delivery of healthy pups.55  
 
The above two studies pointed out the inferiority of the omentopexy method when directly compared 
to the vascular re-anastomotic technique.54,55 This vascular model had already been tried by various 
teams, with initial studies published in the 1960s. The first such study was by Eraslan et al in 1966, 
again performed using a dog model.56 18 virgin female dogs underwent uterine and ovarian dissection. 
It is worth highlighting that unfortunately the authors chose not to disconnect the organs from the 
body throughout the procedure, which impacts negatively on the study. With regards to the pelvic 
vascular supply, the common part of the internal iliac artery was dissected from its origin and freed 
inferiorly with ligations of all branches except the uterine and superior vesicle arteries. Division and 
re-anastomosis were performed immediately with the vagina still intact. The uterine veins on the other 
hand were dissected superiorly from the uterus to the fusion of the internal and external iliacs. The 
ovarian vessels were divided but not re-anastomosed. The vagina was then divided and re-
anastomosed. The author understood the importance of warm and cold ischaemia and flushed the graft 
with heparinised saline through its common iliac artery after 30 minutes of warm ischaemia. Ten dogs 
out of 18 survived the one year follow-up. All had viable uteri based on their gross appearance and 
microscopic analyses. Uterine artery patency was normal in all animals and was appropriately studied 
using retrograde aortography. Following mating, three pregnancies were confirmed with two healthy 
litters delivered. Importantly, the physiological increase of the diameter of pelvic arteries during 
pregnancy did not affect the re-anastomotic sites. The study itself was the first such study in the 
medical literature to prove a useful concept - that vascular re-anastomosis does lead to perfectly viable 
and well perfused uteri, compatible with carrying a healthy pregnancy to term.56  
 
Mattingly et al furthered the above concept by performing both auto- and allo-utero-ovarian 
transplants (again dog model) in a study designed to assess ovarian function.57 However data related 
to the uterus is provided and the study is summarised below. The anastomoses in the two different 
models were different. In the autotransplants, end-to-end common iliac arterial and inferio-veno-caval 
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anastomoses were applied. However, in the allotransplants, the anastomoses were aorto-common iliac 
and cavo-common iliac. The autografts revealed very similar rates to the Eraslan study above with six 
out of seven viable autografts post-operatively. Two dogs carried intrauterine pregnancies with one 
full term and one premature delivery. The autotransplant group almost served as a preliminary project 
prior to the commencement of the more numerous allotransplant cohort. 50 were performed in total. 
29 were administered azathioprine as an immunosuppressant three days pre-operatively whilst 21 also 
underwent a splenectomy. In the first cohort, only there dogs survived long-term, with 21 cases of 
early rejection. In the second cohort, eleven dogs did survive between 6 and 21 days and 
demonstrated graft viability. Assessment techniques were appropriate. Viability was evaluated on 
gross appearance via laparotomies and via imaging using arteriograms. Rejection was assessed using 
an alkaline phosphatase, haematoxylin-eosin and histochemical stains. The study again emphasises 
the need to study the rejection response and the specific role of immunosuppressants in preventing 
acute rejection in UTx specifically. Histocompatibility matching among donor and recipient is also 
required and was not carried out by the authors. The autotransplantation aspect of the study further 
reconfirms the technical advantage of a vascular re-anastomotic model in UTx. It also demonstrated 
that the re-connection of the nerve supply had no bearing on future successful pregnancy.57  
 
Wingate et al focused specifically on an allogeneic UTx experimental model.58 The graft was utero-
tubal-ovarian and was transplanted with its vascular pedicle, thus continuing the development of the 
vascular anastomotic model. 17 dogs were used in total for a set of cross-transplantations. Ten did not 
receive any immunosupression, whereas seven did (six - azathioprine and corticosteroid and one- 
antithymocyte serum). The numbers used are appropriate, although it is not apparent why one dog 
received a completely different immunosuppressant to the other six. The graft was a development on 
previous examples and resembles vascular grafts used for both small and large animals by UTx 
surgeons today. It consisted of the uterus, Fallopian tubes, and ovaries, with its vascular pedicle of the 
uterine, internal and common iliacs to include two inches of the aorta and vena cava. Anastomoses in 
the recipient were end-to-side to the aorta and IVC. Those dogs that did not receive an 
immunosuppressant (eight out of ten survived to the tenth post-operative day) followed the usual 
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acute rejection course: adhesions, oedema, and necrosis. Those that received immunosuppressants 
also experienced necrosis as well as thrombosis of both the medium and large-sized vessels within the 
grafts. This means that the immunosuppressant doses were not adequate enough or that the 
combination of immunosuppressants was not appropriate. Mixed leukocyte culture test demonstrated 
an inadequate suppression of leukocyte transformation, thus suggesting an insufficient dose of 
immunosuppressant. It is a criticism of the study that it would have been more useful to have a small 
number of dogs not receiving immunosuppression (n=5 for example) and therefore have a larger 
number of dogs receiving immunosuppression but split into groups where a dog in each group 
received a different immunosuppressant dose. This was acknowledged in the conclusion. The authors 
also suggested that the donor and recipient should be tested for histocompatibility. They also 
recommended the setting up of a recognized monitoring tool for the efficacy of the 
immunosuppressants. The conclusions are relevant and appropriate and will be evaluated again in the 
2000s.58 
 
The final study of relevance to UTx research carried out pre-1985 was by Yonemoto et al.59 Again a 
dog model was used, involving both auto- and allo-(cross) transplantation of the uterus and ovaries, 
and applying vascular anastomotic techniques. In total, 14 recipients received a utero-ovarian graft, of 
which five recipients were male. The immunosuppressant chosen was azathioprine, which was started 
pre-operatively and continued post-operatively. With respect to the vessels supplying the graft, the 
arterial vasculature included the lower aorta whereas the veins reached up to the common iliac veins. 
The anastomosis was a little different to the above study, with the aorta anastomosed to the internal 
iliac arteries and the common iliac veins to the respective veins in the recipient, in both cases in an 
end-to-side manner. 8 out of 14 recipients survived the operation, six female and two male. The 
authors highlighted the surgical complexity of the procedure in the conclusion. Out of the six females, 
four had viable uterine grafts, and the other two revealed complete necrosis upon euthanasia. The two 
male dogs revealed partial necrosis at day 21 and complete necrosis with rejection at day 37 post-UTx 
following euthanasia. The conclusions themselves do not reveal anything new to what has been 
describe above. The data added to the existing body of knowledge whereby the uterus is confirmed to 
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be a non-privileged site, acute rejection does follow a routine course seen with other organs and the 
myometrium is rejected later than the endometrium, with its architectural structure maintained for the 
longest. The authors explained those conclusions clearly, thus setting a clear path for future work. 
They also usefully reiterated the need for continued experiments focusing on the ideal combination 
and dose of immunosuppressant required and that all future experiments should use the vascular re-
anastomotic model. The latter point has been confirmed by recent studies as will be discussed later in 
the thesis.59 
 
One major criticism of all the studies above is that the studies do not provide in their reports any data 
concerning durations of utero-tubal-ovarian retrieval and whether the surgical technique with regards 
to accuracy and duration altered with the number of transplants performed.  
 
First Human Uterine Transplant 
 
Despite the promising research described above, UTx research had reached a ‘dead-end’ by the end of 
the 1970s. In the 1980s, the situation did not change greatly. Fertility research was dominated by 
developments in IVF, following the birth of the first ‘test-tube baby’ Louise Brown in 1978 in 
Oldham. The rest of the field of transplantation, following a much needed impetus based on recent 
scientific breakthroughs into the specific mechanisms behind the immunological response to ‘foreign’ 
cells (infection, cancer, autoimmunity and transplantation), concentrated on life saving 
transplantation, for example, heart, kidney and liver transplantation. This was more so from the 1980s 
onwards following the discovery of cyclosporine (CsA), a calcineurin inhibitor, which at the time 
represented a major breakthrough in the field of transplantation. The medication demonstrated that 
organ rejection after allogeneic transplantation could be prevented.  
 
However this all changed from the mid-1990s as a result of three important factors. First, 
gynaecologic oncologists began to look at techniques whereby a gynaecologic cancer could be 
surgically removed, yet the fertility of the patient would also be preserved. An example is abdominal 
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radical trachelectomy, applied to treat early stage cervical cancer in those women wishing to preserve 
their fertility.60 Based on the surgical techniques established at the time, some of these surgeons 
developed ideas as to how one may help those women whose uteri are rendered incompatible with 
carrying a healthy pregnancy or are simply not present.  
 
Second, and most crucially, on 6th April 2000, UTx was attempted for the first and until 2011, only 
time in the human setting.61 This was a compelling, courageous and historic attempt by a team in 
Saudi Arabia which should be commended. They transplanted a donor uterus into a 26 year old 
female who had previously had a hysterectomy for post-partum haemorrhage. The donor, a 46 year 
old woman, had completed her family and agreed to a hysterectomy and bilateral salpingo-
opherectomy to treat her bilateral multi-loculated ovarian cysts. The consenting process was queried 
in the international literature as a result of the fact that the standard treatment for such a pathology is a 
laparoscopic salpingo-oophorectomy.62 However following clarification, this was later retracted.63 
HLA tissue matching, ABO compatibility, and negative cytotoxic antibodies in the recipient were 
confirmed prior to transplant procedure. Briefly, the surgical technique is described. As with a 
hysterectomy, the uterine vessels were separated from the ureters, a process aided by the transaction 
of the round ligaments and opening of paracervical/pararectal spaces. Heparin (20,000iu) and 
prednisolone were given after vaginal transaction intravenously (iv) to prevent clotting and 
inflammation. The authors did not mention or describe the uterine veins or their division levels. The 
uterine arteries were divided 25mm away from the uterus. Also not reported is the duration of uterus 
retrieval surgery or the warm and cold ischaemia times. The first warm ischemia probably extended 
over several minutes. The organ was subsequently immersed ex vivo in cold saline and flushed with 
Euro-Collins solution. The Fallopian tubes were included in the transplanted graft which is a step that 
no team would perform today. Thus, only the uterus with its blood supply would be transplanted 
minus the ovaries and oviducts. This would be to avoid the risk of ectopic pregnancy following 
natural conception, which would be particularly high following radical pelvic surgery. The 
hysterectomy was modified so as to maintain the length of the vascular pedicle as long as possible 
(uterine arteries and veins were extended bilaterally by 6-8cm using long segments of the saphenous 
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vein), thus ensuring adequate tissue perfusion and tissue integrity. The uterus was subsequently 
grafted into the recipient’s pelvis. The position was orthotopic with additional fixations to the pelvic 
side walls and ligament remnants as well as the cervical anastomosis to the vaginal vault. To ensure 
uterine perfusion, the uterine artery and three uterine veins were first connected to sections of the 
great saphenous vein, and then joined onto the external iliac arteries and veins, respectively.  
 
As this was an allogeneic UTx, immunosuppression was administered in the form of the following 
drugs: oral CsA, azathioprine and prednisolone. Graft rejection was monitored by Echo Doppler 
studies which indicated uterine perfusion for two months, magnetic resonance imaging and 
measurement of the CD4/CD8+ cell ratio in the peripheral blood. There was only one episode of acute 
rejection on the ninth post-operative day, treated and controlled promptly with anti-thymocytic 
globulin and increased steroid and azathioprine doses. Following that episode, the patient did not 
experience any further issues. Apart from normal Doppler studies, the uterus showed adequate 
function with endometrial proliferation reaching a maximum of 18mm following the administration of 
combined oestrogen-progesterone therapy and two withdrawal bleeds once the medication had been 
stopped. The authors did not explain why the hormonal treatment was administered and the recipient 
had her ovaries preserved. The graft was removed after 99 days due to thrombosis of the uterine 
vasculature, which caused subsequent necrosis of the transplanted uterus, leading to a rescue 
hysterectomy, following the visualisation of a ‘dusky-coloured’ and prolapsing uterus. The authors 
reported ‘acute vascular occlusion appeared to be due to inadequate uterine structure support, which 
led to probable tension, torsion, or kinking of connected vascular grafts.’ 
 
Histopathology revealed acute thrombosis in the vessels of the uterine body, with resulting infarction. 
Interestingly both Fallopian tubes appeared healthy and viable, with no evidence of rejection. 
Therefore, the thrombosis of the uterine vessels was either because of the double anastomosis for each 
vessel or inadequate uterine structural support. This would have meant that the uterus, instead of 
being properly supported, instead ‘sagged’ under the influence of gravity leading to tension, torsion, 
or kinking of the connected vascular uterine grafts.61 However, the authors did not attempt to explain 
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why the Fallopian tubes were of normal histology, as they are also supplied via the uterine arteries. It 
is likely that future attempts would have a greater chance of succeeding provided longer vascular 
pedicles were obtained with increased uterine fixation. Despite this, the actual event provided much 
needed impetus for research into UTx (Figure B).  
 
The third and final factor was the area of ovarian transplantation, involving ovarian cortex 
transplantation and whole ovary transplantation, fresh and frozen in both cases. To date, more than 20 
pregnancies have been reported after ovarian cortex transplantation.64 
 
Conclusion 
 
Currently, gestational surrogacy, adoption, or lifetime infertility are the only options available to 
affected women with AUFI. However, these options may not always be appropriate for every woman 
because of emotional, ethical, religious, social and legal issues.3 Therefore, UTx can be justified as 
another potential solution to the afore-mentioned quality-of-life pursuits. With continued advances in 
transplantation surgery, improved methods of controlling tissue rejection, and advances in IVF 
technology, UTx can bring an end to AUFI by allowing a select group of women to become 
mothers.65 It is worthwhile to recall and note the parallels in the controversy surrounding now 
‘standard’ assisted reproductive techniques when they were first introduced and UTx today. 
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Figure B History of Uterine Transplantation.2 Depiction of the orgins of modern organ 
transplantation leading up to current research into uterine transplantation. 
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Key areas of UTx research 
 
The publication of the world’s first human UTx was a catalyst which sparked a new wave of research 
specifically focusing on AUFI and UTx. Three international teams have carried out the vast majority 
of the research: Professor Mats Brannstrom’s team in Sweden, Professor Giuseppe Del Priore’s team 
in USA and Mr J. Richard Smith’s team her in the UK. The key areas of interest, which all feature in 
the thesis, are listed below. Each is explained in detail in the coming chapters.  
 
a) Surgical techniques, retrieval and grafting 
 
How to achieve an adequate blood supply for the transplanted uterus still presents the biggest 
challenge in UTx. A number of animal models have been tried, including non-human primate 66,67, 
sheep 68,69, rat 68,70,71, and mouse.72 The UK team’s (Smith JR et al) previous experience regarding this 
question initially focused on uterine artery anastomosis, then a microvascular anastomotic model and 
finally ‘the large-vessel patch technique’. 
 
Small and large animal models have demonstrated that current surgical techniques used during UTx 
do not seem to interfere with normal uterine function. This is important as both uterine size and blood 
flow undergo substantial changes during pregnancy.73 However, because of high rates of vascular 
thrombosis in transplant models, it is important to ensure that the vascular anastomotic sites and 
uterine structural support are improved for better adequacy. 
 
b) Ischaemia-reperfusion injury 
 
A transplanted graft is at risk of injury to its parenchyma, both short- and long-term, from ischaemia 
and reperfusion. Actual injury, known as ischaemia-reperfusion injury,74,75 is strongly linked to: (a) 
delayed graft function76 and post-transplantation perfusion leading to post-transplant capillary no-
reflow, leukocytic inflammation, and persistent tissue hypoxia;4,77 (b) increased frequency of 
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rejection, and (c) enhanced acute and chronic rejection.78-81 These mechanisms eventually lead to graft 
failure.82-84 During the ischaemic period, the uterus lacks circulation, and at reperfusion, it is exposed 
to a ‘blood flow rush’ after extended ischaemia. Two ischaemic periods (organ retrieval and vascular 
anastomosis) and one cold ischaemic period (organ storage) have been defined. The first warm 
ischaemic period occurs during organ retrieval. It commences at a point when the vessels supplying 
the graft are clamped and lasts until the graft is flushed with a cold preservation solution. At that 
point, the cold ischaemic period begins. The second warm ischaemic period starts when the graft is 
retrieved form the preservation solution and ends when the vascular anastomoses are established. It is 
thought to be less harmful, because of a gradual rise in organ temperature and also partial protection 
offered by a preservation solution in which the graft is placed.80,84,85 Pathophysiology of the 
ischaemic-reperfusion injury involves a number of different mechanisms, already described in 
literature. They include vasoconstriction,75 oxidative stress,86,87 cellular damage (complement, 
cytokines, leukocytes)88,89 and eventual cell death.4,90,91 In addition, the normal immunological process 
invoked by antigen presenting cells, brings about acute and chronic rejection.4,84 
 
The main strategy of reducing ischaemia-preservation injury involves the use of a cold preservation 
solution, made up of intra- or extracellular-like electrolyte compositions. The vascular system of the 
graft as well as the graft itself is flushed with the solution, which besides electrolytes also contains 
additives such as colloids, antioxidants, metabolic precursors, chelators of calcium and iron, as well as 
vasodilators.84,92,93 The cold preservation solution decreases tissue damage by simply slowing down 
the metabolic rate of the graft. With every 10ºC that are lowered, metabolism declines by about 50%. 
The period during which a graft may be kept in a cold reservation solution varies with different 
organs. Maximum recommended times are around six hours for the heart and 36 hours for the kidney. 
 
The method of separating the potentially harmful effects of ischaemia-reperfusion and surgical trauma 
from the degenerative process of rejection needs further developing. One of the solutions is to use 
auto-/syn-geneic transplant models to exclude rejection. 
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c) Uterine perfusion  
 
The possible injury that may be brought on by ischaemia and reperfusion requires a method of 
assessing uterine perfusion, both intra and post-operatively and comparing those values to pre-
transplant levels. Various methods exist, both invasive and non-invasive, ranging in their degree of 
accuracy. A need exists for a technique which will be able to assess the level of ischaemia and 
reperfusion injury and provide related diagnostic information during the intra-operative and 
immediate post-operative periods, as well as prior to possible pregnancy. No such technique exists. 
 
d) Immunology of UTx 
 
The immune response of a host towards a uterine graft can be just as deleterious as the host response 
towards other transplanted organs. The mechanisms are revised here. Rejection can be defined as 
destruction of the donor graft by the host’s immune response, activated against the graft’s alloantigens 
because of a difference in the genetic make-up of the two individuals. As outlined in an extensive 
review article by Nankivell and Alexander in the New England Journal of Medicine, rejection is 
classified according to: a) time (post-transplant) when rejection occurs: hyperacute (minutes), acute 
(days to weeks), late acute (after 3 months), or chronic (months to years); b) histological changes 
(cellular-interstitial, vascular, antibody-endothelial); c) physiological function; d) adaptive or innate 
immune system response.94 Pregnancy in solid organ transplant recipients has not changed this 
generally observed pattern and timing of rejection. 
 
Hyperacute rejection occurs almost immediately after the donor graft is perfused within the recipient’s 
body. It is a peri-operative complication, where the diagnosis is clinical with macroscopic evidence 
revealing the extent and speed of rejection. Microscopically, host antibodies, activated by the 
complement cascade, attack the HLA antigens expressed on the graft endothelium. UTx hyperacute 
rejection would be expected to have the same natural history and diagnosis as seen in other 
transplanted organs.  
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Acute rejection usually begins one week after transplantation but can occur months to years after 
transplantation, with the risk highest in the first three months. It is caused by a Human Leukocyte 
Antigen (HLA) mismatch, a risk factor which is impossible to completely remove as HLA genes are 
found in all cells of the body. The HLA system is present in the human uterus, endometrium and fetal 
trophoblast. Its role has been described throughout human pregnancy. Acute rejection episodes are 
either antibody-mediated or, more commonly, due to T-cell activation. If the response to the episode 
is prompt, graft failure will rarely occur. Antibody-mediated acute rejection is triggered by the 
membrane-attack complex (C5b–C9), which causes localized endothelial necrosis and apoptosis and 
therefore, a rapid graft dysfunction due to inflammation. In a kidney allograft, histopathology usually 
reveals microthrombi, with haemorrhage and arterial-wall necrosis and infarction.95 T cell–mediated 
rejection, as described by Issa et al in their review is initiated when foreign donor HLA alloantigens 
found on the surface of cells in the graft, are presented to the recipient T cells by both the recipient 
(indirect) and donor (direct) APCs (dendritic cells, macrophages, B cells)96 which bind to those 
antigens and subsequently migrate to the lymph organs in order to locate the T cells.97  
 
Three T cell subtypes have been extensively described in literature: CD4+ T cells (T helper cells, Th1, 
Th2, Th17), CD8+ T cells (T killer cells) and regulatory T (Treg) cells.98 With regard to their roles, 
CD4+ cells initiate both a humoral response via cytokines interleukin-4, interleukin-5, and 
interleukin-13, as well as a CD8+-led cellular response, via interferon-γ and interleukin-2.99 The latter 
T cell subset is responsible for the cytotoxic graft lysis. The former subset is also a prime ‘mover’ in a 
delayed hypersensitivity reaction which causes increased vascular permeability, local accumulation of 
lymphocytes and macrophages and therefore microvascular injury. Together these three effects 
represent an important mechanism in graft rejection and eventual destruction. T cell function has also 
been described in everything from early implantation to inflammatory pre-term labour.  
 
Chronic rejection occurs months to years after transplantation because of an accumulation of various 
assaults by the host immune system over time. These assaults are mediated by host antibodies and 
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lymphocytes which manage to eventually wear down the immunosuppression administered to the 
patient. Of course long term chronic rejection will not be an issue for UTx recipients. UTx is 
envisaged as a temporary graft that will be removed after Caesarean birth or a period of infertility 
despite UTx. 
 
Tremendous advances have been made in the field of solid-organ transplantation, which has led to 
greater benefit and increased survival in patients with pathologies that were once deemed terminal. A 
key discovery was the introduction of CsA, a calcineurin (protein phosphatise) inhibitor, in the 1980s. 
Along with tacrolimus, also a calcineurin inhibitor, it exerts its action by blocking the phosphatase 
activity of calcineurin, which then leads to an inhibition of lymphocytic interleukin-2 production. 
Therefore, interleukin-2-dependent T-cell activation is depressed.100,101 Quality of life issues depend 
greatly on the magnitude of the immunosuppressant ‘burden’, mainly the type, dose, frequency of 
intake, time period during which they must be taken and the potential side-effects. Relevant to this 
research and to obstetrics and gynaecology as a whole, effects of immunosuppressants on fertility and 
fetal outcomes are also of great interest. However these issues have had to be balanced against the risk 
of graft rejection, which can occur at any time if the immunosuppressant regime is altered. Therefore, 
research has attempted to decrease the immunosuppressant ‘burden’ to a level which will not result in 
rejection, yet improve the patient’s quality of life. Common approaches have included avoidance of 
steroids and reduced exposure to calcineurin inhibitors. 
 
e) Pregnancy following UTx 
 
Pregnancy has now been achieved in auto-, syn-, and allogeneic models, both small and large animals, 
and after both embryo transfer as well as natural conception. To date, there have been no reports of 
pregnancies in primate models, both human and non-human. It is also important to establish whether 
pregnancy, once achieved, and subsequent offspring are affected negatively in any way by a 
combination of immunosuppression, adequate uterine perfusion or uterine graft position.4 
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Literature Review 
 
(a) Small-Animal Model 
 
Surgical Techniques: Uterine retrieval and harvest 
 
Techniques for uterine retrieval have been developed in several small-animal models to ensure a safe 
procedure for a human living donor. Initial experiments and operations were therefore performed in 
small animal models, with results and observations subsequently applied on large-animal models, 
where the anatomy, vasculature and size of the organs closely resemble those of humans. Uterine 
retrieval is a technically demanding procedure involving complicated retroperitoneal dissection of the 
pelvic vasculature and ureters. The technique varies depending on size/anatomy of the uterus and 
vasculature. Donors are sacrificed in small animal models since the uterine vessels are too small to be 
dissected and therefore, the vascular segments of the graft contain either the common iliac vessels 
(Figure C) 68,69 or the abdominal aorta (AA) and vena cava (IVC).102  
 
Initial UTx endeavours in the small animal model involved rodents. Various ways of ensuring 
adequate uterine perfusion post-UTx were attempted (for example, including ovarian vessels in the 
graft) but the idea remained the same: the vascular anastomosis which would lead to adequate 
perfusion would be AA-AA and IVC-IVC or common iliac to common iliac. The uterus in rodents 
consists of a left and right horn. Retrieval involved the either one or both horns, and a macrovascular 
patch. The ‘patch’ is made up of the infra-renal aorta, IVC, common and internal iliac vessels and the 
uterine arterial and venous tree. If only one horn is retrieved, the patch would only include the 
aforementioned vessels from that side i.e. left or right. On occasion, the ligation may occur at the 
commencement of the common iliacs and therefore would not involve the AA and IVC. Together 
with one or both horns, the patch en bloc is successfully harvested intact as the large vessel patch and 
graft.   
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Figure C End-to-side vascular anastomosis between the common iliac vessels of the recipient 
and the donor graft in a rat UTx model. The vagina of the recipient and the vaginal rim of the graft are 
connected and the horn is attached to the utero-tubal junction (courtesy of Hanafy et al).80 
 
 
 
The idea of using a patch had evolved as a result of difficulties in ensuring adequate perfusion of the 
graft in question when using smaller vessels for anastomosis. The uterine vessels in the mouse and rat 
are too small for dissection and anastomosis; therefore, the parametria, containing these vessels, are 
preserved up to the internal iliac vessels. Lee et al, in their review of replantation and transplantation 
of reproductive organs in rodents, were the first authors to use a macrovascular patch in an animal 
model of UTx. More importantly, they correctly hypothesized that a full understanding and 
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acquisition of microsurgical techniques and anatomy of the reproductive system would eventually 
lead to successful allogeneic transplantation of genital organs in both males (penis/testis) and females 
(uterus/ovary).70 Their attempts in female rats focused on en bloc (vagino-)utero-tubal-ovarian allo- 
and syn-transplantation with an aorto-vena cava patch. Total number of transplants was satisfactory 
(n=44); 24 were syngeneic and 20 were allogeneic. All lumbar branches of the aorta, iliolumbar 
vessels, branches of the uterine arteries and veins at the level of the vagina, and iliac branches below 
the uterine vessels were ligated and cut. The AA and IVC were clamped about 1cm above the ovarian 
artery origin. They were therefore prepared to a level superior to the origins of the ovarian arteries and 
left renal vein and inferior to the origin of the internal iliac vessels. The vagina was cut at the level of 
the upper two-thirds. Following clamping of the recipient IVC and AA, routine end-to-side AA-AA, 
IVC-IVC anastomoses were performed using 9-0 microsutures. No apparent differences were seen 
between the syngeneic and allogeneic transplants on day one. By day five, moderate haemorrhagic 
oedema was noticed with some loss of mesosalpingeal vascular pattern, and by day 10, it was present 
in all allo-recipients suggesting rejection. However, the adequacy of the surgical model was supported 
by the syn-recipients which demonstrated reperfusion and revascularization as well as normal 
mesosalpingeal vascular arrangements. This persisted until sacrifice at day 20 or three months 
(whichever came first) with the only abnormality on histopathology being abundant suture 
granulomas at the vaginal anastomotic sites but normal vaginal mucosa. The ovarian follicles and 
stroma were normal. Furthermore, recipient survival was 100%.70 As on original concept regarding 
uterine perfusion, the en bloc graft which includes a macrovascular patch proved promising and 
effective. It would have been ideal if the functionality of the graft was assessed (i.e. pregnancy 
attempts), and an attempt to suppress the acute rejection response. 
 
Since the above publication, the aorto-vena cava patch has been used by other teams. Jiga et al 
describe a series of 15 whole-uterus-and-ovaries rat allotransplants.71 However, in this case, the 
transplantation was heterotopic with the AA and IVC anastomosed to the femoral vessels. The smaller 
diameter of the femoral vessels in comparison to the AA and IVC, as well as the allogeneic nature of 
the transplant most likely led to failure in 74% of the grafts at 72 hours. Early thrombosis, starting 
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from the capillary bed and progressing towards the main feeding pedicles, was demonstrated.71 This 
model is not advisable as in addition, to the high likelihood of thrombosis of the femoral vessels, it 
also creates an obvious risk of ischaemia to the hind limbs. 
 
The next set of experiments to advance the techniques relevant to UTx were designed and performed 
by Professor Brannstrom’s team in Sweden. They were all methodical, appropriately planned, with 
each experiment an extension of the previous. Importantly all the experiments were novel in what 
they were trying to achieve. Also, they all had in common a single aspect: to further evaluate the 
principles of a macrovascular patch. Wranning et al developed and evaluated the model with the aim  
 
 
 
Figure D Close-up view of end-to-side vascular anastomoses between the common iliac artery and 
vein of a rat to the vena cava (VC) and the aorta (A) of the recipient rat.68 
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of reproducing and using it in future UTx-related studies. Adult, virgin female rats of inbred Lewis 
strain were used as donors and recipients. Therefore, transplants were performed between syngeneic 
animals where rejection is absent and immunosuppressive treatment is not required. Hence, any 
damage is directly attributable to the surgical process and post-operative inflammation, and not 
secondary to a rejection process. The UTx graft involved only one uterine horn, the common uterine 
part, the cervix and a vaginal rim.68 The right uterine artery and vein were dissected cranially to the 
common iliac vessel, with ligation of all other branches. The vascular graft was transplanted by 
anastomosing the right common iliac artery and vein of the graft end-to-side (Figure D) to the AA 
and IVC.68 The transplants were performed by two individuals with no previous microsurgical 
training with a recording of their learning curves. There was no removal of the native uterus, with it 
being left in situ. The transplanted uterus was then placed in a heterotopic position with the vaginal 
rim of the graft externalised and connected to a cutaneous stoma. When transplant survival exceeded 
70% for both surgeons, 15 animals were transplanted and grafted uteri were evaluated at day(s) 1, 7 
and 21 by assessment of morphology and recording of infiltrating neutrophilic granulocytes. 
Promisingly for UTx in general, both surgeons gained the necessary microsurgical skills needed to 
achieve above 70% transplant survival at a similar rate. The duration of uterus retrieval decreased 
from 90 to 60 minutes after 30 operations. The signs of post-operative inflammation on day one after 
transplantation were minor and further reduced at later time points. Survival transplant was high (70-
80%), which together with the healing of the grafted horn demonstrated a fitting functionality of the 
surgical method. Thrombosis was most likely caused by a sub-optimal technique for the venous 
anastomosis, since the team found narrowing of the vein at the anastomosis site.68 
 
This model has now been validated and modified by subsequent transplantations. The main 
modification was at the anastomotic level with subsequent anastomosis occurring between common 
iliac vessels (Figure C). This has led to pregnancy in both syngeneic 103 and allogeneic models.104 The 
team’s initial rodent model for UTx research was in the mouse.69 The mice chosen were F1-hybrids of 
inbred C57BL/6xCBA/ca (B6 CBAF1) mice of 6–8 weeks of age (n=42). The right uterine horn, 
common uterine cavity, cervix and a vaginal rim were first isolated using microsurgical techniques 
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which preserved the vascular supply from the aorta through the right uterine artery, as well as the 
venous drainage back to the IVC. So that the recipient animal could be prepared, the organ was put on 
ice. Xylocaine and heparinised saline were used to expand the vessels and prevent thrombosis. The 
recipient’s uterus was left intact and remained in situ. This was followed by transplantation to the left 
side of the abdomen, with vascular anastomosis to the donor mouse. Here, as a result of the small 
diameter of the iliac vessels, the AA and IVC of the graft were anastomosed end-to-side to the AA 
and IVC of the recipient animal with 11-0 sutures. It is worth noting the diameter of the vessels: only 
0.7 and 1.5mm respectively. The duration of uterus retrieval decreased with time from 60 to 45 min 
with increased experience. Despite the difficulty of dealing with anastomosis of vessels with such 
small diameters, the overall survival rate of the recipient animals increased from 38% for the first 21 
animals to 71% for the second 21 animals. The respective percentages for the proportion of viable 
grafts, as confirmed by normal blood flow (or at least similar to that of the native uterus) and 
histology showing normal morphology was 25% and 87%. 90% of the grafts exhibited normal blood 
flow on post-operative days 15-30. Light and electron microscopy confirmed normal structure in both 
native and graft uteri. Obviously, the gold standard test for the functionality of the transplanted uterus 
is its ability to implant transferred embryos and subsequently carry a pregnancy to term. In one of the 
transplanted mice (eight weeks old), six blastocysts were transferred to the uterine-transplanted mouse 
one week post-UTx. Three blastocysts were placed in the native uterus and three blastocysts were 
placed in the graft, with needle piercing the uterine wall in both cases. Three and one normal fetuses 
were seen in the native and transplanted uterus respectively. In the transplanted uterus, one absorbed 
pregnancy was seen. Thus, this is first report of a successful UTx with proven functionality in the 
mouse.69 Prior to that, no record in literature exists whereby the function of a cross-transplanted uterus 
had been assessed.  
 
An extension of the above experiment involved a further 19 syngeneic uterine transplants. The 
transplants were heterotopic; therefore, the native uteri were not removed. The vascular anastomosis 
was end-to-side aorto-aortic and cavo-caval. This time however the cervix was externalised with a 
formation of cervico-cutaneous stoma. This was done to ensure adequate mucus and fluid drainage 
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from the transplanted graft and thus, ensure implantation.  The study was well designed, with controls 
used (no transplant, normal mice). A considerable improvement was seen with regards to 
complication/failure rate during the surgeries. Out of 19 transplanted uterus recipients, 12 had viable 
grafts (a satisfactory number) and were used as embryo recipients, with eight becoming pregnant 
(study 5 deals in greater detail with fertility aspects following UTx in a small animal model). The set 
of live births reported are a first set of such cases following cross-UTx.105  
 
Both experiments demonstrated the need to attempt the same type of transplant in an allogeneic 
model. Also, they do not hide from the technical difficulties with regards to microsurgical techniques 
in achieving adequate anastomosis. A steep learning curve for the team in question is almost a 
necessary step towards successful UTx. 
 
The small animal model applied in this thesis was the rabbit model. There is very limited literature on 
UTx in rabbits. Confino et al described the first experiment involving a rabbit UTx model. It is an 
original experiment outlining the surgical retrieval of the rabbit uterus and its non-vascular 
transplantation to the surface of the broad ligament with sutures.106 A number of different study 
groups were formed: a) total uterine horn autotransplants (n=4); b) supracervical uterine horn 
autotransplants (n=4); supracervical unilateral uterine horn cross-transplants (n=10) with the last six 
cases subjected to immunosuppression with CsA. The first group had comprised results secondary to 
direct spread from a non-sterile vagina. All cases revealed tissue necrosis following a month post-
operatively. In the second group, only two cases were followed up for at least month. One horn was 
well preserved whereas the other had necrosed. In the final group, the recipients which did not receive 
immunosuppression showed total rejection. Pelvic abscesses were seen in 75% of recipients that did. 
Despite the lack of big numbers within each group, the experiment is well thought-out with a reason 
behind the design of each group. It also highlights the disadvantages brought on by the use of 
immunosuppression. However, their conclusion is that non-vascular transplantation is an appropriate 
method is not supported by the data.106  
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Sieunarine et al used a rabbit cadaver to study the feasibility of the macrovascular patch including the 
AA and IVC, discussed in length above.107 The infra-renal aorta, IVC, common and internal iliac 
vessels and the uterine arterial and venous tree together with the uterus en bloc were successfully 
harvested intact as a large vessel patch and graft in a single New Zealand white rabbit. The ovaries 
and its vascular pedicle were not included as part of the en bloc harvest because the diameter of the 
ovarian vessels (less than 1mm) is too small for feasible anastomosis. Also, this would not be 
attempted in a human. The exercise proved useful to the team in testing the feasibility of the 
aortic/vena caval macrovascular patch, with respect to the anatomy and surgical vascular dissection. 
Ideally, more than one rabbit cadaver would have been used but it was suitable as a preliminary 
experiment. The vascular tree in a rabbit is much more vascular than in the other rodent models. 
Therefore, the key feature of a rabbit macrovascular patch dissection is the care that must be taken to 
ensure the inclusion of the entire uterine vascular tree, especially the lateral and inferior pelvic 
branches, without accidental transection which would compromise the whole transplantation process. 
The option of using the IVC as a valid venous patch is adequate, yet it will remain a challenge to both 
dissect and anastomose to the recipient IVC.107 
 
The next experiment by the same team attempted to test the use of this macrovascular patch in a series 
of six uterine allotransplants.102 Again, the uterus and its blood supply en bloc were successfully 
harvested with an aortic-caval macrovascular patch from six rabbit donors. The rabbits used were 
standard New Zealand whites weighing between 3 and 4.5kg and of age 6-12 months. After one hour 
of cold ischemic storage, the uterine allograft was transplanted to six recipients using an aortic-aortal 
cavo-caval end-to-side anastomosis as practised in the experiments described above. An attempt was 
made to prevent both venous thrombo-embolism with administration of subcutaneous heparin. Dose 
used was 250IU and was given to the donor and recipient pre-operatively to prevent thrombosis. The 
same dose was given twice daily post-operatively. There was no mention however as to why those 
particular doses were chosen. All six rabbit recipients surgically survived the procedure. Immediate 
post-operative recovery was satisfactory in all six recipients. Demise was for the following reasons: 
three recipients developed non-resolving post-operative paraplegia and were killed on days two, three 
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and four post-operatively. Limb paraplegia was as a result of poor positioning of the hind legs and 
thus insufficient support to the spinal curvature in the supine position for a prolonged operative time. 
It was independent of surgical technique. Two recipients died unexpectedly on days two and three 
post-operatively. Post-mortem demonstrated a pulmonary embolus in both case. The final rabbit died 
of an intra-peritoneal haemorrhage, as a result of poor haemostasis over the left horn anastomosis. 
Importantly for the macrovascular patch concept, all recipient uteri (horns and cavity) appeared viable 
with no evidence of graft vessel thromboses and thus patency of all graft vessels. The aorto-aortic and 
cavo-caval anastomotic sites showed no suggestion of any bleeding or leakage, even in the final 
recipient. The authors believed that the experiment proved the feasibility of allo-UTx using a 
macrovascular patch, in both anatomical and surgical terms. However, this may be perhaps a little 
pre-emptive for two reasons. First longest survival was four days post-operatively - therefore, no long 
term survival. Second, the vascular anastomosis part of the surgery has a tremendously steep learning 
curve, with success dependent on the skill and experience of the surgeon. In this case, the IVC and 
aorta anastomotic times varied considerably.102 Despite this the potential of a macrovascular model 
has been further enhanced - it has been attempted in a third small-animal model and it does work in 
the immediate post-operative period. 
 
The above experiment was repeated by the team, involving five allo-transplants in a rabbit model.108 
The aim was to see if: (i) a large vessel aortocaval vascular patch technique may bring about long-
term graft survival after allogeneic uterine transplantation (UTx) in a rabbit model; and (ii) fertility 
can be achieved following natural mating post-allogeneic UTx. The technique was the same as 
described above. Natural mating was attempted if long-term survival had been achieved. The main 
outcome measures were: (i) long-term recipient survival; (ii) long-term adequate uterine perfusion; 
and (iii) successful pregnancy post-UTx. All five recipient animals survived the surgery with 
satisfactory immediate postoperative recovery. Recipients 1, 2 and 4 died within the first 4 
postoperative days. Both long-term survivors failed to conceive following introduction of a proven 
male breeder despite evidence of mating. Necropsy at 9 and 11 months showed a lack of patency of 
uterine cornua at the point of anastomosis, albeit a small uterus in recipient 3 and a reddish brown 
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amorphous material at the site of the transplanted uterus in recipient 5. This further demonstrated the 
feasibility of uterine allotransplantation using a macrovascular patch technique, but could not 
demonstrate conception because of blocked cornua. To address this, the authors suitably proposed 
using embryo transfer techniques in order to achieve conception.108 
  
Ischaemia-reperfusion injury 
 
A number of different preservation solutions have been used in the three small-animal models; 
murine, rat and rabbit. A small number of studies has looked at the length of cold ischaemia that will 
still lead to a functionally and morphologically adequate uterine graft. Lee et al, as mentioned above, 
first discussed a microsurgical model involving a macrovascular patch to ensure adequate uterine graft 
perfusion. However, they do not report on the type of preservation solution used or on any ischaemic 
conditions. Despite this, it is reassuring to read that all their syngeneic grafts (n=24) demonstrated 
revascularisation for the first three months.70 It is worth reiterating that in a syngeneic model, 
thrombosis secondary to an immunological rejection reaction is not possible. Any damage is therefore 
as a result of surgical performance, ischaemia-reperfusion injury or post-operative inflammation. In 
the other rat syngeneic model, the uterus was flushed in situ with 2ml of cold heparinised Ringer 
Acetate supplemented with xylocaine and then 1ml of Perfadex.68 Cold ischemia and second warm 
ischemia lasted 60 and 90 minutes, respectively. The graft survival was 80% (n=12), with good 
healing shown as assessed by gross appearance and histology at different post-operative time points. 
Only mild oedema and neutrophil influx were noted.  
 
A syngeneic murine model was subjected to two different solutions by Racho El-Akouri et al.69,84 In 
the first example, the uterus was gently flushed to gently flush the specimen with 0.4-0.6ml of ice-
cold saline supplemented with heparin sulfate and xylocaine to expand vessels and prevent 
thrombosis. As is customary, one could see whether the donor uterus was properly perfused by 
evaluating that the uterus blanched and that clear liquid flowed through the incision of the IVC. The 
donor uterus was then stored in the ice-cold saline. The second half of the recipient cohort 
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demonstrated survival results of 71% and graft preservation of 87%, with average cold ischaemic 
times of about 35 minutes and second warm ischaemic time of 50 minutes. However, the study was 
not systematic in that it did not assess cold ischaemic preservation strategically. No time intervals 
were used to assess what may be the maximum amount of time that a graft should be preserved in 
cold solution between donor retrieval and a recipient transplant. The second example did try to answer 
this question. It also involved flushing with ice-cold saline supplemented with heparin sulphate and 
xylocaine to empty the organ from blood. However this time a proper preservation solution (UW 
solution) was used for further flushing and subsequent graft immersion in the solution at 4°C for 24-
72 hours prior to transplantation.84 Per usual, graft viability was assessed by evaluation of morphology 
and contractility in vitro, which after 24, 48 and 72 hours of storage in UW solution revealed a 
relatively high tolerance of the murine uterus to cold ischaemic preservation. Normal morphology was 
seen at 24 hours, with minimal degenerative changes seen after 48 hours. Both spontaneous and 
stimulated contractions using prostaglandin were witnessed after 24 and 48 hours. At two weeks 
following the transplant, blood flow and morphology were normal, with no necrosis in only those 
uteri that were preserved for only 24 hours. This two week ‘rest’ period is advisable; it allows for 
graft and recipient recovery from the effects of inflammatory trauma brought on by the surgery. The 
functionality of these 24 hour preserved uteri was further demonstrated when five out of the six mice 
developed pregnancies after embryo transfer, with offspring showing normal weight and growth 
trajectory.84 This study was the first to demonstrate that a transplanted uterus may carry a pregnancy 
despite undergoing 24 hours of cold ischaemia when preserved in UW solution.  
 
In the rat utero-tubal-ovarian allotransplant model described by Jiga et al, the chosen flushing fluid 
was Ringer solution again.71 Cold ischaemia time did not differ greatly to previous attempts (~30 
minutes), whereas the second warm ischaemia period lasted around 60 minutes. As this was an 
allotransplant, 76% of the grafts were thrombosed at 72 hours as a result of acute rejection. Again this 
study did not try to answer the question as to what is the maximum cold ischaemic time possible, and 
the allo-nature of the transplant gives us an obvious cause of the thrombosis.  
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It was the Brannstrom team that again attempted to quantify specifically the relationship between 
ischaemia and uterine graft damage.109 This time their focus was on the second warm ischaemia 
period. This period is likely to be time consuming, involving pelvic vascular anastomosis. The 
predicted number of such anastomoses is four, two on each side. Therefore how the uterine graft 
responds during a warm ischaemic period that may be lengthy if the duration of achieving adequate 
anastomosis is prolonged is of interest. The aim of the study was to assess the viability of the 
transplanted rat uterus after exposure to the second warm ischaemic period, in order to mimic a time 
frame likely to occur in a human situation following UTx.109 There is no record in literature of an 
experimental UTx study trying to analyse the consequences of warm ischaemia on graft survival. The 
surgery was performed as described previously.69,84,103-105 Pseudopregnant rats were randomly 
allocated into two intervention groups: a standardized syngeneic UTx procedure (control; n = 10) with 
a minimized warm ischaemic period and a modified UTx protocol with a four hour extended period of 
warm ischaemia (n = 10).The graft was flushed through the common iliac artery with 2ml of cold 
(4°C) Perfadex preservation solution, supplemented with xylocaine and heparin, followed by storage 
in the Perfadex solution. After flushing, the graft was initially kept in cold (4◦C) Perfadex during 
preparation of the recipient. Cold ischaemia time was 120 minutes in both groups. As predicted, the 
group undergoing four hours of warm ischaemia demonstrated obvious signs of necrosis in five of 10 
animals compared with only one of 10 in the control group (examinations were performed on days 3 
and 6). The same pattern was demonstrated when evaluating gross morphology scores, with the 
control group faring much better. Surgical findings (colour, consistency, texture, oedema, patency, 
myometrial bleeding, adhesions, and laparotomy scar) correlated with the above histopathological 
findings at inspections three and six days after surgery. Both the gross morphology and 
histopathological variables (the presence of neutrophils, oedema, vasoconstriction, thrombosis, loss of 
endometrial/glandular integrity, haemorrhage and necrosis) were measured using two different 
validated scales. One can see how the avoidance of long warm ischaemic periods above five hours is a 
requirement as otherwise it can have a detrimental effect on the survival of the transplanted uteri. An 
interesting fact is that once you excluded the grafts that had necrosed by day three, the remaining 
‘warm ischaemia’ had a similar total score on day six to the control group. This may be an important 
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finding, whereby those grafts which survive the initial post-ischaemic period should normalize 
morphologically, with functionality still to be tested.109 
 
The two UTx studies in a rabbit model did not focus on the relationship between the level of 
ischaemia-reperfusion injury and graft functionality. However the preservation solution is described 
in both. Confino et al performed a non-vascular autoUTx in the rabbit where the graft was washed ex 
vivo in 37°C lactated Ringers solution.106 Cold ischaemic and warm ischaemic times were not 
reported. Around 75% of the autotransplanted organs were preserved. No scale was used to 
differentiate between the deleterious effects of ischaemia and reperfusion, and acute rejection.106 
Sieunarine et al stored the graft for 1 hour in the transplant storage solution, Celsior, between 2°C and 
8°C while the recipient doe was being prepared.102 In all six recipients, histological analyses showed 
viable transplanted uterine graft tissue throughout with patency of the graft vessels. However, the 
rabbits survived between 1-4 days only and any extrapolation beyond would not be accurate. 
Furthermore, no validated scale was used to try and assess the level of viability of the graft. In 
addition, this was an allogeneic transplant, and again, there is no attempt to measure whether any graft 
tissue has been rejected and whether any damage is as a result of ischaemia or rejection.102 
 
The major limitation of all the above studies is the modest sample sizes. Also only two studies looked 
at the area of ischaemia-reperfusion specifically. However it must be acknowledged that UTx is a 
time-consuming and exhausting procedure both with regards to planning and performing. Also, 
differences do exist between the human uterus and that of the mouse, rat, or rabbit, a fact which 
should be highlighted prior to extrapolating any of these results to possible human attempts. Later 
chapters will discuss the effects of ischaemia and reperfusion in large animal and human models.  
 
Immunology of UTx 
 
The process of rejection in allogeneic UTx was first described by two studies in 1969.59,110 UTx was 
performed in dogs in both instances. Two further sets of experiments carried out a year later looked at 
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the use of azathioprine and cortisone to mediate graft rejection (in dogs).53,58 Rejection occurred in all 
four cases, both with vascular 53,59,110,111 and avascular UTx.58 Endometrium was the primary layer to 
fail. Classic rejection signs were described i.e. haemorrhage, patchy necrosis, intravascular 
thrombosis and features of inflammation: oedema, erythema, and increased temperature reported on 
the fourth post-transplant day. The therapeutic potential of azathioprine and steroid was also 
demonstrated with the level of rejection appearing non-uniform and seen even on the 49th post-
operative day.59 In 1971, Scott et al also reported allogeneic UTx in a non-human primate. The grafts 
were received following sub-total hysterectomy and full rejection was reported on day 14 post-
transplant.67  
 
The first UTx study to be published after the implementation of CsA in practice was by Confino et al 
in 1986.106 As described above, this was the first example of allogeneic UTx in a rabbit model. The 
originality of the experiment comes from its attempt to transplant the uterus using a non-vascular 
method. Exploration of the rejection response to the uterine graft was not the aim. However the results 
were reported and are useful. Ten allogeneic transplants were performed, of which only six recipients 
were treated with CsA. Four were not given any immunosuppression and all revealed rejection, 
supporting the already established hypothesis that a uterine graft behaves in a similar manner to the 
kidney, liver and cardiac grafts. The uterus was transplanted in an avascular manner, with both the 
endometrial and myometrial layers surviving for 4 weeks on CsA (the only immunosuppressant 
administered). However, out of the four recipients that survived a month of follow-up, 75% cases 
developed pelvic abscesses. This negative aspect of using immunosuppression with UTx was rightly 
reported by Confino et al as a concept that will need addressing in future allogeneic models.106,112 
 
Jiga et al were the first team to actively attempt to study graft rejection following allogeneic UTx.71 
Allogeneic utero-tubal-ovarian transplantation was performed in 15 rats and the time course of graft 
rejection was studied. After 72 h, the anastomosis sites were thrombosed in 76% of the grafts and the 
uteri were necrotic. Early thrombosis was seen in the capillary bed, which then progressed to occlude 
the larger vessels as well as the anastomotic sties. Such a pattern of rapid failure may be a result of 
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both a poor anastomotic site and an uncontrolled rejection response, a conclusion elaborated on by the 
authors. The other two examples of allogeneic en bloc uterus-oviduct-ovarian transplantation also 
stated that severe rejection occurred within 72 hours.70,113 The importance of studying the early 
rejection response mechanism, which leads to early endothelial destruction and thrombosis of 
capillary vessels, was also made.  
 
Brannstrom’s group has performed a set of highly useful experiments using the murine model in 
attempt to characterise the rejection response. The mouse is a suitable research model for 
immunological studies because of the ease of creating inbred and gene deleted strains. In 2006, the 
team published the results of a study aiming to characterize the time course of rejection within the 
first 28 post-operative days in a fully allogeneic mouse UTx model. Mice of the BALB/c strain were 
used as donors and mice of the C57BL/6 strain as recipients. C57BL/6 mice were the recipients 
because this strain is the background strain used in the development of most knockout and transgenic 
mice. The MHC complex of the mouse, H-2, has its genetic loci on chromosome 17 and is 
homologous to HLA. The H-2 haplotypes of BALB/c and C57BL/6 mice are termed H-2d and H-2b 
respectively and demonstrate dissimilarity in all alleles except one. Therefore, the equivalent human 
model for the allogeneicity of this model would be a MHC mismatch at both major and minor loci 
between the human donor and recipient. The surgical methodology has already been described 
above.69,84 The cervix of the graft was exteriorized through the abdomen and sutured to the skin to 
create a stoma, thus allowing for a non-invasive assessment of the viability of the graft and level of 
rejection using biopsies. The rejection response was monitored using the following parameters: 
uterine blood flow using laser Doppler flowmetry, macroscopic and histopathological appearance of 
the graft, and density of T lymphocytes during the post-operative period using immunohistochemistry. 
32 out of 63 recipients had to be excluded as a result of post-operative complications, thus further 
supporting the conclusions from previous studies relating to the technical difficulties of the 
macrovascular patch model faced by the surgeons. Hyperacute rejection was not the cause of 
immediate death since a similar portion of mice with unsuccessful grafts was seen in the previous 
syngeneic study.69 Early signs of rejection were noticed from day 2 to day 5. Minimal inflammatory 
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changes were seen from day 5 and massive inflammation and thus severe rejection were seen from 
day 10 to day 15. By day 28, the graft was fully rejected with massive necrosis and fibrosis visualised. 
Microscopically, the density of CD3+ T-cells was increased in the grafted uterus from day 2 in the 
myometrium and from day 5 in the endometrium. Blood flow in the grafted uteri was reduced from 
day 15. The study on the whole is the first such attempt at characterising the rejection response post-
UTx. This has been done rigorously, using an appropriate number of mice (n=29). A murine study 
model for the characterisation of rejection post-UTx has also been defined. The conclusions are 
appropriate.  
 
In addition, Brannstrom’s work demonstrated that exploring immunological issues specific to UTx is 
more valuable than simply relying on evidence from renal, liver and cardiac transplants. This is for 
two reasons. First, each specific types of transplanted organ will affect the rejection process 
differently. Results reported by El-Akouri et al that correspond to severe acute rejection are similar to 
those of cardiac allografts at days 8-15, suggesting an immunological similarity between the heart and 
uterus.53,114,115 Therefore, rejection mechanisms as shown by markers in the recipients’ blood 
recipients are different depending on the type of tissue/organ involved. In addition to the similar 
timing of the rejection phases as with the murine cardiac transplants, no spontaneous acceptance of 
the uterus was seen. With transplanted murine liver and kidneys, the opposite occurs - spontaneous 
acceptance is the case.114 Second, from the histological examination, endometrial and myometrial 
layers differ significantly during the rejection process. Endometrial rejection appears to be more rapid 
than myometrial, with earlier lymphocyte infiltration seen in the endometrial glands. Furthermore, the 
myometrium had the greatest resistance to rejection and retained its tissue structure for the longest 
time.116 This pattern was already seen in the canine allo-UTx experiments described previously.53,58 
This can be explained by the ‘Dr Jekyll/Mr Hyde’ role played by the endometrium: it defends the 
uterus from various pathogens while simultaneously, offering immunological tolerance to semen and 
the early embryo/fetus. Therefore, the uterus is a very different organ immunologically when 
compared to other transplant organs. 
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The same group followed up the above study by evaluating the effect of CsA in a mouse UTx model, 
the first time such a study had been designed. The effect of CsA varies with different species despite 
the conservation of the CsA signalling pathway as a result of evolution.117,118 The dose required varies 
as does the immunosuppressive duration period based on the type of allograft. For example, 
immunosuppression can be completely halted in certain liver transplants which is not the case with 
kidney or heart transplants.117 Therefore the aim of this original study was to evaluate the effect of the 
immunosuppressant CsA on the rejection of the allotransplanted uterus in the mouse. CsA was neatly 
administered to three groups of uterine graft recipient mice: (a) positive control - no CsA (n=5); (b) 
dose: 10mg/kg (n=5); and (c) dose: 20mg/kg (n=5). Three recipients were syngeneic and acted as 
negative controls. The numbers in each group may be a low, but two different doses are compared. 
Also, two control groups were used; one to ensure a rejection response does occur between the donor 
and recipient strains and the other group to ensure that no rejection occurs if the mice are syngeneic. 
Both actions (dose and controls) are to be commended. All mice were culled on day 10 post-UTx. 
Grafted uteri were examined for gross appearance and biopsies were taken for histology and 
quantification of T cells using immunohistochemistry. Necrosis was seen in all recipient mice, but to a 
lesser extent in the CsA mice as expected. Those mice administered the higher dose (20mg/kg) 
showed the least rejection, with suppression of apoptosis and inflammation. The authors’ conclusion 
that CsA, at does given, delayed the progress of rejection of grafted uteri but suppressed T cell 
infiltration insufficiently is suitable. Furthermore, the morphological and histological signs of graft 
rejection were not reduced suggesting that if long-term graft survival is to be achieved, either CsA 
should be administered at higher doses or it should be used in combination with other 
immunosuppressive agents. This point was correctly highlighted by the authors. With respect to the 
cellular response, CD4+ count was increased in all groups without a significant difference between 
them. However, the CD8+ count was higher in the mice receiving CsA as opposed to the non-CsA 
recipient mice. This observation is important and the authors’ do provide an appropriate explanation.  
They hypothesised that the CD8+ increase was secondary to a CsA-dependent depression of 
activation induced cell death (AICD) of  the activated and alloreactive CD8+ T cells. Cebecauer et al 
supported this theory in their study whereby soluble major histocompatibility complex–peptide 
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complexes failed to do induce rapid AICD in the presence of CsA, even though the opposite was seen 
in vitro.117,119 The authors also suggested that those CD8+ cells that avoided cell death need to be 
investigated in order to see whether they have retained their cytotoxic activity or instead produce 
cytokines that promote rejection by modes other than CD8+ cytotoxicity.117  
 
The next experiment by the Brannstrom group continued this pattern of original and highly 
enlightening work. Following on from the above two studies that assessed the time course of acute 
rejection as well as the correct CsA dose, this study aimed to explore exactly which leucocyte  
populations were responsible for bringing about the rejection response to an allogeneic uterus 
transplant.120 By characterising the rejection response in this manner, the immunosuppression regimen 
could then be specifically tailored to control rejection. Again, as the two studies above, this was an 
original study, answering a question that had not been looked at before: ‘What is the character of the 
acute rejection response?’. The surgery has been described before.69 The graft was placed in a 
heterotopic position, with the native uterus left in situ to act as a control. The plan to remove both 
uteri on post-UTx day 2 (n=5), day 5 (n=5) and day 10 (n=6) is fitting. Immunohistochemistry was 
carried out for neutrophilic granulocytes, macrophages, cytotoxic CD8+ T-cells, CD4+ T-helper cells 
and B-cells. The authors explained how this allogeneic model corresponds to a human situation. First,  
the MHC of the mouse H-2 is homologous to HLA in the human.121 Second, the two strains used here 
showed dissimilarity in all alleles except that of the q locus, which is the human equivalent of 
difference at both major and minor MHC loci.120 The decision to evaluate cellular density in both 
myometrium and endometrium is useful, because of the immunological differences of the two layers. 
The endometrium is more susceptible to infection as it has external contact and also needs to accept a 
semi-allogeneic embryo. The main conclusion that predominately neutrophils, macrophages, and 
CD+4/CD+8 T cells were responsible for acute rejection of the allogeneic murine uterine transplant 
between days two and day five appears correct. Primarily, the main leucocytes that invade the graft 
are macrophages and neutrophils. The former are found in the myometrium at day 2 and in the 
endometrium at day five, and the latter at day five in the myometrium. CD8+ cells are also present at 
day two and increase in density by day five; this day two to five increase is not reproduced with CD4+ 
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cells. T cells are the most abundant of the leucocytes. CD19+ B-cell density was low throughout, with 
no time-dependent changes in the myometrial or endometrial layers.120 Therefore, as with the previous 
study, the results here suggest that a potential immunosuppressive regimen for UTx should include 
both a calcineurin inhibitor and a steroid. The authors definitely offered both a time- and site-specific 
description of the infiltration of particular leukocyte subtypes during acute rejection of a mouse 
uterine allograft. 
 
Two very recent studies by the Brannstrom team focused specifically and in more detail on the effects 
of calcineurin inhibitors on the acute rejection response.122,123 This was an extension on the above 
study focusing on CsA,122 with an additional experiment broadening the knowledge of UTx-related 
research to include other types of calcineurin inhibitors (tacrolimus).123 Both studies were 
enlightening, as they reported on the cytokine effect during acute rejection, a previously unknown 
area of uterine graft rejection. Furthermore, the chosen model was a rat model. In the CsA study, a 
total of 23 rats received a uterine graft, transplanted in an orthotopic position. In 16 recipients, the 
graft appeared healthy at inspection on the second post-operative day. The recipients were given CsA 
(10 mg/kg) once daily or no CsA until they were sacrificed on day seven post-UTx. As usual with the 
Brannstrom group, controls were used - syngeneic transplanted Lewis rats. In addition to 
immunohistochemistry and light microscopy, the following additional markers were measured: 
mRNA levels of the implantation/inflammation-related markers leukaemia inhibitory factor (LIF), 
galectin-1, CD200, interleukin (IL)-1a, and IL-15. To date, no such study has been attempted. As with 
the previous CsA study, CsA decreased the level of inflammation initially as well as the CD8+ count 
and mRNA levels of IL-1. The mRNA levels of galectin-1 and IL-15, two agents responsible for 
immunosuppression and immunotolerance respectively were lower in the non-CsA-treated mice. 
There was no difference between the groups concerning mRNA levels of CD200, or LIF, the latter 
result of importance as the LIF is essential for maintaining pregnancy. The authors’ conclusion that 
CsA administration suppresses rejection-associated graft inflammation is apt. The real benefit of this 
study is however the results and therefore conclusions relevant to other immunological mediators. 
CsA appeared to normalise the expression of some mediators that may have further influence on 
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allograft survival but also on pregnancy potential which is of particular value.122 The other study had 
the same aims (investigate whether tacrolimus therapy may prevent rejection and gage the effects on 
the uterine expression of markers related to inflammation and implantation) and also used a rat 
model.123 The only difference was in the calcineurin inhibit used - tacrolimus. The rats were culled on 
day 14. The tacrolimus effect was synonymous with CsA, with rejection and T-lymphocyte 
infiltration suppressed and expression of IL-1 and IP-10 normalized. The author also correctly 
recognised the need for future tests to focus on the effect of calcineurin inhibitors on pregnancy in an 
allogeneic uterine graft.123 
 
Deciding on the correct type of immunosuppressant also depends on the effect of that 
immunosuppressant on the fertility hormones (oestrogen and progesterone) which are required to 
sustain and ‘nourish’ a pregnancy. CsA may be a powerful and effective drug to inhibit T cell 
mediated immunity and thus the rejection response, but may be deleterious to both the mother (renal 
toxicity) and the fetus. Furthermore, immunosuppression in general has a potent role in ensuring graft 
survival yet it can cause greater morbidity for the recipient in question. The down-regulation of the 
immune system renders that individual at risk of Epstein-Barr Virus-induced lymphoid tumours and 
opportunistic fungal, viral and bacterial infections.  
 
The next study by the Brannstrom group was again ‘a literature- first’ study assessing reproductive 
health in animals exposed to immunosuppressive drugs (CsA) in utero.124 This is because little is 
known about the effects of intrauterine exposure to CsA in the growing and adult offspring, and in 
particular how CsA may affect reproduction. The study itself was well thought out with careful 
analysis of blood CsA concentrations, pregnancy variables (implantation and resorption rates, and 
fetal weights) and fertility potential of the offspring. To assess the latter, both female and male 
offspring were mated to partners that did not encounter CsA in utero, with subsequent analysis of 
pregnancy outcomes. Female mice were exposed to different doses of CsA from one week before 
mating and throughout pregnancy [0 mg/kg/day - n=10; 10 mg/kg/day (n=10), 20mg/kg/day - n=10) 
and 30mg/kg/day - n=9). The choice of CsA dose is sound, with a good variation and follows on from 
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previous studies. Number of mice per group is also suitable. The animals were euthanized on day 18 
(gestational age for a mouse is around 21 days). CsA blood concentrations (before and during 
pregnancy), mating frequency, implantation rate, intrauterine deaths of fetuses and fetal weights were 
recorded on the day of euthanasia. Their results demonstrated that direct maternal and in utero 
exposure to high doses of CsA reduced implantation rates, fetal survival and adolescent growth but 
importantly did not affect offspring fertility. Offspring birthweight was also negatively affected. This 
negative correlation was dose-dependent, with higher doses exhibiting a more pronounced negative 
effect. These results are of particular relevance to UTx research as immunosuppression will be the key 
factor to implantation; however one criticism of the study is that it did not involve a UTx group in 
addition to the other groups.  
 
The reduced implantation rates have been reported in previous similar experiments involving murine 
models,125,126 suggesting that CsA can affect the endometrium or decidua in a negative way. In fact 
there is evidence which reveals a possible link between CsA and suboptimal ovarian function, as a 
result of hindrance to sex steroid secretion at the time of ovulation.127,128 This in turn leads to issues 
with conception which tends to occur at the time of ovulation. The endometrial layer depends on the 
sex steroids for its maintenance and if their secretion is impaired, the lining is also dysfunctional. 
Conception, as a result, is impaired, an effect even more pronounced as a result of the negative role 
CsA plays in both T cell and NK cell activation.129  
 
Interestingly, when organ transplantation is performed after long-term organ failure and is deemed 
successful, it results in the restoration of normal endocrine function.127 Ovarian and menstrual 
function is usually restored in both renal and liver transplanted women within an average of six to ten 
months.130-132 The hypothalamus-pituitary-ovary axis in a transplant patient is thought to be 
functioning as normally as it would in a non-transplant female, with serum gonadotrophin and 
prolactin levels very similar in the two groups.129 Higher levels of oestradiol are reported in renal graft 
patients in comparison to non-transplant women.133 This bodes well for a potential future uterine graft 
recipient who would need an unaltered and healthy reproductive function to sustain the pregnancy. 
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There are reports of the decreased levels of libido secondary to a fall in testosterone secondary to 
steroid use, but this would be inconsequential to an established in utero pregnancy.129 
 
Pregnancy 
 
The holy grail of UTx is a live birth of a healthy neonate following allogeneic UTx (Figure E). 
Embryo transfer techniques should be used to transport the already formed embryos into the uterine 
graft after transplantation in order to exclude any events which might compromise the graft. For 
example, it is likely that natural conception would not occur as the Fallopian tubes would not be 
functional and if it did occur, it could lead to intra-/extra-uterine ectopic and tubal miscarriages. Some 
propose that the Fallopian tubes should not be transplanted as part of an UTx.65,104 
 
The Brannstrom group has described five examples (three murine and two rat models) of successful 
pregnancy post-UTx. The first example in 2002 consisted of a syngeneic transplantation of the right 
uterine horn and cervix, with the native uterus remaining in situ and subsequent successful fertility 
following blastocyst transfer and implantation in a single mouse model. The mouse was 8 weeks old, 
with the embryo transfer occurring one week post-UTx. The protocol for blastocyst production and 
retrieval was sound, with six blastocysts retrieved from a naturally mated B6 CBAF1 female. This 
was done only following the visualisation of a vaginal plug. Three blastocysts were transferred to the 
native uterus and three were placed into the transplanted graft, using the protocol described by Hogan 
et al.134 The technique was a standard embryo transfer technique involving the insertion of a glass 
pipette through a hole in the uterine wall made by a 30 gauge needle. This was done following the 
‘preparation’ of the female i.e. three days after the mouse was mated with a male. Number of fetuses 
present were counted ten days following embryo transfer when the mouse was killed. The native 
uterus had three fetuses present whereas the transplanted uterus had one fetus present, and one 
absorbed pregnancy. Fetal weights were similar to that of fetuses in the native uterus and controls. 
This proved, for the first time, the concept of pregnancy following a uterine transplant in a non- 
autotransplant model. The only other pregnancy recorded following UTx was in an autotransplant 
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model, where three out of 18 pregnancies were achieved in female dogs.56 An attempt in only 
onemouse means that it is difficult to make any conclusions relevant to the actual fetuses, but it does 
allow one to base further experiments specifically focusing on the pregnancy aspect of UTx. The aim 
 
 
Figure E Pregnancy and Uterine Transplantation.2 The goal of UTx is to achieve pregnancy 
and the birth of a healthy term infant.  With regards to pregnancy following organ transplantation, 
evidence has slowly been gathered (McKay and Josephson). Pregnancy following allogeneic UTx 
exists only in small animal models. The effect of pregnancy on both the fetus and the mother 
following UTx is an unknown quantity. 
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of the authors was to assess the macrovascular anastomotic model previously described; the 
pregnancy experiment was a secondary aim.69  
 
The second example of pregnancy post-UTx was in fact a pregnancy-related study.105 It was an 
extension of the above study with the focus on pregnancy-related factors. UTx was performed in a 
syngeneic mouse model that used a macrovascular anastomosis concept to ensure uterine perfusion. 
Embryos were transferred 1-3 weeks post-UTx in both the transplanted and native uteri. The embryo 
preparation was no different to standard mouse protocols.134 Embryos were also transferred to a 
control group of non-transplanted 8- to 10-week-old B6CBAF1 female mice. Three to six blastocysts 
were transferred to the lumen of each of the grafted and native uteri, and non-transplanted uteri on 
days 3-4 of the pseudo-pregnancy. The method was the same as described in the above study.69,105 
Three sets of experiments were then performed. In the first set, pregnancies were followed up to day 
18 of pregnancy. In the second set, pregnancy was continued until term as the aim was to assess post-
natal development of the offspring. The offspring were divided into three groups, offspring from: (a) 
non-transplanted mice (control group); (b) native uteri of UTx-mice; and (c) grafted uteri of UTx-
mice. The weight of the offspring was then continuously measured until eight weeks of age. The third 
and final set of experiments looked at the fertility of the offspring. 19 mice received a transplanted 
uterus. Out of those, 12 had viable grafts and thus received an embryo. Pregnancies were found in 
nine of 12 native uteri of transplanted mice and in those nine, eight also had fetuses within the 
transplanted uterus. With respect to he controls, eight out of 13 mice were pregnant. The numbers for 
resorbed pregnancies were respectively, one, two and four. The lengths and weights of the fetuses, as 
well as weights of the placentae, were similar in pregnancies in native, grafted and the ‘control’ uteri. 
The placental aspect should be highlighted as the data may be extrapolated to the human model. 
Major similarities exist between mice and humans (and primates in general) with regard to 
placentation.105,135 For example, the terminal blood space is not lined with endothelial cells, but with 
trophoblast cells. Also, retrograde intra-arterial trophoblast migration occurs in both species. In this 
experiment, UTx did not compromise placental development. Offspring from all three groups 
followed a similar post-natal growth pattern until eight weeks of age. They were then tested to see if 
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they could continue the progeny. Both female and male offspring proved to be fertile and the pups 
reported birth weights within the normal range. Therefore, the experiments demonstrated similar 
implantation and pregnancy rates, as well as birthweight and growth curves (8 weeks) between the 
native and transplanted (syngeneic) uteri. The second-generation offspring from transplanted animals 
were all fertile with normal birth weights.105  The study was an extension of their previous study 69 
which further confirmed the concept that a UTx model which is not an autotransplant, in this case a 
syngeneic model, can result in pregnancy. It is also the first study in which the ability of a 
transplanted uterus to implant inserted blastocysts and to carry a pregnancy has been truly evaluated. 
It was reassuring to have a control group with results that demonstrated no significant difference to 
both the ‘native uteri’ and ‘grafted uteri’. The offspring exhibited normal patterns of development and 
weight increase and future fertility was not compromised.105  
 
In the same year, Racho El-Akouri et al performed studies assessing the effect of cold ischaemic 
storage on post-UTx pregnancy.84 Using the same methodology as described in the experiments 
above, embryos were transferred into six mice (two weeks post-UTx) where the transplanted uteri 
(right uterine horn and cervix) had been preserved for 24 hours in University of Wisconsin solution. 
Five recipient mice fell pregnant and all five gave rise to offspring from the transplanted uterus. In 
total 25 pups were live born; 20 survived through the first day. Eight pups born from native and seven 
from graft uteri were weighed at regular intervals up to 8 weeks of age. The two groups of animals 
followed normal weights and growth trajectories.84 Again, this study did not differ from the two 
above. The model was murine and syngeneic, the graft was made up of a right uterine horn and cervix 
and anastomosis was macrovascular involving an AA- IVC end-to-side anastomosis. The numbers 
were smaller than the previous study (six recipients received an embryo transfer only)105 but here we 
had the novel factor of a pregnancy attempt post-storage in a preservation solution for 24 hours. 
Therefore, achieving pregnancy in this case was a further proof of functionality of a grafted uterus, 
following both a transplant operation and subsequent 24 hour storage in cold ischaemic conditions. 
Both experiments mimic what would happen in a human attempt.  
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However, the above murine experiments still differ somewhat from a human model. Three areas in 
particular are immediately obvious: gestational lengths, no immunological rejection mechanisms to 
consider and anatomical differences. The following experiments tried to counter some of these 
differences. In October of 2010, the Brannstrom group described the first recorded pregnancy in an 
allogeneic uterine transplant (rat model). Three groups underwent a UTx-related procedure. The 
anastomosis was at the common iliac level. With regards to fertility, all groups were exposed to fertile 
males during one oestrous cycle between 35 and 38 days after surgery. The first group consisted of 
eight female rats that had undergone UTx and were immunosuppressed by tacrolimus. The second 
group underwent removal of only one uterine horn, with the five rats treated with an identical 
tacrolimus protocol, whereas the third group did not receive tacrolimus (n=6). Caesarean section was 
performed 17 days after initiation of the mating period. The pregnancy rates in groups I-III were 5/8, 
3/5, and 5/6 respectively. Median number of fetuses for a pregnant rat in each group were 1 [0–3], 1 
[1–5], and 3 [1–4] respectively. Four of the five pregnant mice that underwent UTx (group I) 
demonstrated resorption. Again like with the previous experiments, it would be easy to criticise 
certain aspects of the study. No control group is mentioned (i.e. non-transplanted rats with and 
without tacrolimus), the rejection response is not evaluated, with no assessment of the level of acute 
rejection of the graft, and there is no mention of whether the level of mismatch between donor and 
recipient was carried out. However, these were not the aims. The authors wanted to advance the 
concept of pregnancy post-UTx from a syngeneic model onto an allogeneic model and therefore bring 
the field of UTx closer to what may happen in a human experiment. In this they succeeded. Even 
though, no live pregnancies were recorded, this experiment is a first time record of a pregnancy after 
allogeneic UTx. It is therefore a central proof of a concept that a uterus can function following its 
transplantation from a donor to a recipient and that it can do so under immunosuppression.104 
 
Their next experiment was also an advancement on the existing work - again a rat model, but with an 
attempt to bring about pregnancy following natural mating.103 Furthermore, the actual transplant was 
orthotopic for the first time i.e. the native uterus was removed and the graft was placed in lieu. Female 
Lewis rats underwent hysterectomy and received syngeneic uterine transplants (with one horn 
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removed). The uterine graft was placed in an orthotopic position i.e. in the pelvis with two tissue 
anastomoses: to the vagina and the upper part of the native uterine horn. The anastomosis was end-to-
side between the common iliac vessels of the recipient and the graft. Control rats had only one uterine 
horn removed. The aim was to compare a number of outcomes: mating and pregnancy frequencies, 
successful deliveries and offspring weight and development trajectories. 19 out of 27 recipients 
survived the surgery or the immediate post-operative period. The overall pregnancy rates after 
introduction to male rats were comparable in UTx (11/19; 58%) and control (12/19; 63%) rats. From 
the UTx rat, only one rat delivered two healthy male pups. Two other UTx rats gave birth to at least 
two pups each but committed infanticide prior to the offspring count. The remaining four UTx rats 
experienced stillbirth, with signs of distress at birth. Dead pups of full-term size were found in both 
the recipient vagina and in the common cavity and right uterine horn. The weight and development 
outcomes post-birth for the two surviving male rat pups from the one UTx rat were similar to the 
control rat offspring (32 live born pups). The main differences between the UTx and control groups 
were the increased number of resorptions and decreased number of successful deliveries in the former 
group. Thus, some unknown factor is compromising fetal wellbeing post-UTx, most likely blood flow 
or denervation. In the control group, no nerve manipulation occurred and there were no issues with 
labour. Also vaginal scarring at the anastomosis may cause a synthetic obstruction to the labour 
pathway. Obviously in future models, both animal and human, elective Caesarean section would 
remove these obstacles. In conclusion, this model may be reproduced to assess fertility outcomes 
following allogeneic UTx and ensuing natural mating. The study demonstrates that conception by 
natural mating, and subsequent pregnancy, and birth of live and healthy offspring is possible with 
orthotopic, syngeneic UTx.103  
 
Similarly to other solid-organ transplants, the most pronounced effect of the graft on the fetus will be 
indirect, i.e. via the immunosuppressants that must be administered to the recipient. The idea of using 
immunosuppressive drugs to curb rejection was first suggested by Sir Peter Brian Medawar while he 
was working for the National Institute for Medical Research. He made significant in-roads in the 
1940s in understanding the mechanism behind rejection. Today, immunosuppressants are routinely 
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used after transplantation to minimize the risk of rejection. However, long-term use has its drawbacks, 
mainly the risk of recurrent infections and neoplastic disease, as well as necessary close and 
meticulous medical care.136 UTx would be short term i.e. 1-2 years thus avoiding this risk.  Once the 
uterus and immunosuppressants are removed, any associated neoplasm risk should theoretically return 
to baseline. Many transplant related lymphomas are known to regress after removal of the graft.  
 
Nevertheless, care is taken with the type, dose and monitoring of immunosuppressants prescribed as 
they can cross the human placental barrier and enter the fetal circulation, possibly affecting the 
immune system of the fetus.137 Medications used to suppress immunologic activity include 
glucocorticoids, nonsteroidal anti-inflammatory drugs (NSAIDs), and the antifolate medication 
(methotrexate). In addition, cytokine modulators (CsA: CsA), purine-related medication (analogues: 
azathioprine and 6-mercaptopurine; purine synthesis inhibitor: mycophenolate mofetil), alkylating 
agents (cyclophosphamide and chlorambucil), biologic response modifiers (TNF antagonists) and 
intravenous immunoglobulin are used.138 With pregnant patients, a selected number of available 
immunosuppressants have been stratified into categories, depending on the level of risk that the 
immunosuppressant poses on the fetus (Table B).  
 
McKay and Josephson have summarised the outcomes of approximately 14000 post-transplantation 
live births since the first birth to a transplant recipient occurred in 1963.139 Therefore, the stratification 
of immunosuppressants is necessary as observations on post-transplant pregnancies indicate a higher 
incidence of preterm deliveries, low birth weights, and maternal hypertension but no increased rate of 
structural malformations.140-143 
 
As succinctly reported by Framarino dei Malatesta et al, hypertension and pre-eclampsia with 
premature membrane rupture are the main source of preterm delivery and low birth weight.140,144,145 
The pregnancy incidence of these three complications is related to the type of immunosuppressive 
agents prescribed: hypertension incidence varies between 22% and 29% with corticosteroids,146 68%  
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and 73% with CsA, and 47% and 54% with tacrolimus,147 pre-eclampsia on the other hand develops in 
approximately 30% of pregnant kidney or kidney-pancreas recipients, and 25% of liver, heart, or lung 
recipients.140,144,148,149  
 
With respect to the recipient of UTx, immunosuppression would only be a potential risk to her general 
health as long as the graft is within her pelvis. The plan is that the transplanted uterus will be 
surgically removed after the patient has completed one pregnancy, thus removing the need for 
immunosuppressants. 
 
Table B         Immunosuppressant risk categories according to US Food and Drug Administration 150  
Category Drug Animal / Human studies 
A Paracetamol No risk in human studies 
B Corticosteroids 
No risk in animal studies OR 
Risk in animal studies but that risk not demonstrated in 
human studies 
C 
Tacrolimus 
Rapamycin 
Cyclosporine A 
Mycophenolate Mofetil 
Fetal risk demonstrated in animal studies BUT no adequate 
and well-controlled studies in humans. 
Drugs can be used if potential benefits outweigh risks. 
D Azathioprine 
Fetal risk demonstrated in human studies. 
In exceptional circumstances, drugs can be used if potential 
benefits outweigh risks. 
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Nevertheless, we must acknowledge that long-term data on allograft loss, maternal survival after 
pregnancy (due to an increased risk of viral diseases and neoplasm secondary to 
immunosuppressants)151 and offspring outcomes of transplant recipients is rather limited. Despite 
several reports indicating no increase of congenital anomalies among the offspring of recipients,140,152 
long-term outcomes focusing on physical and mental development, and immunological and 
oncological pathologies later in life in these offspring is necessary.150 Unfortunately, currently, only 
one study has compared pregnancy outcomes in a single group of women before and after 
transplantation. It concluded that despite an initial increased risk for pre-eclampsia, growth restriction, 
pre-term birth, and the risk of miscarriage, the odds of these four outcomes were all statistically 
similar pre- and post-transplantation.153  
 
Theoretically, UTx in animal models could be used to further characterize immune related diseases 
such as recurrent pregnancy loss or immunologic PIH. In these models, an intact gravid uterus would 
be transplanted into a recipient. Or more likely, a pregnancy would be established after UTx into a 
recipient with a known disease propensity and studied for induced changes. In this way UTx could 
isolate ‘maternal versus fetal’ factors in a particular disease state.  
 
It is important to recognise that unfortunately pregnant transplant recipients cannot wait for long term 
results to clearly demonstrate superiority of one regimen over the other. This is especially a problem 
regarding pregnancy outcomes among transplant patients. Regardless if the pregnant transplant 
recipient has a kidney, heart, lung or uterus, it will be impossible to ensure safety to mother and fetus 
if the goal is a healthy child that matures to a healthy adult. 
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(b) Large-Animal Model 
 
Below is a description of the research performed using a porcine model and a sheep model, two of the 
most commonly used large animals.  
 
Porcine model 
 
As already explained in the chapter on trachelectomy, the development of ART served as a prelude to 
research into UTx. Initial concerns were about how adequate uterine perfusion may be achieved, 
whether the answer lay in uterine artery anastomosis and the subsequent function of these vessels in 
pregnancy. The first UTx related study in a porcine model was performed by Dr J. Richard Smith’s 
(head of UK Uterine Transplantation) team in the UK.154 It was an original, preliminary study to the 
possibility of UTx. The aim was not to actually perform a transplant but to see whether division and 
subsequent re-anastomosis of uterine vessels still allowed for normal uterine perfusion. The decision 
to attempt conception and pregnancy was suitable. Thus, the uterine arteries in two sows were divided 
and re-anastomosed. At six weeks, the sows including the control were inseminated. Pregnancy 
occurred and proceeded uneventfully, and all three sows farrowed normally with average litter sizes. 
Three months after delivery, the sows were killed, and post-mortem studies were undertaken. 
Histopathology of the uterine arteries revealed minimal intimal fibrosis across all anastomotic sites, 
with successful re-anastomoses of the uterine arteries accomplished in both study sows.  Thus, uterine 
artery anastomosis in the porcine model was shown to be feasible with subsequent normal vascular 
function in pregnancy of the anastomosed vessels. The expected ‘hour-glass effect’ at the anastomotic 
site did not compromise uterine function. Obviously, the number of sows used was particularly small 
(n=2) and this needs to be taken into account when discussing the conclusions.  
 
JR Smith et al next attempted to assess the feasibility of UTx in a porcine model by attempting 
autotransplantation of the uterine graft.155 Despite pre-1985 canine studies, as well as post-1985 small 
animal studies demonstrating that adequate perfusion of the graft could only be achieved via large 
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vessel anastomoses, the team wished to see whether microvascular anastomoses could work in a 
porcine and thus large animal model. The vessels in question were uterine. A supracervical 
hysterectomy was performed on eight sows of proven fertility. After one hour of cold storage in a 
transplant solution (ex vivo for one hour in University of Wisconsin/Celsior solution), the specimen 
was reintroduced, followed by stepwise vascular re-anastomosis. The use of objective perfusion index 
measurements to assess uterine perfusion added to the quality of the study. The results suggested 
adequate uterine perfusion after transplantation. Post-operatively, sow 1 survived to 3 months with no 
signs of oestrus, and sows 2, 6, and 8 were killed on days 6, 33, and 54, respectively, for pelvic 
infection. Histopathology of the uterine grafts revealed gradual vessel thromboses suggesting that 
microvascular re-anastomosis is unsuccessful in auto-UTx (and most likely in allo-UTx) because of 
gradual vessel thromboses. The advantage of using an autogeneic model was that the effects of 
immunological rejection could be removed, and therefore any conclusion was specifically related to 
the surgical techniques and the anastomotic model chosen. In this case, the anastomotic model that 
should be first choice is a large vessel model. In addition, the porcine model proved to be problematic 
for the authors as it is highly susceptible to post-operative infection.155 
 
The Brannstrom group also carried out a study, which further looked to develop the auto-transplant 
model in a pig.156 They added to existing literature by also evaluating the early reperfusion events 
after short-term cold ischaemia. The bicornuate uterus was dissected and removed from the pelvis, put 
in a sterile isolation bag and continuously flushed through the arterial cannulas with heparinised ice-
cold Ringer Acetate for a time period of between one and two hours. The uterus was then placed in its 
orthotopic pelvic position and the uterine arteries and veins were anastomosed end-to-end to their 
origin. Following re-anastomosis, the graft was reperfused for 100 minutes. Blood samples and tissue 
biopsies were taken in order to monitor reperfusion events and detect of ischaemia-reperfusion 
injuries. Number of auto-transplants performed was commendable (n=19). A novel criterion was 
introduced to judge how successful reperfusion of the auto-transplanted uteri was. The following 
parameters were applied: (i) blanching of the uterus during perfusion for cold ischemia; (ii) the 
colour-shift during reperfusion from the initial bluish appearance towards a more reddish colour, 
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typical for well-perfused and oxygenated tissue; (iii) adequate bleeding from the bed of uterine tissue 
when cut through the myometrium at the end of the experiment; and (iv) blood flow past the venous 
and arterial anastomosis sites at the end of the experiment by bisection of the vessels. However, only 
seven grafts could be appropriately flushed and those were kept for cold ischaemia. From these seven, 
only four grafts were felt to be well reperfused according to the above variables. At least two of these 
transplants were well re-perfused, with no severe ischaemia-reperfusion injuries following analysis of 
blood-gas and metabolite parameters and histology. Helpfully for future attempts, the authors 
described a useful technique alteration whereby the suture placement for the uterine vein anastomosis 
was changed from continuous to interrupted as the use of the former led to constriction and 
thrombosis.156  
 
The conclusions were well explained and important for future UTx research. First, the authors 
demonstrated that acceptable reperfusion can be achieved following uterine vessel re-anastomosis. 
Despite this, the success rate was low (~20%). The primary reasons were the large total size of the pig 
uterus with long uterine horns (~one metre) and the small size of the vessels available for re-
anastomosis, causing most likely thrombotic events within the uterus or markedly reduced flow 
through the sites of anastomosis. Also hindering the process was the large number of ligations of the 
internal iliac branches which would have inevitably led to microthromboses. The authors understood 
that the small calibre of the uterine vessels, and the resulting inadequate blood flow meant that 
technically, small-vessel anastomosis is not the way forward with regards to graft perfusion and UTx 
research in general. The answer lay in developing a large-vessel anastomotic model as in the small-
animals experiments described in the previous chapter, but not involving the great vessels. Finally, the 
authors did explain their reasons for choosing a porcine model. First it parallels well human anatomy 
and physiology. Second, the animal itself is relatively available and there are fewer ethical and 
economical considerations involved in its use in research compared to the use of rabbits, dogs, sheep 
or primates. Their final conclusion that the porcine model is a fairly difficult model for further studies 
on UTx is in total agreement with the Smith team.156 However, the statement that this was the ‘first 
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report ever on auto-transplantation of the pig uterus’ is false as the actual first study was Sieunarine et 
al, described above.155 
 
Avison et al completed an original work and to date the only allogeneic UTx in a porcine model. UTx 
was heterotopic, using genetically defined mini-pigs.157 The choice of immunosuppression was 
appropriate. Tacrolimus acted as an induction agent and was administered intravenously for the first 
12 days post-UTx. This was followed by oral CsA and methylprednisolone, which were used as 
maintenance immunosuppressants, and in higher doses to deal with rejection episodes. The authors 
detailed how they would monitor the rejection response. First, drug levels were measured by the 
application of tandem mass spectroscopy on human peripheral blood. Second, the actual graft was 
assessed by both endoscopy and biopsy. Finally, direct visualisation of the cervix and vaginal vault 
was made possible via exteriorization as a stoma in the lower right abdominal wall. In total ten 
transplants were performed, with five animals surviving for 6-12 months post-UTx. The anastomotic 
model was large-vessel, with an AA-AA and IVC-IVC end-to-side anastomosis. The authors correctly 
explained why they decided upon this, citing previous thrombosis when using small vessels. 
However, their decision not to perform a vaginal anastomosis is to be queried as this step should be 
part of the operation because it provides additional structural support to the graft within the pelvis. A 
cold preservation solution was used to minimise ischaemia-reperfusion injury. The aorta of the donor 
was cannulated above the level of the renal arteries for infusion of cold University of Wisconsin 
solution with the uterus preserved in it until completion of vascular anastomosis in the recipient. The 
team also defend their decision to perform a heterotopic transplant, citing clinical advantages relevant 
to avoidance of the pelvis which is frequently the site of pathology, previous surgeries, and radiation. 
However, an orthotopic transplant should still be the primary choice as the lower pelvis allows for 
natural growth of the uterus during pregnancy without interference with other organs such as bowel.157 
 
The five deaths were caused by pneumonia (n=1), intussusception of the graft (n=1), cardiorespiratory 
arrest during anaesthesia (n=1), and complications of the stoma (n=2). It is evident that the use of 
stoma in a porcine model was less than ideal with complications including stoma prolapse and 
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infection. The authors’ conclusion that the immunosuppression regimen proved to be effective in 
preventing rejection in the uterine transplants for a few weeks after the procedure is suitable. 
Although it is noted that induction immunosuppression was not sufficient and therefore, additional 
maintenance immunosuppression was required to maintain a rejection-free state in the transplanted 
graft. Despite the 50% early mortality rate as well as stoma-related complications, the actual model 
proved that UTx may be successful when using macrovascular anastomoses as long-term survival was 
50%. The conclusion that further studies are required to determine whether pregnancy is possible in 
allogeneic UTx model is appropriate. Finally, it is worth highlighting that the suitability of the porcine 
model was again (similarly to Sieunarine et al described above)155 brought into question. The main 
issue was the high susceptibility of the animal to ascending pelvic infection via the vagina or stomas 
because of its general state of cleanliness.157 
 
Ovine model 
 
A sheep model is particularly appropriate for UTx research and more suitable than a porcine model. 
Both the body and pelvic size is more equivalent to that of a woman, as well as the size and anatomy 
of the pelvic vasculature. UTx in a sheep model really commenced together with the main body of 
UTx-related research following the first human attempt in 2000. There are however reports of auto-
UTx in the 1970s involving a heterotopic grafting technique with vascular anastomosis to the carotid 
artery and jugular vein.158,159 
 
The first two studies involving a sheep model was by Wranning et al (Brannstrom group).68 The 
former involved an autogeneic model, whereby the aim was to study the effects of cold ischaemia and 
reperfusion after transplantation of the sheep uterus and to compare the preservation solution Perfadex 
with Ringer’s acetate. This was an important study carried out a time when UTx research in large 
animal models was at its early stage and there was limited data on the effects of cold ischemia and 
reperfusion injury on the transplanted graft. It is essential to ascertain the time limit of cold ischaemia 
and the degree of reperfusion injury that takes place after initiating circulation in the recipient. One 
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uterine horn with the common uterine cavity and cervix of sexually mature ewes was auto-
transplanted following one hour of cold ischaemic storage in either Perfadex (n=5) or Ringer’s acetate 
(n=5). Anastomosis was as follows - the utero-ovarian vein and the anterior branch of the iliac artery 
of the graft were attached end to side to the external iliac vessels with continuous 6-0 polypropylene 
sutures. Two ewes in each group were excluded as a result of inadequate reperfusion of the uterus 
after anastomosis. Uterine venous blood was collected and analyzed for several parameters during 
three hours of reperfusion. The choice of outcomes to be studied was valid, all-encompassing and of 
diagnostic value. They included: pH, pCO2, pO2, and lactate, as well as indicators of oxidative stress, 
such as semi-dehydroascorbate radicals (ascorbyl radicals), thiobarbituric acid–reactive species 
(TBARS), and total antioxidant capacity, analyzed in uterine venous blood and plasma. In addition, 
light microscopy was used to detect histological signs of ischaemia-reperfusion injuries and quantify 
neutrophils in tissue biopsies. Results showed that storage in Ringer’s acetate was more detrimental to 
the uterine tissue, with a decline in pH and a rise in lactate and pCO2-pO2, as well as an elevation of 
antioxidant capacity, lipid peroxidation, and intensity of ascorbyl radical electron spin resonance 
signal. Storage with both preservation solutions revealed mild inflammation. The study itself was 
useful in providing a time limit to cold ischaemic exposure as well as differentiating between two 
preservation solutions. The authors’ conclusion that a cold-ischaemia time of between one and two 
hours does not induce any immediate severe reperfusion injury in the sheep uterus is appropriate. 
Also, the use of the more complex and protective buffer Perfadex improved the status of the analyzed 
parameters, by decreasing oxidative stress and inflammation when compared with the case of 
Ringer’s acetate.160 
 
Two further studies by the Brannstrom group were performed on an auto-UTx sheep model. Dalm-
Kahler et al carried out a study which was an extension of the study describe above by Wranning et 
al,160 studying the effects of cold ischemia and reperfusion after sheep auto-UTx.161 The aim of this 
study was to develop and evaluate auto-UTx in a sheep model, but to an orthotopic position in the 
pelvis. Thus, the study is not simply a repeat of Wranning et al but is in fact the next step. Seven ewes 
were subjected to laparotomy with the uterus and its vascular supply and drainage being surgically 
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isolated. The excised uterus was kept ex vivo at +4°C in a preservation solution for 60 minutes and 
then auto-transplanted, single horn, uterine cavity and cervix, with vascular end-to-side anastomoses 
to the external iliac vessels (Figure F). A question arises as to why the authors used Ringers-Acetate 
when in their previous study, they demonstrated the superiority of Perfadex solution. The assessment 
of uterine blood reperfusion efficacy had already been evaluated.160 The same methodology was 
therefore applied: measurements of pCO2, pO2, lactate and pH in uterine venous blood. Uterine 
contractility and histology were assessed after three hours of reperfusion. The percentage of ewes 
demonstrating reperfusion was identical to the previous study (71%; 5/7),160 a statistic which supports 
the anastomotic model chosen (anastomosis of utero-ovarian vein and the anterior branch of iliac 
artery in an end-to-side fashion to external iliacs). The authors provided a satisfactory explanation as 
to why the first uterine grafts did not demonstrate a re-established blood flow after vascular 
anastomosis. The reason was that heparin was only given at one time-point, about three to four hours 
before re-initiation of flow. This was too early as the half-life of heparin in the circulation is only 
about one-two hours and thus the effect would have been sub-optimal at this crucial stage. The 
pCO2/pO2-ratio and the lactate level were initially elevated but decreased and became normal after 60 
minutes. Promisingly, visible tissue blood flow and spontaneous uterine contractions were seen after 
three hours of reperfusion. The latter measurement was novel and had not been attempted in UTx 
research previously. This is an important finding as the confirmation of uterine contractions points to 
a non-disrupted inherent neurological function as well as appropriate general signs of functionality. 
The adequacy of uterine perfusion was further supported by histological analysis which revealed a 
mild inflammation, but no oedema or stasis. In conclusion, the study further confirms that auto-
transplantation of a uterine graft in a sheep model can be successful. Placing the graft in an orthotopic 
position was a novel attempt in a large animal model which worked well as did the novel vascular 
connections. Both techniques would be used in a future human model, and the model itself is suitable 
for future experiments studying long-term uterine viability, contractility and even pregnancy. 
However, once again the transplantation of just one horn as opposed to both is highlighted. Perhaps, 
the operation should have mimicked a human attempt as much as possible and therefore both horns 
should have been transplanted. The authors did not offer an explanation.161 
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Leading on form the last study, the following Brannstrom experiment carried out the next logical 
step.162 It investigated the long-term function of a transplanted uterine graft by seeing whether a sheep 
recipient is able to harbour normal pregnancies after auto-UTx achieved using the above vascular 
anastomotic techniques. The study differed slightly to the previous in that together with the single 
uterine horn, both the Fallopian tube and ovary were also retrieved and subsequently auto-
transplanted. 14 ewe recipients were used. The anastomotic model involved end-to-side anastomosis 
of the vessels of the graft to the external iliac vessels. Of the14 autotransplanted ewes, seven were 
excluded from further experiments due to post-operative complications. Only one recipient suffered 
from an anastomotic bleed. The seven surviving recipients all had intact ovarian activity and grafts 
demonstrating normal appearance. Two ewes were examined in more detail two months after surgery, 
 
 
 
Figure F Schematic drawings of the sheep uterus, adnexae and their vasculature before 
transplantation (a) and after transplantation (b). (courtesy of Dahm-Kahler et al) 161 Sites for division 
of the arterial supply and venous drainage are indicated by straight double lines in panel (a); 1, aorta; 
2, ovarian artery; 3, ureter; 4, external iliac vein and artery; 5, utero-ovarian vein; 6, uterine artery; 7, 
round ligament; 8, left uterine horn; 9, vagina. 
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to establish that the procedure had not caused changes that would risk the animals’ well-being during 
the fertility experiments. The remaining five ewes underwent surgical examination and serum 
progesterone measurements to determine appropriate healing and ovarian activity. Afterwards, five 
autotransplanted and five control ewes were placed with a ram for mating. The use of control ewes 
further strengthened the study. All offspring were delivered via Caesarean sections performed before 
the estimated delivery date and fetal-relevant data were compared. Mating occurred in four of five 
transplanted ewes and in all five controls with three transplanted and five control ewes conceiving. 
Torsion of the uterus was observed after spontaneous initiation of labour in one transplanted ewe. All 
fetuses from transplanted mothers were comparable in size to those of controls. The authors achieved 
their primary aim which was to investigate whether orthotopic graft transplantation and a new 
vascular supply affects the fertility potential of the transplanted uterus. They also cleverly avoided 
problems which may arise from immunological reactions and immunosuppressant drugs by using an 
autotransplantation model. A number of techniques have now been firmly established: vascular 
flushing, cold ischaemic preservation of the transplant and the technique and site used for vascular 
anastomosis. The authors draw attention to the 50% survival rate but rightly point out that five out of 
the seven euthanized ewes were put down as a result of species-related problems. Also, fertility rate 
was 60% in the transplanted ewes as opposed to 100% in the controls. One of the reasons may have 
been that the Fallopian tube and ovary were also transplanted together with the uterus. Therefore, 
post-UTx inflammation may have led to obstruction and prevention of conception. The current 
proposed human model does not include the transplantation of a Fallopian tube and ovary so the risk 
of ectopic pregnancy and obstruction within the Fallopian tube would be avoided. The study is first 
report to demonstrate fertility and pregnancies going to term after removal of the graft from the 
abdominal cavity (Eraslan et al did not remove the graft)56 and auto-transplantation of the uterus 
using a macrovascular anastomotic technique as opposed to an avascular process (dog 53 and rhesus 
monkey 67), in a large animal with a pelvis that is comparable in size to a woman’s.162 The plan to use 
external iliac vessels as recipients of the graft vessels received further support here. 
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Ramirez et al have published data on allogeneic UTx in a large-animal model.72 UTx was carried out 
in a sheep model, with the second 2011 study being to date the only study to validate the purpose of 
UTx in a large animal model.163 It demonstrated pregnancy following the transplantation of a uterine 
graft between two non-related ewes. The initial pilot study was performed in 2008, with the aim of 
developing a uterine transplant procedure in the sheep model that may be suitable in women suffering 
from AUFI. The reason for this is that a ewe’s pelvis resembles a woman’s pelvis with regards to 
anatomical landmarks and vascular anatomy, with the exception of a bicornuate uterus. UTx was 
performed through a minilaparotomy incision with the application of a 900-500 modified Mobius 
retractor device. Ten sheep received allografts. Immunological graft rejection was managed with CsA 
therapy. Uterine vessels were re-anastomosed in this case series using a continuous end-to-end non-
interlocking approach to ensure uterine perfusion. This choice of using uterine vessels which failed in 
previous porcine models was a risk, and would not have been recommended by the other international 
teams. It is worth noting that could only be applied in a clinical situation where hysterectomy is 
performed as part of the procedure in the recipient. Therefore, total abdominal hysterectomy without 
oophorectomy was performed. The authors conveniently quantified warm and cold ischaemic times. 
A cold ischaemic time of 45 minutes was recorded. Despite small-vessel anastomoses, complete tissue 
reperfusion of the graft was surprisingly achieved in all ten animals within 30 seconds after vascular 
re-anastomosis without evidence of arterial or venous thrombosis. All ten animals were followed-up 
for six months, which is a suitable period of time to make conclusions related to long-term graft 
viability. At the end of the follow-up period, hysterectomies were performed and histological analysis 
revealed viable uterine tissue and vascular patency in six out of the ten uterine allotransplants. 
Interestingly, the site of uterine vessel re-anastomosis was patent. Neo-vascularization with presence 
of smooth muscle and glandular endometrial tissue was also demonstrated. The conclusions are valid - 
the authors have indeed developed a modified procedure that has allowed them to perform successful 
uterine transplants in the sheep model. The model itself has proved useful especially with its 
correlation to a woman’s pelvis. This is despite using a re-anastomotic model not deemed suitable by 
other UTx teams. It is also important to recognise that this is the first reported case in the literature 
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documenting a successful procedure of allo-UTx in the ewe. Finally, the authors do state their desire 
to demonstrate that a pregnancy can be achieved following allogeneic UTx in a sheep model.72 
 
The second study in 2011 was precisely this attempt.163 It is therefore of particular significance, as it 
reported the first case of pregnancy following large-animal allogeneic UTx. The number of sheep 
used was appropriate; allogeneic UTx was performed in 12 sexually mature African sheep. Usefully, a 
control group was present, consisting of pregnant Romney Marsh sheep with non-transplanted uteri. 
Outcomes that were measured and compared with the control group were all focused on pregnancy 
and the fetus: fetal development, uterine and placental histological findings, and blood samples of 
progeny of the uterine transplant recipient sheep. All animals underwent UTx via a mini-laparotomy 
incision using a Mobius retractor device. The vascular model was again a bilateral end-to-end uterine 
artery re-anastomosis, with the same immunosuppression regimen applied but a higher dose of CsA. 
Four months after the initial UTx, fresh and frozen blastocyst donors were transferred accordingly to 
the surviving five uterine allografts via a mini-laparotomy incision. Three of these resulted in 
pregnancies. One was an ectopic gestation, one sheep carried the pregnancy to 105 days, and one 
delivered a fully developed lamb from the transplanted uterus that was delivered via caesarean 
section. Neonatal lamb blood gas values and chemistry, gross organ examination, and ventilation and 
respiratory compliance studies yielded results normal for gestational age. Although a 60% pregnancy 
rate seems high, the actual live birth rate is 20%, a much lower figure and one which calls for cautious 
optimism. A criticism of the two studies was that the rejection response was not adequately studied, as 
well as the level of graft rejection and to what extent the immunosuppressants prevented rejection. 
However, the knowledge that pregnancy can be carried in an allotransplanted uterus in a large-animal 
model which resembles the human pelvis closely, with the end result a successful delivery, is of huge 
value to future research.163  
 
The last study to describe uterine allotransplantation in a sheep model was by Gauthier et al.164 Like 
the previous studies, this was also an original experiment as an aorto-caval patch was applied to 
ensure uterine perfusion. A standard and appropriate number of recipients (n=10) received a uterine 
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allograft in an orthotopic position. As mentioned, the anastomotic model was macrovascular with the 
application of an aorto-caval donor patch on the left external iliac vessel recipient (Figure G). The 
advantage of the model is that it minimises the risk of thrombosis, yet the procedure is only applicable 
when the organ is recovered from a deceased donor i.e. it is not applicable for all types of donors. The 
authors explained that in their view a brain-stem dead heart-beating donor would be the better choice, 
as opposed to a living donor, as the risk of ureteric and vascular injury would be non-existent with the 
former. This is a significant point and one with which the UK Team is in total agreement.164 
 
The other highlight of this study was its secondary aims. They were to assess the practicability of 
prolonged immunosuppression in ewes and to assess graft integrity by vaginoscopy, magnetic 
resonance imaging, and second look laparotomy at 6, 8 and 10 weeks. The immunosuppressive 
protocol was a combination of CsA (10mg/kg/day) and mycophenolic acid (3g/day). The exposure of 
the graft to the immunosuppressant medication was assessed by measuring the area under the curve of 
the immunosuppressive plasma concentrations. The graft was flushed through with 1000ml of chilled 
protective Celsior solution at 100mmHg pressure. Flushing was continued until clear fluid drained 
from the vena cava. The median times for cold and warm ischemia were acceptable: 95 and 91 
minutes respectively. All the vascular anastomoses were patent at the end of the surgery. Two 
recipients died from graft haemorrhage within six hours of the operation and one died from intestinal 
obstruction. One recipient expelled the graft from the vagina two months after the operation, with no 
clinical signs or consequences with regards to the well-being of the graft. Thus, only six recipients 
were assessed. Cervical biopsies showed signs of necrosis in all six ewes, with thrombosis also seen 
in all six aortocaval vascular pedicles. Most likely reason for the thrombosis is the pedicle length and 
non-prevention of graft mobility via pelvic side wall fixation. This probably gave rise to mechanical 
stress on the vessels, which in turn could have caused thrombosis and subsequent necrosis. The 
authors acknowledged the major weakness in their study which was the lack of early graft assessment 
to distinguish whether necrosis was caused by mechanical or rejection-related reasons.  is a major 
weakness. Their follow-up plan to monitor rejection in a future study is apposite; it would include 
regular biopsy monitoring of the uterine cervix, immunochemistry for neutrophilic granulocytes, 
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macrophages, cytotoxic CD8+ T cells and CD4+ T-helper cells and an early MRI scan immediately 
post-UTx.164 
 
The authors discussed at length the impact of potential rejection on the graft and how it may have 
brought about rejection. The immunosuppression doses used were higher than those used in humans 
which have decreased the impact of acute rejection on renal, hepatic and cardiac transplantation. 
However, the area under the curve was clearly inferior to those recommended for humans. Usefully, 
the authors recommend that future studies should look at setting up an optimum UTx sheep model. 
The studies should assess the relationship between dose and plasma concentration for 
immunosuppressive drugs in sheep for a particular route of administration. Two ewes had grafts 
which demonstrated viability, with graft histology revealing endometrial tissue in the two. Peripheral 
neovascularisation was the explanation as to why perfusion was possible in two grafts despite aorto-
caval thrombosis. This is a valid justification and the knowledge that neovascularisation occurs post-
UTx is surely promising for future attempts. The authors deemed that ischaemia and reperfusion 
injury was not the cause of the necrosis as the times for both cold and warm ischaemia were relatively 
low and the standard preservation solution was applied. The use of MRI to estimate graft viability was 
a novel technique introduced by the authors that had not been recorded before in a sheep model. The 
MRI data correlated with the macroscopic observations of the ‘second look’ laparotomy and appears 
to be a good easy-to-perform, non-invasive examination for graft estimation. Pelvic MRI could thus 
serve as a reference examination in post-UTx follow-up, as well as act as a functional reference 
examination to check vascularisation patency. It is worth highlighting that a lack of control group 
(syngeneic ewe which underwent the same surgical procedure without any immunosuppressant 
treatment) was noticeable (acknowledged by the authors). To conclude, this was a welcome addition 
to the relatively small pool of data on allogeneic UTx in a sheep model, with particular obstacles that 
need further work highlighted: mobility of the transplant within the pelvis, the length of the vascular 
pedicle and difficulty in administering an optimal immunosuppressive treatment in ruminants. The 
potential of MRI to evaluate graft morphology and vascular patency and thus distinguish ischaemic 
risk from the risk of rejection when used in parallel to biopsy is a novel and important idea.164 
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Figure G Orthotopic uterine alloUTx in the ewe. The lower donor aorta and vena cava were 
anastomosed end-to-side with the recipient’s external iliac vessels (courtesy of Gauthier et al) 164 
 
 
(c) Uterine Perfusion 
 
In current medical practice, tissue pathology is diagnosed by the application of two different 
processes: volumetric visualisation of tissue and biopsy. The former is a macroscopic process. It 
includes imaging modalities such as X-ray, γ-ray and computed tomography and magnetic resonance 
imaging which estimate the extent of a disease. The latter is a microscopic process and involves the 
resection of tissue and its subsequent analysis under a microscope. This process is opposite to the 
above as it supplies a restricted but detailed picture on tissue biochemistry and biostructure.  
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Existing blood imaging systems as well as the current methods of ischaemia diagnosis, such as 
angiography, CT and MRI, reveal that none of them can be used intra-operatively. They also provide 
information on anatomic modifications resulting from ischaemia but that could have been caused by 
other pathologies.165 Finally, the processing time of these techniques is long, whereas early diagnosis 
is crucial for graft survival. 
 
Both processes have brought enormous benefit to patient health care and in particular disease 
diagnosis. However the information they provide does not overlap, and a missing link becomes 
apparent. This is the absence of real-time functional and molecular data, pre-, intra- and post-
operatively. It may lead to missed or wrongly diagnosed lesions, resulting in needless biopsies and 
operations. Furthermore, no data at a molecular level means that serious pathologies (e.g. cancer) 
cannot be diagnosed early when ‘abnormal’ change is occurring at a molecular level, which first 
precedes and subsequently triggers anatomic alterations. Additional problems include cost, logistical 
constraints and inadequate technology for use with infants and elderly patients. The exception is X-
ray fluoroscopy which may be used intra-operatively.  
 
Biomedical photonics is a field with potential to bridge the gap between the macroscopic and 
microscopic methodologies described above. It studies the interaction between light and tissue and 
can provide information on processes occurring at a molecular level, both at microscopic spatial 
resolution and nanometre spectral resolution.166,167 The manner in which the light interacts with tissue 
(absorption, transmission, diffuse reflection, fluorescence) may vary, but it carries the common goal 
of supplying more complete tissue diagnostic information to the surgeon with minimal trauma and 
procedure duration. In particular, the technique has shown to be advantageous over medical imaging 
and biopsy in a number of cases. First, it is atraumatic to the patient, whereas ionising radiation is 
used in medical imaging and biopsy involves tissue cutting and therefore damage. Second, biomedical 
photonics can generate immediate data at the time of an operation which therefore speeds up 
diagnosis and subsequent management. With medical imaging and biopsy one is forced to wait for a 
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period of time until the data is processed. Third, the resolution of biomedical photonics is highly 
detailed, with the ability to characterize tissue in the micrometric range and thus, probe biochemical 
alterations that pre-stage pathology. This is definitely not the case in medical imaging and biopsy, 
where a clear demarcation line between diseased and healthy tissue is often unclear.168 Today, 
biomedical photonics are well-established and commonly used tools in hospitals. For example, they 
are applied in pulse oximetry, endoscopes and colposcopes, laser therapy, and microscopes used to 
examine histological sections. Diffuse reflectance spectroscopy in the visible range has been 
successfully used to diagnose chronic mesenteric ischaemia during an endoscopic procedure.165,169  
 
We have already discussed the problems posed by potential ischaemia and reperfusion injury during 
the transplant process. The critical stage of this operation is the uterus re-perfusion in the recipient 
during which ischaemic injury can cause parenchyma and microcirculatory function impairment.4 A 
need exists for a technique which will be able to assess the level of ischaemia and reperfusion injury 
and provide related diagnostic information during the intra-operative and immediate post-operative 
periods, as well as prior to possible pregnancy. No such technique exists.170 
 
Biomedical photonics have the potential to do just that by processing data related to haemoglobin 
concentration and saturation of oxygen directly and intra-operatively. Importantly, the data will be 
non-invasive, real-time, localized and high-resolution. A type of photonics known as reflectance 
spectroscopy has been successfully used to diagnose chronic mesenteric ischaemia during an 
endoscopic procedure.165,169 The physics element behind the use of biomedical photonics is beyond 
the scope of this PhD. However, the background is outlined briefly below. The principle of 
biomedical photonics is based on the complex phenomenon that light is modified by tissue, with the 
spectral range of interest lying in the non-ionizing and richly diagnostic visible domain (400nm - 700 
nm). When striking the surface of a tissue, light can either be reflected or refracted. Reflected light is 
of no particular interest as it does not penetrate the tissue and therefore does not contain significant 
diagnostic information. It is referred to as a specular reflection. The amount of refracted and reflected 
light depends on the refractive index at the air/tissue interface and the angle between the in-coming 
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light beam and the tissue normal. The photons forming the refracted light can be absorbed or scattered 
by the tissue chromophores and scatterers. The fraction of the photons which emerge from the tissue 
after multiple scattering events is called diffuse reflectance as the scattering induces the spreading and 
the loss of directionality of the incident beam.170 
 
Two photonic applications which are both real time and can be used intra-operatively are described 
below.  
 
Application of Pulse Oximetry in Uterine Transplantation 
 
Pulse oximetry is a non-invasive method of measuring the arterial oxygen saturation (O2Sat) of 
haemoglobin. A probe is placed around the cornua in our experiments which is linked to a 
microprocessor unit displaying a waveform, O2Sat, and pulse rate. Two light emitting diodes are 
contained within the probe. The light they emit passes through the cornua to a photodetector. Some of 
the light is absorbed by blood and soft tissues during its passage through a select tissue. The amount 
of absorption in general and at each light frequency is proportional to the degree of oxygenation of 
haemoglobin within the tissues. The microprocessor can then calculate the proportion of oxygenated 
haemoglobin by computing the absorption at the two wavelengths. The pulse oximeter measures 
O2Sat and perfusion index (PI). PI is independent of O2Sat and acts as an indicator of total blood 
volume. The oximeter produces a graph related to the amount of light absorbed by the tissue over 
time. The microprocessor can select out the absorbance of the pulsatile fraction of blood (arterial 
flow) from absorbance of non-pulsatile venous or capillary blood and other tissue pigments. 
 
The first experiment to assess whether pulse oximetry could be a suitable tool for confirming 
adequacy of uterine perfusion was performed by the Smith group in the UK (as advised by Dr Andrew 
Lawson, Consultant Anaesthetist). Sieunarine et al looked at the uterine vascular supply during a set 
of abdominal radical trachelectomies, a novel surgical procedure for conservative cervical cancer 
management.171 Pelvic vessels are selectively ligated during ART. Thus, the question of how many 
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vessels the uterus requires to ensure its viability arose. Originally, the group believed falsely that four 
of the following six vessels (two uterine, two ovarian and also a collateral supply from two vaginal 
vessels) were necessary to maintain a viable uterus. The aims of this highly original study were to 
investigate the vasculature of the infundibulopelvic and broad ligaments, to assess the contribution of 
the ovarian and uterine vessels to overall uterine perfusion, and to consider the clinical applications of 
selective pelvic vessel ligation. The number of dissections performed was adequate. Ten fresh 
dissections of the infundibulopelvic vessels, broad ligaments of benign total abdominal hysterectomy, 
and bilateral salpingo-oophorectomy specimens were performed. PI and O2Sat measurements using a 
modified probe were taken at specified intervals at the uterine cornua during ten routine benign 
abdominal hysterectomies to assess the contribution of the ovarian and uterine vessels to overall 
uterine perfusion. Conclusions drawn from PI and O2Sat measurements implied that uterine and 
ovarian vessels contribute almost equally to uterine perfusion. Of the six supplying vessels (ovarian, 
uterine, and vaginal) to the uterus only two (ovarian or uterine or a combination thereof) are required 
for uterine viability. Such a uterus is indeed capable of pregnancy and delivery 172 except if ART is 
performed in pregnancy when uterine artery preservation is required to allow the pregnancy to run to 
term.173 This fact is particular importance to uterine transplantation where according to the above, 
only two arteries and two veins would be required to ensure adequate perfusion of the uterine graft. 
Clinically, selective ligation of the pelvic vasculature (uterine and ovarian vessels) has been utilized in 
certain gynaecological procedures at particular risk of torrential life-threatening uterine haemorrhage; 
for example, surgical management of chemoresistant gestational trophoblastic disease (Strassman 
procedure),174 and fertility-sparing surgery in ruptured cornual ectopic pregnancies.175 
  
A similar study by the same team was performed to validate the above results. The aim was to further 
confirm that the measurement of PI and O2Sat using pulse oximetry could be used to assess the 
contribution of uterine and ovarian vessels to the overall uterine perfusion.176 During routine 
hysterectomies, PI and O2Sat were measured over the right and left uterine cornua. These 
measurements were taken before any vessels were ligated (baseline), after only the ovarian vessels 
were clamped and then after the uterine vessels were clamped. Clamping of the ovarian and 
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subsequently uterine vessels produced statistically significant decreases in PI and O2Sat. Both pairs of 
vessels therefore contribute almost equally to uterine perfusion and a definite role for O2Sat and PI 
variables exists in determining the success of uterine and ovarian vessel re-anastomosis in UTx. 
 
Application of Multispectral Imaging in Uterine Transplantation 
 
Multispectral imaging requires a multispectral laparoscope to acquire high resolution images of 
changes in tissue oxygen saturation. This technique involves using a white light source and tuneable 
filter to acquire images at many wavelengths in the visible range in order to build up a reflectance 
spectrum at each pixel.177 Here, like with pulse oximetry, the haemoglobin concentration and 
oxygenation, as well as scattering decide the shape of the visible light spectrum reflected from tissue. 
These spectra are then fitted using a linear regression model which uses prior knowledge of the 
optical absorption spectra of oxy- and deoxy-haemoglobin, from which their relative contributions are 
calculated. Previous implementations of this technique have also used hyperspectral data with 
numerical techniques to aid tissue visualisation and ischaemia detection.177,178 Multispectral imaging 
refers to techniques that use a relatively low number of wavelengths (up to 40-50) while hyperspectral 
imaging refers to techniques that can apply hundreds of wavelengths. A strict threshold between the 
two types does not exist but ‘hyper’ usually means hundred or more. 
 
The technique has been applied in current medical practice in a number of ways: gingival 
inflammation quantification,179 brain tumour demarcation,180 fundus analysis,181 imaging of 
Hirschsprung’s disease,182 and analysis of facial skin lesions.183  
 
Endoscopic Laser Speckle Contrast Analysis 
 
The application of biophotonics and its potential benefit to the field of medicine, with regards to 
diagnosis and treatment is outlined above. In particular, its application to assessing uterine perfusion. 
The technique utilizes the interaction between light and tissue, and thus the processes of light 
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refraction, absorption and scattering, to detect, measure and image the vasculature and circulatory 
function. Three main variables are assessed: blood function, vascular structure and flow velocity, 
using both invasive and non-invasive methodology.184 
 
Apart from assessing uterine perfusion, an additional problem that one may face in a human UTx 
model is how to ensure an adequate blood flow of those vessels supplying the uterus: immediately 
post-anastomosis, in the early and late post-operative periods, and during pregnancy when those 
anastomotic sites will be severely tested because of an increase in the size of the diameter. Therefore, 
it is of crucial interest to be able to image the uterine circulatory system that maintains the flow of 
oxygen and nutrients to the relevant tissue. By investigating tissue circulation, one can make 
conclusions relevant to tissue oxygenation. The level of oxygenation of an organ is directly 
proportional to the health of that organ.   
 
Parameters of interest with regards to blood flow specifically are blood pressure, blood volume and 
blood speed. Blood pressure can be easily assessed using a sphygmomanometer; however, the 
measurement is systemic and not a reading of the blood flow speed in a specific area. Blood volume 
can be measured using electrical-impedance plethysmography and chamber plethysmography. The 
former has poor accuracy as the method is based on three assumptions which are often not met: the 
vessels expand uniformly; the resistivity of the blood remains constant; and the direction of the 
current is parallel to the flow. The latter depends on the blockage of the venous flow and 
measurement of the volume, and it is therefore only applicable to the limbs, and not the internal 
organs. Finally, blood flow speed can be assessed by a number of different methods: electromagnetic 
flowmeters, ultrasound-Doppler flowmeters, and optical methods such as photoplethysmography, 
laser Doppler flowmetry and imaging, photoacoustic methods and optical coherence and Doppler 
tomography. However, none of the methods above are able to assess in combination blood flow 
velocity, blood function, vascular anatomy and tissue perfusion. Thus, the measurement of three 
variables in particular: blood flow speed, haemoglobin concentration ([Hb]) and oxygen saturation 
(O2Sat). 
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An imaging technique which could offer a solution, known as Endoscopic Laser Speckle Contrast 
Analysis (eLASCA), is an imaging system which monitors vessel blood flow by measuring changes in 
the light reflected from tissue under laser illumination because of the presence of moving ‘scatterers’ 
(red blood cells).184-186 A laser speckle pattern is produced when a rough area, surface or pattern is 
illuminated by coherent laser light and is imaged onto a camera (Figure H). Randomly distributed 
bright and dark areas on an observation plane are created by the interference of the reflected and 
backscattered light. It is precisely this image which is called a speckle pattern. When imaging the 
surface or the whole particle(s) whilst in motion, the speckle pattern that is generated at each pixel 
varies with time and space. These variations contain flow information about the motion of the 
scattering particles which can be calculated by measuring either the temporal intensity fluctuation of a 
speckle (laser-Doppler flowmetry) or the spatial intensity fluctuation (LASCA). The latter 
fluctuations, assessed by LASCA, appear as blurs which are evaluated by the contrast. Contrast 
decreases with increases in the speed of the scatterers. Therefore the speed can be calculated by 
examining the change of the contrast value which is the basic principle of LASCA.186,187 
 
Laser speckle is a random phenomenon and can only be described statistically which is beyond the 
scope of this thesis. Speckle contrast analysis is based on the statistics of the intensity of the speckles. 
Speckle Contrast is generally described as the ratio of the standard deviation over the mean intensity 
of a small area in the speckle image: 
 
where C is the contrast,  is the standard deviation of the signal and  I  is the mean intensity 
value. In experiments the contrast is calculated based on the values recorded by the CCD pixels.  
Usually in an area defined by an ‘n’ number of pixels, the mean intensity and the standard deviation 
are calculated and the speckle contrast number is allocated for this area.186  
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(a) (b) 
 
Figure H  (a) Generation of the speckle pattern. The red arrows represent the laser illumination 
beam and the purple arrows the scattered beam which is the same wavelength as the laser. The 
scattered beams converge to an interference pattern with random intensities and phases. (b) This is the 
speckle image as it appears from the laser illumination of a paper card. 
 
 
When an object moves, the speckle pattern it produces changes. For small movements of a solid 
object the speckle pattern moves as a whole, i.e the speckle pattern remains correlated. For faster 
motions, the speckles ‘decorrelates’ and the speckle pattern changes completely. Decorrelation also 
occurs when the light is scattered from a large number of individual moving scatterers, such as 
particles in a fluid.  An individual speckle appears as if it is ‘twinkling’ like a star.  This phenomenon 
is known as a ‘time-varying’ speckle.186 Stern at al first recognised that the biggest potential for the 
application of speckle pattern fluctuations could be in assessing the flow of red blood cells.188 In the 
1980s, this effect was used in a photographic technique known as single-exposure speckle 
photography which was developed to image the blood flow at the retina.189 A camera was used to 
obtain a quick snapshot image of the time integrated speckle pattern from which blood flow in the 
retina was estimated from the spatial statistics of the speckle pattern. The term LASCA was then 
introduced to describe this analysis.186 
 
Speckle images of tissues in vivo could be acquired by fast cameras as series of snapshot images with 
acquisition occurring at 1/1000 sec (1ms) with a total duration of several seconds or minutes. The 
contrast calculation is based on a single frame image processing, which is further applied to the whole 
stack of images with image processing algorithms. For a single digital frame the computer program 
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selects a window of an area of 5x5 pixels or 7x7 pixels known as ‘kernel’ and calculates the mean 
intensity and the standard deviation over the mean intensity. Speckle contrast C is automatically 
calculated as the division of the standard deviation over the mean intensity, and the value of C is 
being assigned over the selected pixel area. The “kernel’ window then moves by a pixel step across 
the digital image and the process is repeated. The result is the contrast image of the Area Of Interest. 
The diagram of the calculation of contrast is shown in Figure I. 
 
Theoretically the speckle contrast has values between 0 and 1. A completely stable object maximizes 
the speckle contrast to 1 indicating that there is no blurring and therefore no motion, while moving 
particles with certain speed results in blurred speckle images with contrast values close to 0. The 
faster the motion, which in case of red blood cells is the blood flow, the darker the speckle contrast. 
Pseudo-colour may be added to the contrast map according to the contrast value so that the different 
speeds can be distinguished by different colours.  
 
The application of LASCA is limited however because laser light can be absorbed and then scattered 
whilst passing through tissue. Therefore, the maximum penetration depth is several millimetres. A 
solution is the combination of LASCA with endoscopy (eLASCA) which would allow imaging of 
internal organs for clinical diagnosis and then surgery if deemed necessary, assessment of the 
recovery from disease or injury, as well as the acquisition of real-time information of the in vivo organ 
blood supply. Variations in cardiac and respiratory rates can be extrapolated from the analysis of the 
signal over time as well as the blood oxygenation status based on the changes of concentration of 
oxygenated and deoxygenated haemoglobin. Such information will improve upon current imaging and 
non-imaging techniques for post-operative tissue monitoring, and will therefore analyse uterine ‘well-
being’ both in its non-pregnant and pregnant state, assess recovery and understand haemodynamics 
and oxygenation levels. It is therefore potentially a system which may be capable of detecting tissue 
perfusion, oxygenation level, pulsation and respiration at the same time.185,186,190 
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Figure I Diagram of the Speckle Contrast calculation. The table represents the detector chip 
and each small square represents one pixel. The black square represents the kernel window with the 
size of 5x5 pixels. The contrast value C of the pixels is assigned to the pixel (I,j) and the kernel is 
moved across X axis and then along Y axis to perform the spatial contrast calculation of the whole 
image. The red rectangle shows the position of the kernel for calculating the contrast. For every kernel 
position a number indicating the contrast is assigned to the whole kernel area. A speckle contrast 
image is generated by the derived contrast values. 
 
Currently, LASCA has been applied in practice to quantify and assess blood circulation in the skin, 
retina and cortical tissue.185,191,192 All these areas are easily accessible and that is because LASCA is 
limited by the penetration depth of the light the system emits, as explained above. The combination of 
endoscopy and LASCA has been tried to date but not in gynaecology. The ultimate aim was to see 
whether disease diagnosis and intra- and post-operative supervision could be carried out 
simultaneously. The first application of eLASCA was by Bray et al, who used it to image tissue 
perfusion and blood flow in the medial compartment of the knee of five patients requiring 
arthroscopic knee surgery.193 Changes in tissue perfusion were brought about by tourniquet 
application and intra-articular adrenaline injection, and were then displayed as real-time video 
perfusion images of tissue blood flow in the knee joint. Only a high resolution CCD and a standard 
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arthroscopic sheath with which to cover the rigid Hopkins lens type endoscope were needed for this 
study.193 The next study advanced on the previous. Zimnyakov et al applied a fibre-optic bundle and a 
CCD camera instead of the above rigid endoscope to monitor a speckle-contrast pattern. However, it 
was a point measurement and could therefore not provide images of the scatter speeds.194 
 
(d) Patients and Uterine Transplantation 
 
With respect to AUFI and fertility in general, it is well established in the literature that infertility is 
strongly associated with depression and a reduced (Quality of Life) QoL.195,196 Being able to conceive 
and subsequently bear a child can have a huge influence as to how women perceive their own 
femininity and QoL.196 Unfortunately, the society and culture of the woman in question is an 
important influence. One of the most important groups of AUFI patients are women diagnosed with 
MRKH Syndrome. The above pressures are further pronounced in MRKH women. This group of 
women had to undergo the afore-described introspection at a much earlier age, in particular as 
teenagers. It is around this time that a woman awaits menarche, which, if normal and occurring within 
the expected time period, is indicative of the woman’s physiological normality.196 For the woman in 
question, the onset of menarche is a symbol of reproductive ability.  
 
MRKH patients therefore are forced to face up to a rather distressing diagnosis from a relatively 
young age, with implications related to their body image, psychosexual development, identity and 
femininity.197 All attributes of womanhood are in doubt; absence of menarche equates to loss of 
physiological value, no uterus means no capacity to child bear and in the sub-group of MRKH women 
with vaginal agenesis, failure to engage in sexual intercourse. Ultimately, the malformation itself does 
lead to narcissistic damage.198 The evidence however has remained largely anecdotal.199 Heller-
Boersma et al presented one of the few investigations on the psychological impact of MRKH.200 A 
group of 66 women with MRKH were compared with 31 control-group women on a range of self-
rating scales assessing psychological distress and self-esteem. Women with MRKH had significantly 
more pathological scores on some of the scales and subscales, such as phobic anxiety and 
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psychoticism (interpersonal alienation), with a similar trend for subscales measuring depression and 
anxiety. The authors concluded that MRKH has a lasting negative impact on affected women's level 
of psychological distress and self-esteem.200 
 
MRKH Syndrome is primarily characterised by uterine agenesis, although vaginal agenesis is also 
common. Genetically, the patient is XX and the external phenotype is a normal female. Therefore, the 
management of this condition has mainly focused on the creation of a neovagina for sexual function 
using both surgical and non-surgical approaches.11 Our aim is to widen management options by 
enabling UTx to become accepted in human practice as an infertility treatment. The experience of 
units offering the creation of a neovagina has demonstrated the importance of a holistic approach 
when managing this group of patients. As succinctly described by Edmonds et al, a patient who will 
undergo an anatomic correction or creation of a vagina will first partake in routine psychological 
assessments at the UK National Centre for Adolescent and Adult Females with Congenital 
Abnormalities of the Genital Tract, based at Queen Charlotte's & Chelsea Hospital, London. The aim 
of the treatment as is the aim of UTx is not simply the creation of a new organ i.e. vagina or uterus, 
and thus an improved sexual relationship between a couple and end to infertility but also, an improved 
quality of life and psychological well-being of the patients.11 Edmonds et al demonstrated that 
attempting and then managing to find a ‘cure’ to one of the pathologies associated with MRKH (in 
this case, a non-existent vagina) did lead to improved long-term QoL outcomes. Their retrospective 
study (largest ever reported on the non-surgical management of vaginal agenesis) examined the 
efficacy of vaginal dilators in the management of MRKH Syndrome. The main outcome measure was 
achieving functional vaginal length (defined as greater than 6 cm in length and maximum width 
throughout the vagina and especially at the apex) and sexual satisfaction. Out of 245 patients, 232 
(94.9%) achieved a successful vaginal length and sexual function. When the program was completed 
by all patients, 100% of patients were successful, suggesting that a) surgery is rarely, if ever, required; 
and b) adoption of a holistic approach to management of MRKH patients with a strong psychological 
input can result in long-term QoL outcomes.11 
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Additionally, a number of studies and reviews have confirmed the presence of psychological 
problems, such as anxiety and depression, in women suffering from infertility and in particular 
MRKH syndrome.11,196,201,202 Laggari et al was the first study to examine psychological difficulties in 
adolescents with MRKH. They used the Beck Depression Inventory (BDI) and the State-Trait Anxiety 
Inventory (STAI-Gr) to measure depression and anxiety respectively in 49 adolescent girls, of whom 
27 were patients with confirmed menstrual disorder, 22 with PCOS and 5 with MRKH. 22 girls were 
healthy adolescents with a normal menstrual cycle (control group) matched by age and school grade. 
The results demonstrated that the PCOS group was 1.08 times more likely to have higher scores than 
healthy adolescents on the anxiety scale and for the MRKH group it was 1.12 times more likely. 
Furthermore, the MRKH group was 1.40 times more likely to have a higher number of depressive 
symptoms than the control group. Therefore, the authors findings, although based on a small sample, 
suggest a relationship between PCOS and MRKH and anxiety and depressive symptoms in 
adolescents.196 
 
A number of various psychological treatments have been used with MRKH patients. Heller-Boersma 
et al developed a cognitive-behavioural group treatment (CBT) for MRKH patients.203 39 women with 
MRKH were randomized to group CBT (n=19) or waiting list (n=20).  Participants allocated to group 
CBT showed significantly reduced psychological symptoms on the SCL-90-R, whereas those on the 
waiting list remained unchanged.203 Using  the Medical Research Council’s (2002) framework for the 
development and evaluation of complex health interventions, the same team then went on to develop a 
speciﬁc model of the core negative psychological impact of the MRKH diagnosis and medical 
treatment as well as CBT for MRKH.199 This approach may also be applicable to a number of other 
congenital or acquired gynaecological conditions such as premature ovarian failure, female genital 
mutilation, Turner’s Syndrome, ovarian dys-/agenesis or, Complete Androgen Insensitivity Syndrome 
have a psychological impact not dissimilar to MRKH in terms of these women’s sense of self-esteem 
and femininity. 
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For MRKH, and AUFI women in general, UTx may offer a way for these women to re-discover their 
own femininity through the restoration of fertility. Thus, when faced with a patient who may undergo 
UTx, the afore-mentioned phrase ‘holistic approach’ takes on an extra meaning. This is because the 
psychological element is two sided for these patients. On one side lies the psychology of infertility, 
and on the other side, equally important is the substantially higher prevalence of psychiatric disorders 
in transplant candidates and recipients than in the general population. Additionally, a psychiatric issue 
may have an impact on a medical outcome for a non-transplant-related disease. It is for this reason 
that the pre-transplant evaluation phase routinely includes an assessment of the mental health of 
transplant candidates. This helps to highlight both psychological and psychiatric issues that may be 
affecting a potential candidate’s pre-operative preparation and post-operative care. The patient’s 
overall QoL can therefore be improved as identifying and treating mental health issues before or in 
the early aftermath of a transplant could reduce symptoms and distress. Frequent monitoring of 
psychiatric and psychological symptoms during the first year after transplantation is in place in some 
institutions.204  
 
To accomplish this, a validated assessment tool for patients who have registered a wish to undergo 
UTx and which addresses the above points is necessary. No such tool exists in the current medical 
literature. The face transplantation (also a QoL improving procedure) effort faced a similar problem 
approximately ten years ago. This was highlighted by the report drafted by the Royal College of 
Surgeons working party set up to investigate and provide recommendations related to face 
transplantation.205 The report stated that despite the adequately developed surgical techniques required 
to carry out face transplantation, ‘the risks of failure and long-term consequences of 
immunosuppression presented very considerable psychological and ethical problems.’205 Their 
revised report in 2006, produced following further research into face transplantation, provide good 
practice guidelines - 15 core requirements that had to be fulfilled before a research ethics 
committee/institutional review board could approve a proposal to carry out face transplantation.206 A 
number of these requirements focused on factors necessary for adequate selection, preparation, 
evaluation and monitoring of those patients selected to undergo face transplantation.207 Similarly, 
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these issues are also of importance in UTx. The afore-mentioned tool must be designed in such a 
manner that it addresses these points as well as any other similar psychological and social concerns 
(Box A).206,207  
 
Box A     Psychological and Societal Issues identified by the Royal College of Surgeons Working 
Party Report on Facial Transplantation 2007 that may be of importance to UTx (courtesy of Clarke & 
Butler, 2009) 207  
 
 Psychological responses to transplantation in general 
- Fears related to viability of transplanted organ 
- Fear of aftermath of rejection 
- Anxiety related to potential side effects of immunosuppressive medication, including risk of 
infection and malignancy 
- Feelings of personal responsibility for the success of the graft, linked to the need for adherence 
to a drug routine, regular monitoring of symptoms, regular attendance at outpatient 
appointments 
- Integration of the transplant into existing body image and sense of identity  
- Emotional responses to the experience of receiving a transplanted organ 
 
 Potential additional factors 
- Effectiveness of surrogacy and adoption and prior engagement with these alternative 
interventions 
- Psychological support for UTx patients (pre-, peri-, post-transplant and for those not suitable 
for the procedure) 
- Motivation to seek treatment and expectations of outcome 
- Psychological stability and adjustment 
- Level of cognitive functioning 
- Likelihood of adherence to treatment regimens 
- Social support 
- Implications of chronic rejection 
- Impact of transplant failure/fetal & neonatal abnormalities 
- Recipient and donor family support 
 
 Societal issues 
- Negative impact on national organ donation programs 
- Press intrusion for recipient and donor family 
- Pressure on AUFI [patients to seek surgical solutions 
- Raised expectations for many, solution for few 
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Psychological Domain Measure 
Cognitive Function Wechsler Adult Intelligence Scale III 
Mood 
Hospital Anxiety and Depression Scale  
Beck Depression Inventory 
Post-traumatic Stress Disorder Brief Post-traumatic Stress Disorder Screen 
Quality of Life Short Form-36 
Appearance Anxiety and Social Avoidance Fear of Negative Evaluation Scale 
Beliefs Regarding Medicines Beliefs Regarding Medicines Questionnaire 
 
Table C Standardised psychological measures used in assessment (courtesy of Clarke & 
Butler) 207 
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STUDY 1 
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1. Study 1: Abdominal Radical Trachelectomy in West London 
 
This study has now been peer-reviewed and published as per following reference: Saso S, Ghaem-
Maghami S, Chatterjee J, Naji O, Farthing A, Mason P, McIndoe A, Hird V, Ungar L, Del Priore G, 
Smith JR. Abdominal radical trachelectomy in West London. BJOG 2012; 119:187-93. 
 
Abstract 
 
Objective: Traditionally, the surgical management of invasive cervical carcinoma that has progressed 
beyond microinvasion has been a radical abdominal hysterectomy. However, this results in the loss of 
fertility, with significant consequences for the young patient. This report describes abdominal radical 
trachelectomy (ART) as a potential replacement for radical hysterectomy in patients with stage IA2-
IIA cervical cancer who desire a fertility-sparing procedure without decreasing the curative rates. 
Design: Observational, retrospective study. 
Setting: Teaching hospital and regional cancer centre in London, UK. 
Population: Patients undergoing ART. Methods: Patients presenting during the period 2000-2009 
with cervical cancer stage IA2-IIA were offered a trachelectomy, if they expressed a desire to 
preserve fertility. The type of trachelectomy (vaginal/abdominal) was chosen based on patient 
anatomy and neoplastic and magnetic resonance imaging characteristics. Each patient was counselled 
as to the experimental nature of the procedure. 
Main Outcome Features: Survival, recurrence and fertility issues among ART patients. 
Results: A total of 30 patients underwent ART (open and laparoscopic) between 2001 and 2009. 
Three patients presented with a recurrence, two of which have died (median follow-up: 24 months). 
Only three patients required further surgical re-intervention because of operative complications. Ten 
patients attempted to conceive, resulting in three conceptions (30%) and two live children. 
Conclusions: Abdominal radical trachelectomy provides a feasible, cost-effective and safe treatment 
option for young women who have been diagnosed with early-stage cervical cancer and wish to 
preserve their fertility. 
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1.1. Background 
 
The UK’s efforts into developing the field of UTx began in the late 1990s as a continuation of a 
number of studies looking at the potential of Abdominal Radical Trachelectomy (ART) as a curative 
and fertility-preserving surgical procedure.60 This work focused on finding out how many vessels 
were required to keep a uterus viable. It is supplied by two uterine, two ovarian (via collaterals) and 
two vaginal arteries (via collaterals) (Figure 1.1). At the Society of Gynecologic Oncologists 
Conference (USA) in 1996 during an interactive session between the panel and members, the 
membership believed that at least four of these arteries should be patent to maintain a viable uterus.60 
Subsequent experience with ART has shown this hypothesis to be false, with two ovarian arteries and 
veins proving to be enough. This is because ART results in the division of vaginal arteries to remove 
the cervix and upper vagina and the uterine arteries to complete adequate ureteric dissection. It was 
these lessons learned with regards to preserving adequate uterine blood supply post-operatively, as 
well as the technical aspects of ART that led a few gynaecological surgeons to consider UTx (also a 
fertility-preserving procedure) as a realistic rather than ‘science fiction-esque’ goal. A study of ART 
and its clinical and practical applications is therefore a necessary introduction into the field of UTx. 
 
Traditionally, surgical management of invasive cervical carcinoma which has progressed micro-
invasion has been a radical abdominal hysterectomy and pelvic lymphadenectomy. This treatment 
method has shown excellent results in terms of survival but results in the loss of fertility, which can 
cause added stress and reduced quality of life to a young female patient. 
 
In current gynaecological oncology practice, fertility preservation has become a significant and 
meaningful issue when deciding on how to treat stage IA2-IB cervical cancer.208,66,209 A fertility-
preserving operation, known as ‘radical trachelectomy’ was coined in 1994 in a seminal paper by the 
late Daniel Dargent  210 who described a new technique suitable for exophytic tumours of Stages IA 
to IIA. This procedure preserves the uterine body while removing the cervix, parametrium and upper 
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one-third of the vagina.211,212 Two types of radical trachelectomy are now recognised: vaginal (VRT) 
and abdominal (ART). 
 
The benefits of VRT, in treating early-stage cervical cancer and successful fertility outcomes 
thereafter have been detailed.213,214 However certain problems have arisen. Recurrence rates for 
example range from 12.5% to 29% for tumours that are greater than 2cm in diameter.211,215 
 
        
 
Figure 1.1 ART involves the removal of the cervix, upper third of the vagina and parametrium. 
This area is shown in the figure below enclosed by the dotted line. The vaginal and uterine arteries are 
divided (courtesy of Smith et al) 60 
 
The radicality of the ART procedure is identical to that of a traditional type II Wertheim 
hysterectomy. The similarity in the operative techniques between the two operations have allowed 
ART to become an acceptable alternative. It has also been used to treat pregnant women diagnosed 
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with cervical cancer.216 Mandic et al 217 and Abu-Rustum et al 218 reported their experiences of 
performing ART on pregnant women in the 19th and 15th gestational week (GW) respectively. In both 
cases, the patients had a caesarean section in the 36th GW and 39th GW respectively and delivered a 
healthy newborn. No further relapse has been demonstrated post-ART. 
 
1.2. Materials and Methods 
 
This was a retrospective study performed at the beginning of the research programme. Project 
proposal was reviewed and approved as a clinical audit project by the Quality and Safety Co-ordinator 
for the Women’s and Children’s Clinical Programme Group at Queen Charlotte’s Hospital. Case 
notes were retrieved and studied and the following data were extracted: mean age, mean length of 
operating time, pre- and post-ART tumour histology (tumour type, stage and grade), size and margin 
status of cervical tumour, number and disease status of lymph nodes removed, estimated blood loss 
and type of cervical suture used to anastomose the uterine stump with the upper vagina. We also 
recorded post-operative complications, follow-up time and outcome, recurrence of disease and 
fertility outcomes.  
 
With respect to the ART procedure, approval to perform it was granted by the Institute Review Board 
of the Chelsea and Westminster Hospital Ethics Committee in 1997, which is the where JR Smith first 
performed an ART.60 Since the publication of that initial study, the selection criteria employed in 
order to choose suitable patients has remained unaltered. At West London Gynaecological Cancer 
Centre, all patients presenting from 2000 to 2009 with cervical cancer stage IA2 to IIA expressing a 
desire to preserve fertility were given the option of undergoing an ART. Each patient was counseled 
as to the novel nature of the procedure and appropriate consent was obtained. The surgical technique 
has been described previously.172,219 The operation was performed by the five gynaecologic 
oncologists at the West London Gynaecological Cancer Centre (Queen Charlotte’s and Hammersmith 
Hospitals). 
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Follow-up 
 
All patients were discharged from hospital once they demonstrated an adequate level of comfort and 
fluid and food intake, complained of minimal abdominal pain only and had voided a sufficient amount 
of urine. They were also instructed, prior to discharge, to seek medical help if a significant amount of 
blood was passed per vaginam, lower abdominal pain became intolerable or problems with 
micturition became apparent. 
 
Routine follow-up was organised in the gynaecology oncology clinic every three months in the first 
year, four months in the second year, six months in the next three years and annually thereafter. Each 
appointment consisted of a focused history and examination, followed by a ‘cervical’ smear and 
pelvic ultrasonography if deemed necessary. It is also worth mentioning that our patients had direct 
access to our Cancer Nurse Specialists if they required specific support. With regards to attempts at 
pregnancy, our recommendations were for the patients to use contraception during the first year 
following ART to allow the tissue to heal.  
 
Prior to surgery, all patients had preoperative magnetic resonance imaging of the pelvis to assess 
tumour location, tumour size and involvement of the parametria and upper endocervix. Computerized 
tomography of the chest, abdomen and pelvis was performed to investigate possible distant spread. 
Examination under anaesthetic and cystoscopy +/- sigmoidoscopy were performed in order to 
complete the clinical staging process. Pathologic parameters were gathered from the pre- and post-
operative reports. At our institution, all cervical specimens were evaluated by specialist gynaecologic 
pathologists. Case notes were reviewed by two of the investigators to confirm the accuracy of the data 
collected. 
 
Data Presentation and Analysis 
 
Statistical analysis was not required for this study with the data described using descriptive tables. 
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1.3. Results 
 
General outcomes 
 
The patient characteristics and surgical outcomes are listed in Table 1.1. Following in-depth 
consultation between the patient and members of the gynaecology oncology team, 31 women chose to 
undergo an elective fertility-sparing ART. This operation was selected over a radical hysterectomy 
primarily in order to protect the patient’s fertility while at the same time managing the chief diagnosis 
of cervical carcinoma.  
 
At the time of diagnosis the mean age of the 31 patients was 32.5 years (range 23-41). The stage of 
cervical tumour that patients presented with was: stage IA2 (n=2; 6.7%), stage IB1 (n=25; 83.3%), 
stage IB2 (n=2; 6.7%) stage IIA (n=1; 3.3%). Five tumours (16.7%) were greater than 2cm in 
diameter. Notably, patients with non-squamous tumours were advised of the risk of ovarian and 
distant metastases. 
 
ART was performed simultaneously with bilateral pelvic lymphadenectomy. Mean length of 
operating time was 2 hours 50 minutes (range: 1 hours 50 minutes to 5 hours). The tumour was 
excised completely in 27 patients, with the median number of lymph nodes removed from the pelvis 
equalling 24 (range 7-52). 27 patients (90%) had no lymph node involvement. In the 3 patients (10%) 
who did demonstrate such spread, the lymph nodes involved were left internal iliac (1/23), right and 
left internal and external iliac (3/22), and right obturator (2/28). Lymph nodes removed were from the 
following groups: external, internal and common iliac, sacral and obturator. Microscopic evaluation 
demonstrated the resection margins of more than 3mm to be tumour-free in all cases, with endo- and 
ecto-cervical and circumferential margins commented on most frequently. None of the tumours 
displayed perineural spread. During surgery, 11 patients (36.7%) had a frozen section of the margins 
sample sent for histology. All revealed tumour-free resection margins. Magnetic resonance imaging 
revealed the largest tumour to be of the following size, 5cm x 3.7cm x 6cm, with a volume of 48cc 
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(stage IIA) and in contact with the posterior wall of bladder. Following EUA and imaging, as well as 
a team discussion, it was felt that ART could safely remove the tumour. The patient was also keen to 
preserve her fertility. She did not suffer from recurrence during follow-up and is still alive. 
 
Finally, with regards to the cervical suture, insertion depended on ease of application during surgery 
and surgeon’s choice. 24 patients (80%) had a cervical cerclage to aid future pregnancies.  
 
Pre- / Intra- / Post- operative characteristics 
Patient characteristics 
Age 32.5 years (mean) 
Follow-up 24 months (median) 
 Number of patients (%) 
FIGO Classification 
 
Stage IA2 
 
Stage IB1 
 
Stage IB2 
 
Stage IIA 
 
 
2 (6.7) 
 
25 (83) 
 
2 (6.7) 
 
1 (3.3) 
Histological Type 
 
Squamous 
 
Adenosquamous 
 
Adenocarcinoma 
 
Glassy cell carcinoma 
 
 
15 (48) 
 
4 (13) 
 
10 (32) 
 
1 (3.2) 
Intra-operative / Post-operative characteristics 
Mean Operative Time 
(minutes) 
170 (110-300) 
Median number of lymph nodes retrieved 24 (7-52) 
 Number of patients (%) 
ART - open approach 
ART - laparoscopic approach 
27 (90) 
3 (10) 
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Post-operative Antibiotics 8 (27) 
Estimated Blood Loss 813 ml (50-4500) 
Transfusion 6 (20) 
Lymphatic invasion 3 (10) 
Post-operative complications 14 (47) 
Re-operation 3 (10) 
Recurrence 3 (10) 
Survival Rate 28 (93) 
Pregnancy Rate 3 (10) 
 
Table 1.1 Pre- / Intra- / Post- operative characteristics 220 
 
Recurrence and Mortality 
 
28 patients (93.3%) who underwent ART are alive at the time of writing this manuscript, with a 
median follow up of 24 months (range 7-113 months). Two patients have died following recurrence of 
disease. One patient (30 years of age) presented ten months after her ART for stage IB1 cervical 
adenocarcinoma (diagnosed in June 2006) with non-specific respiratory symptoms, breathlessness and 
intermittent pleuritic chest pain, as well as several lumps situated in the anterior abdominal wall. 
Imaging revealed a highly suspicious right lung and abdominal wall lesions with para-tracheal 
lymphadenopathy. CT guided biopsies demonstrated neoplastic lesions of identical histology as the 
original cervical cancer, mucinous adenocarcinoma, and therefore, confirmed a metastatic picture. 
The patient underwent surgical removal of the abdominal masses and several cycles of 
chemoradiotherapy but died in 2008, twenty-two months after her initial diagnosis. 
 
The second patient also underwent ART for stage IB1 cervical adenocarcinoma. A follow-up MRI 
three months post-ART revealed extensive disease in the anterior portion of the uterus, invading 
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towards the bladder and posteriorly towards the rectum. She was treated with radical 
chemoradiotherapy and 2 months post-treatment, a new MRI scan showed residual disease still 
present and new lung nodules, thus confirming further metastatic disease. As her condition worsened, 
the patient underwent a defunctioning colostomy formation following admission for large bowel 
obstruction. She died 11 months after diagnosis.  
 
One other patient has presented with disease recurrence (November 2010). She was diagnosed with a 
grade 2 squamous cervical carcinoma (stage IB) in November 2007 and underwent ART with bilateral 
pelvic lymphadenectomy (24 lymph nodes, all clear). Resection margins were tumour free. Her post-
operative recovery period had been uneventful until the time of recurrence. It consisted of a pelvic 
mass, extending to pelvic side walls and pressing against rectum and bladder, with right ovarian 
involvement. She underwent chemoradiotherapy with no subsequent evidence of persistent disease. 
 
Pregnancy 
 
Prior to ART, four patients had a history of pregnancy, with only one patient out of the four reporting 
the birth of a healthy baby. The other three patients had suffered a miscarriage(s). Ten patients 
reported a desire to conceive during the follow-up period. Fertility treatment or oocyte 
cryopreservation was not sought by any of the patients prior to ART. The mean age of this particular 
group was 30 years (range 26-36 years), with a median follow up of 53 months (range 11-113 
months). The pregnancy rate was 30%, with two of the patients delivering successfully. 
  
Two patients conceived spontaneously four and five years after ART respectively and both 
experienced an uneventful pregnancy. Healthy term female infants were delivered at 37 weeks 
gestation via a Caesarean Section. Noting the sole reliance on ovarian vessels for uterine perfusion 
during pregnancy, we were reassured by the weight of the ‘term’ babies, which were within normal 
range. The third patient conceived six years post-ART via IVF but had to undergo a termination of 
pregnancy at 17 weeks gestation. This was a consequence of spontaneous rupture of membranes and 
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subsequent fulminating chorioamnioitis. Notably, all three patients had a cervical cerclage suture 
inserted at the time of ART, with the suture removed in the chorioamnioitis case. 
 
1.4. Discussion 
 
The drive behind UTx research was fuelled by initial work in ART, another fertility-preserving 
surgical procedure used to treat early stage cervical carcinoma. Although worldwide, most cervical 
cancer patients are treated with hysterectomy, fertility-preserving methods are becoming more 
accepted and available as the survival rates continue to mimic those of a radical hysterectomy.221 This 
important treatment alteration followed the realisation that the uterine body can be preserved without 
apparent compromise of therapeutic efficacy.221 The current accepted fertility-preserving procedure in 
Europe and Canada is VRT with laparoscopic pelvic lymphadenectomy, with over 600 cases reported 
in literature, and therefore, the largest experience to date as a method of fertility-sparing surgery in 
early cervical cancer. ART is becoming a favoured fertility-sparing procedure in the UK and is well-
established in the USA, with extremely promising and improved oncological results (1.9% recurrence 
rate in tumours < 2cm following ART) but worse fertility outcomes in comparison to VRT (15.5% 
versus 30% of all pregnant women from the international series), for tumours < 2cm in size.222 
 
When looking at the literature, ART seems to be a reasonable option for selected patients whose 
tumours are < 2cm in diameter. We are aware that the fertility rates currently favour VRT and this 
issue requires further investigation. Despite this, we believe that in future, gynaecological oncologists 
should consider both ART and VRT with every patient diagnosed with early stage cervical cancer 
(tumour size < 2cm) who wish to preserve their fertility. The choice should depend on the eligibility 
criteria (Box 1.1), treatment centre, availability of trained personnel and patient choice. The patient in 
particular should be made aware of recurrence, mortality and fertility outcomes of ART and VRT, as 
well as the experience of surgeons at that institution in both procedures. The techniques for an open 
ART and routine radical hysterectomy are extremely similar. Therefore, in theory, a learning curve 
should not exist as more trainee surgeons should be able to master the operative techniques of open 
  - 122 - 
Box 1.1     Eligibility of patient for ART - What are the criteria? 220 
Cervical carcinoma: FIGO Stage IA1 with lymph-vascular space involvement (LVSI) or  
Stage IA2 / IB1 
Histological sub-types: squamous, adenosquamous, adenocarcinoma 
No evidence (clinical or radiological) to suspect extra-pelvic spread or lymph node metastases 
Lesion size greater than 2cm 
Desire to preserve fertility 
No diagnosis or indication to suspect infertility 
Favourable age (relating to fertility outcomes) 
 
ART relatively easily because radical hysterectomy is readily taught and reproducible in any 
gynaecologic oncology unit. The overall incidence of intra- and post-operative complications is likely 
to be lower with ART than with VRT when performed in average-sized gynaecologic oncology 
centres. This cohort of patients supports this theory with no intra-operative injury demonstrated. Only 
three patients required further surgical re-intervention because of complications related to the 
operation: surgical treatment of haematocolpos, laparoscopic repair of an omental prolapse and low 
transverse laparotomy, ovarian cystectomy and adhesiolysis. With regards to urinary symptoms, only 
one patient experienced a single episode of urinary retention in the first month post-operatively. 
 
ART is a safer option with regards to bulky, exophytic or > 2cm tumours as the extent and location of 
tumours this size and shape require increased radicality of parametrial, sacrouterine, vesico-cervical 
and pelvic lymphatic tissue resection, which is not possible with VRT, where the approach limits the 
parametrial resection to tissue in the medial half of the broad ligament. With regards to the two deaths 
from this cohort, one of the patients was advised that ART would not give her the greatest chance of 
cure because of her bulky tumour mass (>4cm). However, she still opted for ART for fertility reasons 
(patient was only 29 years of age at time of diagnosis), which unfortunately did not lead to recovery. 
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Fertility 
 
Only ten of our cohort attempted to conceive, in part due to our earlier recommendation that each 
patient waits for two years following the procedure while undergoing close surveillance. This 
recommendation has now changed to one year. Our pregnancy rate (when focusing on the sub-group 
who attempted to conceive) was 30%, and delivery rate 20% (term pregnancies). This is comparable 
to the rates reported in literature; worldwide, 194 patients have undergone ART, 15% became 
pregnant and 10% delivered.222 Furthermore, when compared to the fertility rate following 
hysterectomy (0%), one can immediately see that as a fertility-sparing procedure, ART is a definite 
success. 
 
Ungar et al have reported previously the birth of two healthy term infants and the loss of 3 fetuses in 
the 7th, 8th and 15th gestational weeks of five pregnant patients who underwent ART (Hungarian 
patient cohort).216 The patients were followed-up for 40 months with no record of relapse. However, 
on closer analysis of the ‘lost’ fetuses, we note that 2 of these 3 were in fact the first 2 cases 
performed. We believe this to be of significance because since then, the surgical technique has 
improved as both knowledge and experience of the procedure have advanced.  
 
The potential use of ART in pregnant women during the second trimester is an added challenge that is 
currently being a debated. Management of cervical cancer during pregnancy depends on five factors: 
stage of the disease (and the tumour size), nodal status, histological subtype of the tumour, term of the 
pregnancy, and whether the patient wishes to continue her pregnancy.223 The gynaecological team has 
three choices when deciding upon treatment during pregnancy. First is a radical hysterectomy with 
termination of pregnancy. Second is a planned delay in treatment until delivery. Finally, the third 
option is chemotherapy until lung maturation has occurred, both followed by a radical hysterectomy.10 
The trachelectomy approach in early gestation is feasible and may result in the most favourable 
oncologic and obstetrical outcomes when compared to the above three options. It also offers the added 
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bonus of preservation of future fertility. In addition, it is worth highlighting that the role of adjuvant 
therapy in node-positive post-ART patients deserves further investigation.223 
 
We believe that trachelectomy should now be offered as a first line treatment in very specific cases of 
women diagnosed with early stage cervical cancer during pregnancy. It is a cost-effective, feasible 
and safe treatment option. Both ART and VRT should be considered prior to deciding which 
operation is more suitable for treating tumours <2cm in diameter. For tumours >2cm in diameter, 
ART seems to be the most appropriate choice.  
 
Certain criteria must apply in order to arrive at a carefully chosen group: (a) Patient diagnosed with 
early stage cervical cancer during second trimester pregnancy; (b) Trachelectomy should be offered 
only in specialist gynaecologic oncology centres with long-standing experience of performing this 
procedure; (c) Loss of fertility and/or loss of fetus secondary to a standard hysterectomy will impact 
considerably on patient’s quality of life; (d) The benefits of performing trachelectomy far outweigh 
the risks; and (e) The final decision should rest with a fully informed and consented patient in all 
cases. The discussion regarding the management of the patient should take place within a 
gynaecologic oncology multidisciplinary team meeting, with pre-operative counselling and post-
operative support already in place.  
 
In conclusion, radical trachelectomy may expand the management options for pregnant women 
diagnosed with stage IB1 cervical cancer who wish for both immediate cancer treatment as well as 
prevention of definitive pregnancy termination. We look forward to more publications on this topic, 
with further welcome news regarding successful pregnancies post-trachelectomy performed during a 
second trimester. This data should be accumulated but more importantly openly discussed in order to 
verify the strengths, weaknesses, efficiency and safety of the technique.216 Only successful outcomes 
with regards to both cancer clearance and fertility preservation can resolve any arguments relevant to 
the moral, ethical and financial aspects of performing a trachelectomy procedure in a pregnant 
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woman. Furthermore, we strongly encourage surgeons to report in detail post-operative outcomes, 
including complications, length of follow-up, and future fertility outcomes. 
 
Limitations 
 
We acknowledge, however, that our conclusions have their limitations, mainly as a result of the size 
of our data set and duration of follow-up. Our data set includes only 31 patients and the median 
follow-up length of time is only 24 months. 
 
The fact that the final decision rests with the principal surgeon was perfectly highlighted when you 
apply the ART eligibility criteria (Box 1.1) to our data. Our patient cohort ‘disagreed’ with the criteria 
on two accounts: size and stage. Imaging revealed only five patients with tumour size > 2cm and 3 
patients were diagnosed with a stage IB2/IIA tumour. With respect to the latter 3 patients, all are still 
alive at the time of writing. Our conclusions below are partly based on these findings. 
 
Finally, it is worth asking the question whether ART is an adequate fertility-preserving procedure 
when only a third of the cohort attempted to become pregnant post-ART and the mortality rate was 
6.7%. This proposition can be rejected when looking closely at the results. One of the two patients 
that died was advised against ART. Second, all women in our cohort underwent ART as opposed to 
radical abdominal hysterectomy in order to preserve their fertility for the purpose of future pregnancy. 
A third of the cohort has tried to get pregnant post-ART but this is only to date (median follow-up: 
two years). From the remaining 20 patients who have not attempted pregnancy, some did not have a 
partner/were not married at the time of the operation, whereas others felt that they wanted to wait 
longer prior to starting a family. Hence, the low number of women attempting to conceive to date 
should not be confused with the fact that all of our ART patients were hoping to fall pregnant 
eventually. 
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Need for a RCT? 
 
Ultimately, we believe that for patients wishing to preserve their fertility and diagnosed with early 
stage cervical cancer, the next stage of trachelectomy research should be a treatment comparison 
between abdominal and vaginal RT (open and laparoscopic) in a large-scale, multi-centre, prospective 
randomized trial of ART vs. VRT vs. cone biopsy and lymphadenectomy for lesion size 0–2cm, 
correlating recurrence rates and fertility outcomes as primary end-points. If fertility is no longer an 
issue, then vaginal RT vs. RH is also a valid trial. No such trials exist in the literature.224 
 
We do not believe that it is ethically acceptable to do a trial of abdominal RT compared to vaginal RT 
for lesion size 2–4cm because of Dargent’s high recurrence rates after VRT of tumours >2cm 
(6/27).225 Secondary aims should try to define the incidence of specific post-operative complications 
within the three trial groups, arrive at a more suitable method of pre-operative patient selection for a 
specific procedure and investigate how to apply adjuvant therapy in node positive patients. A closer 
look at surgical techniques employed in the formation of a neocervix, application of a permanent 
cervical cerclage suture (and timing: during ART or pregnancy) and the process of re-anastomosis are 
also worthy of study. To provide quality assurance of surgical technique between hospitals, a limited 
number of centres with recognized surgical skills to perform this procedure should be included first. 
Another trial option may be to randomize patients between either ‘a radical trachelectomy and 
lymphadenectomy (any approaches)’ and ‘simple trachelectomy and lymphadenectomy’ for small 
volume lesions, as recent literature is slowly suggesting that radical surgery is probably not necessary 
in most cases. We hope that information gained from the research proposed above would greatly 
improve our understanding of fertility-sparing surgery and ultimately demonstrate its appropriateness 
in treating the patient group highlighted in this study, with respect to oncological safety and 
pregnancy outcomes. 
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Relevance to UTx 
 
The ART patient series described in this report represents the largest data set from a single institution 
in the UK. Fertility outcomes and the role of adjuvant therapy in node-positive, post-ART patients 
deserve further investigation. We also believe that ART should qualify as a ‘required skill’, and 
therefore, feature on the Gynaecologic Oncology surgical curriculum.  
 
There is an ultimate benefit with respect to UTx research. First, as a fertility-preserving procedure, it 
can raise awareness of other such procedures such as UTx and lesser known operations, for example 
Modified Strassman Procedure (MSP). The standard management of placental site trophoblastic 
tumours is a radical hysterectomy with pelvic lymph node sampling. MSP is an alternative fertility-
sparing technique. Saso et al presented five cases who underwent MSP to treat a presumed solitary 
uterine placental site trophoblastic tumour.174 Following surgery, all patients remained in remission. 
Only one patient has remained in remission with her fertility intact. The other four underwent a 
completion hysterectomy because of possible incomplete excision of the disease. No residual disease 
was later found in two of these four uteri.4 Since then, the sole patient who had her fertility preserved 
has delivered a healthy, term baby. Therefore, an MSP can be added to an ever-growing list of 
gynaecological surgical procedures which are both curative and fertility preserving. Apart from 
radical trachelectomy (vaginal and abdominal), other cases described involve the first case of fertility 
sparing surgery for a giant adenomatoid tumour of the uterus (a tumour previously managed by 
hysterectomy),226 a successful cessation of haemorrhage in a patient with a ruptured cornual ectopic 
pregnancy without recourse to hysterectomy,175 and the surgical management of uterine arterio-
venous malformation where selective temporary ligation of the uterine and ovarian vessels was 
applied.227  
 
Second, the surgical techniques required to carry out ART overlap significantly with the graft retrieval 
and anastomotic aspect of the UTx procedure. Finally, lessons learned from ART with regards to 
uterine perfusion can be applied to UTx. Namely, the fact that the uterus remains viable if supplied by 
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two vessels out of the six that supply it (three pairs of ovarian, uterine and vaginal arteries). Post-
ART, the uterus is most commonly supplied and drained by the left and right ovarian vessels only. 
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STUDY 2a 
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2. Study 2a: Uterine allotransplantation in a rabbit model using aorto-caval anastomosis: 
a long-term viability study 
 
This study has now been peer-reviewed and published as per following reference: Saso S, Petts G, 
Chatterjee J, Thum MY, David AL, Corless D, Boyd M, Noakes D, Lindsay I, Del Priore G, Ghaem-
Maghami S, Smith JR. Uterine allotransplantation in a rabbit model using aorto-caval anastomosis: a 
long-term viability study. Eur J Obstet Gynecol Reprod Biol 2014; 182C:185-193.  
 
Abstract 
 
Objective: Uterine transplantation (UTx) has been proposed as a treatment option for women 
diagnosed with absolute uterine factor infertility. Allogeneic UTx has been attempted in a number of 
animal models, but achieving an adequate blood supply for the transplanted uterus still presents the 
biggest challenge. Microvascular re-anastomosis was unsuccessful in a number of animal models. The 
aim was to assess whether a large vessel aortic-caval vascular patch technique can bring about long-
term graft survival after allogeneic UTx in a rabbit model. 
Study Design: A longitudinal study involving uterine cross transplantations (n=9 donors, n=9 
recipients) was performed in New Zealand white rabbits using an aortic-caval macrovascular patch 
harvested as part of the uterine allograft. All rabbits were allogeneic and of proven fertility, with at 
least one previous litter each. The end result of the donor graft harvest was a total hysterectomy 
transecting across the vagina and the most lateral aspects of the uterine horns together with an aortic-
caval macrovascular patch (aorta, inferior vena cava, common and internal iliacs, and uterine arterial 
and venous tree). Tacrolimus (500μg twice daily) was administered for immunosuppression post-
transplant. The recipients were closely monitored until death or euthanasia. 
Results: In this case series, long-term rabbit survival was 11% (n=1). Surgical survival was 56% 
(n=5). Three rabbits (UTx #3, #4 and #8) died intra-operatively as a result of blood aspiration, 
ventricular hematoma, and massive haemorrhage. Three does (#1, #2, #7 and #9) died within the first 
24h as a result of the veno-vena and anastomosis breakdown. Does #6 and #9 died secondary to pre-
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operative pneumonia and a pulmonary embolus, respectively. Only one rabbit survived longer than a 
month. 
Conclusion: Our method used a macrovascular patch technique to ensure adequate blood supply to 
the donor uterine graft. We have demonstrated the feasibility of uterine allotransplantation using this 
technique in the rabbit, but were unable to demonstrate a higher long-term survival percentage 
because of issues related to using a rabbit model. 
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2a.1. Background 
 
Various models, both small-animal (mouse, rat, dog, and rabbit) and large-animal (sheep, pig, and 
primate) have been used to study different aspects of UTx.4 In this chapter, efforts to perform UTx in 
a rabbit model are described. Thus, the focus with respect to surgical techniques will be on small 
animal models. The literature review has already been covered in an earlier chapter titled ‘Literature 
Review’. The next chapter deals with a large animal model.  
 
Aims 
 
The primary aim was to investigate anatomical and surgical aspects necessary for a successful UTx. 
In those recipients that survived the surgery, the (secondary) aim was to characterise the 
immunological mechanisms involved in allogeneic UTx (rejection patterns) and suppress acute 
rejection with an adequate immunosuppression regimen. Finally, the tertiary aim was to assess 
whether fertility (conception, pregnancy and fetal well-being) was possible following orthotopic, 
allogeneic UTx, whereby the recipient had demonstrated long-term survival and had been 
administered immunosuppression. Presented also is a comparison of pre- and post-operative 
reproductive and multi-organ function. 
 
2a.2. Materials and Methods 
 
Rabbit model 
 
The feasibility of the uterine allograft dissection together with its vascular supply that includes the 
internal and common iliacs, the AA and the IVC was first ensured by a series of uterine 
transplantations in the rabbit model performed by this team.3 Here, we performed two surgically 
explorative procedures and nine allogeneic uterine cross transplantations in the rabbit model using a 
pre-determined protocol. 
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18 New Zealand white rabbits were used as donor and recipient animals (nine donors, nine recipients). 
None of the transplants were syngeneic; all were allogeneic. The animals were acquired a few days 
before the operation to ensure appropriate acclimatization to their surroundings. The rabbit uterus is 
similar in shape to the rat/murine uterus. It is composed of two long horns, approximately 7-9cm in 
length and 1cm in width, which join in the midline to form a single uterine cavity-like structure 
(Figure 2a.1a-b). 
 
Surgical protocol 
 
This particular surgical procedure has already been described in detail.3 A brief outline is provided 
below. The donor rabbit was anesthetized using a combination of intramuscular ketamine (35mg/kg) 
and xylazine (7mg/kg). After intubation, anaesthesia was maintained with 1.5–2.0% isoflurane. The 
anterior abdominal wall was shaved and cleaned, and the abdomen was opened through a midline 
incision. The end result of the donor graft harvest was a simple hysterectomy transecting across the 
vagina and the most lateral aspects of the uterine horns together with an aortic-caval 
macrovascularpatch. Following graft harvesting, the AA was cannulated and the uterine specimen 
with its vascular patch was generously flushed with heparinised normal saline and transplant storage 
solution, Histidin-Tryptophan-Ketoglutarat (HTK). 
 
The uterine allograft along with the AA, IVC, common and internal iliacs, and uterine arterial and 
venous tree all intact were harvested en bloc. The uterus was flushed and subsequently stored for 90 
minutes in the Celsior solution, between 2°C and 8°C while the recipient doe was being prepared. The 
recipient animal was anesthetized and prepared in a similar manner as the organ donor and injected 
with 250 IU subcutaneous heparin. A midline laparotomy was performed, and the loose connective 
tissue overlying the infra-renal aorta and IVC were removed to expose this area of the major vessels. 
Soft tissue vascular clamps were placed first around the recipient’s AA. A longitudinal cut (4mm  
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Figure 2a.1a and Figure 2a.1b. Rabbit uterus with ‘macrovascular patch’. The first figure is a 
photograph of the recipient uterus following hysterectomy. The macrovascular path showing the AA 
and IVC is clearly shown. The second figure shows the graft uterus immediately after the end-to-side 
AA and IVC anastomosis. 
Left cornua Right cornua 
Cervix 
Common 
iliac vessels 
Aorta and IVC 
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length) was made in the anterior aortic wall to create an opening. An end-to-side anastomosis was 
performed to the AA of the graft using 6-0 Prolene sutures. A total of six to eight stitches were used 
for the aortic connection. A similar procedure was carried out for the cava-cava end-to-side 
anastomosis. The vagina was anastomosed initially to ensure proper orientation and positioning of the 
specimen followed by the aorto-caval patch, end-to-side vascular re-anastomosis to the recipient’s 
AA/IVC, ensuring vascular integrity, haemostasis, and patency. The uterine horns were finally 
rejoined. Successful reperfusion of the graft was judged on the colour shift of the uterus during 
reperfusion from its blanched appearance after flushing to a more reddish colour. Blood flow past the 
venous and arterial anastomotic sites was also ensured. 
 
The graft retrieval and transplant was performed by Mr J. Richard Smith and Dr S Saso. The vascular 
anastomosis was carried out by Mr DJ Corless (Consultant Upper GI Surgeon, Mid Cheshire 
Hospitals Trust), with Mr JR Smith and Dr S Saso assisting. Dr M Boyd (Veterinary Anaesthetist, 
Royal Veterinary College) was the anaesthetist for all nine transplants. Blood samples from the does 
were taken by either Dr M Boyd or Dr S Saso. Advice on technical aspects and rabbit physiology 
during a major surgical procedure was given throughout by Professor D Noakes. 
 
Medication 
 
Subcutaneous heparin 250 IU was given to the donor before organ procurement and to the recipient 
pre- and intra-operatively to prevent thrombosis. Empirical immunosuppression was administered in 
allotransplants #4-#9 using CsA and hydrocortisone (intravenous intra-operative doses of 10µg/kg 
and 40mg respectively) commenced during the vascular patch anastomosis, followed by oral 
tacrolimus (500μg twice daily postoperatively) and prednisolone (10mg post-operative days 1-4 and 
5mg post-operative days 5-7). Quinolone enrofloxacin (Baytril) was used as antibiotic prophylaxis at 
an intra-operative dose of 5 mg/kg through a slow intravenous infusion. 
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Post-operative course 
 
The rabbits were closely monitored post-operatively within a specialist enclosure at The Royal 
Veterinary College, London. Multiple siring of transplanted rabbits occurred during this period. Heart 
rate and oxygen saturation were recorded daily in the first two weeks with twice weekly 
measurements taken subsequently until their demise. They were allowed to eat ad libitum and were 
fed with autoclaved hay as well as with a proprietary pellet called GD99 that contains a coccidiostat.  
 
The room temperature varied between 19ºC and 21ºC, with a relative humidity of 47-62%. Their 
lighting schedule was 12 hours on and 12 hours off. Close collaboration with veterinary specialists 
was extremely important, and all work undertaken was strictly under the Animals (Scientific 
Procedures) Act 1986. 
 
Post-mortem & Histopathology 
 
All post-mortems were performed within two hours of the rabbit dying. The same laparotomy incision 
as used in the actual surgery was opened and extended to become a thoraco-laparotomy. The thoracic 
and abdominal cavities were inspected, including the macrovascular patch, the uterine graft and each 
organ individually (heart, lungs, liver, kidneys, spleen). These organs were then placed in 
formaldehyde to fix the tissue and prepare it for histopathology. An incision was made on the uterine 
cornua to allow for the formaldehyde to access the inside of the cornua. 
 
The gross morphology findings were recorded according to a scoring system previously validated by 
the Brannstrom team 117 and also used by Diaz-Garcia et al in UTx.109 The following characteristics 
were evaluated by the scoring system: (a) abnormal appearance of the uterus (colour, texture and 
hardness); (b) presence of adhesions; and (c) thrombosis of the graft vessels (both artery and vein). 
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Prior to haematoxylin & eosin (H&E’s) staining, tissue was cut and placed on slides, with the 
assistance of Dr Iain Lindsay (Consultant Pathologist, St Mary’s Hospital, London). All routine 
H&E’s were stained on the Tissue-Tek staining machine. The haematoxylin dye is a poor dyeing 
agent. To obtain purposeful results it needs to be converted to its oxidation product haematin. This is 
achieved by the use of an oxidising agent such as mercuric II oxide (HgO). Before this conversion is 
brought about, haematoxylin is added to an aqueous solution of aluminium potassium sulphate. This 
is the mediating step, where aluminium ions combine with the haematoxylin dye. The resultant 
aluminium-haematin complex then stains via the metal ion - Al++. Haematoxylin possesses acid-base 
indicator properties (red in acid - blue in alkali solutions) so the stained tissue components must be 
'blued' after differentiation using an alkaline solution (London tap water or a blueing agent). This then 
allows the rest of the tissue components to be counterstained as desired (normally eosin). The sections 
are first immersed in water. Visible nuclei are then stained in Harris haematoxylin for five minutes. 
This is then followed by a wash in water and differentiation in 1% acid alcohol. The well is washed in 
water and ‘blue’ in Scott’s water. Subsequently the sections are all washed in water again, followed 
by staining in 1% eosin Y for five minutes. Washing in water implies de-waxing in xylene in 1-2 
minutes, then in 99% alcohol for 10 seconds which is repeated three times and finally repeated in 
running tap water for 10 seconds. A repeat wash in water, followed by dehydration, clearing and 
mounting. This implies the following method: dehydration in 99% alcohol for 10 seconds repeated 
three times, clearance in xylene for 20 seconds and mounting on cover-slipping machine. 
 
Immunological, reproductive and organ profiles 
 
Blood samples and donor grafts were used for the experiments. We have performed nine allogeneic 
UTx in the rabbit model: 
 
3 transplants (no immunosuppression):  (3 donors, 3 recipients) 
6 transplants (immunosuppression): (6 donors, 6 recipients) 
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Peripheral blood samples (6ml - 4ml for immunological profile and 2ml for reproductive and organ 
profiles) were obtained from the marginal auricular vein or artery and placed into sterile heparin-
containing anticoagulant tubes on the following post-transplant days: D0 (prior to transplant - control 
group), D5, D12, and from then onwards at weekly intervals until (depending on which occurred first) 
either the rabbit died or the time of the Caesarean section providing pregnancy had been achieved.  
 
Markers of rejection consisted of all lymphocytes, circulating T lymphocytes - CD4+ T helper cells 
and CD8+ cytotoxic cells - B lymphocytes and monocytes/macrophages. 
  
Hormones levels measured with regards to presenting a reproductive profile were as follows: Follicle-
Stimulating Profile (FSH), Luteinising Hormone (LH), Testosterone, 17β-oestradiol and progesterone. 
 
Standard biochemistry markers were used to assess organ function: urea and electrolytes (U&Es), 
creatinine for kidneys, liver function tests (LFTs) for the liver, albumin for general metabolic function 
and C-reactive protein to monitor the inflammatory process.  
 
Tacrolimus levels were also measured to therapeutic levels.   
 
With regards to the isolation of peripheral blood mononuclear cells (PBMCs), blood obtained from 
the transplanted rabbit was first placed into a Falcon tube and subsequently centrifuged at 1500rpm 
for 5 minutes to separate the plasma and supernatant. The separated plasma was collected and stored 
in cryovials at -20oC to -80oC for future functional studies (five cryovials containing the following 
volumes: one cryovial of 1ml and four vials of 250μl). The remaining plasma supernatant was 
discarded. The plasma free blood was then layered over Histopaque/Ficoll (solution containing 
polysucrose and sodium diatrizoate, adjusted to a density of 1.077 g/mL, Sigma-Aldrich 
Biotechnology LP and Sigma-Aldrich Co.-10771, Axis Shield, Cambridge, UK) in a 1:2 ratio (blood 
pellet is first diluted with Phosphate Buffer Saline, PBS in a 1:1 ratio) and centrifuged at 2500 rpm for 
25 minutes at room temperature with no brake. Composition of PBS was as follows: 8g NaCl, 0.2g 
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KCl, 1.44g Na2HPO4, 0.24g KH2PO4. The mononuclear cells formed a white layer (‘buffy coat’) 
which was removed using a pipette and transferred into a clean tube. Cells were then washed in PBS 
three times. Any red blood cell (RBC) contaminants were removed by re-suspending the pelleted cells 
in a RBC lysis buffer for 10 minutes at room temperature. Lysed cells were subsequently removed by 
washing in PBS. The number of PBMCs extracted from 4ml of rabbit blood ranged from 6-60 million 
cells.  
 
Flow cytometry was the next step. PBMCs were washed and counted. They were then re-suspended in 
PBS in eight FACS tubes. The number of PBMCs pipetted into each FACS tube ranged from 
600,000-1.3 million cells. Antibodies were added at the appropriate dilution (Table 2a.1), and the 
cells were incubated in the dark on ice for 15 minutes. Optimal antibody concentration was based on 
titration experiments. Following washing with 1ml of PBS and subsequent centrifuging at 1500rpm 
for 5 minutes, cells were incubated with a secondary antibody (goat anti-mouse IgG:FITC), or if the 
primary antibody was directly conjugated, cells were re-suspended in around 100μl of PBS. PBMCs 
which required a secondary staining (in bold in Table 2a.1) were re-suspended in PBS containing the 
secondary antibody for a further 15 minutes in the dark on ice. Cells were then washed a further time 
in 1ml of PBS. The antibody stained cell suspension was then transferred to FACS tubes containing 
300μl of PBS for FACS analysis using the FACScalibur (Becton Dickinson) and analysed using the 
FlowJo software (Tree Star, Inc.). The machine was set to analyse exactly 10,000 cells/FACS tube. 
Both forward (cell size/volume) and side scatter (cell granularity) detectors were aimed at the column 
of cells passed through the FACScalibur. The unstained and mouse IgG1 antibody stained samples 
were used as negative controls for this experiment. All cells located to the right of the latter group on 
the scatter plot were defined as being positive for the marker in question. 
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Marker Antibody Target Fluorochrome Concentration Source 
Mouse IgG1 Negative control FITC 10μl/106 cells AbD Serotec 
Mouse Anti-Rabbit CD4 ‘Helper’ T lymphocytes FITC 3μl/106 cells AbD Serotec 
Mouse Anti-Rabbit CD8 
‘Cytotoxic Killer’  
T Lymphocytes 
FITC 3μl/106 cells AbD Serotec 
Mouse Anti-Rabbit CD25 Activated T cells FITC 3μl/106 cells AbD Serotec 
Mouse Anti-Rabbit  CD11b Monocytes/Macrophages FITC 3μl/106 cells AbD Serotec 
Mouse Anti-Rabbit CD45 All lymphocytes FITC 3μl/106 cells AbD Serotec 
Goat Anti-Rabbit IgM:FITC B cells FITC 2μl/106 cells AbD Serotec 
Secondary Antibody 
Goat Anti-mouse IgG:FITC IgM (B cells) FITC 1μl/106 cells AbD Serotec 
 
Table 2a.1 List of antibodies used for FACS analysis  
 
Pregnancy 
 
The protocol was prepared by the rabbit fertility team of the Polytechnic Institute, Valencia, Spain, 
led by Professor Jose Vicente. It has already been described in Dr Gamal Mehaisen’s thesis, 
supervised by Professor J Vicente. Sixty hours before insemination time, superovulation was induced 
in nine donor does following subcutaneous injection of 20IU/kg of eCG (Gonaser, Hipra, S.A.). 
Ejaculates from five proven males were collected using an artificial vagina. A 10µL aliquot samples 
from ejaculates were diluted 1:10 with Tris-citrate-glucose extender (250mM tris-
hydroxymethylaminomethane, 83mM citric acid, 50mM glucose, pH 6.8-7.0, 300 mOsmkg-1) for a 
previous motility rate evaluation. Ejaculates with an estimated motility higher than 70% were pooled. 
From ejaculates, two aliquot sample of 10µL were taken. The first sample was diluted 1:10 with Tris-
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citrate-glucose extender for motility rate evaluation in a computer assisted sperm analysis (CASA) 
system. The second sample was diluted 1:10 with 1% of glutaraldehyde solution in phosphate 
buffered saline to calculate the concentration in a Thoma chamber and to evaluate both the 
percentages of normal intact acrosome and abnormal sperm by phase contrast at a magnification of 
x400. Only ejaculates with more than 70% of motility rate, 85% of normal intact acrosome, and less 
than 15% of abnormal sperm were pooled and used to inseminate donor does. Pooled semen was 
diluted to 40 million per milliliter adding Tris-citrate-glucose extender in order to elaborate the 
seminal doses. Donors were inseminated with a seminal dose of 0.5 ml.228,229 
 
Ovulation was induced in two does immediately following insemination by an intramuscular injection 
of 2μg of Buserelin Acetate (Hoechst, S.A.). The embryos were recovered in vivo by ventral midline 
laparoscopy 76-78 hours after the insemination, applying a method described by Besenfelder et al.230 
First, anaesthesia was induced by an intramuscular injection of 16mg xylacine (0.8ml of Rompun; 
Bayer AG, Leverkusen, Germany), followed by an intravenous reinjection of ketamine chlorohydrate 
(Imalgene; Merial, S.A., Lyon, France) to maintain does under anaesthesia during laparoscopy. Rabbit 
donor does were placed in a head-down position at a 45ºC angle. A Verres needle was inserted in the 
lower right abdominal quadrant and attached to CO2 automatic insufflator. After CO2 abdominal 
distension, a trocar-cannula unit of 5mm diameter was inserted into the abdominal cavity at 10cm 
caudal to the sternum. Another accessory (3mm diameter) trocar-cannula unit was inserted 4-5cm 
laterally to right of the former. After both were removed, they were respectively replaced by the 
laparoscope (Wolf paediatric 0º) and grasping forceps (length: 28.5cm). Subsequently, an epidural 
needle (inner diameter: 1mm, Vigor Epidural G17) was inserted near the ovary and a sterile 
polyethylene tube (inner diameter: 0.3 mm) attached to a 5ml sterile syringe was introduced for 2-3cm 
through the epidural needle into the oviduct. After fixation with the grasping forceps, ova and 
embryos were flushed from the oviducts to uterine horns with 5ml of Dulbecco´s phosphate buffered 
saline (DPBS, Sigma) containing 0.2 %  (w/v) of Bovine Serum Albumin (BSA, Sigma) and 
supplemented with antibiotics (200 IU/mL penicillin G and 0.25mg/mL dihydrostreptomycin; Penivet 
1). This was followed by flushing of the uterine horns, elevated with the grasping forceps placed near 
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the oviduct-tube junction, with 50ml of the same flushing solution. It was achieved via insertion of a 
sterile epidural needle directly through abdominal wall into each uterine horn. Finally, the recovery 
medium was aspirated from the vagina by a Foley Catheter (Minitube, Tiefenbach, Germany) 
connected with a vacuum pump of 20-40mmHg. After the recovery of does, the reproductive tract was 
washed with 0.1% ethylenediaminetetraacetic acid solution in PBS in order to prevent any abdominal 
adhesions post-laparoscopy.228 
 
In both groups, recovered embryos were scored by morphological criteria. Only embryos in the 
morula stage with homogeneous blastomeres as well as a visible regular mucin coat and zona 
pellucida were catalogued as normal embryos.67,71,228,231 
 
Vitrification and thawing process 
 
All normal embryos (morulae) were vitrified by the methodology described by Vicente et al.232 
Briefly, the vitrification procedure was carried out in two steps at 20ºC. In the first step, embryos were 
placed for 2 minutes in a vitrification solution consisting of 12.5% (v/v) dimethyl sulphoxide (DMSO, 
Sigma) and 12.5% (v/v) ethylene glycol (EG, Sigma) in DPBS supplemented with 0.2% (w/v) of 
BSA. In the second step, embryos were suspended for 1 minute in a solution of 20% (v/v) DMSO and 
20% (v/v) EG in DPBS supplemented with 0.2% (w/v) of BSA. Then, embryos suspended in 
vitrification medium were loaded into 0.125ml plastic ministraws (IMV, L´Aigle, France) between 
two drops of DPBS separated by air bubbles. Finally, the straws were sealed and plunged directly into 
liquid nitrogen. De-vitrification was performed in two steps, first ministraws were placed to 10 cm 
from vapour nitrogen until  vitrified fraction begin to cristalize (20-30 sec) and, then, submerged into 
a water bath at 20 °C for 10 sec. To remove the vitrification, warmed embryos were introduced into a 
culture dish containing 0.33 M sucrose in DPBS supplemented with 0.2% BSA, after 5 min embryos 
were washed in DPBS for another 5 minutes. Thereafter, 30 de-vitrified embryos were cultured for 48 
hours in Medium 199+20% FBS (Sigma) at 38.5ºC, 5% CO2 and saturated humidity to assess post-
vitrification viability. Twenty-four embryos reached a state of ‘hatchable’ blastocyst (80%).67,171,228 
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Embryo transfer 
 
The recipient doe was injected intramuscularly with 25IU of eCG 60 hours prior to induce the 
ovulation with an intramuscular injection of 2μg of Buserelin Acetate (Hoechst, S.A.). The transfer 
was performed by mini-midline laparotomy, using previous scar to enter the abdomen. The uterus was 
externalised to allow for ease of access. Seventeen intact de-vitrified embryos were placed in  cornua 
using an epidural catheter (G17, Baxter, Deerfield, Illinois, USA).228 
 
Pregnancy monitoring 
 
Experiments were carried out in the first four weeks following the above ET. 3ml of blood was taken 
at appropriate intervals during the gestational period to obtain a reproductive profile (βhCG, FSH, LH, 
Testosterone, 17β-Oestradiol and Progesterone). Furthermore, a colour Doppler ultrasound with a 
two-dimensional 7.5MHz (range: 7-10MHz) probe was used to monitor fetal development and 
growth. The protocol has been described already by Chavatte-Palmer et al.233 The ultrasound 
examination was performed from right to left with the probe in the sagittal orientation, following 
localisation of the urinary bladder. The initial scan was performed on Day 5 post-ET with the aim to 
judge whether any fetal sacks were present. Complete fetal sack examination is performed on a 
maximum of six fetuses (three first on the right and three first on the left) in order to try to avoid 
repeated measurements on one fetus. Subsequent scans are done at 3-4 day intervals until the day of 
the elective Caesarean section. With respect to measurements, for the fetal sack, they are made when 
the largest surface area appears on the screen. Important for growth, crown-rump length (CRL) is 
determined as the maximum distance from crown to tail basis with the fetus on a sagittal plane.154 
 
Data Presentation and Analysis 
 
Statistical analysis was not required for this study. Data has been presented using 2D graphs, 
histopathology slides, figures and descriptive tables. 
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2a.3. Results 
 
Three recipient does died intra-operatively. Five died within 24 hours. One doe survived long-term 
and was culled in the fourth post-operative month.  
 
The mean weight of the donor rabbits was 3.93kg (3.4-4.4kg) and of the recipient rabbits 437kg (3.8-
5.1kg). All rabbits were New Zealand White from an outbred strain. The first two UTx procedures 
were carried out with ‘virgin’ does. Recipient rabbits #3-#9 were all of proven fertility, having carried 
at least one litter in the past. Immunosuppression was given to recipients #4-9 as the initial aim was to 
characterise the acute rejection response using recipients #1-3. Operative details and hepatic, renal 
and reproductive profiles are outlined in Tables 2a.2 and 2a.3. Morphological findings are 
summarised in Table 2a.4. 
 
Intra- and Post-operative course 
 
Recipient #1 was euthanized Day 1 post-operatively (15 hours). Clinically, the rabbit appeared 
ischaemic and pale inferiorly from mid-abdomen and the hind legs were paralysed. On opening of the 
abdomen at post-mortem, a significant intra-abdominal collection of blood was revealed. Post-mortem 
examination and histology of fixed organs revealed a healthy looking and well perfused uterine graft. 
A haematoma at the right cornu-cornual anastomosis was visualised. The impression as to the cause 
of the rabbit’s demise was most likely an exsanguination due to bleeding from an anastomotic 
breakdown. It was not possible to confirm whether an aorto-aorta/veno-vena anastomotic breakdown 
had occurred histologically. Therefore an alternative explanation could be a slow bleed from a 
peripheral vessel (haematoma noted at the cornua), causing a large haematoma that put pressure on 
the iliac (or uterine vessels) causing the ischaemia of the lower limbs. The well perfused uterus 
supports this as it suggests that the major inflow aortic and major outflow veno-vena anatamoses were 
intact thus ensuring perfusion and prevention of congestion and stasis related ischaemia respectively. 
However, ultimately the cause of death is still exsanguination due to the operation. 
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Recipient #2 died Day 1 post-operatively (12 hours). The rabbit was initially well post-operatively but 
found dead between regular checks with early rigor mortis. At post-mortem there was significant 
intra-abdominal bleeding. Again, the impression as to the cause of the rabbit’s demise was 
exsanguination due to bleeding from an anastomotic breakdown, probably relating to intra-operative 
donor IVC injury. Major anastomotic breakdown was further supported following post-mortem 
examination and histology of fixed organs which revealed a dusky and veno-congested looking 
uterine graft suggesting poor perfusion. In this case the recipient uterine horns and utero-vaginal 
anastomoses appeared healthy suggesting that the recipient blood supply to these areas had remained 
largely intact.  
 
Recipient #3 died intra-operatively. The rabbit was anaesthetised and prepped. However during 
intubation, she bit her tongue and aspirated ~5-10ml of blood. As a result her respiratory rate and 
heart rate both increased and it took 30 minutes to stabilise the rabbit and proceed with surgery. 
Between the re-commencement of the hysterectomy and the start of recipient engraftment (32 
minutes), the recipient doe deteriorated and arrested four times requiring intravenous dose of 
adrenaline. Following the fifth arrest the decision was made to stop the surgery. Four anastomoses 
were completed before the rabbit died (vagina, left and right cornua, veno-vena). The cause of death 
was attributed to aspiration of blood resulting in cardiorespiratory arrest. 
 
Recipient #4 also died intra-operatively. As with the previous attempt, the donor graft, together with 
the macrovascular patch was harvested en bloc. Four anastomoses were completed before the rabbit 
died (vagina, left and right cornua, veno-vena). However this time the anaesthetic and surgical 
preparation had been uneventful but the doe arrested five times during the course of the surgery 
(adrenaline given for all four arrests) with the decision being made to stop the surgery after the fifth 
arrest. The cause of death was unknown at the time of the post-mortem. 
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Recipient #5 is the only long-term survivor at the time of writing (post-operative D74). Intra-
operatively she arrested twice during the uterine engraftment part of the surgery. However she was 
successfully rescued with adrenaline both times and experienced no further intra or post-operative 
problems. The abdominal wound had healed by the tenth post-operative day and normal patterns of 
behaviour such as self - grooming were re-established around the same time. She was mobilising well 
by the end of the second post-operative week. Her weight had returned to the pre-operative level by 
the end of the third week. She did not experience any further complications in the period up to D74. 
 
Recipient #6 was the third rabbit to die intra-operatively. This time the doe had arrested twice and was 
revived successfully both times. The actual transplantation was completed with the donor graft, 
together with the macrovascular patch harvested and grafted en bloc. All anastomoses were completed 
(vagina, left and right cornua, veno-vena, aorto-aorta) and the abdomen was closed before the rabbit 
was pronounced dead exactly two minutes post-abdominal closure. The cause of death was unknown 
at the time of the post-mortem. 
 
Recipient #7 followed a similar course to recipients #1 and #2. The team attempted a novel strategy 
where the cornua were not anastomosed in an attempt to decrease the time during which the doe 
anaesthetised. The cornua were left free-floating in the lower abdomen. Excellent vascular control 
was achieved with under-running of the IVC with fine ties and use of bulldog clamps. Shortening the 
length of prolene suture made for a faster and easier vena cava and aorta anastomoses. The aorta-cava 
was skeletonised with extensive skeletonisation (top 1.5cm aorta-IVC well separated), over an area of 
4cm. The uterine allograft along with the aorta, inferior vena cava, common and internal iliacs, and 
uterine arterial and venous tree all intact were harvested en bloc. Blood loss was minimal, four sutures 
were required for the two vascular anastomoses and following clamp removal the uterus appeared 
adequately perfused. The time under anaesthesia was decreased by 20 minutes compared to the six 
previous cases. The doe recovered well and was placed back into the cage where she showed 
immediate signs of alertness. Surgically the team felt that this novel surgical strategy had gone well. 
However, within 12 hours of the operation ending, the recipient was found dead. At post-mortem a 
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large haematoma was found in the abdomen and the vagina. However the uterus appeared well 
perfused. The source of the post-operative haemorrhage was not identifiable macroscopically and it is 
felt that it could have been bleeding from the un-anastomosed recipient cornua and/or tearing of the 
aorta-vena anastomoses secondary to twisting of the unanchored free-floating donor uterus cornua. 
 
Recipient #8 died intra-operatively. Donor and recipient hysterectomy were performed without issues. 
Ligaclips were used during graft retrieval during this operation and therefore, no difficulties arose 
with bleeding from perforators as seen on occasion with previous transplants. As with recipient 7 the 
practice of not placing a suture into the IVC prior to dividing the IVC and under-running of both the 
aorta and IVC with fine ties was continued. The aorta-cava was skeletonised with the same extensive 
skeletonisation as last time. However, unlike Recipient 7, tubal cornua were anastomosed this time 
and were not left free-floating. Excellent vascular control similar to UTx #7 was achieved. 
Unfortunately, a stitch in the aorta to prevent a small bleed that started twenty minutes after the team 
had completed the surgery caused a sudden estimated blood loss of 30ml, leading to demise. 
 
Recipient #9 received the final uterine graft in this series. Surgical technique was the same as with 
UTx #7 and #8. With regards to haemostasis, achieving adequate vascular control, and a successful 
IVC-IVC and AA-AA end-to-side anastomosis, the operation proceeded without concern. The doe 
was found dead in the first 24 hours of the operation finishing. No pooling of coagulated bloods was 
found in the organ, together with absence of any obvious pathology of the organs. The cause of death 
was unknown at the time of the post-mortem. 
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Table 2a.2 Operative details from the nine transplant procedures in the rabbit model showing 
retrieval, ischaemic, clamping, reperfusion and recipient hysterectomy times in minutes
UTx 
Graft 
Retrieval 
(min) 
1st Warm 
Ischaemia 
(min) 
Cold 
Ischaemia 
(min) 
2nd Warm 
Ischaemia 
(min) 
Clamp on 
(IVC/AA) 
(min) 
Reperfusion 
(min) 
Recipient 
Hysterectomy 
(min) 
Grafting 
(min) 
EBL 
(ml) 
1 120 6 90 125 35 / 17 15 40 125 35 
2 120 6 90 135 55 / 27 20 50 135 50 
3* 165 5 90 78* 37 / NA NA 45 78* 30 
4* 98 5 90 107* 27 / NA NA 40 107* 40 
5 110 8 90 153 39/ 25 17 45 153 20 
6 90 8 90 150 33 / 28 20 40 150 20 
7 80 8 90 122 34 / 20 15 30 122 20 
8* 90 7 90 118 38 / 24 20 35 118 20 
9 85 6 90 115 35 / 65 10 25 115 15 
Mean 106 6.6 90 131 40 / 29 16 39 131 28 
 - 149 - 
 
 
Key:  NA. Non-applicable, NM, Not Measured (lab error, insufficient sample received, haemolysed sample) 
 
Table 2a.3 Hepatic, Renal and Reproductive Profiles (Non-Pregnant Rabbit)
Marker 
UTx 1 UTx 2 UTx 3 UTx 4 UTx 5 UTx 6 UTx 7 UTx 8 UTx 9 
D0 D1 D0 D1 D0 D0 D0 D2 D6 D9 D13 D20 D36 D46 D60 D74 D0 D0 D0 D0 
Sodium 142 NM 140 NM 142 136 151 141 142 143 142 143 144 144 144 141 146 145 148 142 
Potassium 5.1 NM 4.5 NM 4.3 5.6 3.9 4.7 NM 4.3 4.5 3.8 3.8 4.0 NM 4.2 3.8 3.7 3.8 3.8 
Urea 7.2 NM 6.3 NM 6.2 6.8 8.9 21.8 12.2 7.6 6.2 6.8 5.8 6.7 7.6 7.2 10.7 6 7 5.9 
Creatinine 65 NM 82 NM 69 72 131 115 91 89 82 79 82 91 106 95 130 96 96 112 
AST 15 NM 22 NM 24 53 40 63 21 14 23 30 22 29 NM 25 25 21 17 18 
ALT 27 NM 16 NM 19 68 28 71 44 26 17 22 21 27 31 23 26 47 46 35 
ALP 38 NM 35 NM 34 31 41 21 NM 37 34 34 38 36 42 50 22 39 35 40 
Albumin 40 NM 32 NM 30 43 57 42 50 49 45 50 51 56 55 56 55 56 54 47 
CRP NA NM NA NM NA NA NA <0.6 <0.6 <0.6 <0.6 <0.6 <0.6 <0.6 <0.6 <0.6 <0.6 <0.6 <0.6 <0.6 
Reproductive profile 
17β-oestradiol 56 NM 46 NM 56 77 70 47 57 83 90 112 60 102 101 92 108 44 88 44 
LH 0.1 NM 0.1 NM 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 
FSH 0.1 NM 0.1 NM 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 
Testosterone 0.4 NM 0.4 NM 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 
Progesterone 0.5 NM 0.5 NM 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.6 0.5 0.7 0.5 0.5 1.3 0.8 0.5 0.5 
Immunosuppressant 
Tacrolimus 
level 
NA NA NA NA NA NM 2 2 2 2 2 2 2 2 NA NA NA NA 
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Ranges 234 
 
 
SODIUM    mmol/L   138 - 148                 
POTASSIUM   mmol/L   3.4 - 5.1                 
UREA    mmol/L   3.5 - 10.7                 
CREATININE   umol/L   12 - 146                   
 
 
ALKALINE PHOSPHATASE  IU/L   10 - 140                   
ASPARTATE TRANSFERASE IU/L   14 - 113                    
ALANINE TRANSFERASE  IU/L   14 - 80                                   
 
 
ALBUMIN   g/L         24 - 46                   
 
             
FOLLICLE STIM. HORMONE       IU/L                                
                           
           Follicular   3.5  -  12.5                          
                                        Mid-cycle  4.7  -  21.5                          
                                                          Luteal   1.7  -   7.7                          
 
                               
LUTEINISING HORMONE           IU/L                                
                               
           Follicular   2.4  -  12.6                          
                                        Mid-cycle  14.0  -  95.6                          
                                        Luteal   1.0  -  11.4                          
              
                  
PROGESTERONE         nmol/L                               
                               
           Follicular   0.6  -   4.7                          
                                        Periovulatory  2.4  -   9.4                          
                                        Luteal   5.3  -  86.0                        
 
 
TESTOSTERONE                           nmol/L     
 
 
17-β OESTRADIOL              nmol/L 
                               
           Follicular   46  -  607                         
                                        Mid-cycle  315  -  1828                          
                                        Luteal   161  -  774                          
 
                               
FK506 (Tacrolimus)              ug/litre  
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Post-mortem and Histopathology 
Table 2a.4 and 2a.5 below and Figure 2a.2a-i summarise the findings following post-mortem and histopathology. 
Table 2a.4 Summary of gross morphology findings at post-mortem, performed within 60 minutes of the death of the recipient doe (Wranning et al) 117  
UTx  
Colour 
 
0, pink 
1, dusky  
2, white 
Texture 
 
0, soft 
1, firm 
2, hard 
Size 
 
0, normal  
1, oedematous 
2, markedly 
bigger 
Anastomosis 
(IVC-IVC) 
 
0, intact 
1, broken down 
Anastomosis 
(aorta-aorta) 
 
0, intact 
1, broken down 
Uterine bleeding 
 
0, absent 
1, present 
Adhesions 
 
0, absent  
1, minor  
2, severe signs of 
inflammation 
Laparotomy scar 
 
0, normal 
1, swelling or inflammation 
2, pus or hernia 
1 1 1 1 1 1 
1 
(total blood volume 
within abdomen: 30ml) 
0 0 
2 1 1 1 1 1 
1 
(total blood volume 
within abdomen: 20ml) 
0 0 
3 0 0 0 0 N/A 0 N/A N/A 
4 0 0 0 0 N/A 0 N/A N/A 
5 0 1 2 0 0 0 1 0 
6 0 0 0 0 0 0 N/A N/A 
7 1 1 1 1 1 
1 
(total blood volume 
within abdomen: 30ml) 
0 0 
8 0 0 0 0 0 0 N/A N/A 
9 1 2 1 0 0 0 0 0 
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Table 2a.5 Summary of histopathology findings (UTx #1-9) 
UTx Macroscopic examination of fixed tissue and Histopathology Clinico-Pathological Correlation 
1 
19 slides 
 
Heart & major vessels: No infarction/thrombus/pericarditis 
 
Lungs: Small thrombi in branches of PA suggestive of DIC 
 
Spleen: No sepsis/neutrophilia 
 
Graft w/ patch: Evidence of RBC extravasation at the anastomotic 
site; no evidence of a thrombus or embolus 
Cavo-caval &  
aorto-aortic  
anastomosis breakdown leading to 
intraperitoneal haemorrhage 
2 
8 slides 
 
Heart & major vessels: No infarction/thrombus/pericarditis 
 
Lungs: No evidence of PE 
 
Spleen: No sepsis/neutrophilia. Decreased number of RBCs 
 
Graft w/ patch: Evidence of RBC extravasation at the anastomotic 
site; no evidence of a thrombus or embolus; congestion of venous return, 
including IVC 
Cavo-caval &  
aorto-aortic  
anastomosis breakdown leading to 
intraperitoneal haemorrhage 
3 
5 slides 
 
Heart & major vessels: No infarction/thrombus/pericarditis 
 
Lungs: Upper, middle, and lower lobes of right lung all collapsed; 
RBC in trachea and right bronchus; no evidence of PE 
 
Spleen: No sepsis/neutrophilia/pathology 
 
Graft w/ patch: Grafting process not complete 
Respiratory compromise following 
blood aspiration 
4 
5 slides 
 
Heart & major vessels: Haematoma in left ventricular papillary 
muscle 
 
Lungs: No evidence of PE/thrombus/collapse/oedema 
 
Spleen: No sepsis/neutrophilia/pathology 
 
Kidneys/Liver: No pathology 
 
Graft w/ patch: Grafting process not complete 
Cardiac damage 
 
(Left ventricular rupture) 
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5 
12 slides 
 
Heart & major vessels: Acute venous congestion. No 
infarction/thrombus/pericarditis. 
 
Lungs: Mild oedema. No evidence of pulmonary embolus. 
 
Kidneys/liver: Overall no pathology. Mild focal interstitial inflammation 
in right kidney. 
 
Spleen: No sepsis/neutrophilia/pathology 
 
Graft w/ patch: Gravid uterus. Chorionic villi and syncytiotrophoblasts 
confirmed. Evidence of chronic inflammation, giant cell necrosis and 
muscle and fat necrosis witnessed. 
Rabbit culled electively 
6 
5 slides 
 
Heart & major vessels: No infarction/thrombus/pericarditis 
 
Lungs: Evidence of cell destruction and fluid-filled alveoli 
 
Spleen: No sepsis/neutrophilia/pathology 
 
Graft w/ patch: No evidence of RBC extravasation at the anastomotic 
site; no evidence of a thrombus or embolus; congestion of venous return, 
including IVC 
Widespread pneumonia 
7 
10 slides 
 
Heart & major vessels: Heart discoloured. No vascular abnormalities or 
thrombi identified. No evidence of ischaemia or infarction. Coronary 
arteries widely patent, no evidence of thrombosis. 
 
Lungs: No evidence of pneumonia, oedema or pulmonary embolism. 
 
Spleen: No sepsis/neutrophilia/pathology. 
 
Graft w/ patch: Vascular anastomosis showed intact sutures intact with 
no evidence of perivascular soft tissue haemorrhage. Evidence of damage 
to vessel wall, likely because of surgical manipulation. No evidence of 
thrombotic occlusion. Genital tract organs reveal intact sutures with early 
but mild ischaemic changes. Possibly some epithelial loss but very little 
associated inflammation so likely to be artefact. 
Shearing of the aorto-aortic and 
cavo-caval anastomosis leading to 
intraperitoneal haemorrhage  
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8 
6 slides 
 
Heart & major vessels: Single small focus of acute inflammatory cell 
infiltration seen in the subendothelial myocardium of the septal wall of 
the left ventricle. No other abnormalities seen. 
 
Lungs: Patchy alveolar capillary congestion is present throughout. Focal 
acute inflammation is seen and in one area an excess of alveolar 
macrophages is witnessed. The features are consistent with early acute 
lung injury. No evidence of pulmonary embolism. 
 
Kidney: An occasional acute inflammatory cell is seen within the wall of 
glomerular capillaries. Red blood cells are seen in the renal tubules and 
collecting ducts – this may be artefact or secondary to acute kidney 
injury. 
 
Spleen: No sepsis/neutrophilia/pathology. Appeared congested. 
 
Graft w/ patch: Tissue sutures intact. Vascular anastomosis reveal a 
single, non-occlusive thrombus in the lumen of a thin walled (vein) vessel. 
The reproductive organs reveal a mild chronic (lymphocytic) inflammatory 
cell infiltrate within the superficial endometrium. This may be related to 
normal endometrial turnover or may represent early ischaemic change. 
There is a patchy mild lymphocytic infiltrate in the outer muscle layer the 
lower genital tract. A single focus of coagulative necrosis is seen in the 
muscular wall of the vagina/cervix, consistent with ischaemic injury. 
Features in multiple organs of early 
ischaemia/hypoxia related injury, 
consistent with the history of 
hypovolaemic/haemorrhagic shock 
9 
Heart & major vessels: Subendocardial fat deposition, consistent with 
age related changes. Possible thrombus in right ventricle. No myocardial 
rupture or infarction. 
 
Lungs: Parenchyma of both lungs congested with firm consistency. Large 
adherent thrombi seen in both pulmonary arteries, extending into 
parenchymal vessels. Appearance consistent with a bilateral pulmonary 
embolus. One large vessel (artery) contained possible thrombus - features 
may be consistent with pulmonary embolism. 
 
Kidney: No pathology 
 
Spleen: No sepsis/neutrophilia/pathology 
 
Graft w/ patch: Vaginal sutures intact. Vaginal anastomosis shows 
changes consistent with recent surgery. Both cornua/oviduct anastomoses 
show marked vascular congestion of the recipient portion of the 
cornua/oviduct but no evidence of ischaemia. Both distal oviducts 
haemorrhagic and friable. No perforation. The donor cornua/oviduct 
appear viable and are without significant congestion. Vascular anastomosis 
shows sutures intact. No evidence of perivascular soft tissue haemorrhage. 
One thick walled vessel (artery) demonstrating  inflammation of the media 
associated with luminal fibrin deposition.  
Macroscopic features of a pulmonary 
embolism 
 
Features of early peritonitis which 
may represent a systemic inflammatory 
response to recent surgery or early 
infection 
 
This, along with the recent surgery, is a 
risk factor for venous thrombosis and 
pulmonary embolism 
 
Key: DIC; disseminated intravascular coagulation; PA, pulmonary artery; PE, pulmonary embolus 
  - 155 - 
Figure 2a.2a-i Selected histopathology microscopic images demonstrating cause of demise (slides 
are H&E unless stated otherwise) 
 
 
Figure 2a.2a UTx #1 - evidence of RBC extravasation at the IVC-IVC and AA-AA anastomosis 
 
 
 
Figure 2a.2b UTx #2 - evidence of donor IVC dilatation secondary to anastomotic breakdown 
RBC 
Extravasation 
Dilated IVC 
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Figure 2a.3c UTx #3 - right lung collapse 
 
                                   
 
Figure 2a.4d UTx  #4 - Left ventricular papillary muscle haematoma 
 
 
Magnification:  
x 4 
Magnification:  
x 10 
Evidence of 
collapsed 
alveoli & 
bronchioles 
Magnification:  
x 4 
Magnification:  
x 10 
Evidence of 
haematoma 
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Figure 2a.4e UTx #5 - Evidence of necrosis and inflammation  
 
Evidence of mild renal 
focal interstitial 
inflammation 
Congestion and mild 
oedema within lungs 
Giant cells within 
myometrial wall 
Fluid within alveoli 
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Figure 2a.2f UTx #6 - Evidence of pneumonia within the hilum of left lung  
 
        
 
Figure 2a.2g UTx #7 - Anastomosis shearing and consequences  
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Figure 2a.2g (continued) 
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Figure 2a.2h UTx #8 - Evidence of early ischaemia/hypoxia related injury, consistent with the 
history of hypovolaemic/haemorrhagic shock secondary to aortic trauma 
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Figure 2a.2i UTx #9 - Evidence of Pulmonary embolus  
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Rejection response 
 
The results (Figures 2a.3 and 2a.4) below describe the rejection response following UTx #5. As 
outlined above, rabbits #3, #4, #6 and #8 all died intra-operatively. Rabbit #1 died within the first 
post-operative 24 hours and was not given any immunosuppression. Rabbit #5 was the only long-term 
survivor of our cohort and received immunosuppression both intra- and post-operatively. Rabbits #7 
and #9 also died within the first 24hours but were given immunosuppression. The distribution of the 
rejection markers in both UTx #1 and UTx #2 was not significant, most likely as we only had one 
sample group for each day. There was no difference between D0 and D1 (15 hours post-op) levels in 
UTx #1. In UTx #2, #7 and #9, the doe has had already died before blood could be extracted to study 
the rejection response. 
 
 
Figure 2a.3 White Blood Cell subset levels shown as a percentage of the total (y axis) following 
UTx #5 (day zero to day 81, x axis) 
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Figure 2a.4 Cellular levels depicting rejection response following UTx #5 (from left to right, 1st row: unstained FACS sample: negative control; IgG1: 
negative control; CD4: T Helper cells; CD8: cytotoxic T cells; 2nd row: Monocytes/macrophages; B cells; all lymphocytes, activated T cells). The machine 
was set to analyse exactly 10,000 cells/FACS tube. Both forward (cell size/volume; x axis) and side scatter (cell granularity; y axis) detectors were aimed at 
the column of cells passed through the FACScalibur. All cells located to the right of the IgG1/negative control group on the scatter plot were defined as being 
positive for the marker in question. 
 
Figure 2a.4a Post-UTx #5 Day 0 
 
  - 164 - 
Figure 2a.4b Post-UTx #5 Day 74 (see legend above) 
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Long-term Survival and Pregnancy 
 
Recipient #5 was the sole surviving doe out of the cohort of nine. The doe showed no adverse effects 
post-operatively and throughout the recovery period. She was feeding and drinking well, with 
appropriate movement and affect. Following visualization of certain signs suggesting a receptive doe, 
embryo transfer was performed on day 89 post-UTx. Vitrified embryos were prepared at the same 
time, with 17 transferred into the cornua of the sole surviving doe by open laparotomy and insertion 
of catheter transmurally (nine into the right and eight in the left cornua). The doe began to 
demonstrate signs of pregnancy, including nesting and an increase in abdominal size towards the end 
of the first gestational week.  
 
D5 scan did not demonstrate a fetal sac. Fetal sac diameter on D9, D13, D16 and D18 was (mm): 
17.3x13.1, 22.1x19.5, 25.2x22.7, and 10.2x6.3 (Figure 2a.5). CRL was only recordable on D9, D13 
and D16 (mm): 10.2, 14.3, and 16.4 respectively. Subsequent scans on D22 and D25 did not 
demonstrate a fetal sac, which together with the fetal sac diameter was suggestive of resorption. No 
bleeding was witnessed around the cage. The doe’s behaviour was noticed to have returned to pre-
embryo transfer period four days before she was culled. The recipient was sacrificed on D27. 
Necropsy and histopathology confirmed evidence of a gravid uterus and the presence of a gestational 
sac (Figures 2a.6 and 2a.7). 
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Figure 2a.5 Graph depicting the growth and subsequent decline in the size of the Fetal Sac 
Diameter and Crown Rump Length during Gestation 
 
 
White Arrow-head Uterus containing fetal sac and now resorped fetus 
 
Figure 2a.6 Photograph of the abdominal cavity on D113 following UTx taken prior to the 
commencement of the post-mortem 
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Figure 2a.7 A histopathology slide illustrating the chorionic villi embedded into the endometrium 
and therefore acting as proof for the presence of products of conception and thus pregnancy  
 
Unfortunately as a result of resistance from the doe, only one blood sample was possible during the 
gestational period. The graph from Figure 4.6 can be extended to include white cell subset levels 
from D102, which was D13 of the gestational period (Figure 2a.8). Similarly Table 2a.6 
demonstrates renal, hepatic and reproductive profiles from D0 to D102. 
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Table 2a.6 Renal, hepatic and reproductive profiles of recipient #5 from D0 to D102 
 
Figure 2a.8  White Blood Cell subset levels shown as a percentage of the total (y axis) following 
UTx #5, including those taken during pregnancy (day zero to day 102, x axis; D102=D13 post-
embryo transfer) 
 UTx 5  
Gestational Age D0 D2 D6 D9 D13 D20 D36 D46 D60 D74 D102 
Sodium 151 141 142 143 142 143 144 144 144 141 141 
Potassium 3.9 4.7 NM 4.3 4.5 3.8 3.8 4.0 NM 4.2 4.4 
Urea 8.9 21.8 12.2 7.6 6.2 6.8 5.8 6.7 7.6 7.2 7.6 
Creatinine 131 115 91 89 82 79 82 91 106 95 95 
AST 40 63 21 14 23 30 22 29 NM 25 36 
ALT 28 71 44 26 17 22 21 27 31 23 19 
ALP 41 21 NM 37 34 34 38 36 42 50 18 
Albumin 57 42 50 49 45 50 51 56 55 56 48 
CRP NA <0.6 <0.6 <0.6 <0.6 <0.6 <0.6 <0.6 <0.6 <0.6 - 
Reproductive profile 
17β-oestradiol 70 47 57 83 90 112 60 102 101 92 45 
LH 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 
FSH 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 
Testosterone 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 
Progesterone 0.5 0.5 0.5 0.5 0.5 0.6 0.5 0.7 0.5 0.5 15.5 
Immunosuppressant 
Tacrolimus Levels NA NM 2 2 2 2 2 2 2 2 - 
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2a.4. Discussion 
 
This case series was a continuation of existing small animal models: murine, rat and rabbit, with the 
aim to further investigate the surgical model which may be applied in a human. Nine allogeneic UTx 
procedures in a rabbit model are presented here. They are an extension of work performed by 
Sieunarine et al and Saso et al described above.108,235  In this case series, long-term rabbit survival 
was 11% (n=1). Surgical operative survival was 56% (n=5). Four rabbits (UTx #3, #4, #6 and #8) 
died intra-operatively or within one hour of the operation as a result of blood aspiration, ventricular 
haematoma, pre-operative pneumonia and massive haemorrhage. Three does (#1, #2 and #7) died 
within the first 24 hours as a result of the veno-vena and anastomosis breakdown and one died 
secondary to a pulmonary embolus. Part of the surgical procedure which took the longest time was 
grafting of the transplanted uterus, where great caution had to be taken to preserve the blood supply to 
the uterus throughout the operation and also to avoid leakage from the anastomotic sites. All rabbits 
demonstrated normal renal, hepatic and reproductive profiles throughout, both pre- and post-
operatively (Table 2a.3). Our single long-term survivor revealed fluctuating 17β-oestradiol and no 
decrease in progesterone and testosterone levels despite the maintenance immunosuppression dose. 
FSH and LH remained constantly low throughout, even during fertility treatment suggesting an issue 
with the detection assay. This suggests a healthy and normal reproductive system. The sole long-term 
surviving doe underwent embryo transfer. 
 
Surgical technique 
 
Before commencing with this UTx series, we performed two hysterectomies in a rabbit model in order 
to re-acquaint ourselves with rabbit pelvic anatomy. Particular attention was paid to skeletonization of 
the infra-renal AA and IVC. From the outcomes above (long-term survival of 11%), one may 
conclude that the surgical learning curve has remained steep, and that it can only be surmounted with 
further attempts in the future. This was demonstrated by Racho El Akouri et al who reported a gradual 
learning curve for their murine UTx model.69 The reported rate of successful uterine transplantation 
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was 25% for the first 1-21 animals, which increased to 87% for animals 22-42. However, on closer 
inspection, a number of issues challenge the above statement (‘the surgical learning curve has 
remained steep’): (a) other factors that may have contributed to the recipients’ demise; (b) decrease in 
duration of each stage of UTx procedure when comparing UTx #1-6 and UTx #7-#9; and (c) the 
actual rabbit model. Each is discussed individually below. 
 
Failure secondary to the anastomotic technique was 43% (n=3/7); these were recipients #1, #2 and #8. 
Other deaths were independent of the macrovascular method proposed and would have most likely 
been avoided in the human setting. Recipient #3 died as a result of aspiration pneumonia, brought on 
by difficulties in intubation. In a woman, intubation is likely to be straight forward and any 
anatomical issues would have already been vetted during pre-operative pre-assessment. Recipient #4 
died secondary to a ventricular haematoma, cause of which may be one of the following: intravenous 
CsA administered intra-operatively, an undiagnosed pathology already present pre-operatively which 
during stressed conditions brought on a decreased cardiac output and subsequent arrest or a pathology 
which developed intra-operatively. In human UTx, an intra-ventricular haematoma would have been 
reported during pre-operative assessment, in particular an echocardiogram. The human CsA dose is 
highly unlikely to cause an intra-cardiac bleed and a UTx procedure is equivalent to a hysterectomy 
with regards to patient risk. Thus an appropriately assessed patient should be able to cope with 
surgical stress. Recipient #6 died secondary to respiratory arrest brought on by a pre-operative 
pneumonia only diagnosed during histopathology. Again, this condition would have been diagnosed 
prior to the operation. Recipient #7 bled post-operatively from the anastomosis. However this bleed 
was secondary to anastomotic damage caused by non-fixation of the recipient cornual ends to the 
donor cornua. This was a decision made by the team to shorten the operative procedure and therefore 
decrease surgical stress on the rabbit. However the results were disastrous and it was not repeated 
again, with the previous method of cornual anastomosis re-applied. In a human UTx, the uterus would 
be fixed to the pelvic side walls and base and such a scenario would not arise. Finally, recipient #9 
died secondary to a pulmonary embolus, despite the use of a dose of heparin that had worked in the 
previous 12 of 13 rabbit transplants. Pulmonary embolus in a woman following the use of an 
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appropriate heparin dose is extremely unlikely and if it occurs diagnosis should be imminent as the 
women will spend at least a week in hospital post-operatively.   
 
It is therefore evident how factors independent of surgical technique and especially the vascular 
anastomotic technique contributed to reported early deaths. Table 2a.2 clearly demonstrates the 
decrease in duration of various stages of the surgical procedure when comparing the last three 
operations to the first six: graft retrieval (UTx #1-#6: 114min; UTx #7-#9: 85min); cold ischaemia 
(UTx #1-#6: 118min; UTx #7-#9: 90min); grafting (UTx #1-#6: 128min; UTx #7-#9: 124min); 
recipient hysterectomy (UTx #1-#6: 43min; UTx #7-#9: 30min); and estimated blood loss (UTx #1-
#6: 33ml; UTx #7-#9: 18ml). Subjectively, each transplant seemed an improvement with how the 
surgeons felt about each stage of the procedure with respect to anatomical awareness and technical 
expertise. Lessons learned were applied in each subsequent transplant (Table 2a.7). With regards to 
the vascular anastomotic model, the surgical survival rate of 54% (and 80% if you include previous 
rabbit transplants) as well as the macroscopic appearance of the transplanted uterus supports the use 
of a macrovascular model. This has been the accepted method for ensuring uterine perfusion with all 
animal experiments since the first human attempt in 2000. Omentopexy, uterine anastomosis and the 
use of venous grafts to extend the pedicle are now definitely unacceptable.  
 
Despite this, the biggest difficulty remains the viability and length of time it takes to form the veno-
vena and aorto-aorta anastomosis. The first two rabbits died directly as a result of this anastomotic 
breakdown, whereas #8 died because of uncontrolled blood loss during veno-caval anastomosis. 
Therefore, the anastomotic breakdowns described above did not occur in UTx #3-7 and #9. The 
number of stitches required to form the anastomosis may be a possible cause of breakdown but this 
number (three to five stitches for both IVC and AA anastomosis) was maintained from UTx #1 to 
UTx #9. Therefore, this number was perfectly adequate to allow for long-term survivor of recipient #5 
as well as the two long-term survivors in the previous cohort. In addition, a suture used to be placed 
into the IVC at the time of graft harvesting to help distinguish it during veno-vena anastomosis. This  
practice was abolished for UTx #3-9 so as to minimise IVC damage prior to anastomosis. To improve 
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Table 2a.7 Modifications to Surgical Technique UTx #1-9 
Transplantation  
Number 
Learning Points 
UTx #1 
1) Smaller size Yankauer required with suction tube to go with Yankauer of this 
size - this should allow us to cope with unexpected blood loss. 
2) Appropriate size Bulldog Clamps - clamps used here too large for AA/IVC of 
this diameter. A smaller size must be available. 
3) Suction blood from abdomen for immunological studies to avoid potential 
difficulties with venesection or cardiac puncture. 
4) Always remember to insert a suture into the posterior aspect of the uterus. 
UTx #2 
1) Blue cannula into IVC post-Celsior flushing and to remain there until the 
grafting stage of UTx. This should aid with IVC recognition. 
2) To help with IVC recognition, only one stitch to be inserted into it during uterine 
retrieval (in-out, out-in, through the edge). Not 2 stitches. 
3) Better skeletonization and separation of IVC from AA at the top 2 cm. 
4) ~40 Ligaclips are required per operation. To be used predominantly instead of 
surgical ties. 
5) Does from now on must be of proven fertility and no longer virgins. 
UTx #3 
1) Skeletonization of IVC and aorta should involve the top 4cm. 
2) As blue cannula falls out from IVC, gray or green should be applied. 
UTx #4 
1) Try to minimize the time that the recipient is anaesthetized in any way possible. 
2) When performing the all-important anastomosis, use vascular slings to underrun 
IVC and AA and ease the process. 
3) No longer apply stitches into IVC. Instead, to locate it, run Celsior solution 
through IVC and watch for its exit through the lumen of the IVC. 
4) To aid blood haemostasis, apply Flocil powder to the anastomosis. 
UTx #5 Above lessons were all applied. Long-term survivor (> 90 days). 
UTx #6 
Above lessons were all applied BUT… should we consider a more robust animal 
model? 
UTx #7 
Uterine graft must be fixed to pelvic side walls and cornua must be anastomosed to 
the recipient’s cornual ends. This is to prevent twisting at the cavo-caval and aorto-
aortic anastamoses and subsequent shearing. 
UTx #8 
IVC anastomosis proved to be the most difficult again. 4 stitches are the maximum 
that should be attempted with the vascular anastomoses. 
UTx #9 
Prophylaxis of venous thromboembolic disease again an issue. 
Above lessons were all applied BUT… should we consider a more robust animal 
model? 
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the probability of long-term survival and a patent veno-vena and aorto-aorta anastomosis, we decided 
to change the rabbit used in UTx #1-2 from a virgin doe to a doe of proven fertility of a weight >4kg. 
This eased the process of uterine grafting as we were operating on a larger-size pelvis and therefore, 
an AA and IVC of a slightly bigger diameter. 
 
Another particular problem of the anastomotic process is the IVC clamp placed just before the IVC is 
cut to allow for insertion of the first anastomotic suture. A delay in return of blood to the heart 
consequently ensues. The length of the delay does not seem to predict the level of compromise, but it 
was evident that the recipients did not react favourably once the clamp was placed. Heart rate and 
respiratory rate suddenly dropped in both cases, with each recipient experiencing at least four cardiac 
arrests until their demise. The solution to the problem is not a quick fix - the delay can only be 
minimised with an increase in speed of veno-vena anastomosis, which in turn can only happen with 
more practice.  
 
With regards to a human UTx, the blood vessel diameter is longer, suggesting that achieving patient 
anastomosis should be more straightforward. If a graft is obtained from a multi-organ donor, it would 
include vessels such as the common iliacs or even IVC and AA. A graft harvested from a living donor 
would obviously not contain common, internal or external iliacs, or IVC and AA. Therefore, the 
vascular grafts will be shorter in length and diameter. Skeletonization of uterine vessels allows for 
free vascular pedicles of around 6cm. These can subsequently be utilised to form direct end-to-side 
anastomosis to both the internal and external iliacs. The hysterectomy was modified so as to maintain 
the length of the vascular pedicle as long as possible, thus ensuring adequate tissue perfusion and 
tissue integrity. This was achieved by transecting the round ligaments as laterally as possible. Also 
divided were the infundibulopelvic and uterosacral ligaments. The paravesical and pararectal spaces 
were dissected in order to ease identification and protection of the ureters, and avoid a potential 
confusion with uterine vessels. The uterine arteries were encircled with vessel loops, whereas the 
bladder was freed from the vagina and the cervix. 
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Finally one has to consider the genuine issue of using a rabbit model for such extensive surgery. A 
rabbit model was chosen because of its reproductive potential, its short gestational period and its large 
litters. However, as explained above, the small size of the rabbit pelvic vessels, the necessary 
development of surgical methodologies and achievement of adequate microsurgical skills to master 
vascular anastomosis require both dedication and long hours at the surgery table. This implies a steep 
surgical learning curve. When adding the previous rabbit UTx numbers to this cohort, surgical 
survival increased from 50% to 70% (14/20). However, long-term survival increased from 11% to 
only 15% (3/20). Despite 11 previous attempts, in the subsequent nine, only one recipient survived. 
This is not an acceptable result especially when compared to the Brannstrom murine and rat 
experiments described previously whereby the small-animal model is even smaller. At least 30 full 
transplantations are needed to achieve satisfactory graft survival rates (~70%) in a small-animal UTx 
model and in this experiment, the final result was considerably short of this target.68,69 The rabbit 
model is therefore not recommended by the UK team for future UTx experiments.  
 
Ischaemia-Reperfusion injury 
 
Ischaemia-reperfusion injury occurs in different degrees during a transplantation procedure. Its effects 
are unavoidable, with the aim being to minimise them as much as possible. Ischaemia leads to 
deprivation of oxygen and blood nutrients to the tissue, which in turn brings about a steady loss of 
cellular homeostasis. Subsequently, reperfusion result is a sudden in-flow of blood, the constituents of 
which induce an inflammatory response that if severe can lead to loss of organ function.160,236 The 
main way to minimize this damage is to store the graft in a storage solution, at a low temperature 
which decreases both the cellular metabolic and catabolic rates. Generally, preservation solutions are 
used to maintain the organ in optimal condition from the time of explanation until transplantation. 
Five major advantages to the transplantation programme are offered: time to transport the organ, time 
to allow tissue matching, time to prepare the recipient and surgical team, quality of organ function, 
and better post-operative recovery. 
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A number of different types exist: EuroCollins, University of Wisconsin, Celsior, Perfadex, and the 
solution used here HTK. HTK is not a colloid, with therefore a viscosity equal to that of pure water 
from 1 to 350C, and a mean flow rate three times that of University of Wisconsin solution at an equal 
perfusion pressure. Tryptophan acts as membrane stabilizer whereas ketoglutarate as an energy 
substrate. Interestingly, organs cool down to lower temperatures more rapidly than with other 
preservation solutions. According to the University of Pittsburgh criteria for Organ Preservation, HTK 
is now the gold standard solution for preservation of all organs. Its advantages are obvious - it has no 
additives, is ready to use immediately when retrieving from unstable donors, no solution waste if case 
is aborted, costs less, requires less packaging than other solutions, and transport/storage is at room 
temperature which further decreases the cost. 
 
Different organs tolerate ischaemia for varying periods of time. Main reasons have been described 
extensively in the literature: energy demand, parenchymal cell function, and resident immune-cell 
populations. The kidney can tolerate cold ischaemia times of ≥24 hours,237 whereas the heart and 
lungs can last for only <6 hours and intestinal mucosa of the small bowel degenerates after <12 hours 
of cold ischaemia.238 Obviously the organs have completely different purposes which explains the 
above. The heart has a particularly high content of contractile protein, and more importantly, needs to 
be at its optimum with respect to function in a shorter period following the retrieval (life-saving 
organ). The uterus on the other hand would need to be functional at a much later point in time and can 
therefore take longer to repair damage induced during the transplantation process.  
 
Furthermore, in comparison to the heart, the uterus is much more durable organ. The murine uterus 
for example produced healthy pups after embryo transfer, having been stored for 24 hours in cold 
ischaemia post-syngeneic UTx.84 The Brannstrom team have also reported a similar time frame for a 
human uterus. Following its storage in a cold preservation solution for 24 hours, the human 
myometrium was able to contract spontaneously and to respond to prostaglandin. The preservation 
solutions are in most cases buffered saccharide solutions. They are designed to maintain a neutral pH, 
prevent cell swelling and loss of cellular homeostasis brought on by hypothermia by providing a high 
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concentration of an impermeant (mannitol, histidine, and phosphate), provide an antioxidant defence 
against reperfusion, and enable quick recovery from the ischemic depletion of energy stores. 
Sieunarine et al assessed the morphological changes in human uterine tissue after its preservation in a 
transplant solution under the influence of cold ischaemia.235 Small tissue samples of human uteri were 
submerged in Celsior transplant solution which mimicked a cold ischaemic environment (2-8 degrees 
Celsius for up to 48 hours). To assess evidence of cold ischaemic injury, histological analysis by light 
and electron microscopy was applied. It did not demonstrate any major uterine tissue changes after 
48-hour cold preservation. Electron microscopy after 24 hours confirmed unchanged structural 
integrity of the uterine myoendometrium. The authors concluded that human uterus is 
morphologically resistant toward cold ischaemia in Celsior preservation solution for up to 24 hours 
and may therefore be suitable for transplantation purposes. 
 
Graft manipulation may also add to post-operative inflammation. Mechanical manipulation of 
intestines induces a local inflammatory response mainly mediated by the usual culprits, macrophages, 
followed by an infiltration of leukocytes peaking at 24 hours.68,239,240 Similarly, mechanical 
manipulation during dissection of the uterus transplant could lead to an inflammatory response in the 
actual uterine graft. As per advice of Wranning et al,68 the surgical team avoided overall extensive 
manipulation by creating an adequate operating field without touching the uterine graft unless 
absolutely necessary.  
 
Perfusion of the uterine graft with a cold preservation solution functioned well in this cohort of 
recipients. Perfusion and storage of all nine uterine grafts was kept constant at 90 minutes, with the 
graft changing in colour from pale, dusky white to a pink or red. This allowed us to conclude that the 
vascular anatomy of the graft was intact and had not been damaged during the retrieval process, thus 
permitting flow of solution throughout the graft. 
 
Recipients which exhibited any signs of cornual ischaemia were #5, #7 and #8 (3/9). The sole long-
term survivor, recipient #5, demonstrated evidence of chronic inflammation, giant cell necrosis and 
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muscle and fat necrosis following its cull on Day 113 post-UTx. Microscopically, perfusion was 
evident and thus, the evidence of inflammation and necrosis would be most likely secondary to a 
failure to control the rejection process. Recipients #7 and #8 died as a result of a heavy haemorrhage 
which was gradual enough to bring about mild ischaemia of the graft. Recipients #3, #4 and #6 died 
intra-operatively and recipient #9 within 24 hours, secondary to reasons not related to significant 
haemorrhage and therefore, ischaemia was not expected. Recipients #1 and #2 did suffer from 
significant blood loss from the anastomotic sites. The lack of signs of ischaemia is most likely 
because of the sudden and total nature of the blood loss, leading to a quick death. Therefore, there was 
not enough time for ischaemia to be evident on the uterine graft.  
 
It is difficult to draw definite conclusions as to whether 90 minutes of preservation in Celsior solution 
minimised ischaemia-reperfusion injury in this case series. The flushing process certainly allowed for 
assessment of uterine graft and especially the vascular integrity. The long-term survival rate of only 
11%, coupled with a 44% intra-operative death rate means that judgment as to whether long-term 
protection is possible is not appropriate. However the lack of ischaemic damage in those that survived 
surgery (recipients #1, #2 and #9), the mild element of inflammation in recipients #7 and #8  as well 
as that macroscopically the graft of recipient #5 was judged ready for embryo transfer is promising. It 
is worth recognising that uterine tissue has a relatively high resistance to ischaemia and reperfusion 
injury despite moderately long ischaemic times during the grafting process and subjectively, minimal 
mechanical manipulation of the uterus itself.68 
 
Venous Thromboembolic disease 
 
It should be noted that pulmonary embolism, a major cause of post-operative mortality, has been 
addressed carefully in the previous cohort of five recipients as well as this case series. When 
addressing all rabbit recipients, 3/11 does died from a post-operative pulmonary embolus. In this 
present cohort, one out of nine recipients died from this pathology. The uterus was washed 
continuously with Celsior transplant solution which was run through under low flow pressure 
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produced by gravitational effect. High flow pressures can result in damage of the intimal layer of the 
arterial wall, thus increasing the risk of thromboembolic disease. Additionally, heparin was given pre-
operatively to the recipient and intra-operatively to both the donor and the recipient. We did not 
administer any heparin post-operatively in order to prevent any intra-abdominal bleeding, especially 
form the vascular anastomotic sites. The type of heparin used is low molecular weight heparin as it 
has a longer duration of action and is easier to administer. In a human, the same principle would be 
applied, with the added benefit of post-operative thromboprophylaxis, which is administered in other 
types of transplantation surgery. 
 
Immunology 
 
The biggest milestone in UTx was the first human UTx in 2000, which we have detailed earlier. 
Because of limited use of animal model experiments prior to the human setting, important anatomical, 
technical and immunological factors were not tested, leading to the conclusion that the attempt may 
have been premature. With regards to immunosuppressants, they were administered pre-operatively: 
CsA A, 6 hours prior to surgery; intra-operatively: prednisolone (to maintain uterine perfusion); and 
post-operatively: conventional CsA A, azathioprine, prednisolone and a boost by antithymocyte 
globulin. CD+4/CD+8-ratio in blood and Doppler of uterine blood flow were the only techniques 
employed to monitor possible rejection patterns. Despite initial successful immunosuppression, the 
transplanted graft’s vascular anastomosis failed and the UTx infarcted, surviving for only 99 days.66 
 
This is the first attempt to characterise and suppress an allogeneic rejection response in a rabbit model 
following any type of organ transplant. Immunosuppressants were administered in UTx #4-9 as the 
initial aim was to characterise the acute rejection response when unaffected by immunosuppression. 
Therefore recipients #1-3 were not administered any immunosuppressants. However as none of the 
three were long-term survivors, it was not possible to achieve this. The study design was created so as 
to allow comparison of the rejection response when immunosuppressants are administered and when 
they are purposefully left out. Available data is only for recipients #1 and #5. Recipient #1 (died 
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within first 24 hours) was not provided with immunosuppression whereas recipient #5 (long-term 
survivor) was. Tacrolimus was the main immunosuppressant used. The other calcineurin inhibitor 
(CNI), CsA, was administered only intra-operatively. Tacrolimus was the post-operative CNI of 
choice, as it had been used extensively in the rabbit model, with a greater number of published results 
related to its effect and toxicity than CsA-related data.241 In addition, tacrolimus had been used in our 
previous rabbit UTx cohort.3 Two does were long-term survivors, with one uterus viable and well-
perfused prior to the cull. Histopathology was also normal. The dose administered was 500µcg, twice 
per day. Finally, it has shown promising results when used in the UTx model. Three reports of its use 
related to UTx exist in the literature, with one involving pregnancy. Brannstrom et al in their 
description of a first time pregnancy after allogeneic UTx used a dose of 0.5mg/kg/day. The dose used 
was chosen according to an initial dose-study (0.2-0.5mg/kg/day), demonstrating the absence of 
morphological signs of uterus rejection by this dose.115 The same team studied the effect of combining 
tacrolimus with CsA on long-term uterine survival in a sheep model.242 Initially, tacrolimus was given 
for 12 days intravenously, followed by CsA only orally. Immunosuppression after allotransplantation 
consisted of administration of intravenous CsA (2-5 mg/kg) or oral tacrolimus (0.3-0.5 mg/kg) for 3 
weeks and the animals were then examined and euthanized. In allotransplanted animals the ovary and 
uterus showed normal appearance in 33% (2 of 6) of CsA-treated and 66% (2 of 3) of tacrolimus-
treated ewes at 3 weeks post-transfusion. Histology analysis of these confirmed normal appearance. 
These results indicate that immunosuppression by tacrolimus, rather than CsA is preferred in the 
sheep allo-UTx model. Finally, Avison et al also used tacrolimus in a porcine model. Ten transplants 
were performed, with five animals alive and healthy at the end of follow-up (0.5-12 months). 
Immunosupression given was as follows: intravenous tacrolimus administered for the first 12 days 
post-UTx, together with 10-20 mg/day of methylprednisolone for a month and oral CsA 
(10mg/kg/day) as maintenance. Rejection episodes were treated with steroids (10-20 mg/kg/day) and 
increased doses of oral CsA.157 
 
With regard to other immunosuppressants, intravenous CsA and hydrocortisone (intravenous intra-
operative doses of 10µg/kg and 40mg respectively) were administered only intra-operatively. 
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Prednisolone was also given orally throughout the first post-operative week (daily dose). The dose of 
CsA was chosen based on previous published reports describing CsA toxicity levels in rabbits.243,244 In 
addition, results from Wranning et al demonstrated that CsA dose of 10-20µg/kg can delay the 
process of rejection.120  
 
In our long-term survivor, acute rejection appears to have been adequately controlled, with IgM, 
CD11b and CD8 levels maintained below their pre-UTx levels. CD45 and CD25 counts spiked on 
Days 36 and 74, whereas CD4 was higher from Day 36 onwards. As CD45 is a marker for the white 
blood cells in general and CD25 for activated T cells, the spikes correlated to an increase in rejection 
activity. It was therefore important to suppress these two acute rejection episodes. 10mg prednisolone 
was given for three days following the results alongside an increase in tacrolimus dose from 500μg to 
1g twice/day. The Doppler examination of the grafted internal iliac at the time was entirely normal 
and the rabbit did not appear distressed or unwell at any of point during this period. The rabbit 
maintained her weight and appetite, with no pus or offensive smell noticed from the vagina end. 
Decreased CD45 and CD25 levels following Day 36 and Day 74 and non-elevated CD8 levels 
throughout appear to demonstrate that the rejection episode was controlled. It would be interesting to 
see whether Tregs were responsible for this ‘control’ and therefore the overall CD4 T-cell increase 
post-Day 36. It has not possible to analyse Tregs as an appropriate marker for a rabbit model has not 
been found to date. The graft did not exhibit visible signs of rejection during embryo transfer. It 
appeared well-perfused, with no signs of ischaemia or necrosis. Results relevant to O2Sat obtained 
with a multispectral laparoscope are awaited. The ultimate test is success with regards to embryo 
implantation and a subsequent pregnancy. This is discussed in the next chapter. 
 
Theoretically, the risk of graft rejection is lowered during the pregnancy because pregnancy itself is 
thought to be inducing a transient ‘physiological’ state of immunosuppression within the host’s body. 
Chaouat et al 150 described a variation in both the population and activity of immune cells during 
pregnancy, suggesting an existence of protective wall of effector T lymphocytes, Tregs and uterine-
specific NK cells which all induce tolerance of the allogeneic fetus.177,245,246 Nevertheless, the 
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rejection rate varies in comparison to the non-pregnant population. With regards to kidney allografts, 
pregnant to non-pregnant is similar,247 whereas in cases of liver transplantation, reports state a higher 
rejection rate at the same interval after transplantation in the pregnant patient. For instance, an average 
of 10% of pregnant recipients suffered rejections at 39 months after transplant versus 3% in a 
comparable non-pregnant population approximately three years after transplantation.140,150 
 
The biggest limitation of the study is the paucity of data. It was obtained on eight different post-
operative days, ranging from day 0 to day 81. However, this was possible for only one recipient, as 
the other eight died within the first 24 hours. Also immunosuppressants were administered to the sole 
surviving doe. The data obtained from it has no control, i.e. a long-term survivor free of 
immunosuppression for which the rejection response could be monitored and used for comparison. 
We therefore recognise that it is difficult to make any conclusions regarding our immunosuppression 
regimen but the combination of a CNI and a steroid can clearly slow down the rejection process, if not 
completely inhibit it. This would correlate with other transplant programmes. If UTx were available in 
humans, one can envisage the addition of a monoclonal antibody for the induction part. Another 
limitation was that MHC matching was not carried out for the donor and recipient in the nine 
transplants and it was therefore not possible to comment on the adequacy of the donor and recipient 
parings. The breeders who provided us with the animals made sure that we received two does from 
the same family line (not twins) to ensure a degree of compatibility. This would mimic human UTx 
where a degree of MHC matching is expected.   
 
The ability to characterise the rejection response in a rabbit allo-UTx model is of course dependent on 
long-term recipient survival. Ideally, data obtained would depict the rejection response in both a non-
pregnant and, post-ET, pregnant doe. At least one model should characterise the rejection response in 
a doe not administered any immunosuppressants. Furthermore, all uterine grafts will undergo 
immunohistochemistry following post-mortem. Beyond the scope of this PhD, a need for future UTx 
animal models to clarify the type and dose of immunosuppressant ideal for prevention of uterine 
rejection exists. This choice must also prove to be of value from the safety aspect, with minimal harm 
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affecting the mother but in particular to the growth and well-being of the fetus. Small studies can also 
investigate whether combinations of different immunosuppressants (CsA, tacrolimus and steroids) 
carry greater clinical benefit. Finally, the results of such targeted research should be pooled together 
to create a protocol which outlines a clear methodological structure for the induction of allotolerance 
and more importantly, leads to long-term (i.e. 9 months) survival of the allotransplanted uterus. 
 
Pregnancy 
 
Our pregnancy did not result in the birth of a healthy term offspring. However the demonstration of 
pregnancy in this allogeneic model is a central proof of concept of UTx in a rabbit model and thereby 
an essential step in the research toward its clinical application in the human. The study represents only 
the third example of conception and pregnacy following an allogeneic UTx. To date, there has only 
been one live birth following allogeneic UTx. The animal model was large (sheep), and thus, no live 
births have been achieved in a small animal model. 
 
The macrovascular patch model functioned in that the uterine graft received an adequate blood 
supply, allowing for implantation and  fetal growth. The renal, hepatic and reproductive profiles were 
normal throughout the post-operative period, during which time the recipient doe was taking daily 
tacrolimus. Its daily routine was also normal, with no adverse characteristics demonstrated with 
respect to behaviour, eating and drinking patterns, movement and fertility induction. Embryo transfer 
was chosen as the optimum method to achieve conception following the conclusions from Saso et 
al.108 In this study, the two rabbit long -term survivors following allogeneic UTx could not conceive 
via natural conception, most likely as a result of blocked anastomosed cornua.108 
 
One of the key issues concerning UTx is finding a suitable immunosuppressive protocol which 
achieves graft protection from the body’s rejection processes but also does not harm the embryo of the 
fetus. This resorbed pregnancy may therefore be explained by either the potential negative impact of 
tacrolimus on early fetal growth, or by a clinical rejected uterus because of inadequate 
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immunosuppression. With regards to the former point, tacrolimus was selected as it is now widely 
used in clinical organ transplantation. It has lower nephrotoxicity, with reports from large studies 
stating fewer episodes of acute rejection compared with the traditional calcineurin inhibitor CsA.248 Its 
mode of action suppresses T-lymphocyte activation via the inhibition of calcineurin-dependent 
interleukin IL-2 production.249 Importantly it can be used after initial induction therapy as a single 
immunosuppressant in liver transplantation,250 and tacrolimus has been used extensively during 
pregnancies in organ transplant recipients (a significant consideration for UTx).123,251 The latest study 
on the effects of tacrolimus on UTx, evaluated the effects of tacrolimus on the rejection of a 
transplanted rat uterus and on uterine expression of markers of inflammation and implantation.123 
Non-treated uterine grafts showed rejection with necrosis. Tacrolimus-treated transplanted group 
exhibited normal uterine morphology with low numbers of T-lymphocytes in all uteri except in two 
out of seven uteri of the tacrolimus-treated transplant group. Uteri of the non-treated transplanted 
group showed elevated mRNA expression of IL-1a and IP-10 and reduced galectin-1, compared with 
the tacrolimus-treated transplanted group. Therefore, tacrolimus monotherapy suppressed rejection of 
an allotransplanted uterus, normalized the expression of IL-1a and IP-10 and prevented T-lymphocyte 
infiltration. The tacrolimus in our experiment did overall decrease the rejection response (Figure 
2a.8). However, three rejection episodes did occur, with the ultimate episode occurring during 
pregnancy. Despite managing to control the first two (occurring on days 36 and 74), some uterine 
structural damage must have occurred, thus rendering the graft less suitable for carrying a pregnancy 
until term. The third episode on day 102 could have been the final insult which led to miscarriage, 
most probably occurring three days later (Figure 2a.6). It is therefore unlikely that it was the effects 
of tacrolimus which led to intra-uterine death but rather that the rejection response itself was 
inadequate to protect the graft carrying the pregnancy. This could be either because the dose of 
tacrolimus was inadequate or that an additional immunosuppressant, in the form of a monoclonal 
antibody, should be added. Further such experiments are required but should be carried out in a 
larger-animal model, because of difficulties of using a rabbit model as described in the previous 
chapter.  
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Advances in immunosuppression as well as original modalities to induce tolerance of a transplanted 
uterus may reduce these problems in the future. The induction of immunological tolerance to a 
transplanted graft offers a novel potential solution to inhibiting immune-mediated graft rejection. 
Tolerance is defined as the specific and permanent absence of an attack or response by the immune 
system to a foreign antigen, which in our case is represented by the uterine graft antigen, without 
immunosuppression.252  It can be classified as either natural which occurs via either a central (in the 
thymus and bone marrow) or peripheral (circulating mature T and B cells) pathway, or acquired. The 
ultimate clinical goal would be for the patient to ‘acquire’ tolerance, both in the non-pregnant and 
pregnant state, as natural tolerance cannot deal with foreign antigens. This would mean an almost 
complete allo-unresponsiveness to donor cells and therefore a diminished use of immunosuppressants 
and negligible damage to the uterine graft as a result of both the pre-clinical and clinical rejection 
process. Thus, it is important to differentiate between the role of immunosuppressants and tolerance 
modulation in the graft acceptance process. The level of an immunosuppressant administered to a 
patient can indeed portray the state of clinical tolerance, yet the drug does not provide tolerance 
induction in general. In certain cases, immunosuppressants can diminish the overall tolerance effect, 
for example, calcineurin inhibitors which downgrade the action of all T cells, including regulatory T 
cells (Tregs).253 
 
Boosting the role of Tregs may offer a ‘tolerance’ pathway. Natural Tregs are a subset of CD4+ cells, 
known for their ability to induce peripheral tolerance and are also known as CD4+CD25+FOXP3 
cells.254 Tregs are developed either naturally from the thymus as a separate lineage or similarly to 
other suppressive T cell subsets like Th3 or CD8+ suppressor cells are induced peripherally under 
certain regulatory conditions.253,255 It is the latter type of Treg which may be able to downregulate a 
post-transplant rejection response. The idea behind this process would involve in vitro isolation of 
Tregs specific to the uterine graft alloantigen prior to transplantation. Following Treg number 
expansion, these de novo cells would be transferred into the patient’s peripheral circulation, with the 
aim to induce immunomodulatory graft tolerance, minimal rejection and a decrease (or even 
disappearance) of immunosuppressive medication. Protocols under good manufacturing practice 
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conditions have already been created,253,256 with Phase I clinical trials in allogeneic bone marrow 
transplantation looking at this particular issue.257 Treg expansion during pregnancy (they make up a 
third of all CD4+ cells in the pregnant uterus) has been demonstrated in both allogeneic and syngeneic 
pregnancies, suggesting that paternal alloantigens are not the primary cause for this rise.245 Aluvihare 
et al confirmed the link between the establishment of a healthy fetus and normal Treg levels at the 
maternal-fetal interface by demonstrating a much smaller proportion of decidual Tregs following 
miscarriage, as opposed to elective abortions.245,258 It is thought that this particular inherent model of 
localized (uterine) tolerance may be responsible for a decreased rejection pattern on the graft during 
pregnancy,120 which necessitates further research into immunomodulatory techniques using the 
aforementioned agents, similar to the ‘Treg’ ideas described above. 
 
The field of immunomodulation continues to develop, and could lead to the ultimate goal, a post-
transplant world involving no regular immunosuppression medication. Aside from Tregs, 
immunosuppression may also be induced after a single treatment course. For example, T10B9, a 
monoclonal antibody directed against the alpha-beta heterodimer of the T-lymphocyte receptor 
complex, has been used successfully to treat acute cellular rejection in renal transplantation and as an 
immunosuppression induction agent in heart and simultaneous kidney-pancreas transplantation.259 
Kawai et al described combined bone marrow and kidney transplants from HLA single-haplotype 
mismatched living, related donors resulting in induced immunotolerance.260 
 
Unfortunately, pregnant transplant recipients cannot wait for long term results to clearly demonstrate 
superiority of one regimen over the other. This is especially a problem regarding pregnancy outcomes 
among transplant patients. Regardless, if the pregnant transplant recipient has a kidney, heart, lung or 
uterus, it will be impossible to ensure safety to mother and fetus if the goal is a healthy child that 
matures to a healthy adult.2  
 
We cautiously predict that from the immunological point of view, the risks to mother and fetus will be 
no different to those faced by renal, hepatic or cardiac transplant patients undergoing pregnancy. The 
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patient must be considered as high risk from the beginning of the pregnancy. She should be managed 
under a multi-disciplinary team, involving in particular a physician specializing in high-risk obstetrics 
and a transplant immunologist. The care pathway would be very similar to any pregnant patient with a 
transplanted organ.150 Because of the effects of immunosuppressants on the maternal immune system, 
viral serology for cytomegalovirus as well as microbiological cultures of vaginal smears should be 
repeated monthly. Levels of immunosuppressive drugs in the blood should be monitored, thus 
permitting adjustments of drug dose relative to graft function and physiological changes of pregnancy. 
Doppler assessment of the vascular uterine supply as well as anastomosis may be helpful if not 
interesting. Visual inspection of the transplanted cervix would likely provide clinical clues of the 
graft’s condition. Both vaginal delivery and a Caesarean Section would be possible for delivery. 
However, as the uterus will be removed following delivery, and in order to create a controlled 
environment during the labour process, a Caesarean section would be more advisable.2  
 
Conclusion 
  
Although this case series of allo-UTx described only nine cases, it highlighted some of the challenges 
with the choice of animal model and the complexity of the surgical procedure involved. The 
macrovascular patch technique involves aorto-aorta and veno-vena anastomoses. This type of 
anastomosis would not be attempted in a human because of its highly risky strategy involving the 
most important blood vessels. Damage to them could lead to catastrophic outcomes. Anastomosis at a 
lower level (common iliac, internal iliac or uterine arteries) would not be possible in a small animal 
model such as a rabbit as the diameter of these vessels is too small to allow for satisfactory 
anastomosis. Therefore, the macrovascular patch technique allows us to bypass this problem, and thus 
provide an adequate blood supply to the uterus - the most important prerequisite to long-term graft 
survival and subsequent pregnancy. In a human, internal iliac to internal iliac or even external iliac 
vessel anastomosis would be possible however as the diameter of these vessels is large enough for 
precise microsurgery. 
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With regards to the attempted pregnancy, despite the end result i.e. termination of pregnacy as a result 
of miscarriage, the study represents only the third example of conception and pregnacy following an 
animal allogeneic UTx. The surgical anatomical macrovascular model was successful, with an 
appropriate level of perfusion attained (see Chapter 3). Post-operative recovery was uneventful, with 
no adverse effects recorded. The cause of fetal demise is most likely secondary to inadequate 
prevention of the immunological rejection response.  
 
In summary, when including all 20 rabbit UTx performed by the team, results were as follows: (a) 
surgical survival rate: 80% (16/20); (b) UTx success rate: 67% (11/18); and (c) anastomotic success 
rate: 83% (15/18). These results support the feasibility of uterine allo-UTx using a macrovascular 
patch technique in the rabbit with respect to anatomical terms and surgical vascular achievability. 
Immunosuppression would follow kidney transplantation, with definite use of a steroid and a CNI. 
With regards to the robustness of the rabbit to withstand the operation, a solution could be to transfer 
the UTx experience onto a larger-animal model. A porcine model has been attempted and proved also 
a less-than-ideal model.84 A sheep model could be the next logical step, especially as the first birth 
post-allogeneic UTx was achieved using in this model.163 
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2. Study 2b: Achieving uterine auto-transplantation in a sheep model using iliac 
vessel anastomosis: a short-term viability study 
 
This study has now been peer-reviewed and published as per following reference: Saso S, Petts G, 
Thum MY, Corless D, Boyd M, Noakes D, Del Priore G, Ghaem-Maghami S, Smith JR. Achieving 
uterine auto-transplantation in a sheep model using iliac vessel anastomosis: a short-term viability 
study. Acta Obstet Gynecol Scand 2014 Nov 24. [Epub ahead of print] 
 
Abstract 
 
Objective: To investigate, develop and evaluate anatomical, surgical and anastomotic aspects 
necessary for a successful uterine transplant in a large-animal model. 
Design: Sheep model; longitudinal study involving five ewes. 
Setting: Royal Veterinary College, London, UK. 
Population: Five ewes of proven fertility. 
Methods: The uterine allograft along with the internal iliacs, and uterine arterial and venous tree all 
intact were harvested en bloc. An end-to-side anastomosis was performed between the external iliac 
vessels and the internal iliac vessels of the graft using 6-0 Prolene sutures. Successful reperfusion of 
the graft was initially judged by the colour shift of the uterus during reperfusion. Blood flow past the 
venous and arterial anastomotic sites was also ensured by visual inspection, together with pulse 
oximetry and multispectral imaging. 
Main Outcome Measures: Operative details (retrieval, ischaemic, clamping, reperfusion and 
recipient hysterectomy duration); physiological profiles; gross morphology and histopathology. 
Results: Five autotransplants were performed. One procedure was abandoned because of the 
inappropriate size of sheep model. Another procedure was halted because the animal suffered from 
respiratory failure in the immediate intra-operative period. Three transplants were completed. In 
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those, at least two out of four possible anastomoses were finished and the grafted uteri demonstrated 
immediate perfusion and appropriate viability 45 minutes post-operatively. 
Conclusions: Internal to external iliac vessel anastomoses is an acceptable surgical technique that 
should be applied in a human model to ensure adequate subsequent uterine perfusion. 
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2b.1. Introduction 
 
The challenges that one faces when attempting uterine transplantation (UTx) in a small animal model 
have been described in length in the previous chapters. Additionally, the human UTx attempt in 2000 
demonstrated the deleterious effects of vascular thrombosis, which in this case led to the demise of the 
graft and subsequent hysterectomy. Thrombosis was brought on by surgical techniques related to 
vascular anastomosis and the fixation of the transplant. Together, the above problems highlight the 
need for the development of a large animal model in order to further develop vascular anastomotic 
and other surgical techniques. Thus, the next step in achieving successful human UTx is carrying out 
the actual procedure in a large animal model. The large animal models resemble the human pelvis 
much more closely than small animals. Surgeons can therefore perform procedures that may be 
reproduced clinically in the future. The literature review has already been covered in an earlier 
chapter titled ‘Literature Review’. 
 
Aims 
 
Five autogeneic UTx procedures in a sheep model are presented here. The aim was to investigate, 
develop and evaluate anatomical, surgical and anastomotic aspects necessary for a successful UTx.  
UTx will be carried out in an orthotopic position in the pelvis and with vascular anastomosis to the 
external iliac vessels. 
 
2b.2. Methods and Materials 
 
Sheep model 
 
The feasibility of the uterine autograft dissection together with its vascular supply that includes the 
internal iliacs up to the point of division, the AA and the IVC was assessed by a series of uterine 
autotransplantations in the sheep model performed by this team. Two surgically explorative 
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procedures and five autogeneic uterine cross transplantations were performed using a pre-determined 
protocol. 
 
Five mature ewes (2–5 years of age) were purchased from an accredited breeder and used as both 
donor and recipient animals (auto-transplant). They were all of proven fertility with at least one 
previous litter each. The animals were acquired two to three weeks before the operation to ensure 
appropriate acclimatization to their surroundings. The animals had free access to hay and water and 
were fed pelleted concentrated fodder twice a day. The study followed the guidelines for the handling 
and care of experimental animals issued by the appropriate UK body and was approved by the Animal 
Ethics Committee in UK as well as the Institutional Review Board. 
 
Surgical protocol 
 
The aim of surgery was to isolate a specimen including the common uterine cavity and cervix, both 
uterine horns (without the oviducts and ovaries), the uterine arteries, leading to the anterior divisions 
of the internal iliac artery and accompanying vein, and ultimately the internal iliac vessels up to the 
point where they originate directly from the common iliac vessels.  
 
The ewe was anesthetized using a combination of intramuscular ketamine (4mg/kg) and diazepam 
(2mg/kg). After intubation, anaesthesia was maintained with 1.5–2.0% isoflurane. The anterior 
abdominal wall was shaved and cleaned, and the abdomen was opened through a midline incision. 
The end result of the graft harvest was a radical hysterectomy transecting across the vagina and the 
most lateral aspects of the uterine horns together with an internal iliac macrovascular patch. Following 
graft harvesting, the internal iliac artery was cannulated and the uterine specimen with its vascular 
patch was generously flushed with heparinised normal saline and transplant storage solution, Histidin-
Tryptophan-Ketoglutarat (HTK). 
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The uterine allograft along with the internal iliacs, and uterine arterial and venous tree all intact were 
harvested en bloc. The utero-tubal-ovarian specimen was continuously flushed and subsequently 
stored for 60 minutes ex vivo in the HTK solution, between 2°C and 8°C while the recipient doe was 
being prepared.  
 
The vagina was anastomosed initially to ensure proper orientation and positioning of the specimen 
followed by the uterine horns which were finally rejoined. Subsequently, soft tissue vascular clamps 
were placed first around the recipient’s external iliac artery. A longitudinal cut (4mm length) was 
made in the anterior external iliac artery wall to create an opening. An end-to-side anastomosis was 
performed between the external iliac artery and the internal iliac artery of the graft using 6-0 Prolene 
sutures. A total of three to five continuous stitches were used for the aortic connection. A similar 
procedure was carried out for the venous end-to-side anastomosis. Successful reperfusion of the graft 
was judged on the colour shift of the uterus during reperfusion from its blanched appearance after 
flushing to a more reddish colour. Blood flow past the venous and arterial anastomotic sites was also 
ensured. 
 
In all ewes, immediate surgical outcome was assessed 30-60 min after reflow by inspection of the 
patency of the vascular anastomosis sites, pulsation through the transplanted vessels, colour of the 
transplant and occurrence of spontaneous uterine contractions. 
 
Blood samples (full blood count, kidney and liver function, reproductive hormone profile) were taken 
just before the commencement of surgery by Dr M Boyd and Dr S Saso and again just before the 
animal was culled.  
 
The graft retrieval and transplant was performed by Mr J. Richard Smith and Dr S Saso. The vascular 
anastomosis was carried out by Mr DJ Corless (Consultant Upper GI Surgeon, Mid Cheshire 
Hospitals Trust), with Mr JR Smith and Dr S Saso assisting. Dr M Boyd (Veterinary Anaesthetist, 
Royal Veterinary College) was the anaesthetist for all nine transplants. Blood samples from the does 
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were taken by either Dr M Boyd or Dr S Saso. Advice on technical aspects and rabbit physiology 
during a major surgical procedure was given throughout by Professor D Noakes. 
 
Medication 
 
Subcutaneous heparin 1000IU was given both before and after organ procurement to prevent 
thrombosis. Quinolone enrofloxacin (Baytril) was used as antibiotic prophylaxis at an intra-operative 
dose of 5 mg/kg through a slow intravenous infusion. 
 
Post-mortem & Histopathology 
 
All post-mortems were performed immediately after the ewe had been euthanized. The same 
laparotomy incision as used in the actual surgery was opened and extended to become a thoraco-
laparotomy. The thoracic and abdominal cavities were inspected, including the macrovascular patch, 
the uterine graft and each organ individually (heart, lungs, liver, kidneys, spleen). Certain organs were 
then placed in formaldehyde to fix the tissue and prepare it for histopathology. An incision was made 
on the uterine cornua to allow for the formaldehyde to access the inside of the cornua. 
 
The gross morphology findings were recorded according to a scoring system previously validated by 
the Brannstrom team 117 and also used by Diaz-Garcia et al in UTx.109 The following characteristics 
were evaluated by the scoring system: (a) abnormal appearance of the uterus (colour, texture and 
hardness); (b) presence of adhesions; and (c) thrombosis of the graft vessels (both artery and vein). 
 
Prior to haematoxylin & eosin (H&E’s) staining, tissue was cut and placed on slides, with the 
assistance of Dr Gemma Petts (Specialist Registrar, Pathology, St Mary’s Hospital, London). All 
routine H&E’s were stained on the Tissue-Tek staining machine. The haematoxylin dye is a poor 
dyeing agent. To obtain purposeful results it needs to be converted to its oxidation product haematin. 
This is achieved by the use of an oxidising agent such as mercuric II oxide (HgO). Before this 
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conversion is brought about, haematoxylin is added to an aqueous solution of aluminium potassium 
sulphate. This is the mordanting step, where aluminium ions combine with the haematoxylin dye. The 
resultant aluminium-haematin complex then stains via the metal ion - Al++. Haematoxylin possesses 
acid-base indicator properties (red in acid - blue in alkali solutions) so the stained tissue components 
must be 'blued' after differentiation using an alkaline solution (London tap water or a blueing agent). 
This then allows the rest of the tissue components to be counterstained as desired (normally eosin). 
The sections are first immersed in water. Visible nuclei are then stained in Harris haematoxylin for 
five minutes. This is then followed by a wash in water and differentiation in 1% acid alcohol. The 
well is washed in water and ‘blue’ in Scott’s water. Subsequently the sections are all washed in water 
again, followed by staining in 1% eosin Y for five minutes. Washing in water implies de-waxing in 
xylene in 1-2 minutes, then in 99% alcohol for 10 seconds which is repeated three times and finally 
repeated in running tap water for 10 seconds. A repeat wash in water, followed by dehydration, 
clearing and mounting. This implies the following method: dehydration in 99% alcohol for 10 seconds 
repeated three times, clearance in xylene for 20 seconds and mounting on cover-slipping machine. 
 
Data Presentation and Analysis 
 
Statistical analysis was not required for this study. Data has been presented using 2D graphs, 
histopathology slides, figures and descriptive tables. 
 
2b.3. Results 
 
Five uterine auto-transplants were carried out. The aim was to first remove the whole uterine graft 
(cervix, cavity, both cornua), including its blood supply (uterine vessels, anterior division of internal 
iliac and the internal iliac from their origin to the section where they divide into anterior and posterior 
divisions. Accompanying veins were also included. The anastomotic goal was to join the origin of the 
internal iliac vessels to the external iliac vessels bilaterally, perform both left and right cornua-cornual 
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anastomoses and finally carry out a cervico-vaginal anastomosis. Mastery of the microvascular 
techniques of iliac arterial and venous anastomosis was the primary focus. 
 
The first cadaveric study focused on the vascular and pelvic surgical anatomy of the sheep model and 
its variations from the human pelvis. The dissections of the internal and external iliac vessels allowed 
us to believe that we could perform uterine auto-transplantation successfully. The morning of the first 
transplant commenced with the sheep being administered a general anaesthetic, and then washed and 
draped. The weight of the ewe was 80kg. The animal was not catheterised. A midline incision was 
made, which in retrospect should have been longer both in a caudal and cephalic direction. On 
opening the abdomen the uterus was easily identified. The uterine horns were then isolated, followed 
by identification of the middle uterine arteries and the utero-ovarian vessels which were clamped and 
ligated. The external iliac vessels were identified and skeletonised for the later attachment of vessels. 
A dissection was subsequently performed down to the vagina. An enormous number of vessels down 
the anterior aspect of the cervix were witnessed and the cervix in fact proved to be approximately four 
inches long. By the time the vagina was entered, the surgical team was deep into the abdomen in both 
an inferior and posterior direction. This depth was uncomfortable and would not have been 
encountered in a woman’s pelvis. Having opened the vagina, the dissection of the uterine vessels was 
continued inferiorly and the uterine vessels were dissected free of the vagina. Unfortunately, it did not 
prove possible, having identified the internal iliac vessels, to allow for the dissection of the ‘meeting’ 
of the internal iliac with the base of the uterine arteries. They were too far under the pelvic joints to be 
visible. Therefore the uterine arteries were ligated with approximately 1.5-2.0 inches of spare artery to 
utilise, as the aim was now to attempt uterine artery to external iliac artery anastomosis. Unfortunately 
following the removal of the sample, it became clear that these arteries had grossly retracted and were 
the equivalent of a uterine artery in a woman. They were also impossible to separate from the cervix 
and furthermore, the uterus could not be anastomosed at the vagina as planned. Only one connection 
was possible, from the identified uterine artery and vein to the external iliac on the right side.  This 
was duly cross clamped at the vein.  Four sutures were put in. Bearing in mind the uterus was now in 
the wrong place, it proved impossible to complete the anastomosis and the procedure had to be 
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abandoned. The animal was subsequently culled. In order to see whether the technique could be 
improved, the incision was lengthened in the cephalic direction which delivered a better angle of 
approach and access. A Mercedes scar was subsequently utilised which did finally allow us to gain 
access to the distal end of the internal iliac. It did however involve cutting through a large body of 
muscle with potential for heavy haemorrhage secondary to incision of large-diameter vessels within 
the muscle. The decision was made that prior to the next transplant, a further cadaveric dissection was 
required to ensure that this procedure could be carried out in a sheep model. This was indeed 
performed, and the use of a lighter and smaller ewe solved the problem of the afore-mentioned 
abdominal depth which was greatly decreased. This allowed for definite visualisation of the point 
where the uterine arteries meet the anterior division of the internal iliac.  
 
The second autotransplant commenced in the same manner as the transplant above. The sheep 
weighed approximately 50kg. Catheterisation proved difficult again and the bladder was emptied 
using a needle and syringe intra-abdominally. This was performed with the subsequent three 
autotransplants. A mid-line incision was made which proved difficult in the region of the mammary 
teats as a result of the venous supply within the subcutaneous fat.  Having entered the abdomen, the 
bowel was packed posteriorly. Dissection then commenced by dividing the round ligament, opening 
the broad ligament and identifying the external and internal iliac vessels. The internal iliac vessel was 
completely skeletonised down to the insertion of the uterine artery and beyond. The ovarian ligament 
was divided separating the ovary and Fallopian tube from the uterus. The bladder was dissected down. 
Ureters were slung and dissected out in their entirety. The vagina was opened anteriorly and 
posteriorly and the uterine artery was then dissected free down a distance of approximately 8cm until 
it met the internal iliac. The ligation of the internal iliac beyond the uterine artery/venous junction 
proved difficult since a ligature could not be placed round it, since again it was well under the pelvic 
arch. Therefore, four large ligaclips were applied to good effect and this allowed separation of the 
uterus, cervix, upper vagina, along with attendant uterine arteries. At the end of it, the uterine arteries 
twisted rather easily which did not allow perfusion with the HTK solution in a satisfactory fashion. 
The external iliac vessels were completely skeletonised and rendered free to allow vascular clamps to 
  - 199 - 
be put round them. The left external iliac vein was first incised. Appropriate haemostasis was difficult 
to achieve with the equipment present. This was however done and the internal iliac vein was 
anastomosed to the external iliac. Six sutures were required to create a seal. Identical steps were 
repeated for the arterial supply. There did not appear to be any arterial flow with the entire vessel 
seeming to have spasmed. After much discussion the decision was made to complete the experiments 
by joining the right internal iliac to the right external iliac artery. This was duly performed with the 
uterus in fact gradually appearing pink and perfused. The animal was kept alive for 45 minutes and 
then culled.  
 
The third autotransplant proceeded in the same manner. The ewe weighed 48kg. It was again possible 
having identified the internal iliac vessels to make the dissection ‘meet-up’ i.e. internal iliac artery 
with the base of the uterine arteries. The skeletonization of the uterine vessels towards internal iliac 
was again a challenge but the uterus with the uterine vessels as well as the internal iliac vessels was 
dissected en bloc. All four vascular anastomoses were completed: left internal iliac to left external 
iliac artery, left internal iliac vein to left external iliac vein, right internal iliac to right external iliac 
artery, and finally right internal iliac vein to right external iliac vein. The uterus appeared well 
perfused at completion of surgery. The animal was kept alive for 45 minutes and then culled. 
 
The fourth operation commenced in the same manner as the previous three autotransplants, with a 
midline laparotomy. The ewe weighed 55kg. The anaesthetics team had reported pre-operatively that 
intubation had been challenging, with the animal observed to be respiring at a higher rate than normal. 
Immediately on entering the abdomen it was clear that there was more intra-abdominal pressure than 
normal. The uterus was subsequently identified, with the bowel packed back. At that point 
unfortunately the animal arrested and died. Resuscitation was attempted without success. Full post-
mortem was undertaken with retrieval of uterus, liver, lungs and heart. The lungs looked obviously 
diseased.   
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The fifth animal weighed 62kg. Following the mid-line laparotomy, the bowel was packed with good 
access obtained into the pelvis. The external iliac vessels were skeletonised and under-run in 
preparation for the anastomosis later. The internal iliac vessels were identified as far as the bifurcation 
where the uterine vessels branched off. This part of the operation was similar to auto-UTx #1 i.e. 
extremely deep in the pelvis. The uterus was isolated by dividing the ovarian ligaments. The uterine 
arteries were clearly identified running down either side of the vagina. The utero-vesical space was 
opened to reach the vagina down to 2.5-3 inches below the cervix. The recto-vaginal septum was also 
opened to achieve the same dissection. The ureters had slings applied. Unfortunately at the end of the 
dissection on the left side, accidental trans-section of the left uterine artery occurred, approximately 
4cm from the cervix and 3cm from the internal iliac. On the right side it appeared that the uterine 
artery bifurcated twice and this resulted again in a short sample. This therefore led to us being unable 
to do an internal iliac to external iliac anastomosis. Thus, the anastomosis performed was uterine 
vessels to external iliac vessels. Hence, the uterine arteries were skeletonised clear of the uterus i.e. in 
the parametrium. The right uterine vein was anastomosed to the right external iliac vein and the left 
uterine artery was anastomosed to the left external iliac artery. The uterus immediately demonstrated 
good blood flow and was pink and functional. The animal was culled 45 minutes after completion of 
anastomosis.   
 
Operative details for the above five auto-transplants are shown in Table 2b.1 below. Blood results are 
shown in Table 2b.2. 
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Key: * UTx not completed 
 
 
Table 2b.1 Operative details from the five transplant procedures in the sheep model showing 
retrieval, ischaemic, clamping, reperfusion and recipient hysterectomy times in minutes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
UTx 
Graft 
Retrieval 
(min) 
1st Warm 
Ischaemia 
(min) 
Cold 
Ischaemia 
(min) 
2nd Warm 
Ischaemia 
(min) 
Clamp on 
(LEIV/LEIA/ 
REIV/REIA) 
(min) 
Grafting 
(min) 
Reperfusion 
(min) 
EBL 
(ml) 
1* 478 5 60 30* 25 / - / - / - 30* N/A 35* 
2 375 5 60 120 35 / 26 / - / 22 120 45 200 
3 300 5 60 125 42 / 23 / 22 / 15 125 45 800 
4* N/A N/A N/A N/A N/A N/A N/A N/A 
5 205 5 60 90 - / 24 / 27 / - 90 45 100 
Mean 340 5 60 115 34 / 24 / 25 / 19 115 45 367 
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Key:  NA. Non-applicable, NM, Not Measured (lab error, insufficient sample received, 
haemolysed sample 
 
 
Table 2b.2 Hepatic, Renal and Reproductive Profiles (Non-Pregnant Ewe) 
 
 
 
 
 
 
 
 
 
 
Marker 
UTx 1 UTx 2 UTx 3 UTx 4 UTx 5 
pre post pre post pre post pre post pre post 
Sodium 147 NA 145 145 144 142 143 NA 143 143 
Potassium 4.1 NA 4.2 6.5 4.1 4.3 4.2 NA 4.5 6.1 
Urea 6.3 NA 7.7 11.7 8.9 5.1 9.5 NA 8.5 12.4 
Creatinine 82 NA 64 186 80 56 69 NA 73 128 
AST 72 NA 89 80 97 83 109 NA 239 271 
ALT 27 NA 25 21 21 60 34 NA 27 31 
ALP 107 NA 146 149 138 125 174 NA 57 48 
Albumin 36 NA 30 23 31 28 33 NA 32 23 
CRP <0.6 NA <0.6 <0.6 <0.6 <0.6 <0.6 NA <0.6 <0.6 
Reproductive Profile 
17β-oestradiol 56 NA 73 88 56 91 133 NA 88 94 
LH 0.1 NA 0.1 0.1 0.1 0.1 0.1 NA 0.1 0.1 
FSH 0.1 NA 0.2 0.2 0.1 0.1 0.1 NA 0.1 0.1 
Testosterone 0.4 NA 0.4 0.4 0.4 0.4 0.4 NA 0.4 0.4 
Progesterone 0.5 NA 0.5 0.8 0.5 0.8 0.8 NA 0.5 0.8 
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Post-mortem and Histopathology 
 
Tables 2b.3 and 2b.4 below and Figures 2b.1-2b.3 summarise the findings following post-mortem 
and histopathology. 
 
 
UTx  
Colour 
 
0, pink 
1, dusky  
2, white 
Texture 
 
0, soft 
1, firm 
2, hard 
Size 
 
0, normal  
1, oedematous  
2, markedly bigger 
Anastomosis 
(vein-vein) 
 
0, intact 
1, broken down 
Anastomosis 
(artery-artery) 
 
0, intact 
1, broken down 
Uterine 
bleeding 
 
0, absent 
1, present 
1 N/A N/A N/A N/A N/A N/A 
2 1 1 1 0+1 0+1 0 
3 0 0 0 0 0 0 
4 N/A N/A N/A N/A N/A N/A 
5 0 0 0 0+1 0+1 0 
 
 
Table 2b.3 Summary of gross morphology findings at post-mortem, performed within 60 minutes 
of the death of the ewe (Wranning et al) 117 
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Table 2b.4 Summary of histopathology findings (UTx #1-5) 
UTx Post-mortem 
Macroscopic examination of fixed tissue and 
Histopathology 
Clinico-Pathological 
Correlation 
1 N/A N/A N/A 
2 
Left vascular anastomosis 
appears to have failed. 
 
Right vascular 
anastomosis appeared 
successful. 
10 slides 
 
Vascular anastomosis: The left internal-external iliac 
anastomosis shows evidence of intravascular thrombosis 
and damage to the vessel wall (Figure 6.3a-b). The 
thrombosis appears extensive but it is difficult to comment 
on whether there is complete occlusion of the vessel due to 
suboptimal sectioning of the histology block. 
 
Vagina, uterus, and oviduct: The vaginal anastomosis 
shows diffuse mild to moderate acute inflammation of the 
squamous (Figure 6.3c) and glandular (Figure 6.3d) 
epithelium, probably representing mild ischaemic changes. 
 
The left and right cornua show evidence of early ischaemia 
(peri-glandular inflammation, Figure 6.3e). There are 
small polypoid stromal proliferations probably 
representing benign uterine polyps (Figure 6.3f).  
 
The right oviduct shows evidence of early ischaemic 
changes (Figure 6.3g). The left oviduct shows marked 
congestion and inflammation, suggesting more severe 
ischaemia (Figure 6.3h-j). 
Uterus and oviduct show 
evidence of mild to 
moderate ischaemia. 
 
Thrombus in the left 
internal-external iliac 
anastomosis but the extent 
of the vessel lumen 
occlusion cannot be 
assessed. 
3 No obvious pathology 
Vascular anastomosis: No thrombus formation or 
significant abnormality identified. Extravascular 
connective tissue haemorrhage and fibrin deposition 
containing numerous polymorphs seen. Most likely 
representing a blood clot associated with handling and 
surgery (left vascular anastomosis, not photographed). 
 
Uterus, and oviduct: The uterine body shows small 
polypoid stromal proliferations possibly representing 
benign uterine polyps (similar to those seen in uterus 2). 
No other abnormalities noted. 
 
The left cornua appears congested. The right cornua 
appears within normal limits. There is no evidence of 
ischaemia. 
Uterus and oviduct showing 
no significant abnormalities. 
 
No evidence of thrombus in 
the vascular anastomoses. 
4 
Heart:  
Small lesion in the lateral 
wall of the left ventricle 
 
Lungs:  
Congested with areas of 
?haemorrhage/infarct. 
 
6 slides 
 
Heart: The lesion in the wall of the left ventricle is a 
partially calcified nodule surrounded by a rim of dense 
connective tissue containing a chronic inflammatory cell 
infiltrate (Figure 6.4a). The origin (infection, foreign 
body, infarction) of the nodule is unclear. In further 
sections taken from the wall of the left and right ventricles 
and septum there are occasional scattered aggregates of 
chronic inflammatory cells (Figure 6.4b). The overall 
appearance is of mild patchy myocarditis. 
 
Lungs: Cuffing of large airways by aggregates of 
Features of myocarditis and 
an allergen induced 
bronchial hypersensitivity 
reaction. 
 
Both of these, alone or in 
combination would have 
affected the animal’s ability 
to withstand the 
physiological stress of 
anaesthesia. 
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eosinophils, consistent with an airway/bronchocentric 
allergic inflammatory reaction (in humans this would be 
associated with allergen induced bronchial hypersensitivity 
as seen in asthma)(Figure 6.4c). Focally there are 
aggregates of haemosiderin/degraded foreign material 
surrounded by giant cells, suggestive of previous 
aspiration. 
 
Mediastinal and paratracheal lymph nodes show reactive 
changes. 
5 No obvious pathology 
2 slides 
 
Vascular anastomosis: There is a possible thrombus 
present in the right vascular anastamosis, however the 
plane of tissue sectioning is suboptimal and it is not 
possible to comment on the occlusive nature of the 
thrombus (Figure 5.5a). There are some inflammatory 
cells adherent to the luminal surface of the left vascular 
anastomosis but these are not associated with thrombus 
and probably represent early activation of the clotting 
system or early recruitment of inflammatory cells (Figure 
5.5b). 
 
Uterus, and oviduct: The uterine body shows small 
polypoid stromal proliferations possibly representing 
benign uterine polyps (similar to those seen in UTx #2 and 
#3, therefore this may represent normal histology for a 
sheep uterus). No other abnormalities noted. 
 
The right and left cornua appears within normal limits. 
There is no evidence of ischaemia. 
 
 
Possible thrombus in the 
right vascular anastomosis. 
 
Uterus and oviduct showing 
no significant abnormalities. 
 
No evidence of ischaemia. 
 
 
 
 
 
Key: DIC; disseminated intravascular coagulation; PA, pulmonary artery; PE, pulmonary embolus 
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Figure 2b.1-2b.3 Selected histopathology images (slides are H&E unless stated otherwise) 
 
UTx #1 - Histopathology was not performed here as the procedure was abandoned because of a poor 
choice of animal 
 
Figure 2b.1 UTx #2 - Demonstration of anastomotic failure of left vascular field 
Figure 2b.1a 
 
Left internal-
external iliac 
anastomosis. 
x 12.5, H&E. 
 
Intravascular 
thrombosis and 
damage to the 
vessel wall. 
 
Figure 2b.1b 
 
Left internal-
external iliac 
anastomosis. 
x 40, H&E 
 
Intravascular 
thrombosis and 
damage to the 
vessel wall.  
Figure 2b.1c 
 
Vaginal 
anastomosis. 
x 100, H&E. 
 
Squamous 
epithelium, 
mild ischaemic 
changes.  
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Figure 2b.1d 
 
Vaginal 
anastomosis. 
x 100, H&E. 
 
Glandular 
epithelium, 
mild ischaemic 
changes.  
Figure 2b.1e 
 
Left cornua. 
x100, H&E. 
 
Early ischaemia 
(peri-glandular 
inflammation) 
 
Figure 2b.1f 
 
Right cornua. 
x12.4, H&E. 
 
Benign uterine 
polyp. 
 
Figure 2b.1g 
 
Right oviduct. 
x12.5, H&E. 
 
 
Figure 2b.1h 
 
Left oviduct. 
x12.5, H&E. 
 
Marked 
congestion. 
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Figure 2b.1i 
 
Left oviduct. 
x40, H&E. 
 
Marked 
congestion and 
inflammation, 
consistent with 
ischaemia. 
 
Figure 2b.1j 
 
Left oviduct. 
x100, H&E. 
 
Marked 
congestion and 
inflammation, 
consistent with 
ischaemia. 
(Black pigment 
= formalin 
pigment 
artefact). 
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Figure 2b.2 UTx #4 - Cause of early demise 
Figure 2b.2a 
 
Left ventricle 
lesion. 
x 40, H&E. 
 
 
Figure 2b.2b 
 
Right ventricle. 
x 100, H&E. 
 
Patchy chronic 
inflammation. 
 
Figure 2b.2c 
 
Left lung. 
x 200, H&E. 
 
Peribronchiolar 
cuff of eosinophils 
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Figure 2b.3 UTx #5 - Demonstration of a patent left vascular anastomosis 
 
Figure 2b.3a 
 
Right vascular 
anastomosis. 
Original x 40, 
H&E. 
 
Intravascular 
thrombosis. 
 
Figure 2b.3b 
 
Left vascular 
anastomosis. 
x 200, H&E 
 
Inflammatory 
cells adherent to 
the vascular 
lumen  
(possible 
coagulation 
activation or 
margination) 
 
Intact 
anastomosis  
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2b.4. Discussion 
 
A natural progression from the animal model towards the human setting involves performing UTx 
first in the small animal model followed by a large animal model, and finally working with primates. 
Work with animal models allows the team to address various aspects of the whole UTx procedure, 
thus ensuring that future human UTx attempts may be clinically appropriate and have an adequate 
likelihood of a positive outcome. To date, the UK Team has worked with both a small animal model 
(rabbit) and a large animal model (pig) but the macrovascular model was only attempted in the rabbit. 
This study describes the ‘transfer’ of that macrovascular technique to a sheep model, with the main 
objective being the success of the external iliac-internal iliac anastomotic technique, allowing for 
normal uterine perfusion. The sheep model is perfectly suitable for this as the size of its pelvic organs 
and associated vessels is similar to those of a woman, and especially when compared with other large 
experimental animal models such as pigs and dogs. An autotransplant model was used (as opposed to 
an allogeneic) in order to judge accurately and exclusively the effects of the anastomosis in 
maintaining a well-perfused uterus. Therefore, by applying an autotransplant model, one can isolate 
the potential damage that may be caused by an acute rejection, as well as immunosuppressive 
medications that need to be administered.162 
 
This is only the seventh study at the time of writing whereby a uterine transplant has been attempted 
in a sheep model. Our previous attempt to achieve a successful orthotopic auto-UTx in a large animal 
model failed. The model was porcine and the vascular model applied was microvascular. Uterine 
arteries were anastomosed back together which resulted in subsequent thrombosis and graft failure 
post-operatively, most likely as a result of the small diameter of the uterine vessels and the associated 
high rate of thrombosis at these sites.  
 
Five autotransplants were performed. Three were completed. The first autotransplant was not 
completed because of the inappropriate size of the ewe, which resulted in a ewe of correct weight 
being chosen for the subsequent four autotransplants. The fourth autotransplant was also not 
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completed as the animal arrested just as the pelvic dissection began during retrieval. The uteri in the 
three autotransplants that were completed all demonstrated macroscopically appropriate viability 45 
minutes following re-establishment of reperfusion. This is despite only one of the autotransplants (#3) 
having all four vessels anastomosed (left and right internal-external iliac veins and left and right 
internal-external iliac arteries). Good surgical access was achieved to the external and more 
importantly internal iliac vessels, especially where the uterine vessels meet the anterior division of the 
internal iliac. In UTx #5, a surgical error resulted in accidental transection of the left internal iliac 
artery. To overcome this problem, the left uterine artery was anastomosed to the left external iliac 
artery. Despite this, macroscopically, the end-point was considered a success: a viable uterus with 
adequate perfusion. Microscopically, no ischaemia was seen in UTx #3 and UTx #5, with good 
viability in the uterus, cornua and oviducts. Thrombosis was demonstrated as hypothesised intra-
operatively in the left internal-external iliac anastomosis of UTx #2, secondary to the spasm of the left 
internal iliac artery. This led to early ischaemia of the left cornua and marked ischaemia of the left 
oviducts. However as the right internal-external iliac anastomosis was intact, the uterus did not 
ultimately fail and demonstrated good peristalsis, colour and tone by the end of the 45 minute 
perfusion period. Therefore, from a technical as well as learning point of view, this case series is 
deemed to have been overall successful, where success is deemed to be uterine viability after 45 
minutes of perfusion following re-anastomosis. When provided with a suitable and healthy model, the 
uterus was considered viable in two out of the three transplants (UTx #3 and #5), and partially viable 
in one (UTx #2). Out of the 12 potential anastomoses (four per transplant), eight anastomoses were 
achieved and considered patent. 
 
The advantage of using external and internal iliac vessels is primarily the large diameter of the vessels 
(when compared to both small animal models and the uterine vessels). Furthermore, the size of the 
vessels is equivalent to those in a human. Third, the external iliac vessels can be easily accessed and 
mobilized. In both human attempts to date, the graft vessels were anastomosed to the external iliac 
vessels.61,261 Extending vein grafts however were not required in the second attempt.61 From this 
study, one can also conclude that the uterus can be transplanted orthotopically, with bilateral 
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anastomoses, and no requirement for vascular extensions. These should be avoided as they predispose 
to thrombosis, as is what occurred 90 days after the operation was performed on the Saudi case, which 
led to subsequent graft necrosis.61  
 
Lessons 
 
The study itself is a valuable lesson in the importance of choosing an appropriate animal to carry out 
surgical work and having the correct equipment. The team wished for ewes with proven fertility to 
ensure easier access to the pelvis but the size of the first ewe meant that it was impossible to reach the 
point whereby the uterine artery meets the anterior division of the internal iliac artery. A smaller sized 
ewe (suggested by Professor Brannstrom’s team) that was used in the next four transplants allowed 
the team to test the vascular anastomotic model and from that make decisions as to how to approach a 
future human UTx attempt. Also, from problems encountered during the first attempt, the subsequent 
four procedures were performed with the correct equipment. 
 
First, having learnt from auto-UTx #1, the uterus had to be retrieved in such a way as to remove a 
large proportion of the vagina - as far as the posterior aspect of the bladder as well as the recto-vaginal 
septum in order to allow the uterine artery to be supported by the vagina to which it is attached. The 
anatomy at this juncture is much different from a woman’s. In a woman the uterine artery comes off at 
the level of the cervix, whereas in a ewe the uterine artery comes off approximately 8cm below the 
cervix and carefully dissection is paramount. The surgeons managed to gain access to the ‘meeting 
point’ described above, and thus ligate caudally to it. This ensured that the uterine graft could be 
retrieved with its vascular supply i.e. uterine vessels, anterior division of iliac vessels and the internal 
iliac up to the common iliac vessels. The ligaclips proved utterly invaluable for removing the anterior 
division of the internal iliac and the operation would not have been completed without this device. 
Second, a smaller ewe meant that it was much more straight-forward to skeletonize the external iliac 
vessels and retrieve the whole uterus because of the lower amount of adipose tissue. This also meant a 
lower volume of estimated blood loss. Third, an animal of appropriate size also meant that the 
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surgical model may be deemed successful (Table 2b.1). Graft retrieval and subsequent grafting 
demonstrated a significant decrease in duration (retrieval: 1st transplant - 478 minutes, 2nd transplant - 
375 minutes, 5th transplant - 205 minutes; grafting: 2nd transplant - 120 minutes, 5th transplant - 90 
minutes) whereas the vascular anastomosis was below 30 minutes in all but two cases (8/10 attempted 
were performed in under 30 minutes). Estimated blood loss was only 100ml following the last case 
(<5% of a ewe’s total blood volume). The surgeon responsible for this section reported that the 
technique and ease of operation was no different to what he is accustomed to in a human with regards 
to vascular anastomosis of similar-sized vessels. Fourth, from Table 2b.3, it is apparent that the uterus 
demonstrated appropriate colour, texture and size 45 minutes following reperfusion in completed 
transplants #2, #3 and #5, with an improvement in colour in the latter two. Finally, it is worth 
highlighting that two out of the three ewes which completed the auto-transplantation process suffered 
from acute renal failure during the operation (Table 2b.2). Vascular supply to the kidneys was not 
manipulated, and pre-operative renal function was normal. The most likely explanation was that 
‘third-space tissue losses’ as well as the gastrointestinal secretions were not replaced adequately with 
intravenous fluids. Table 2b.5 summarises the lessons gained from this study. 
 
Limitations 
 
Five cases were attempted, out of which only three were completed. Importantly, the reasons for the 
non-completion of autotransplants #1 and #4 were non-surgical. A larger cohort would have been 
preferable. Furthermore, each case was terminated 45 minutes following reperfusion. Ideally, the next 
study should assess long-term morbidity and especially uterine function, both in an autogeneic and 
allogeneic model. Uterine function would be ideally assessed by attempting conception, pregnancy 
and delivery, with analysis of fetal weight and well-being. Finally, fluid balance must be recorded and 
if so, accurately to prevent future occurrences of renal failure. 
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Conclusion 
 
The present study was the ﬁrst time that the UK team attempted a macrovascular UTx large-animal 
model. In particular, internal to external iliac vessel anastomoses. The surgical technique was very 
similar to what would be used in a human model, with an obvious improvement with regards to 
procedure duration and skill. In the three (out of five) ewes where grafting was possible, at least two 
out of four vessels were joined and the grafted uteri demonstrated immediate perfusion. Therefore, the 
external iliac vessels may definitely be used as recipients of the graft vessels in order to allow for a 
secure blood flow. The following chapters analyse the level of perfusion. A future experiment should 
attempt to achieve normal pregnancies after removal and subsequent autotransplantation of the uterus 
in a sheep. 
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Table 2b.5 Modifications to Surgical Technique: UTx #1-5 
Transplantation Number Learning Points 
UTx #1 
1) Too big an animal (80kg) was the main issue which resulted in an incomplete 
experiment. The size meant a difficult dissection, inability to locate the point where 
the uterine artery meets the anterior division of the internal iliac artery. It was even 
challenging to skeletonize the external iliac vessels for the latter anastomosis. This 
was mainly secondary to the amount of adipose tissue present. 
2) A further cadaveric dissection is necessary to see whether this procedure can 
actually be carried out i.e. whether one can arrive to the appropriate part of the 
internal iliac artery described above to make the experiment feasible. 
3) The following instruments will be necessary for the next operation: ring 
retractor, medium and large sized swabs, long scissors and forceps and medium 
sized ligaclips. 
4) It is also necessary to utilize a longer mid-line incision. 
UTx #2 
1) Much improved in comparison to UTx #1. 
2) With the correct equipment and a lighter animal (40-60kg, rather than >80kg), 
this procedure can be carried out in a sheep model. This includes graft retrieval 
together with the iliac vessels as well as subsequent internal iliac to external iliac 
vessel anastomosis. 
3) In the next three procedures, the uterine artery should be skeletonized less to 
prevent spasm. This can be achieved during dissection so that the uterine artery is 
dissected away with adventitial support. 
4) In theatre for approximately 10 hours, so next step is try to decrease that time by 
improving surgical speed. 
5) The following instruments will be necessary for the next operation: all three 
types of ‘ligaclip’ (small, medium, large) and one self-retaining retractor. 
UTx #3 
Above lessons all applied. All four vascular anastomosis completed. No particular 
issues to highlight.  
UTx #4 
Animal died early on the operating table. To that point, no problems were 
encountered during the operation. 
UTx #5 
1) Above lessons all applied.  
2) Satisfactory anastomosis. Comfortable operative technique.  
3) This transplant concludes this case series. 
 
The next experiment should focus on human work, in particular, fresh human 
cadaveric dissection. 
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STUDY 3 
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3. Study 3: Imaging of Organ Viability during Uterine Transplantation Surgery 
 
This study has now been submitted for peer-review and potential publication. 
 
Abstract 
 
Background Uterine transplantation surgery has been proposed as a treatment for permanent 
absolute uterine factor infertility in the case of loss of the uterus. Due to the complexity of the 
vasculature correct re-anastomosis of the blood supply during transplantation surgery is a crucial step 
to ensure reperfusion and viability of the organ. While techniques such as fluorescent dye imaging 
have been proposed to visualise perfusion there is no gold standard for intraoperative visualisation of 
tissue oxygenation. In this paper results from pulse oximetry, a liquid crystal tuneable filter (LCTF)-
based multispectral imaging (MSI) laparoscope and laser speckle contrast analysis are described.  
Methods The system was used to monitor uterine oxygen saturation (SaO2) before and after 
transplantation. Results from surgeries on two animal models (rabbits and sheep) are presented. A 
feature-based registration algorithm was used to correct for misalignment induced by breathing or 
peristalsis in the tissues of interest prior to analysis. An absorption spectrum was calculated at each 
spatial pixel location using reflectance data from a reference standard, and the relative contributions 
from oxy- and deoxyhaemoglobin were calculated using a least squares regression algorithm with 
non-negativity constraints.  
Results  Results acquired during animal surgeries show that cornual oxygenation changes are 
consistent with those observed in point measurements taken using a pulse oximeter, showing reduced 
SaO2 following re-anastomosis. Values obtained using the MSI laparoscope were lower than those 
taken with the pulse oximeter, which may be due to the latter’s use of the pulsatile arterial blood 
signal.  
Conclusion Future work incorporating immunological test results will help to correlate SaO2 
levels with surgical outcomes. 
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3.1. Introduction 
 
The literature review has already been completed in an earlier chapter titled ‘Literature Review’. 
 
Aims 
 
The aims of this study were to explore and compare the above imaging modalities, pulse oximetry, 
optical spectroscopy, and endoscopic laser speckle contrast analysis. In particular, their suitability for 
assessing uterine perfusion, extent of ischaemia and circulatory function of the uterus in order to 
provide image information relevant to uterine perfusion, function, as well as operative success. This 
was carried out in two animal uterine transplant models: rabbit (small-animal model) and sheep (large 
animal model). 
 
3.2. Materials and Methods 
 
Oxygen Saturation and Perfusion Index 
 
This model has been applied previously by this team to assess uterine perfusion and, therefore 
viability, immediately following UTx.80,156 A normal finger pulse oximetry probe was modified to 
allow the jaws to open wider so as to fit around the uterine horns (Figure 3.1). It was placed in a 
sterile endoscopic bag/drape to maintain aseptic technique. Once in direct contact with the uterine 
tissue, it measured O2Sat and PI, two independent variables.262,263 This was possible as the oximeter 
(Datex-Ohmeda 3600P, Louiseville, USA) has the capacity to measure both variables (Figure 3.2). 
The heart rate recorded on uterine oximeter was constantly compared to that of the anaesthetic 
oximeter to ensure accuracy. The probe was placed on both the medial and lateral aspects of the right 
and left uterine horns. This area of the organ is relatively thin allowing infra-red light needed in 
oximetry to pass through the structure. Use of a superficial marker suture on the broad ligament 
allowed for consistency in the probe site application.  
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In the allogeneic rabbit model, we modified the application in comparison to its previous use by 
applying it on three separate occasions: (i) prior to graft retrieval from donor - donor uterus; (ii) prior 
to recipient hysterectomy - recipient native uterus; and (iii) post-transplantation - recipient donor 
uterus. In the first two instances, readings were taken once normal pelvic anatomy had been 
established and uterine vasculature was skeletonised. Readings were taken post-UTx following visual 
confirmation of uterine viability by restoration of its pink pre-transplant appearance. 
 
In the autogeneic sheep model, measurements were taken on two separate occasions: prior to graft 
retrieval, and 20-30 minutes post-transplantation. 
 
PI is a relative indicator of blood volume at the probe site. PI measurements were only used to 
compare volume in a longitudinal fashion in the same animal because blood volume at the probe site 
is relative to individual patient tissue and vessel elasticity. The age, weight, stage of the menstrual 
cycle or any anatomic variants of the rabbit should not have interfered with the comparisons as PI was 
used to compare volume in a longitudinal fashion in the same animal. Blood flow studies in a 
longitudinal manner have been successfully utilised previously in the description of variation of blood 
flow in the testis 112 and ovary.264  
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Figure 3.1 Modified finger probe to allow wider opening of the jaws to fit satisfactorily around 
the uterine cornua. 
 
 
 
Figure 3.2 Datex-Ohmeda 3600P pulse oximeter which also measures perfusion index, a relative 
indicator of blood volume at the probe site independent of oxygen saturation. 
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Minimally Invasive Optical Spectroscopy 
 
The protocols for both optical spectroscopy and eLASCA were devised by Drs N Clancy, L Song 
(MSI) and M Tziraki (eLASCA) (Department of Surgical Imaging in the Hamlyn Centre for Robotic 
Surgery). As per references #170 and #186, the methodology for spectroscopy were also included in 
Drs V Sauvage’s and L Song’s PhD theses. The hyperspectral laparoscope (Figures 3.3 and 3.4) 
consisted of a Liquid Crystal Tuneable Filter (LCTF, VariSpec, Cambridge Research & 
Instrumentation, Inc., USA) that transmitted light with an average bandwidth of 15nm as well as a 
computer controlled central wavelength between 400-720nm. The light emitted by the Xenon light 
source (model 20133020, Storz GmbH, Germany) ranged between 400nm and 700nm. It was then 
subsequently transmitted by a fibre bundle light guide and coupled into the 12mm rigid 30 degree 
laparoscope (Storz GmbH, Germany). The sample was usually placed 50mm from the distal tip of the 
laparoscope. The central Hopkins rod lens channel of the laparoscope imaged the reflected light in the 
usual way. To form an image on a monochrome charged-coupled device (CCD) camera (DCU223M, 
Thorlabs, Inc., USA), an additional 50mm focal length lens was inserted at the proximal end. This 
lens was then mounted in a helicoid barrel (1 inch linear travel) to adjust the image plan to the 
laparoscope-sample distance. The LCTF was placed between the lens and the CCD with the 
laparoscope attached to the LCTF via a clip. This allowed easy removal of the LCTF/CCD 
block.170,186,265 
 
Control of the camera settings was enabled via a LabVIEW programme. It also provided a choice of 
wavelength range and increment at which images could be acquired and saved. The combination of 
three images at wavelengths of 450nm, 550nm and 650nm allowed for the display of a live RGB 
video. With respect to the key element of understanding the principle behind multispectral imaging, 
the measured reflectance spectrum at each pixel is a linear combination of the oxy- and deoxy-
haemoglobin spectra. This is only possible if the scattering is assumed to be approximately constant 
across the wavelength range and the dominant mechanism of light attenuation in the field of view is 
absorption by blood. A multiple linear regression algorithm was applied in Matlab (The Math Works, 
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Inc, USA) to calculate the relative fractions of both of the above haemoglobin species 177 and also to 
minimise the difference between the experimental reflectance and the predicted value. The 
programme enabled both generation and display of the spectrum at each pixel of the image by storing 
the intensities for all the images of what was ‘loaded-up’. Therefore, it was possible to draw the 
spectrum by plotting the two variables (wavelength, intensity) for every pixel of the image because 
each image was acquired at a known wavelength.170,186,265 
 
The instrument spatial and spectral resolutions were measured. The spatial resolution was quantified 
by acquiring an image of a paper 1951 USAF test pattern (Edmund Optics, Inc., USA) (Figure 3.5). It 
consists of sets of horizontal and vertical bars separated by decreasing spacings when going clockwise 
from the left bottom of the target to its centre. 
 
 
 
Figure 3.3 Multispectral imaging laparoscope with xenon light source and control computer 
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Figure 3.4 Hyperspectral laparoscopic system consisting in a CCD camera and a LCTF attached 
to a regular rigid laparoscope 
 
 
 
 
Figure 3.5 1951 USAF test patterns. This target was used to determine optical system resolution 
 
CCD 
LCTF 
Objective Lens 
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The spectral resolution is best described as the bandwidth of the LCTF transmission spectra. It was 
evaluated every 10 nm, from 420nm to 680nm, by recording the light reflected by the Xenon lamp 
from a spectralon reflectance standard (Labsphere, Inc., USA), with a spectrometer (HR4000, Ocean 
Optics, Inc., USA) through the hyperspectral laparoscope (minus the camera). The bandwidths were 
calculated at the Full Width at Half Maximum (FWHM) of the transmission spectra. It was crucial to 
ensure the system response was proportional to the sample emitted light and the CCD exposure time 
because the principle of measurement of haemoglobin is based on the intensity of the reflected light. 
This would allow a comparison of the stack of images acquired with different exposure time. The 
system linearity with sample emission was assessed by recording the light from the standard 
reflectance target and by inserting neutral density filters of increasing optical density. The linearity 
with exposure times was checked by acquiring images at increasing exposure times. O2Sat was then 
calculated as the quantity of oxyhaemoglobin which is a fraction of the sum of oxy- and 
deoxyhaemoglobin.170,186,265 
 
The key element of multispectral imaging is a tuneable filter. Its band-pass filter, a device capable of 
passing frequencies within a certain range and rejecting frequencies outside that range, can be 
electronically tuned. This generates more finely spaced band-pass wavelengths than filter wheel are 
able to, as they have a lower filter switching time. Hyperspectral imaging is put into practice by three 
main technologies: Fourier interferometry, acousto-optic tuneable filter, and LCTF. A LCTF consists 
of several stages, each of them made up of a quartz birefringence retarder and layers of liquid crystal, 
sandwiched between two polarisers. The principle of the LCTF is to select the desired band-pass by 
adjusting the retardance of the polarized light.170,186 
 
Both the rabbit and sheep uteri were imaged with the left and right cornua, and Fallopian tubes 
visible. In the rabbit, this was performed (i) prior to transplantation - donor uterus; (ii) prior to 
recipient hysterectomy - recipient native uterus; and (iii) post-transplantation - recipient donor uterus. 
In the sheep, measurements were taken prior to retrieval and 20-30 minutes following commencement 
of -reperfusion (i.e. post-UTx completion). 
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eLASCA 
 
eLASCA was performed after multi-spectral imaging in both the rabbit and sheep models. Details 
with respect to the operations are described in studies 2 and 4. For the rabbit transplants, the aim was 
to carry out eLASCA prior to the recipient hysterectomy only in order to simply trial the technique 
and apparatus. In the sheep cohort, eLASCA was performed prior to graft retrieval and once more, 30 
minutes following establishment of perfusion. Figure 3.6 illustrates a rabbit uterus. The green circle 
marks the imaging area containing the uterine artery and the vein. 
 
Prior to the surgery the heart rate and the O2Sat were measured using an oximeter. The field of view 
of the probe was 6mm in diameter, thus altered in order to obtain a higher spatial resolution. The 
experiment for the rabbit animal model consisted of two parts: (a) detection of the heart beat (with 
single wavelength and high CCD frame rate), and (b) detection of a change in blood flow and tissue 
oxygenation following a vessel occlusion. In the sheep model experiment no vessels were occluded.  
 
In the rabbit experiment, a single laser diodes (λ=660 nm) was turned on. The heartbeat of the rabbit 
ranges from 130-220 beats per minute (bpm). Therefore to capture the structure of the contrast change 
in one pulse period, the frame rate for the rabbit required the value used in the finger test to be 
doubled (this was not the case with the sheep experiments, where the heart rate is comparable to the 
human). This in turn meant a decrease in the exposure time leading to a decrease the signal intensity 
and spatial resolution. In order to limit the effects of the latter two, the exposure time was set to 
0.5ms, thus reaching a compromise between the frame rate and the intensity. Frame rate was 22fps. 30 
frames were recorded at a time, the process lasting 1.4 seconds. In the latter experiment, both the laser 
Dopplers were used. Data was acquired initially for 25 seconds, with normal circulation throughout; 
subsequently the artery was occluded for 25 seconds while the CCD continued to record images. 
Finally, the artery was released and the speckle images were recorded for another 15 seconds. The 
acquisition time of every frame was also recorded into an excel document. A customized Labview 
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programme controlled and synchronized the filter wheel. The exposure time was 20ms and the 
average frame rate was 1.6fps for each wavelength.  
 
 
 
Figure 3.6 Rabbit uterine graft following the IVC and AA anastomosis (green circle indicates 
the imaging area) 
 
 
Figure 3.7 shows eLASCA performed in the sheep model. The imaging area is approximately 6mm2 
and is marked by the illumination of the red laser as it shines from the imaging probe placed 3cm 
above the tissue. 
 
The optical experimental system is shown in Figure 3.8. The two laser lights were coupled into the 
fibre and were directed onto the sample by the probe. The speckle image of the target was transmitted 
through the leached fibre image guide (LFIG), and passed through a magnification system before 
reaching the CCD camera. The magnification system consisted of a microscope objective (x10, 
Olympus), and an achromatic lens (f=100mm, Thorlabs) to give a x7 magnification.  The images were 
magnified and captured by a 12bit CCD camera (Retiga Exi cooled CCD, Qimaging). An electronic 
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data acquisition card (DAQ, National Instruments) was introduced to control the laser excitation and 
the acquisition of the images. The lasers were switched on alternatively and an image was captured 
each time with a given acquisition time controlled by the shatter of the camera. A customized 
LabVIEW programme was used to synchronise the data acquisition card, the laser controllers and the 
exposure of the CCD. An exposure time and a delay time were characterised for each recording. The 
slower recording condition was 5 frames per second (fps) for each wavelength and 10fps for both. The 
imaging probe was guided over the imaging area (6mm2). The lasers, magnification system and the 
CCD camera were set on a portable optical bench. The stack of raw images were processed, and post-
acquisition were written in a Matlab programming language with custom algorithms. 
 
The probe used in both the rabbit and sheep models is depicted in Figure 3.9. The laser beam from 
two laser diodes (ML101J27 660nm and DL8142 830nm, Thorlabs) were coupled into two 
polarization maintaining fibres (PM fibre, Thorlabs). The two fibres were passed through channels in 
a custom made adapter to direct the light exiting from the fibres at an incident angle of ±3.6° to the 
axis so that the illumination area of both wavelengths overlaps. The polarization directions of the 
lasers from the PM fibre were adjusted so as to beam in the same direction. This way the direct 
reflected light could be eliminated together by a single polarizer thus increasing the speed contrast 
sensitivity. The plano-convex lens (f=6mm, D=3 mm, Edmund Scientific) imaged the sample onto the 
entrance end of the LFIG (Schott North America). 
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Figure 3.7 Measurement site for eLASCA performed on a sheep uterus. This photograph was 
taken shortly after the abdomen was opened and the uterus was exteriorized. 
 
 
Figure 3.8 Experimental model set up 
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Figure 3.9 Diagram showing a cross-section design of the probe used in eLASCA 
 
Oxy-haemoglobin and deoxy-haemoglobin have different absorption coefficients at most wavelengths 
and can be therefore used to detect the haemodynamics of blood circulation. Oxygenized blood is 
supplied continuously to the tissue whereas deoxygenized blood flows back to the heart. When the 
blood flow is stopped in the vessels, the concentration of the oxy- and deoxy-haemoglobin varies 
which results in a change in the light intensity absorbed and reflected back by the blood. Therefore the 
blood supply can be monitored by the change of the intensity of the reflected light. The modified 
Beer-Lambert law is used to calculate the change of the oxygenation.191,266 In this experiment two 
wavelengths, 660nm and 830nm, were used. 
 
The acquisition of the data with respect to initial experiment and equipment provision and set-up to 
subsequent data presentation and depiction as shown in the results section below was done by Drs N 
Clancy, V Sauvage (MSI), L Song (MSI) and M Tziraki (eLASCA) (Department of Surgical Imaging 
in the Hamlyn Centre for Robotic Surgery). As per reference #238, results for UTx #3-7 (rabbit) were 
also included in Dr L Song’s and Dr V Sauvage’s PhD theses. 
 
  - 233 - 
Data Presentation and Analysis 
 
In general, data has been presented using 2D graphs, 2D images, histopathology slides, figures and 
descriptive tables. Data related to O2Sat and PI was defined as non-parametric and Mann-Whitney U 
test was therefore carried out for analysis. A statistically significant difference was applied for a p-
value <0.05. All statistical analysis was done using the Statistical Package for the Social Sciences 
version 19 (SPSS Inc, Chicago, Illinois, USA). 
 
3.3. Results 
 
3.3.1. Rabbit model 
 
Pulse oximetry was applied in all nine transplantations. As the does died intra-operatively in UTx #3, 
4 and 6, no values for O2Sat and PI were obtained on the recipient donor uteri (post-UTx). The 
averages and standard deviations for these measurements are provided in Table 3.1a and 3.1b. 
Comparison of O2Sat values between the pre-UTx donor and post-UTx recipient, and pre-UTx 
recipient and post-UTx recipient revealed a statistically significant decrease in saturation levels post-
UTx. A similar comparison of PI values did not demonstrate any fall in PI level post-UTx, and 
importantly no statistical difference. This variation in O2Sat and PI values is depicted in Figure 
3.10a-c. 
 
Optical Spectroscopy was applied in UTx #3-9. Images of the donor uterus, recipient native uterus 
and recipient donor uterus were obtained in all seven transplants. Following the re-anastomosis of the 
IVC and AA, the uterus was observed to undergo a colour shift during reperfusion from its blanched 
appearance after flushing to a more reddish colour. However, as the does died intra-operatively in 
UTx #3 and #4, O2Sat measurements were calculated with a multispectral imaging laparoscope only 
on the recipient donor uteri #5-#9 (post-UTx). Even though recipients #6 and #8 also died intra-
operatively, measurements were obtained in these cases as deaths occurred 18 minutes and 23 minutes 
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after the donor uterus had been transplanted and re-perfusion had been established. Recipient #5 was 
the only doe to survive long-term and underwent an embryo transfer process to see if pregnancy could 
be achieved following allogeneic UTx. As a result an additional measurement was taken on day 89 
post-operatively just prior to the embryo transfer. The averages and standard deviations for O2Sat are 
provided in Table 3.1c. 
 
The processed O2Sat images for the donor uterus pre- and post-UTx, along with colour images 
reconstructed from the multispectral data after integration under the RGB filter transmission response 
of a digital colour camera are shown in Figure 3.11a-g. The pre-UTx images show that the graft is 
well-perfused in the donor doe, with high oxygen content in both cornua. The area of low O2Sat in the 
centre may correspond to a less vascularised area or possibly an area with a higher venous to arterial 
supply ratio. The post-UTx images show similar features after blood supply is re-established from the 
AA. Areas of low O2Sat correspond to connective tissue where re-perfusion is expected to last the 
longest. Here, the comparison of O2Sat values between the pre-UTx donor and post-UTx recipient, 
and pre-UTx recipient and post-UTx recipient revealed a statistically non-significant decrease in 
saturation levels post-UTx. 
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Key: NA, Non applicable; S.D, Standard Deviation 
 
Table 3.1a Oxygen Saturation values of the Donor and the Recipient rabbit (measured with a pulse oximeter)
    Rabbit     Side Cornua Oxygen Saturation Mean ± S.D. 
 UTx 1 UTx 2 UTx 3 UTx 4 UTx 5 UTx 6 UTx 7 UTx 8 UTx 9 All UTx 
Donor 
(pre-UTx) 
Right 
Medial 99% 99% 93% 98% 99% 96% 100% 100% 100% 98±0.02% 
Lateral 98% 98% 95% 99% 99% 99% 100% 100% 97% 98±0.02% 
Left 
Medial 99% 97% 96% 100% 100% 97% 100% 98% 98% 98±0.02% 
Lateral 99% 97% 87% 96% 100% 98% 96% 98% 97% 96±0.04% 
Recipient 
(pre-UTx) 
Right 
Medial 100% 99% 98% 99% 97% 100% 100% 100% 100% 99±0.01% 
Lateral 100% 100% 96% 98% 97% 97% 97% 99% 98% 98±0.01% 
Left 
Medial 100% 99% 92% 97% 98% 100% 98% 100% 100% 98±0.03% 
Lateral 100% 100% 99% 99% 95% 92% 96% 100% 98% 98±0.03% 
Recipient 
(post-UTx) 
Right 
Medial 90% 87% NA NA 92% NA 91% 95% 90% 91±0.03% 
Lateral 89% 80% NA NA 96% NA 92% 91% 83% 89±0.06% 
Left 
Medial 87% 88% NA NA 95% NA 94% 95% 80% 90±0.06% 
Lateral 85% 83% NA NA 95% NA 93% 95% 90% 90±0.05% 
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Key: NA, Non applicable; S.D, Standard Deviation 
 
Table 3.1b Perfusion Index values of the Donor and the Recipient rabbit (measured with a pulse oximeter) 
Rabbit Side Cornua Perfusion Index Mean ± S.D. 
 UTx 1 UTx 2 UTx 3 UTx 4 UTx 5 UTx 6 UTx 7 UTx 8 UTx 9 All UTx 
Donor 
(pre-UTx) 
Right 
Medial 0.38 0.17 0.44 0.41 0.41 0.19 0.36 0.77 0.44 0.40±0.17 
Lateral 0.33 0.16 0.15 0.36 0.36 0.13 0.32 0.25 0.39 0.27±0.10 
Left 
Medial 0.54 0.15 0.15 0.35 0.35 0.38 0.43 0.33 0.42 0.34±0.13 
Lateral 0.31 0.14 0.25 0.41 0.41 0.28 0.47 0.33 0.47 0.34±0.11 
Recipient 
(pre-UTx) 
Right 
Medial 0.27 0.42 0.25 0.40 0.40 0.59 0.44 0.20 0.36 0.37±0.12 
Lateral 0.25 0.73 0.13 0.41 0.41 0.43 0.32 0.18 0.25 0.35±0.18 
Left 
Medial 0.37 0.63 0.35 0.41 0.41 0.56 0.30 0.21 0.38 0.40±0.13 
Lateral 0.24 0.46 0.23 0.22 0.22 0.17 0.29 0.29 0.22 0.26±0.08 
Recipient 
(post-UTx) 
Right 
Medial 0.16 0.30 NA NA 0.30 NA 0.33 0.14 0.43 0.28±0.11 
Lateral 0.19 0.56 NA NA 0.29 NA 0.43 0.32 0.23 0.34±0.14 
Left 
Medial 0.19 0.52 NA NA 0.35 NA 0.32 0.29 0.15 0.30±0.13 
Lateral 0.12 0.35 NA NA 0.37 NA 0.24 0.27 0.24 0.27±0.09 
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Cornua 
Rabbit Side Cornua O2 Saturation Mean ± S.D. 
 UTx 5 
UTx 5 
pre-ET 
UTx 6 UTx 7 UTx 8 UTx 9 All UTx 
Donor 
(pre-UTx) 
Right 
Medial 83% NA 76% 86% 93% 81% 80±5% 
Lateral 89% NA 92% 79% 77% 86% 91±2.1% 
Left 
Medial 90% NA 88% 80% 89% 92% 89±1.4% 
Lateral 82% NA 86% 83% 84% 83% 84±2.8% 
Recipient 
(pre-UTx) 
Right 
Medial 89% NA 83% 84% 85% 89% 86±4.2% 
Lateral 89% NA 88% 77% 67% 82% 89±0.7% 
Left 
Medial 93% NA 88% 85% 56% 90% 91±3.5% 
Lateral 78% NA 81% 64% 68% 81% 80±2.1% 
Recipient 
(post-UTx) 
Right 
Medial 60% 84% 44% 21% 57% 66% 55±0.21% 
Lateral 58% 84% 51% 46% 68% 51% 60±0.14% 
Left 
Medial 59% 82% 68% 24% 51% 58% 57±0.19% 
Lateral 63% 82% 93% 7% 58% 59% 60±0.30% 
 
Key: ET, Embryo Transfer 
 
 
Table 3.1c Oxygen Saturation values of the Donor and the Recipient rabbit when measured with 
a multispectral imaging laparoscope 
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Figure 3.10a-c Variation in Oxygen Saturation and Perfusion Index values when measured with a pulse oximeter and a multispectral imaging laparoscope 
 
 
Figure 3.10a Oxygen Saturation values of the Donor and the Recipient rabbit (measured with a pulse oximeter) 
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Figure 3.10b Perfusion index values of the Donor and the Recipient rabbit (measured with a pulse oximeter) 
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Figure 3.10c Oxygen Saturation values of the Donor and the Recipient rabbit measured with a multispectral imaging laparoscope 
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Figure 3.11a-h The images on the left are standard images of the rabbit cornua produced using a 
RGB filter. The images on the right are reference tissue O2Sat images. The O2Sat images are 
displayed using a colour scale that ranges from ‘0’ (dark blue) to ‘1’ (bright red). 
 
Figure 3.11a Images correspond to UTx #3 
Donor (Pre-UTx #3) 
                       
Recipient (Pre-UTx #3) 
                
Recipient (Post-UTx #3) 
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Figure 3.11b Images correspond to UTx #4 
Donor (Pre-UTx #4) 
         
Recipient (Pre-UTx #4) 
                      
Recipient (Post-UTx #4) 
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Figure 3.11c Images correspond to UTx #5 
Donor (Pre-UTx #5) 
                     
Recipient (Pre-UTx #5) 
                  
Recipient (Post-UTx #5) 
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Recipient (Day 89 post-UTx #5) 
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Figure 3.11d Images correspond to UTx #6 
Donor (Pre-UTx #6) 
                     
Recipient (Pre-UTx #6) 
                         
Recipient (Post-UTx #6) 
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Figure 3.11e Images correspond to UTx #7 
Donor (Pre-UTx #7) 
                    
Recipient (Pre-UTx #7) 
                   
Recipient (Post-UTx #7) 
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Figure 3.11f Images correspond to UTx #8 
Donor (Pre-UTx #8) 
                   
Recipient (Pre-UTx #8) 
                  
Recipient (Post-UTx #8) 
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Figure 3.11g Images correspond to UTx #9 
Donor (Pre-UTx #9) 
                  
Recipient (Pre-UTx #9) 
                  
Recipient (Post-UTx #9) 
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eLASCA 
 
Rabbit model (UTx #7 and #9) 
 
Rabbit experiment - UTx #7 
 
Figure 3.12 showed the rotated contrast image. After rotation, the AOI was chosen to be a rectangle, 
which was marked in red in Figure 3.13. The vessel area showed slightly lower contrast in blue 
colours than the surrounding area.  
 
 
Figure 3.12 Rotated contrast image with the red rectangular marking the AOI 
 
The averaged contrast from the AOI was detrended to remove the DC component and interpolated 
with a double sampling frequency. Then a FFT was applied on the resulting contrast used to calculate 
the frequency at which the contrast changed. Figure 3.13a-b depicts the raw contrast as a function of 
time and the contrast after being detrended and interpolated. The contrast displayed a periodic change. 
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The frequency spectrum of the contrast is shown in Figure 3.13c. The peak frequency was around 
3.5Hz, corresponding to 210bpm, which is slightly higher than 160-180bpm measured using an 
oximeter at the commencement of the trial. 
 
Figure 3.13a-c The contrast and the spectrum of the contrast 186  
 
Figure 3.13a Graph showing raw contrast as a function of time 
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Figure 3.13b Graph showing contrast after detrending and interpolation 
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Figure 3.13c Graph showing frequency spectrum of the interpolated contrast 
 
 
As outlined in the methods section, the second experiment which was performed on the recipient in 
UTx #7 involved an occlusion of the aorta. 
 
Figure 3.14a-b demonstrates the contrast change using both wavelengths, following the occlusion of 
the blood flow. The two figures depict a matching increase in contrast after the 25th second when the 
occlusion was applied, thus confirming that the blood flow was blocked, and a drop in contrast at the 
50th second when the blood flow had been re-commenced. The spikes show a periodic change of two 
seconds, most likely brought about by the breath cycle as the respiration rate of the rabbit is 30-
60bpm. 
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Figure 3.14a-b  Graph showing contrast portrayed as a function of frames 186 
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Figure 3.14a Data acquired at 660 nm 
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Figure 3.14b Data acquired at 830 nm 
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A change in the [Hb] is shown in Figure 3.15a-b. Large fluctuations are apparent in the first 20 
seconds in all three figures and are shaded Figure 3.15b. This fluctuation was brought about by the 
power fluctuation of one of the lasers with a wavelength 830nm prior to it reaching a stable state. In 
Figure 3.15a, the concentration of oxyHb increased during the occlusion, whereas 3.15b shows that 
the concentration of deoxyHb decreased. The total Hb increased overall during the occlusion as 
shown in Figure 3.15c.  
 
Figure 3.15a-c Demonstration in the change of Hb concentration 186 
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Experimental data
Smoothed data
 
 
Figure 3.15a Graph showing the variation of Oxy-haemoglobin concentration with time 
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Experimental data
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Figure 3.15b Graph showing the variation of deoxy-haemoglobin concentration with time 
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Experimental data
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Figure 3.15c Graph showing the variation of total haemoglobin concentration with time 
 
NB The shaded area in Figure 3.15b marks the error of the concentration induced by the intensity 
fluctuation of the laser 880 nm. 
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Rabbit experiment - UTx #9 
 
Two exposure times were used for the rabbit does: 500μs and 10ms. Frequency was set at 0.5Hz. 
 
Donor: Exposure time 10ms; Frame rate: about 21fps; Frame: 0-199 frame 
 
 
Figure 3.16a A focused and imaged fibre bundle pattern 
 
Figure 3.16b Image of interest when the low pass Butterworth filter was applied. It removed the 
fibre bundle pattern thus ensuring that the contrast is mainly from the fibre pattern and not from the 
sample. 
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Figure 3.17a-d Graphs of contrast and mean intensity over time and frequency 
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Recipient (1): Exposure time 500μs; Frame rate: about 21fps; Frame: 0-60 frame 
 
Figure 3.18a-d Graphs of contrast and mean intensity over time and frequency 
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Recipient (2): Exposure time 10ms; Frame rate: about 21fps; Frame: 0-60 frame 
 
According to the timing of the frame capture, a sudden delay of frame rate at the 65th frame arose. We 
chose therefore to process the first 60 frames. Calculation was the same as for the donor doe: a low 
pass filter-contrast calculation-frequency. 
 
Figure 3.19a-d Graphs of contrast and mean intensity over time and frequency 
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Figure 3.20 Graph depicting the variation of contrast and intensity simultaneously for comparison 
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3.3.2. Sheep model 
 
Pulse oximetry was applied in all five autotransplants. As the uterus was not retrieved in UTx #1 and 
the ewe died intra-operatively in UTx #4, no values for O2Sat and PI were obtained post-UTx. The 
averages and standard deviations for these measurements are provided in Table 3.2a. Comparison of 
O2Sat values prior to graft retrieval and post-UTx revealed a statistically significant decrease in 
saturation levels post-UTx. A similar comparison of PI values did not demonstrate any fall in PI level 
post-UTx, and importantly no statistical difference. This variation in O2Sat and PI values is depicted 
in Figure 3.21a-b. 
 
Optical Spectroscopy was applied for all five transplants. However for reasons explained above, 
images of the uterus prior to retrieval and post-UTx were obtained only in UTx #2, #3 and #5. 
Following the anastomosis of the internal to external iliac vessels (details are outlined in study 4), the 
uterus was observed to undergo a colour shift during reperfusion from its blanched appearance after 
flushing to a more reddish colour. The averages and standard deviations for O2Sat are provided in 
Table 3.2b, with variation depicted in Figure 3.21c. 
 
The processed O2Sat images of the uterus prior to retrieval and post-UTx, along with colour images 
reconstructed from the multispectral data after integration under the RGB filter transmission response 
of a digital colour camera are shown in Figure 3.22a-e. The pre-retrieval images show that the graft is 
well-perfused in the donor doe, with high oxygen content in both cornua. The area of low O2Sat in the 
centre may correspond to a less vascularised area or possibly an area with a higher venous to arterial 
supply ratio. The post-UTx images show similar features after blood supply is re-established from the 
external iliac arteries. Areas of low O2Sat correspond to connective tissue where re-perfusion is 
expected to last the longest. Here, the comparison of O2Sat values between the uterus prior to retrieval 
and post-UTx revealed a statistically non-significant decrease in saturation levels post-UTx.
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Sheep Side Cornua O2 Saturation 
Mean  
± S.D. 
Perfusion index 
Mean  
± S.D. 
 UTx 1 UTx 2 UTx 3 UTx 4 UTx 5 All UTx UTx 1 UTx 2 UTx 3 UTx 4 UTx 5 All UTx 
Ewe 
(pre-retrieval) 
Right 
Medial 94% 100% 95% 96% 95% 96±0.02% 0.34 0.58 0.38 1.25 0.52 0.61±0.37 
Lateral 92% 88% 95% 95% 95% 93±0.03% 0.44 0.61 0.38 1.33 0.48 0.65±0.39 
Left 
Medial 94% 96% 97% 94% 95% 95±0.01% 0.23 0.64 0.47 1.55 0.52 0.68±0.51 
Lateral 96% 88% 92% 96% 96% 94±0.04% 0.55 0.78 0.39 1.50 0.37 0.72±0.47 
Ewe 
(post-UTx) 
Right 
Medial NA 94% 77% NA 94% 88±0.10% NA 0.42 0.55 NA 0.63 0.53±0.11 
Lateral NA 82% 77% NA 87% 82±0.05% NA 0.53 0.67 NA 0.93 0.71±0.20 
Left 
Medial NA 78% 86% NA 94% 86±0.08% NA 0.24 0.36 NA 1.63 0.74±0.77 
Lateral NA 76% 90% NA 90% 85±0.08% NA 0.38 0.23 NA 1.31 0.64±0.59 
 
 
Key: NA, Non applicable; S.D, Standard Deviation 
 
 
Table 3.2a Oxygen Saturation and Perfusion Index values when measured with a pulse oximeter 
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Sheep Side Cornua O2 Saturation Mean ± S.D. 
 UTx 1 UTx 2 UTx 3 UTx 4 UTx 5 All UTx 
Ewe 
(pre-retrieval) 
Right 
Medial 76% 63% 53% 74% 76% 68±0.10% 
Lateral 70% 54% 50% 73% 72% 64±0.11% 
Left 
Medial 65% 67% 42% 64% 76% 63±0.13% 
Lateral 70% 60% 49% 69% 74% 64±0.10% 
Ewe 
(post-UTx) 
Right 
Medial NA 62% 72% NA 60% 65±0.06% 
Lateral NA 55% 71% NA 61% 62±0.08% 
Left 
Medial NA 58% 66% NA 58% 61±0.05% 
Lateral NA 51% 74% NA 61% 62±0.12% 
 
 
Table 3.2b Oxygen Saturation values when measured with a multispectral imaging laparoscope 
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Figure 3.21a-c Variation in Oxygen Saturation and Perfusion Index values when measured with a pulse oximeter and a multispectral imaging laparoscope 
 
 
 
Figure 3.21a Oxygen Saturation values measured with a pulse oximeter 
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Figure 3.21b Perfusion index values measured with a pulse oximeter 
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Figure 3.21c Oxygen Saturation values measured with a multispectral imaging laparoscope 
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Figure 3.22a-e The images on the left are standard images of the sheep cornua produced using a 
RGB filter. The images on the right are reference tissue O2Sat images. The O2Sat images are 
displayed using a colour scale that ranges from ‘0’ (dark blue) to ‘1’ (bright red). 
 
Figure 3.22a Images correspond to UTx #1 
 
Pre-retrieval 
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Figure 3.22b Images correspond to UTx #2 
 
Pre-retrieval 
 
                
 
 
Post-UTx 
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Figure 3.22c Images correspond to UTx #3 
 
Pre-retrieval 
 
                
 
 
Post-UTx 
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Figure 3.22d Images correspond to UTx #4 
 
Pre-retrieval 
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Figure 3.22e Images correspond to UTx #5 
 
Pre-retrieval 
 
                
 
 
Post-UTx 
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eLASCA 
 
Sheep model (UTx #2-#5) 
 
Sheep experiment - UTx #2 
 
Pre-retrieval. Acquisition time: 1ms and delay time: 100ms 
The exposure time of the camera is 1ms. The delay corresponds to the time period from the moment 
that the camera is shut to the moment that the programme gives a signal to switch on the laser 
controller and thus open the camera for the next acquisition. The time period from one picture to the 
other is ~100ms. As the exposure time alternates from 660nm to 830nm the acquisition for a single 
wavelength is 200ms, which corresponds to 5 fps. The acquisition for both wavelengths is 10fps. 
 
Figure 3.23 Image acquisition pre-retrieval. The Speckle Contrast images (C660 and C830) 
demonstrate blood circulation, which is depicted by the blue areas.  The lower the contrast (a bigger 
area in blue), the faster is the blood flow. The oxygenation image is ratio-metrically calculated by the 
images at wavelengths of 660nm and 830nm based on the difference between absorption coefficients 
of the tissue chromophores. Blood circulation is indicated by the colour red. These results are 
qualitative and show that the speckle contrast images are a good indicator of blood flow. 
 
One full set of acquired images is shown below. With respect to the other transplants, only the best 
acquired image is presented here. 
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C660_fr40 C830_fr40 Oxygenation image_fr40 
   
C660_fr41 C830_fr41 Oxygenation image _fr41 
   
C660_fr42 C830_fr42 Oxygenation image _fr42 
   
C660_fr43 C830_fr43 Oxygenation image _fr43 
   
C660_fr44 C830 _fr44 Oxygenation image _fr44 
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C660_fr45 C830_fr45 Oxygenation image _fr45 
  
 
C660_fr46 C830_fr46 Oxygenation image _fr46 
   
C660_fr47 C830_fr47 Oxygenation image _fr47 
   
C660_fr48 C830_fr48 Oxygenation image _fr48 
   
C660_fr49 C830_fr49 Oxygenation image _fr49 
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Figure 3.24 The mean intensity and mean contrast calculated for every image of the time 
sequence during the acquisition at 660nm. It shows that the contrast is inversely proportional to the 
intensity. 
 
Figure 3.25 The mean intensity and the mean contrast calculated for every image of the time 
sequence during the acquisition at 830nm 
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Figure 3.26  Intensity distribution of the various frequencies of Speckle Contrast at 660nm 
 
 
a) 0.13Hz attributed to a breathing rate of 7.8 breaths per min 
b) 0.38Hz attributed to a breathing rate of 22.8 breaths per min or to any vibration of the system  
c) 1.83Hz attributed to a cardiac rate of 109bpm 
d) 2.13Hz attributed to a cardiac rate of 127bpm 
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Figure 3.27 Intensity distribution of the various frequencies of Speckle Contrast at 830nm 
 
a) 0.23Hz attributed to a breathing rate of 13.8 breaths per min 
b) 0.38Hz attributed to a breathing rate of 22.8 breaths per min or to any vibration of the system 
c) 1.82Hz attributed to a cardiac rate of 109.2bpm 
d) 2.06Hz attributed to a cardiac rate of 123.6bpm 
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Figure 3.28 Intensity distribution of the various frequencies of the Oxygenation map 
a) 0.23Hz attributed to a breathing rate of 13.8 breaths per min 
b) 0.38Hz attributed to a breathing rate of 22.8 breaths per min or to any vibration of the system  
c) 1.815Hz attributed to a cardiac rate of 109bpm 
d) 2.08Hz attributed to a cardiac rate of 123.6bpm 
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Post-transplantation Acquisition time: 1ms and delay time: 100ms 
Figure 3.29 Image acquisition post-transplantation  
   
C660_fr1     (100ms) C830_fr1 (200ms) Oxygenation image _fr1  (200ms) 
   
C660_fr2    (300ms) C830_fr2  (400ms) Oxygenation image _fr2 (400ms) 
   
C660_fr3 (500ms) C830_fr3  (600ms) Oxygenation image _fr3 (600ms) 
   
C660_fr4 (700ms) C830_fr4 (800ms) Oxygenation image _fr4  (800ms) 
   
C660_fr6 C830_fr6 Oxygenation image _fr6  1200ms 
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C660_fr11 C830_fr11 Oxygenation image _fr11 
   
C660_fr22 C830_fr22 Oxygenation image _fr22 
   
C660_fr28 C830_fr28 Oxygenation image _fr28 
   
C660_fr35 C830_fr35 Oxygenation image _fr35 
   
C660_fr36 C830_fr36 Oxygenation image _fr36 
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C660_fr37 C830_fr37 Oxygenation image _fr37 
 
 
 
 
 
 
 
 
Figure 3.30 Intensity distribution of the various frequencies of Speckle Contrast at 660nm. 
 
(a) 0.13Hz attributed to a breathing rate of 7.8 breaths per min  
(b) 0.50Hz attributed to a breathing rate of 22.8breaths per min or to any vibration of the system 
(c) 1.15Hz attributed to a cardiac rate of 69bpm 
(d) 1.70Hz attributed to a cardiac rate of 102bpm 
(e) 1.82Hz attributed to a cardiac rate of 109bpm 
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Figure 3.31 Intensity distribution of the various frequencies of the Speckle Contrast at 660nm 
 
(a) 0.24Hz attributed to a breathing rate of 14.4breaths per min 
(b) 0.63Hz attributed to a breathing rate of 37 breaths per min or to any vibration of the system  
(c) 1.33Hz attributed to a cardiac rate of 79.8bpm 
(d) 1.46Hz attributed to a cardiac rate of 87.6bpm 
(e) 1.71Hz attributed to a cardiac rate of 102.61.84Hz attributed to a cardiac rate of 110.4bpm 
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Figure 3.32 Intensity distribution of the various frequencies of Speckle Contrast of the 
Oxygenation map 
 
(a) 0.27Hz attributed to a breathing rate of 16.2 breaths per min 
(b) 0.51Hz attributed to a breathing rate of 30.6 breaths per min or to any vibration of the system  
(c) 0.62Hz attributed to a cardiac rate of 37.2bpm  
(d) 1.72Hz attributed to a cardiac rate of 103.2bpm 
(e) 1.81Hz attributed to a cardiac rate of 108.6bpm 
(f) 2.22Hz attributed to a cardiac rate of 133.2bpm 
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Sheep experiment - UTx #3 
Exposure time: 1ms; Delay: 100ms; Frame rate: 5frps for a single wavelength and 10frps for two 
wavelengths 
                 
 
 
C660__Frame17 
 
 
 
C830_ Frame17 
 
 
Oxygenation image _Frame17 
660nm: peak at (a) 0.17Hz corresponding to a respiratory rate of 10 breaths per minute; peaks also at (b) 
1Hz and (c) 1.93Hz corresponding to heart rates of 60bpm and 116bpm respectively. 830nm: nil 
significant. Oxygenation map frequencies: peak at 2Hz corresponding to 120bpm. 
Figure 3.33 Pre-retrieval Speckle Contrast results (UTx #3) 
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C660 _Frame25 
 
 
 
C830_ Frame25 
 
 
Oxygenation image _Frame17 
 
Figure 3.34 Post-transplant Speckle Contrast results (UTx #3) 
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The following set of data is recorded with illumination set at 660nm, exposure time at 1ms and delay 
at 40ms. This corresponds to acquisition frame rate of 25fps. The faster recording allows better 
sampling, therefore more precise frequencies measurements. 
 
 
Figure 3.35 Power spectrum of the frequencies of the speckle (pre-retrieval, ‘donor’). Peaks can 
be seen at: (a) 0.51Hz corresponding to a respiratory rate of 16 breaths per minute; (b) 1.24Hz 
corresponding to a heart rate of 75bpm; and (c) 2.12Hz corresponding to a heart rate of 135bpm.  
 
 
 
 
Figure 3.36 Power spectrum of the frequencies of the speckle (post-transplant, ‘recipient’). Peaks 
can be seen at: (a) 0.32Hz corresponding to a respiratory rate of 19 breaths per minute; (b) 1.16Hz 
corresponding to a heart rate of 70bpm; and (c) 2.18Hz corresponding to a heart rate of 131bpm.  
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Sheep experiment - UTx #4 
Only pre-retrieval data was recorded as the ewe arrested before retrieval was commenced. Exposure 
time was 20ms and delay 40ms at 10fr/sec. 
 
Figure 3.37 Image acquisition pre-retrieval 
  
 
C660_fr1 ( 0ms) C830_fr1 (40ms) Oxygenation image _fr1 (40ms) 
   
C660_fr2 (80ms) C830_fr2 (120ms) Oxygenation image _fr2 (120ms) 
   
C660_fr3 (160ms) C830_fr3 (200ms) Oxygenation image _fr3 (200ms) 
  
 
C660_fr4 (240ms) C830_fr4 (280ms) Oxygenation image _fr4 (280ms) 
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Figure 3.38 Intensity distribution of the frequencies of the speckle as calculated when applying all 
data. Peaks can be seen at: (a) 0.35Hz corresponding to a heart rate of 21bpm; (b) 0.675Hz 
corresponding to a heart rate of 40bpm, and (c) 1.75Hz corresponding to a heart rate of 105bpm. 
  
 
 
 
Figure 3.39 Peaks can be seen at: (a) 0.15Hz corresponding to a respiratory rate of 9 breaths per 
minute; (b) 0.8Hz corresponding to a heart rate of 48bpm and (c) 1.57Hz corresponding to a heart rate 
of 94bpm. 
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Figure 3.40 Intensity distribution of the speckle frequencies as derived from the oxygenation map 
images. Peaks can be seen at: (a) 0.13Hz corresponding to a respiratory rate of 7.8 breaths per minute; 
(b) 0.4Hz corresponding to a heart rate of 24bpm; and (c) 0.8Hz corresponding to a heart rate of 
48bpm. 
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Sheep experiment - UTx #5 
Exposure time: 20msec; Delay: 30mseC; Frame rate: 10 fps for both wavelengths 
 
 
C660 _Frame35 
 
 
C830_ Frame35 
 
 
Oxygenation image _Frame35 
660nm: peaks at 0.3Hz and at 1.55Hz corresponding to a heart rate of 93bpm. 880nm: broad continuum 
from 0.5Hz to 2.5Hz and thus not much to conclude. Oxygenation map: peak at 0.5Hz corresponding to 
a breathing rate of 16 breaths per minute, and peaks at 1.4Hz, 1.7Hz, and 2Hz corresponding to 85bpm, 
105bpm and 120bpm respectively. 
 
Figure 3.41 Pre-retrieval Speckle Contrast results (UTx #5) 
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C660 _Frame28 
 
 
C830_ Frame28 
 
 
Oxygenation image _Frame28 
660nm: peaks at 0.4Hz corresponding to a respiratory rate of 12 breaths per minute and 1.52Hz 
corresponding to a heart rate of 93bpm. 880nm: peaks at 0.15Hz corresponding to a respiratory rate of 9 
breaths per minute, and 1.7Hz corresponding to a heart rate of 102bpm. Oxygenation map: peak at 0.5Hz 
corresponding to a breathing rate of 16 breaths per minute, and peaks at 1.4Hz, 1.7Hz, and 2Hz 
corresponding to 85bpm, 105bpm and 120bpm respectively. 
Figure 3.42 Post-Transplant Speckle Contrast results (UTx #5) 
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3.4. Discussion 
 
The ultimate aim of UTx is to enable a feasible allogeneic transplant with respect to anatomy and 
vascular viability, in order to allow for embryo transfer and pregnancy at a later date. The visual 
appearance of the graft, O2Sat and PI measurements and optical spectrometry were used to ensure 
adequate graft reperfusion immediately after UTx. Prior to abdominal closure in those animals that 
survived the operation, the uterine graft appeared well perfused each time. Overall, both pulse 
oximetry and multispectral imaging recorded a reduction in O2Sat following completion of the 
transplant i.e. anastomosis of the relevant vessels. Perfusion index levels were not different when 
competing pre- and post-levels. 
 
Pulse Oximetry and Perfusion Index 
 
In the rabbit, uterine perfusion was assessed using a pulse oximeter at three different time points: 
donor (pre-UTx), recipient (pre-UTx, native uterus) and recipient (post-UTx, donor uterus). It is worth 
highlighting that the timing of each measurement was standardised. Donor and recipient native uteri 
were scanned immediately following laparotomy, with the recipient donor uterus scanned just prior to 
closure. In UTx #1, #2, #5, #7-#9, where the recipient did not die intra-operatively, O2Sat 
measurements taken after graft perfusion had been re-established were statistically different to the 
pre-transplant values of both donor and native uteri. The appliance was sensitive enough to detect a 
statistically significant 10% reduction in O2Sat when comparing the cornua at four different points 
(right and left medial and lateral) pre- and post-UTx. Promisingly, however, the mean absolute O2Sat 
values were still 89-90%. This is a level perfectly adequate to maintain a viable uterus. PI was 
statistically no different before retrieval and after completion of the transplantation. Moxey et al 
designed a study to establish if a pulse oximeter could assess the contribution of both the uterine and 
ovarian vessels to the overall perfusion of the uterus.176 The two markers used for the study were 
O2Sat and PI which were measured over the right and left uterine cornu. Clamping both sets of vessels 
alone, first the ovarian and the uterine, decreased O2Sat and PI by a statistically significant amount. 
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The conclusion was that as the level of reduction in O2Sat and PI was the same whether the ovarian or 
uterine vessels were ligated, then both pairs of vessels contribute almost equally to uterine 
perfusion.176 During an abdominal radical trachelectomy procedure, the ovarian arteries are the only 
two arteries that are maintained as the uterine blood supply. Despite this, a woman can still have a 
normal menstrual cycle as well as fall pregnant following this operation. Therefore, an O2Sat level of 
40-50% appears to be perfectly adequate to ensure a healthy and viable uterus. This percentage was 
recorded upon ligation of both uterine and ovarian vessels, thus leaving the uterus supplied with only 
two arteries (as would be post-UTx), which are the left and right vaginal. Furthermore, the idea of 
using a pulse oximeter to assess uterine perfusion and therefore, the success of uterine and ovarian 
vessel re-anastomosis via O2Sat and PI following UTx has its origins in this experiment. 
 
The sheep cohort produced results which confirmed the above findings. Only three out of five sheep 
received the autograft (UTx #2, #3 and #5), and from those three the O2Sat post-UTx ranged from 82-
88%. Perfusion index was again statistically no different before retrieval and after completion of the 
transplantation. This means that in the lager animal model, where technically the team had a much 
easier access to the vessels, and a larger surgical field to work on, uterine perfusion, as well uterine 
blood flow were adequately high at the end of the surgery. This is reassuring as the sheep model 
closely resembles the female pelvis, and the type of vessel anastomosis (internal to external iliac 
vessels) applied will be exactly the same in a human model.  
 
Our results also suggest that the surgical expertise necessary for adequate vessel anastomosis has 
improved in comparison to the previous rabbit and pig cohorts. The latter view is also supported by 
the fact that there was no significant change in PI level pre- and post-UTx. The difference in the 
pattern of O2Sat and PI values pre- and post-UTx can be explained by two factors. First, the 
anastomosis appears to be patent in the immediate post-operative period which would explain the 
consistency in PI value. PI is an indicator of blood volume as explained previously. However, the 
delay in vessel vasodilatation secondary to both cold and warm ischaemia as well as a minimal 
  - 296 - 
reperfusion time between re-anastomosis and pulse oximetry would have contributed to a reduction in 
O2Sat. 
 
The limitations of this model are self-evident from the methodology. Positioning and manipulating the 
probe and cornua is a practically difficult task, especially in smaller animals such as rabbits. It is a 
model which requires constant contact with the target in question i.e. cornua, can be ‘trial and error’ at 
times, and the actual oximeter is calibrated on human volunteers. It also only provides a point 
measurement of arterial oxygenation giving no spatial information on the overall supply to the tissue. 
Furthermore, blood volume differs with each animal, vessel elasticity and probe site. For that reason, 
O2Sat and PI have been compared in a longitudinal fashion in the same animal. Finally, probe size and 
positioning must be correct, with excessive pressure avoided at all times so as to prevent cornual 
damage. The number of separate factors which can affect data derived from pulse oximetry calls for 
an improved and more precise tool.  
 
Optical spectrometry 
 
A multispectral imaging laparoscope has been demonstrated as a potentially useful tool during UTx. 
On comparison of its methodology with pulse oximetry, it appears to be more accurate and scientific. 
The advantages were the ability of the technique to monitor cornual O2Sat over the entire visible 
section of the organ in a fast and non-contact method. Furthermore, one does not have to ‘wrestle’ 
with the cornua to find a strong pulsatile signal. All these might be important for stages of the 
operation where time is critical. 
 
Image warping allowed correct alignment of the multispectral data in order to remove artefacts 
because of cornual peristalsis during acquisition. As with previous measurements using pulse 
oximetry in the rabbit model, measured values of both cornual O2Sat show a statistically significant 
decrease after transplantation, as well as a greater one. The absolute values of O2Sat are therefore 
much lower, on average ~25%. This is lower than the decrease recorded with a pulse oximeter. 
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Reasons for this could be that multispectral methodology is simply more accurate and precise. Also it 
may reflect the fact that pulse oximeters measure arterial O2Sat only, while this imaging method also 
takes the venous side into account in addition to areas of the tissue that are not well-perfused, 
reducing the mean value. This also explains the lower oxygenated area in the centre. With regards to 
the most important part of the grafting process, re-anastomosis of IVC and AA, the O2Sat map 
demonstrated a successful anastomosis as highlighted by the O2Sat regions close to the region where 
AA was re-connected. The O2Sat map was processed from a hyperspectral image stack acquired 
immediately after the re-anastomosis. Finally, it is worth highlighting that the average value of 58% is 
still acceptable in ensuring a perfused uterus, based on the above discussion. 
 
Multispectral imaging was performed post-operatively only once and on one rabbit recipient only. 
This was the only rabbit that had survived long-term, with the measurement taken on the day of the 
embryo transfer (day 89). Interestingly, the level of perfusion in the one long-term surviving doe (#5) 
was almost back to pre-operative levels when measured on day 89 post-UTx (83% versus 85% 
respectively). It is difficult to draw conclusions based on just one result but it should be highlighted 
that a pregnancy was achieved with that specific uterine graft, thus adding to certainty regarding the 
result. In addition, it seems that small vessel neovascularisation of the uterus occurs once the abdomen 
is closed, which restores the uterine oxygen saturation to pre-operative levels (or from 58% in the 
immediate post-operative period to 83% on day 89). This is promising for a future human uterine 
attempt and perfusion of a human uterine graft which would have only two arteries supplying it - 
therefore, generation of new vessels supplying the graft would be beneficial.  
 
The results demonstrated with the sheep model are extremely promising. There was no statistically 
significant difference between the pre-retrieval and post-UTx O2Sat values, which ranged from 63-
68% to 63-68% respectively. Again the most obvious explanation lies in the anatomical similarity 
when comparing the pelvis of a sheep and a woman, and therefore a surgery with which the operators 
felt more at ease and more comfortable. A perfusion level above 60% would be more than acceptable 
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to ensure future fertility, especially as we now that the level is likely to increase in the long-term 
secondary to uterine vascular neo-generation.  
 
This data also comes with its limitations. One of the major disadvantages that arises with optical 
spectrometry is motion artefacts. They are introduced by breathing, peristalsis and relaxation of tissue 
during acquisition of the image stack, with peristalsis of cornua the major issue in our model. This, 
together with the current assumption of a flat scattering spectrum may be contributing to 
underestimating O2Sat as the optical path length is longer in the red end of the spectrum than the blue. 
Motion artefacts were corrected using a registration algorithm based on ‘sparse feature 
correspondences’. These techniques are applied to detect and track change induced by unwanted 
motion of deformable surfaces such as a peristalsing cornua.267 The effectiveness of the approach has 
been demonstrated for tracking the motion of the beating heart endoscopically.111 
 
In this study, where motion of the organ was significant enough to cause misalignment of the 
multispectral stack and introduce artefacts, the image registration approach described above was used. 
This could successfully correct for movements which caused blurring of blood vessels, for example, 
as shown in Figure 3.43. In summary, multispectral imaging could be an efficient tool to temporally 
and spatially follow tissue re-oxygenation subsequent to re-anastomosis of blood vessels required to 
sustain a viable uterus.  
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Figure 3.43 Colour images of a section of uterus reconstructed from the full multispectral stack.  
(a) Organ motion is visible as blur and is especially noticeable around the blood vessels (indicated by 
arrows); (b) Feature detection and tracking in multispectral space; (c) After registration the vessels are 
correctly aligned and blur reduced. 
 
When assessing the overall picture, hyperspectral imaging may be an efficient tool to assess uterine 
tissue re-oxygenation in both time and space in the period immediately following the re-anastomosis, 
as well as in the post-operative period overall. Mapping of O2Sat is now possible over the entire 
uterine graft and visible range, as opposed to a few selected points. Minor movements of the operators 
could be corrected for, without hindering the overall result, and thus allow for the registration of the 
complete stack of images. From the physics aspect, more work needs to be done on the system in 
order to continue the transportation of biophotonics into the surgical sphere. In conclusion, the use of 
multispectral imaging in this scenario is the first such case with respect to gynaecological surgery and 
has demonstrated promise of possible future use in a human model. It is also the first time it has been 
applied in a rabbit and a sheep model. 
 
eLASCA 
 
Whereas multispectral imaging assessed the level of uterine perfusion, the plan here was to see 
whether a novel technique (eLASCA) could primarily assess uterine blood flow and circulatory 
function and subsequently, use that data to provide information on other crucial physiological 
variables: respiratory and heart rates and O2Sat. The principle of eLASCA is based on the interaction 
(a) (b) (c) 
 
  
  - 300 - 
of light and tissue in terms of refraction, absorption and scattering. This is the first time that this 
experiment has been attempted in the field of gynaecology. The ultimate aim was to see whether the 
current range of available investigations involving minimal or non-invasive techniques could be 
expanded by eLASCA.184 
 
eLASCA was introduced in the rabbit transplants from UTx #7 onwards and was attempted in UTx #7 
and #9. It was not possible to perform it in UTx #8 as a result of recipient demise. With respect to the 
sheep studies, the aim was to perform eLASCA in all five autotransplants. However, it was only 
attempted pre-retrieval and post-UTx in UTx #2, #3 and #5, and pre-retrieval only in UTx #4 because 
the first autotransplant was abandoned and the fourth ewe demised very early during the surgery. The 
figures demonstrated that some data was collected and contrast and intensity was plotted against time, 
with the power spectrum plotted against frequency. For UTx #9, the range of results increased as two 
exposure times were used for the rabbit does: 500μs and 10ms, with frequency set at 0.5Hz. In Figure 
3.15a-c, which refers to UTx #7, the oxy-haemoglobin concentration as well as the total haemoglobin 
increased following active cessation of arterial blood flow. In theory the opposite is supposed to 
occur.186 The main reason for this may be that during the occlusion of the abdominal aorta, a 
significant section of the inferior vena cava was also occluded as the two major vessels are found 
adjacent and parallel to each other. This would then result in a greater proportion of venous blood 
flow rather than arterial being blocked off during the occlusion because the uterine artery and the 
uterine vein are parallel with each other and the vein is close to the surface.186 The experiment had to 
be curtailed because the rabbit became haemodynamically unstable. Therefore, the rabbit’s abdomen 
had to be closed promptly allowing for no time to repeat the results.  
 
In UTx #9, when exposure was 500μs, the intensity of the image as well as the contrast fell with 
identical trends. However here the frequency of the contrast peaked at 2.5Hz, which allows us to 
calculate the heart rate: (2.5x60) 150bpm. When exposure was 10ms, no obvious frequency peak was 
seen in the contrast frequency. This is most likely because of too long an exposure time resulting in an 
inability to catch the contrast changes induced by the heartbeat.  
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Figure 3.13b demonstrates suitably the rather experimental nature of eLASCA. When plotted against 
time, it is the contrast which indicates the heart rate. At increased heart rates, for example 200bpm, 
the frame rate needs to be higher than 27fps (real frame rate was 22fps).186 Therefore the normal 
triphasic change associated with a single heart beat could only be captured when the frame rate was 
adjusted accordingly. In addition, the interaction between light and the tissue upon which it is shone is 
complex. In a single cardiac period, blood volume, blood flow speed and O2Sat can all alter, and 
additionally, the vessel walls move.268 All of these factors may potentially affect the contrast value. 
Therefore the heart beat induces the frequency of the contrast change but other cardiac-related 
periodic changes in the blood circulation may also contribute to this.186 
 
Future experiments can be improved by adding a well-established system to monitor the change of 
O2Sat simultaneously and thus compare the two sets of results, one obtained from an established 
system and the other from a trialled procedure.186 
 
The sheep model differed to the rabbit model. The aim in the rabbit model was to see whether 
LASCA could pick up blood flow in the pelvis of a small animal model. In the sheep the experiment 
was set up as would be in a human model in order to test whether LASCA may have some use in 
human UTx. Therefore measurements were taken prior to retrieval and post-transplantation, and 
occlusion was unnecessary.  
 
The preliminary results show that LASCA has the potential to determine blood flow, as well heart 
rate, respiratory rate and oxygen saturation. At this early stage accuracy is questionable, but not 
whether these parameters were recorded. The oxygenation saturation images are ratio-metrically 
calculated by the images at 660nm and 830nm based on the difference of the absorption co-efficients 
of the oxy and de-oxy haemoglobins. In the maps above, blood circulation was indicated with the red 
colour. The importance of such findings must not be underestimated. In medical practice, an 
innovation such as LASCA does not exist. What we have here is a system which is non-contact and 
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therefore does not cause any tissue damage, and also provides real-time data. This data gives us 
information related to presence of adequate blood flow to a particular tissue, and from that 
information, heart and respiratory rates and oxygen saturation is calculated. The latter parameter is 
given in a numerical and a pictorial form. In UTx #2, #3 and #5, the results obtained allow us to 
conclude that (a) blood flow was present in the uterine graft following transplantation; (b) post-UTx, 
the animal had heart and respiratory rates, and oxygen saturation compatible with a normal 
haemodynamic status, and (c) pre-retrieval and post-UTx oxygen saturation of the tissue was 
comparable. This last point confirms the findings form multi-spectral imaging.  
 
Even though the ewe in the fourth transplant arrested before retrieval could be commenced, it proved 
useful in assessing LASCA. The technique managed to pick up the falling heart rate of an animal that 
was suffering and beginning its demise. The heart rate was 21bpm at a frequency of 0.4Hz. At a signal 
of 0.8Hz, the heart rate was 48bpm most probably because of the second harmonic of equal to 21bpm. 
A second harmonic can be explained as follows. In a simple sinusoidal signal, the negative values of 
the sine curve may sometimes be received as positive values. Therefore a signal at 1Hz can be 
counted as 2Hz if the negative values are added. Therefore, 0.4Hz may be a signal of the reduced 
cardiac rate of 24bpm which appears as a second harmonic at 0.8Hz. The actual heart rate of the ewe 
at that time was around 50bpm. 
 
The eLASCA system currently remains a prototype for further experimental investigation. The data 
acquired was limited and difficult to use in order to make any definitive conclusions. However, 
images were acquired and as seen from the results section, a number of graphs could still be drawn. In 
the sheep model, data related to the heart and respiratory rates and oxygen saturation was acquired 
both pre-retrieval and post-UTx allowing for comparisons. Blood flow was determined in all sheep 
transplants. Therefore, as a first attempt to trial an experimental technique in a previously untested 
area of medicine, the experience may be considered as useful. With further trials in the future in both 
the animal and human models, a more definitive conclusion may be arrived at. 
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These preliminary results demonstrate vast potential of LASCA to surgery and importantly UTx. An 
accurate, real-time imaging modality, which uses a mathematical model to process the final results, is 
an improvement on current tools. The LASCA system is in principle a non-contact and real-time tool 
for the observation of flow in this case blood from which other parameters can be derived: heart rate, 
respiratory rate and oxygen saturation (level and map). Therefore its application is both qualitative 
and quantitative. Its strengths were revealed when applied to the sheep model. However there are still 
many challenges that need to be resolved before it can be reliably introduced in clinical practice. 
 
The challenges are mostly related to the data acquisition methodology. The movements of the target 
sample in vivo, brought on by pulsation, respiration or uterine contraction, lead to faulty contrast 
images with a low ‘signal-to-noise ratio’. A faster acquisition system is required for more precise 
diagnostic information. Further improvement of the hardware and the synchronisation of the various 
electronic devices may be the answer. 
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STUDY 4a 
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4. Study 4a: Psychological Issues Associated with Absolute Uterine Factor 
Infertility and Attitudes of Patients towards Uterine Transplantation 
 
This study has now been submitted for peer-review and potential publication. 
 
4a.1. Introduction 
 
The challenges that have arisen as UTx has slowly crept towards accepted human practice have 
included the development of multidisciplinary teams, with transplant surgeons, physicians and 
ethicists working together in a systematic way. Technical aspects regarding the surgery, 
immunological factors as to the optimal ‘anti-rejection’ regimen and practical features relevant to 
embryo harvest and transfer have been steadily overcome. However the psychology of a potential 
recipient of a uterine graft in order to bring about fertility has not been adequately explored or 
reviewed scientifically. This is a glaring omission which requires rectification. The scenario is this: ‘A 
potential UTx patient who has already faced elements of depression and self-examination brought on 
by her existing infertility is now preparing herself both physically and mentally to undergo an 
experimental procedure with an unquantifiable level of risk to herself and her unborn child without 
the certainty of future success’. One can immediately see how psychology now takes a front seat. 
 
The literature review has already been completed in an earlier chapter bearing the same name as its 
title. 
 
Areas that require exploration 
 
Despite the progress made towards managing the psychological sequelae for these patients, the barrier 
of infertility remains. UTx has been proposed as a potential solution. This study was therefore 
designed to explore patients’ knowledge of and attitudes (A), motivations (M) and feelings (F) 
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towards UTx before and after a short educational intervention via video and ‘question and answer’ 
session.  
 
4a.2. Materials and Methods 
 
The study sample included only women previously diagnosed with AUFI. They had volunteered to 
participate in the study having heard about the project either via our website or from the health-care 
team at the National Centre for Adolescent and Adult Females with Congenital Abnormalities of the 
Genital Tract, Queen Charlotte's Hospital. They contacted us via email or telephone, expressing an 
interest in managing their AUFI diagnosis. The sole inclusion criterion was age between 18 and 50. 
Permission to conduct the study was granted by the NRES West London Ethics Committee (study ID: 
11/LO/1057). 
 
Interview 
 
Participation in the study lasted approximately two to three hours and consisted of the following parts 
(Appendix B): 
 
a) Meeting and Introduction 
b) Agreement to conduct interview with investigator and a chance to for the potential participants to 
ask questions about the study. 
c) Consent form signed 
d) Part 1: Completion of questionnaire (15 minutes) 
e) Part 2: Discussion/Q&A session (30 minutes)  
f) Part 3: Video viewed by participant (30 minutes) 
g) Part 4: Completion of the above shortened questionnaire (15 minutes)  
h) Part 5: Structured interview (25 minutes); conversation to be recorded using audio recording 
equipment or answers to open-ended questions written down depending on patient preference. 
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Part 1: Completion of a guided questionnaire completed together with patient 
Part 1 involved the completion of a questionnaire. The researcher goes through each question in order 
and records the answers given to him by the participant on the same sheet as the questions. 
 
Part 2: Discussion of topics relevant to UTx/Q&A session 
All the main topics relevant to UTx (surgery, immunology, IVF, timeline, ethics, human attempts, 
animal research) were discussed with the participant. The options available to the participant with 
regards to fertility are discussed as well as how UTx may aid the patient in the future. Any questions 
that the participant has are answered.  
 
Part 3: Patient watches a 20 minute video whereby Mr JR Smith and Dr S Saso discuss UTx 
Following the discussion, the participant was left alone in the room to watch a 20 minute video which 
shows a discussion between Mr JR Smith (Chief Investigator) and Dr S Saso (researcher) about UTx 
(history, reasons for doing it, advantages, risks and other options). 
 
Part 4: Patient completes a shorter version of the guided questionnaire 
 
Part 5:  Patient answers a number of semi-structured questions (audio-recorded) 
After the patient completed a shortened version of the above questionnaire, the participant was asked 
to respond to a series of open-ended questions. The participant either wrote down the answers on a 
sheet of a paper which is stored by the researcher or if she preferred, her answers are recorded on a 
tape to allow for the content of the conversation to be transcribed in verbatim.  
 
The interview schedule consisted of seven structured questions as follows: 
 
a) How does the diagnosis of infertility affect your day-to-day life? 
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b) Have you given any thought to having children in the future? If you have, which methods have you 
considered (surrogacy, adoption)? What are your thoughts about such options? 
c) Why is the idea of ‘having children’ important to you? 
d) In the questionnaire, you had to answer questions regarding uterine transplantation. Following that, 
you watched a video on this topic. Have you ever heard of this proposed procedure before and what 
are your thoughts regarding it? 
e) Do you feel that uterine transplantation can ever become a valid option? Can you explain your 
answer? 
f) Can you describe what the process of uterine transplantation might entail (e.g. patient selection, 
surgery, IVF, pregnancy, delivery, immunosuppression, support)? 
g) Do you have any other questions? Is there something regarding the questionnaire or this interview 
that you would like to discuss? 
 
The presence of the participant’s family or partner was always welcomed. Support is necessary and 
important. They were only asked to leave while the participant completes the questionnaire in order to 
prevent any undue influence with answers. 
 
No such study has been performed before although the suggested patient assessment has been used by 
the UK face transplantation team when attempting to select a potential patient for the UK’s first face 
transplant. Professor Alex Clarke (Professor of Clinical Psychology at UCL, closely involved with the 
UK Face Transplantation team) and Miss Maria Jalmbrant (Clinical Psychologist, Imperial College 
London)) were involved in creating the questionnaires. The questionnaires also underwent numerous 
revisions as suggested by the West London Ethics Committee (made up of physicians, obstetricians 
and psychologists) so as to obtain ethical approval. 
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Methodology 
 
The study employed a quantitative (Parts 1 & 4 - questionnaire) and qualitative (Part 5 - interview) 
design. Part 5 involved a structured interview with the participants in order to fully and sensitively 
explore the issues that are pertinent to them in relation to UTx. The reason for the qualitative aspect 
(Part 5) is because qualitative data provides more detail, can capture constructs and narratives, is 
often popular amongst participants as answers are not constrained and is suitable for hypothesis 
generation. The data was transcribed in verbatim.  
 
Data Presentation and Analysis 
 
Attitudes, motivations and feelings of UTx patients (Tables 4a.1-2) and the sub-group analysis 
(Table 4a.3) were analysed using Fisher’s exact test. A bar graph was used to demonstrate ranking. A 
statistically significant difference was applied for a p-value <0.05. All statistical analysis was done 
using the Statistical Package for the Social Sciences version 19 (SPSS Inc, Chicago, Illinois, USA). 
 
4a.3. Results 
 
General 
 
Forty women were interviewed. Each interview took between 2-3 hours to complete. No patients felt 
upset by the questions posed, and all interviews were completed. Median age of interviewees was 29 
(range: 19-55). 92.5% (n=37) were in stable relationships and considered to have a found a partner 
with whom they would consider starting a family. All reported a strong support system around them, 
including family and friends. Age of AUFI diagnosis ranged from 7-39 years; median age was 18 
years. Cause of AUFI in this cohort to patients was as follows:  
 
(a) 65% (n=26) were MRKH sufferers, diagnosed during their teenage years;   
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(b) 20% (n=8) underwent a hysterectomy as a treatment for cancer (cervical carcinoma - n=4; 
rhabdomyosarcoma - n=2; placental site trophoblastic tumour - n=1; uterine cancer secondary to in 
utero diethylstilboestrol exposure - n=1); 
(c) 7.5% (n=3) underwent a Caesarean hysterectomy to halt severe post-partum haemorrhage; 
(d) 7.5% (n=3) suffered from a benign cause of AUFI (hypoplastic uterus, adenomyosis and multi-
fibroid uterus). 
 
17.5% (n=7) have children of their own, either via surrogacy or adoption, whereas the remaining 
(n=33) do not have any children (genetic or adopted). Three of the seven women achieved 
motherhood through surrogacy. Two women delivered their own child just prior to the Caesarean 
hysterectomy. One woman had a child prior to being diagnosed with cervical cancer and undergoing a 
hysterectomy as a result. Finally, one woman had two children via adoption. All women have to date 
expressed a wish to have a child or in case of women with children already, to add to the family. All 
women but one deemed the ability to have a child of their own as (very) important to them and 
expressed a strong wish to have children from the time of AUFI diagnosis to the time of the interview. 
This desire was based solely on their own feelings, with no external influence from a partner or family 
(again all women but one). The sole woman who differed from the majority stated that she had found 
a way to cope without children following her diagnosis and was content to lead her life without 
children. Surrogacy and/or adoption offered a viable solution to 52.5% of women (n=21). 
 
All patients had heard and read about fertility options that may be relevant to them: adoption, 
surrogacy and UTx, from a variety of sources: internet, GP, and gynaecology clinic. Each had 
contacted Mr J. Richard Smith (Head of Uterine Transplant UK) in order to find out more about the 
subject and participate in this project. Knowledge of UTx prior to the interview was divided with 
52.5% of participants stating that they either knew nothing or had heard UTx discussed only a few 
times and thus had minimal knowledge.   
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Attitudes towards UTx 
 
All found UTx an interesting and relevant topic. 82.5% (n=33) understood fully the benefits of UTx 
and 42.5% (n=17) stated that they were either undecided or did not comprehend the risks of UTx. 
42.5% were undecided as to whether the benefits outweighed the risks. 57.5% (n=23) thought that the 
benefits did outweigh the risks. 97.5% (n=39) thought that UTx research would benefit the fields of 
medicine and surgery whereas 95% (n=38) believed that it would be of benefit to obstetrics and 
gynaecology even if the final goal is not achieved (healthy pregnancy post-human UTx). All patients 
thought that funds should be channelled towards UTx research. 92.5% (n=37) would be happy to 
donate a deceased family member’s uterus to the Organ Donation register. 
 
An overwhelming majority, 85% (n=34) would accept a uterine graft if it could lead to a healthy 
pregnancy and are of that opinion that it should take place as soon as possible. 90% (n=36) thought 
that UTx is achievable.  
 
Motivation towards UTx 
 
90% (n=36) found UTx relevant to their quality of life, whereas 10% were undecided. 97.5% believed 
that UTx would lead to greater personal happiness (one patient was undecided) and all thought that it 
should be offered as soon as it was proven to be safe. 95% (n=38) of patients felt that UTx would suit 
them the most. One patient strongly disagreed with this and one was undecided. Crucially, 92.5% 
(n=37) would undergo UTx (or would have in the past) as a first choice treatment (ahead of surrogacy 
and adoption) for AUFI, provided it was a safe and accepted procedure in the medical literature. 
When the idea of graft failure and potential risk to fetus were introduced, that proportion fell to 87.5% 
(n=35) in both cases. Finally, all reported that they had a strong support system around them, 
including family and friends and would therefore not be alone experiencing UTx, with their 
motivation remaining undiminished. 
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Ranking of UTx-related issues 
 
With regards to the ranking of issues relevant to UTx (surgery, graft rejection, immunosuppression, 
achieving and maintaining pregnancy, risk to fetal and child development and donor family issues), 
all patients found issues related to the donor family the least important as there was no genetic link.  
The other most important issues were, in order, the ability to achieve pregnancy, risk to fetal/child 
development, and related to graft rejection, including immunosuppression.  
 
Following the three areas above, the next issue thought to be of importance prior to the video and 
discussion, was the surgical aspect of UTx. Interestingly, following the video and discussion, this 
issue was considered the second least important after donor family issues. Importantly, difference in 
ranking of each issue before and after discussion was statistically non-significant. Please refer to 
Figure 4a.1 for p-values. 
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Figure 4a.1 Mean ranking of topics related to Uterine Transplantation before and after discussion.  
The topics are shown on the x axis. They were scored according to how important the patients felt 
they were in relation to each other (score: 1-10, y axis; 1=least important and 10=most important). 
Topics were permitted to be scored equally. 
 
 
Difference in ranking of each issue before and after discussion was statistically non-significant. P-
values are as follows (1-tail):  
 
Surgery     0.42 
Maintaining pregnancy   0.21 
Risk to fetus    0.16 
Graft rejection    0.34 
Achieving pregnancy   0.37 
Risks to Child Development  0.23  
Immunosuppressants   0.25     
Donor Family    0.44 
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Opinions following Video Presentation 
 
Following a 20 minute discussion of UTx involving the interviewer (Dr S Saso) and the interviewee, 
aided by a video presentation, the above results were re-assessed. Some significant changes in the 
patients’ answers were noted. All now felt that they understood the benefits and only one woman was 
undecided as to whether she fully understood the risks of UTx. Similarly, only two women were 
undecided as to whether they believed that the benefits outweighed the risks; the rest of the cohort 
(95%) was in agreement that this was the case.  
 
All women now felt that UTx research and the whole process of attempting to bring it about in 
humans would be of benefit to the fields of medicine, surgery, obstetrics and gynaecology. Similarly, 
all thought further funds and grants should be made for infertility research including UTx. All other 
answers remained the same.  
 
With respect to the most important conclusions, only two women (5%) would not accept a uterine 
graft if it could lead to a healthy pregnancy. The patient, who was undecided as to whether she would 
undergo UTx ahead of surrogacy or adoption, provided UTx was a safe and acceptable procedure, 
now felt that she would not have chosen UTx. She has already experienced surrogacy and that would 
remain her first choice. The second patient was concerned about the potential risk to her well-being 
and fetus and would wait prior to making a final decision. 97.5% (n=39) would undergo UTx ahead of 
surrogacy and adoption in full knowledge that the latter two options would be ultimately safer for 
their own wellbeing and the fact that the graft could fail even prior to conception. All felt that UTx 
should take place, but 92.5% saw UTx as achievable. Importantly, four women felt that they could not 
undergo UTx with current risks posed to the fetus. For them, the risk posed by the surgical process 
and the immunosuppression to themselves were not an issue but the fetal risks still need further 
clarification before they could fully decide upon undergoing UTx. 
 
Results are summarised in Tables 4a.1 and 4a.2. 
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Key findings Percentage, % (n) 
Interview completion 100 (40) 
Age Median: 29; Range: 19-55 
In a stable relationship 92.5 (37) 
Have children 17.5 (7) 
Surrogacy/Adoption as a viable 
solution 
52.5 (21) 
Minimal Knowledge of UTx 52.5 (21) 
Attitudes, Motivations, Feelings towards UTx 
 Pre-Video Post-Video Significance 
Understanding of benefit 82.5 (33) 100 (40) <0.001 
Understanding of risks 57.5 (23) 97.5 (39) <0.001 
Benefit outweighs risks 57.5 (23) 95 (38) <0.001 
UTx as option 85 (34) 95 (38) 0.5 
UTx as a 1st choice option 92.5 (37) 90 (36) 0.44 
UTx as an option  
with current risks to mother 
87.5 (35) 97.5 (39) 0.10 
UTx as an option  
with current risks to fetus 
87.5 (35) 90 (36) 0.20 
Human UTx is achievable 90 (36) 92.5 (37) 0.32 
 
Table 4a.1 Summary of results 
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Questions Average Score (out of 10) 
 
 Pre-Video Post-Video Significance 
1. If uterine transplantation became possible 
in humans, I would undergo this procedure 
in order to have a child. 
9.8 9.7 0.40 
2. If uterine transplantation became possible 
in humans, I would not undergo this 
procedure, as I am fully aware that adoption 
or surrogacy would be ultimately safer for 
my wellbeing. 
1.6 1.5 0.44 
3. If uterine transplantation became possible 
in humans, I would undergo this procedure, 
fully aware that it could fail and the ultimate 
goal of achieving successful pregnancy 
would not be achieved. 
9.1 9.6 0.10 
4. If uterine transplantation became possible 
in humans, I would not undergo this 
procedure, fully aware of significant risks to 
my future baby. 
2.3 1.9 0.10 
 
 
Table 4a.2 Mean scores to four key questions assessing patient motivation (key: 1 = strongly 
disagree; 10 = strongly agree) 
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Sub-group Analysis 
 
a) Women with MRKH 
 
Overall, no statistical difference was found when comparing the responses between women diagnosed 
with MRKH and those women diagnosed with other types of AUFI. The only response that differed 
was whether surrogacy or adoption may be a viable option for the patient. MRKH patients were more 
in favour of these two treatments, currently the only two accepted in practice, than non-MRKH 
patients. 
 
b) Women who were already mothers at the time of the interview 
 
Seven women were already mothers at the time of the interview. Median age was 40 (range: 29-43 
years). Overall, the responses in this small sub-set did not statistically differ to the answers provided 
by the whole cohort. One patient differed in her replies and her case was described above. The patient 
was initially undecided as to whether she would undergo UTx ahead of surrogacy or adoption, 
provided UTx was a safe and acceptable procedure, but following the video, felt that she would not 
have chosen UTx. She has already experienced surrogacy and that would remain her first choice. 
However she did feel that UTx was achievable whereas she was undecided previously. One other 
patient also changed her mind following the video and felt that UTx was not achievable although she 
was supportive of the whole process and would undergo the procedure as a first choice as oppose to 
surrogacy and adoption.  
 
Only two responses differed statistically.  First, the ‘Mothers group’ was strongly in favour of 
surrogacy and adoption as alternative options, in comparison to the ‘Non-Mothers’ group. Second, the 
two groups also differed significantly as to whether they would proceed with UTx fully aware of the 
potential risks to the fetus, with the ‘Non-Mothers’ group appearing a little more cautious. This 
difference arose following the discussion and the video. 
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c) Women with minimal knowledge of UTx prior to the interview 
 
Again, overall the responses between these two groups did not differ. Those that did are as follows: 
(a) understanding of potential benefit of UTx to women suffering from AUFI prior to the video and 
discussion; and (b) understanding of how the benefits of UTx outweigh the risks. 
 
All results above are summarised in Table 4a.3. 
 
 
Sub-Group Analysis 
 
MRKH v. non-MRKH 
(pre-video / post-video) 
Mothers v. Non-Mothers 
(pre-video / post-video) 
UTx non-awareness 
v. awareness 
(pre-video / post-video) 
Understanding of benefit 0.22 / 0.44 0.53 / 0.55 0.004 / 0.34 
Understanding of risks 0.43 / 0.31 0.10 / 0.23 0.28 / 0.16 
Benefit outweighs risks 0.45 / 0.45 0.43 / 0.44 0.18 / 0.03 
UTx as option 0.65 / 0.20 0.24 / 0.29 0.20 / 0.41 
UTx as a 1st choice option 0.57 / 0.48 0.36 / 0.14 0.21 / 0.15 
UTx as an option  
with current risks to mother 
0.30 / 0.13 0.12 / 0.35 0.39 / 0.053 
UTx as an option  
with current risks to fetus 
0.40 / 0.37 0.47 / 0.048 0.24 / 0.08 
Human UTx is achievable 0.56 / 0.57 0.45 / 0.45 0.34 / 0.40 
 
 
 
Table 4a.3 Statistical significance of Sub-Group Analysis 
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4a.4. Discussion 
 
Before a patient can be selected for UTx, she will have to undergo an appropriate psychological 
assessment. This will include a series of appraisals looking at, for example, cognitive function, mood, 
stress disorder, quality of life and beliefs regarding medicine. One of these assessments should gauge 
the motivations, attitudes and reasons why a patient would choose UTx ahead of surrogacy or 
adoption. This study aims to assess perceptions of AUFI patients to UTx. No such study exists yet in 
the literature and thus no attempt to quantitatively or qualitatively report what AUFI patients feel 
about UTx. After almost 50 years of research, our evidence with regards to this topic is still anecdotal.   
 
The goal here is not to influence a patient; there is recognition among UTx researchers that UTx is a 
procedure which may be suitable for a small number of AUFI sufferers only. The ultimate aim of this 
research programme is to understand the patient perspective in considering UTx as one of the list of 
possible solutions to AUFI, including surrogacy or adoption. 
 
The actual study clearly demonstrated an overwhelming level of interest and support from AUFI 
patients towards the continuation of UTx research, its benefit to medicine and surgery in general and 
most importantly the application of UTx to clinical practice. 
 
Interpretation 
 
The forty patients interviewed were from a diverse sample group, with a wide age range (19-55), 
comprising of mothers and non-mothers, and MRKH and non-MRKH patients. There was 
considerable support from all these groups about UTx as a concept, a research field, an area that may 
lead to advancement of the medical field as a whole, and a possible treatment option in the future. 
They considered UTx as an option which could lead to greater personal happiness and should 
therefore be offered as soon as it proven to be safe. Most crucial of all, and possibly rather surprising, 
was the statistic that 92.5% of the women interviewed would undergo UTx ahead of surrogacy and 
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adoption. When made fully aware that these two options would be safer for their own and their fetus’s 
wellbeing and the graft could fail even prior to conception, the percentage still in favour of UTx as a 
first choice was 87.5%. The immediate reaction to such a high percentage following the video 
discussion is a positive one as it clearly supports a human UTx attempt. However, this statistic should 
be treated with caution. One can easily conclude that rather worryingly, despite being warned about 
the risks of UTx, patients are potentially distancing themselves from them in order to achieve their 
goal of fertility. They are so focused on improving their QoL that their views on UTx and whether it 
may be right for them become one-dimensional to the extent where they would undergo UTx ignoring 
the potential harm to themselves and the unborn fetus. A question then arises - does the patient require 
further time and evidence in addition to the 20 minute video to gage for herself whether the benefits 
truly outweigh the risks and if so how much more time and what additional evidence? A patient 
undergoing a radical hysterectomy, an operation similar to UTx in scope and duration, will be 
consented following, from my experience a 10-20 minute discussion. To the UTx patient, having a 
child is a paramount issue and is as important to them as is continuation of life to a end-stage renal 
failure patient requiring a renal transplant. They are simple prepared to face the risk to achieve their 
aims, which would considerably improve their life. A solution may be the setting-up of a series of 
teaching session whereby the selected patients would undergo one hour classes focused on the main 
topics related to UTx, taught by transplant surgeons, donor co-ordinators and transplant nurses for 
example. This would give them the necessary one-to-one teaching and adequate time to study the 
process in its entirety, as well as have all their questions answered.     
 
90% felt that UTx was achievable within the next three years. The explanation for this elicited from 
the women was that UTx, if deemed safe in humans, would enable them to have their own genetic 
child and allow them to be in control throughout the pregnancy. It would also be the cheapest option 
and one where they did not have to rely on anybody else for results. The former point raises another 
ethical dilemma - one of patients choosing a high-risk operation because it is cheaper. To answer this 
point, it is important to clarify that the procedure may be cheaper only at its initial stage, as the aim is 
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to ensure UTx is funded through private, charitable donations. Future funding (NHS or private) will 
greatly depend on the outcomes of the initial 10-20 human UTx worldwide.  
 
For some of the patients, their nationality played a part. Here is a transcript from one of the patient’s 
interviewed:  
 
‘We have given a lot of thought to having children and have looked at both options, surrogacy and 
adoption. Given our nationality and poor legislation in Ireland in relation to surrogacy and adoption, 
the pursuit of either option for us was/ is fraught with red tape and bureaucracy, not to mention any 
legality issues that could arise with a surrogate mother. While we are ready and willing to go down 
these roads if left with no other alternative, we feel that either option would have to be approached 
with great caution as both options are filled with trepidation.’ 
 
It is important to note that this was a highly motivated patient group who all felt deeply distressed and 
devastated when initially diagnosed with AUFI. One patient had to see a psychologist, and issues 
related to femininity and sexuality affected all our MRKH sufferers. Even the three patients who had 
their own biological child prior to losing their uteri (Caesarean or standard hysterectomy) still felt that 
‘something was missing’ as they could not complete their respective families. The concept of not 
being able to have a child was initially overwhelming. For them, ‘a life without a child was empty and 
simply not worth it’. Eventually all found ways of coping with this diagnosis, and one patient 
managed to completely block out the idea of having children. 52.5% considered surrogacy and 
adoption perfectly acceptable options, but only one would still choose surrogacy if UTx was a safe 
and accepted procedure with minimal risk to the mother and fetus. The main problems with surrogacy 
listed by the patients were the lack of control, costs ranging from £15,000-£30,000 and no actual 
experience of gestation. Adoption also seemed like a laborious, bureaucratic and long-winded process, 
and it could not meet the need to have a biological child. 
 
  - 323 - 
This agrees with the prior assessment that UTx would fit the need of a select, highly motivated group 
of patients, for whom being a mother was of the utmost importance. Even though they found 
surrogacy and adoption perfectly acceptable options, these women would only consider them if UTx 
were not an option in humans. In particular, this enthusiasm for UTx improved following an open 
discussion and video presentation about UTx. Once the participants knew more, they felt more 
confident and thus, UTx was consolidated even further as a ‘number one’ option. One result, however, 
should be highlighted. One participant out of the seven stated that she would still choose surrogacy 
over UTx, as she had gone through it and now has two healthy biological children. This decision is 
perhaps based on the success of surrogacy in her case.  
 
The benefit of having a discussion and showing the patients a video on UTx was highlighted most 
clearly when seeing whether they understood the benefits and risks of UTx. In both cases an obvious 
and statistically significant increase was seen following the discussion and video, from 87.5% to 
100% in the former and 52.5% to 97.5% in the latter. Following the video, 95% felt that the benefits 
outweighed the risks. It is important for the team to realise how valuable in the consenting process 
will be this one-to-one discussion with the patients. This will serve to answer their questions and try 
to gage how ready they may be. 
 
Following the video, 36 women would choose UTx ahead of surrogacy and adoption, having been 
briefed on all possible consequences that they or their fetuses may have to endure. These women 
present the optimum patient group from which to choose a potential recipient. Apart from being fully 
independent women with at least secondary school education to the age of 18 as well as a supportive 
family and partner, one can find no fault for their motivation to have a UTx. They were able to weigh 
up the benefits and risks of UTx and think carefully about which areas they felt to be the most 
important (in this study, surgery, maintaining pregnancy and risks to fetus).  
 
The limitations of this study are, firstly, as discussed above 40 patients is not a large cohort. This may 
appear as a small sample size and therefore a drawback. However, the results are so definitive that a 
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greater sample would not have altered the drawn conclusions. Secondly, the patients were not drawn 
randomly from an AUFI clinic. They all contacted us expressing an interest in UTx. Therefore, one 
could argue that this cohort is a biased group in favour of UTx. In my opinion, this is not a valid 
point. An interest in a novel procedure does not automatically mean a wish to undergo it or in this 
case, find it more to one’s liking than surrogacy or adoption. It is the right of all couples who desire to 
have children to investigate all possibilities that may bring this about. Those who have heard about it 
decided to contact us and the expectation is that the vast majority of women who hear of our team and 
UTx will contact us in the future. 
 
The sub-group analysis focused on three groups. One of them, women who were aware of UTx prior 
to the discussion and those women who were not, is relevant to the previous point. When comparing 
the answers of those two groups, one can see that almost all answers do not differ significantly. This 
was also the case with the other two sub-groups: MRKH and non-MRKH women; and mothers and 
non-mothers. This suggests that having a child is the most important factor for an AUFI patient when 
it comes to deciding whether UTx should be her first option, and the differences between AUFI 
sufferers become unnoticeable at that point. 
 
Psychological Assessment  
 
Upon deciding on a potential patient, the UTx team should initially investigate her motivations for 
undergoing UTx, as well as her attitudes and expectations following the operation. The patient ought 
to have considered and ruled out surrogacy and/or adoption as her main choice. Prior to commencing 
any aspect of the UTx process, the team should feel confident that the patient fully understands the 
plan proposed, the reasons behind it and the potential risks, and in her ability to make an independent 
decision. 
 
The parameters described below provide a conceptual framework for the proposed AMF assessment 
tool. They are based on published material related to other recent ‘life-improving’ transplantation 
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research, i.e. face transplantation.206,207 It is important to understand that this tool will form a 
significant and first part of an overall psychological assessment prior to UTx.  
 
Motivation to seek treatment, goals and expectations of outcome  
The transplant team should have a clear understanding of the problems that motivate the candidate to 
seek a uterine transplant in the first place, and her expectation of the potential of surgery in alleviating 
them. Unrealistic pre-operative expectations of fertility outcomes from the procedure are likely to be 
associated with poor post-operative psychological adjustment. Discussions between the patient and 
members of the transplant team should focus on surgical risks of UTx, as well as risks of viral 
infections and neoplastic changes caused by use of immunosuppressants. Type and duration of 
treatment should be clarified beforehand - a transplanted uterus should stay in for a maximum time of 
2-3 years to allow a successful pregnancy. If the patient wishes, she could retain her uterus for a 
repeat pregnancy. However, such wishes should be noted prior to the surgery. 
 
Pre-operative information into other fertility solutions 
An evaluation should be made as to whether the prospective patient has been offered any alternative 
interventions (which offer a lower level of risk) such as surrogacy and adoption. Surrogacy offers 
genetic parenthood and benefits over transplantation by excluding risks related to the transplant 
recipient such as surgery and immunosuppressants. For example, following the first ever hand 
transplant, the patient, a convicted con-man, failed to follow the post-operative drug and 
physiotherapy program, and as a result the donated hand was rejected.269 
 
However, disadvantages exist: one cannot control for lifestyle factors of the surrogate mother such as 
smoking/alcohol. In addition, the pregnancy-morbidity risk is placed on another person, and legal 
conflicts about the motherhood of the newborn may emerge.65  
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Psychological stability and adjustment 
The prospective patient should be assessed as to her likely resilience in coping with potential negative 
outcomes associated with the transplant. These would also include several ‘unknown’ variables, such 
as outcomes associated with complex drug regimens, risks of graft rejection, poor fertility outcomes 
and intrusive media interest. 
 
Level of cognitive functioning 
This should be at a sufficient and appropriate level, thus enabling the patient to have full 
understanding of the risk/benefit information, which is likely to be detailed and complex in a 
procedure of this nature. Cognitive testing should therefore be performed on potential recipients. 
 
Adherence “credentials” 
Experience from other organ transplants has demonstrated that strict adherence to a complex post-
operative drug regimen is crucial to a successful graft and would be even more paramount in 
obtaining a subsequent successful fertility outcome. It is worth noting that around 30% of organ 
transplant recipients are non-adherent at some point during the post-transplant period.270 A screening 
test that could highlight this group prior to transplantation would be useful, as it would allow the 
transplant team to advise a candidate against having the procedure. Furthermore, if the candidate were 
still to be considered suitable, the team could prepare her adequately so she would cope well 
psychologically following the procedure. 
 
Candidate’s social support network 
A consideration of the level and quality of support from the candidate’s family and friends should be 
made. 
 
Support for those deemed unsuitable for uterine transplantation 
The possibility of fertility restoration through UTx may raise the hopes of many, whilst only a small 
number of women may be suitable for the procedure. An investigation will be carried out as to how a 
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support network for these women deemed unsuitable to have the procedure may be implemented in 
the future. 
 
Potential psychological responses to transplantation 
UTx may give rise to psychological ‘stressors’ found following other solid organ transplants such as 
liver and kidney, and also potentially novel stressors unique to the procedure. These stressors include 
fears relating to the viability of the transplanted organ and a number of emotional responses 
associated with the experience of receiving a transplanted organ; for example, feelings of gratitude or 
guilt towards the donor.206  
 
Conclusion 
 
In conclusion, this study, apart from being the first to demonstrate a qualitative relationship between 
AUFI patients and their curiosity and desire for UTx, also paves the way for forming the introduction 
into the psychological assessment of a potential patient. There is a keen interest in this new technique 
by potential UTx patient, partly because surrogacy and adoption seem difficult to access currently , 
but primarily because UTx gives a patient total control from start to finish as well as a child which 
genetically they can call their own. However, the results must be treated with caution. Paitents appear 
to be distancing themselves from the risk and this issue will need very careful assessment in any 
clinical programme. 
 
The argument whether we should try to improve surrogacy and adoption services to make them more 
successful instead of focusing on UTx seems redundant. There is no ethical argument against UTx 
research and if it were to become a safe and accepted procedure, it would be unethical not to offer it to 
patients in addition to the other two options. 
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Study 4b: A UK Survey Assessing the Perceptions of Healthcare Professionals towards 
Uterine Transplantation 
 
This study has now been peer-reviewed and accepted for publication as per following reference: Saso 
S, Clarke A, Bracewell-Milnes T, Al-Memar M, Hamed AH, Thum MY, Ghaem-Maghami S, Del 
Priore G, Smith JR. A UK Survey Assessing the Perceptions of Healthcare Professionals towards 
Uterine Transplantation Prog Transplant 2014. 
 
Abstract 
 
Context: Uterine Transplantation 
Objective: To investigate the opinions and views of UK healthcare professionals towards uterine 
transplantation (UTx) and create a rank order of importance of UTx-related issues in order to make 
UTx transparent and understandable to colleagues. 
Design: Large, in-depth survey investigating health care professionals' opinions on UTx. 
Setting: UK Locations. Analysis done at Imperial College London. 
Participants: UK transplant professionals (surgeons, nurses, operating room staff, and donor 
coordinators) and obstetricians and gynaecologists (trainees, members and fellows of the Royal 
College of Obstetricians and Gynaecologists).  
Intervention: Questionnaires were given out at hospital grand-rounds, trainee teaching days, and 
conferences (national and international).  
Main outcome measures: Should UTx takes place? Is UTx achievable? What is the rank order of 
importance of key issues related to UTx? 
Results: 528 participants participated in the study. With respect to overall support for UTx and as a 
possible future therapeutic option for Absolute Uterine Factor Infertility, 93.8% (n=495) felt that UTx 
should take place if considered appropriate medically, surgically and ethically. 57.2% (n=302) 
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thought it was an achievable objective. Issues related to immunology of UTx and pregnancy post-UTx 
were unanimously thought of as most important.  
Conclusion: This study is the first in literature to try to sample the opinions and concerns of health-
care professionals towards UTx. A substantial majority of the participants support the development of 
the UTx research programme and believe that UTx should be performed in the near future. More 
effort is required to educate health care professionals about all aspects of UTx. 
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4b.1. Introduction 
 
Any innovative and new surgical procedure brings with it a potentially polarized ethical debate. One 
of the ways of moving that innovation closer to reality i.e. the clinical setting is by assessing and 
gathering support amongst colleagues or to use a better term, health care professionals. This group is 
well placed to understand what the aim of that innovation is, its benefits and risks, its long-term 
outcome and most importantly, likelihood of success. To demonstrate face transplantation as an 
ethically accepted procedure, the UK team assessed the level of support amongst colleagues as well as 
professionals who deal with transplant surgery (i.e. transplant community).271 They surveyed 170 
transplant professionals by means of a questionnaire generated by a focus group of transplant 
coordinators. A high level of support for facial transplantation was revealed, with 76% of respondents 
in favour and none opposed to the procedure in principle. Areas of concern were also highlighted, 
mainly factors that affect organ retrieval and the impact on the retrieval team and the donor family.271 
Clarke et al used closed-ended questions to allow for appropriate statistical analysis of quantitative 
data as well as open-ended questions to allow for qualitative data which can explore particular issues 
in more depth.272 A similar pragmatic approach, applying the methodology of the UK face 
transplantation team to deal with ethical issues, is necessary with respect to UTx. 
 
By sampling such diverse groups, one can gather the following information: attitudes to practical 
issues related to organ retrieval, professionals’ concerns for the recipient, her baby and donor families, 
and perceived impact on the transplant program as a whole. The UK face transplantation team was 
able to explore a number of different issues (Box 4b.1).163,271,272 
 
Published material from research related to the other recent ‘life-improving’ transplantation, i.e. face 
transplantation can form the model for the above experiments. A significant overlap between face 
transplant and potential uterine transplant patients is evident, as both sets of patients are planned to 
undergo a ‘QoL’ improving transplant rather than a life-saving transplant. 
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Box 4b.1. Issues that require investigation amongst health-care professionals and donor co-
ordinator teams 271 
 
 Uterine retrieval & grafting  
- patient wellbeing after retrieval 
- development of donor criteria 
- liaison with other retrieval teams 
- surgical and technical issues 
 
 Pregnancy with a transplanted uterus  
- wellbeing of mother and fetus 
- immunosuppressant effects 
 
 Retrieval team 
- education of other health professionals about UTx  
- development of a specific patient UTx team 
- impact of UTx on operating room and intensive care unit staff 
- support for health professionals 
- negative impact on other transplant programs 
- press intrusion for health professionals 
 
 Donor co-ordinators 
- likelihood of benefit for recipient 
- long-term support for donor family 
- discussion of process involved 
- interest in baby from donor family 
- consent issues and consent form 
- press intrusion 
 
 
4b.2. Materials and Methods 
 
A large, in-depth survey investigating health care professionals’ opinions on UTx was devised. The 
survey consists of a simple questionnaire which takes a maximum of 15 minutes to complete. The 
questionnaire was of a similar format to the one used and validated by the face transplantation team in 
the exercise described in the introduction. Professor Alex Clarke (Professor of Clinical Psychology at 
University College London, closely involved with the UK Face Transplantation team) and Miss Maria 
Jalmbrant (Clinical Psychologist, Imperial College London)) were involved in creating a 
questionnaire specific for UTx (Appendix C). Permission to conduct the study was granted by the 
NRES West London Ethics Committee (study ID: 11/LO/1057).  
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The target populations are: 
 
 Group I: transplant professionals (surgeons, nurses, operating room staff, transplant and 
donor coordinators); 
 Group II: obstetricians and gynaecologists (trainees, members and fellows of the Royal 
College of Obstetricians and Gynaecologists)  
 Group III: fellows of the Royal College of Obstetricians and Gynaecologists only 
 
While sampling three different groups, the following information was gathered: attitudes to practical 
issues related to uterine retrieval and grafting, professionals’ concerns for the recipient, her baby and 
donor families, and perceived impact on the UTx program as a whole. With regards to Group I, this 
population came from teaching and non-teaching hospitals in the UK, as well as study days organized 
by transplant coordinators. Mainly because of geography, the London Donor Transplant Coordinators 
Team helped with organising the relevant information days. As this is a gynaecological project, our 
biggest group was obstetricians and gynaecologists who make up Group II. To obtain a national 
sample distribution, members and fellows of the Royal College of Obstetricians and Gynaecologists 
(RCOG) were sampled on a national basis. Regarding the groups, opportunities to give out 
questionnaires to participants was at hospital grand round days, trainee teaching days, and conferences 
(national and international). A letter explaining our project (Appendix D) with the questionnaire and 
an envelope (with our address stamped on it) attached to it was sent out to all the fellows of the 
RCOG. 
 
Questionnaires were designed using closed-ended questions to allow for appropriate statistical 
analysis for quantitative data. The following issues are explored: 
 
a) general concepts related to UTx (operation technique, time length, complications; immunology;  
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achieving pregnancy post-transplantation; maintaining pregnancy; risks to fetus and child 
development) 
b) uterine retrieval and grafting (development of donor criteria; liaison with other retrieval teams; 
surgical and technical issues); 
c) pregnancy with a transplanted uterus (wellbeing of mother and fetus; immunosuppressant effects), 
d) retrieval team (education of other health professionals about UTx; development of a specific 
patient UTx team; impact of UTx on operating room and intensive care unit staff; support for health 
professionals; negative impact on other transplant programs; press intrusion for health professionals 
and patients); 
e) donor family (likelihood of benefit for recipient; long-term support for donor family; discussion of 
process involved; interest in baby from donor family; consent issues and consent form; donor family 
press intrusion). 
 
Our ultimate aim was to create a rank order of importance of each set of described issues so that 
information could be obtained as to which target areas had to be focused on in order to make UTx 
more transparent and understandable to the colleagues within our own profession. Target population 
number is 500. 
 
Data Presentation and Analysis  
 
A bar graph was used to demonstrate ranking. The ranking data for the ‘Health-care Professionals’ 
survey was analysed using a one-sample Kolmogorov-Smirnov test. A statistically significant 
difference was applied for a p-value <0.05. All statistical analysis was done using the Statistical 
Package for the Social Sciences version 19 (SPSS Inc, Chicago, Illinois, USA). 
 
 
 
 
  - 336 - 
4b.3. Results 
 
528 participants took part in the study; 59.8% were female (n=316) and 40.2% (n=212) were male. 
398 participants were surveyed after presentations on the topic of UTx given by Dr S Saso and/or Mr 
J. Richard Smith at a national and international level. More than a 1000 questionnaires were sent out 
to the Fellows of the RCOG, out of whom 130 responded and sent them back. All participants took a 
maximum of 15 minutes to complete the survey and their entries were anonymised. Table 4b.1 shows 
the break-down of participants according to profession. The cohort was evenly split according to age: 
(a) < 30 years: 25% (n=132); (b) 30-40 years: 33.5% (n=177); (c) 40-60 years: 32.2% (n=170); and 
(d) > 60 years: 9.3% (n=49). Also extracted was the level of experience within the medical profession: 
(a) < 1 year: 3.8%; (b) 1-5 years: 27.4%; (c) 5-10 years: 15.5%; and (d) > 10 years: 53.0%. 
 
73.4% (n=388) know someone (woman/couple) who has experienced problems with infertility and 
17.2% (n=91) have suffered personally with infertility. 31.6% (n=167) stated that they have at least 
some knowledge of the history and research into UTx. More than two thirds of the surveyed 
population, 68.6% (n=188), reported that they found the field of UTx interesting. Importantly, only 
9.5% (n=50) felt that they did not understand the benefits and 25.2% (n=133) the risks of UTx. 35.8% 
(n=189) felt those benefits outweighed the risks, 50.8% (n=268) were undecided and 13.4% (n=70) 
disagreed. Only 11.7% (n=62) felt that UTx will not lead to greater human happiness, although 41.3% 
(n=218) were undecided. More than 50% of participants felt that research into UTx is of a benefit to 
medicine (56.6%), transplant surgery (55.9%) and obstetrics and gynaecology (53.0%), even if it does 
not lead to an eventual healthy pregnancy. However, only 41.9% (n=221) were adamant that more 
funds and grants should be made available for novel and innovative fields such as UTx, instead of 
focusing it all on life-saving research programmes e.g. cancer research. 65.0% (n=343) would be 
happy to donate their own or their family’s uterus to the donor registry if this option were to be 
available.  
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With respect to overall support for UTx and as a possible future therapeutic option for AUFI, 93.8% 
(n=495) felt that UTx should take place if considered appropriate medically, surgically and ethically, 
with 42.6% (n=225) of the surveyed population believing that it should take palace ‘as soon as 
possible’. Therefore, 51.1% (n=270) support the eventual commencement of the human UTx 
programme in the UK but not in its current state. 57.2% (n=302) thought it was an achievable 
objective, with the second largest group, 39.2% (n=207), not able to confidently decide (box ticked: 
’not sure’). 
 
Responses by Group 
 
Group I: Transplant Professionals (transplant surgeons and donor coordinators) 
 
54.1% (40/74) felt undecided as to whether benefits outweighed the risk of UTx, with 24.3% (18/74) 
believing they did and 21.6% (16/74) stating that in fact the risks outweighed the benefits. Only 9.5% 
(7/74) felt that development of UTx would not lead to greater patient happiness, but 44.6% were 
undecided (33/74). With respect to bringing benefit to medicine in general, over 50% of respondents 
thought that the development of UTx would also lead to a furthering of the medical, surgical, 
gynaecological and transplantation fields. 66.2% (49/74) thought that UTx is achievable, 32.4% 
(24/74) were not sure and only 4.1% (3/74) felt that it should never take place. 39.2% (29/74) 
believed that UTx should take place as soon as possible. 
 
Group II: obstetricians and gynaecologists (trainees, members and fellows of the Royal College of 
Obstetricians and Gynaecologists)  
 
47.4% (136/287) felt that the benefits of UTx outweighed the risks, 37.3% (107/287) were undecided, 
with only 15.3% (44/287) stating that in fact the risks outweighed the benefits. 14.3% (41/287) felt 
that development of UTx would not lead to greater patient happiness, but 31.7% were undecided 
(91/287). Therefore, the majority (54%) could see clinical UTx would lead to greater human 
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happiness. With respect to bringing benefit to medicine in general, over 60% of respondents thought 
that the development of UTx would also lead to a furthering of the medical, surgical and 
transplantation fields. 68.6% (197/287) thought that UTx is achievable, 27.2% (78/287) were not sure 
and only 8.4% (24/287) felt that it should never take place. 47.7% (137/287) believed that UTx should 
take place as soon as possible. 
 
Group III: Fellows of the Royal College of Obstetricians and Gynaecologists only 
 
23.1% (30/130) felt that the benefits of UTx outweighed the risks, 54.6% (71/130) were undecided, 
with 22.3% (29/130) stating that in fact the risks outweighed the benefits. 24.6% (32/130) felt that 
development of UTx would not lead to greater patient happiness, but 42.3% were undecided (55/130). 
Therefore, 33.1% (43/130) stated that clinical UTx would lead to greater human happiness. With 
respect to bringing benefit to medicine in general, less than 22% of respondents thought that the 
development of UTx would not lead to a furthering of the medical, surgical, gynaecological and 
transplantation fields. 54.6% (71/130) felt that UTx is achievable, 40.8% (53/130) were not sure and 
12.3% (16/130) thought that it should never take place. 38.5% (50/130) believed that UTx should take 
place as soon as possible. 
 
Group IV: Respondents who have encountered personal issues with infertility 
 
54.9% (50/91) felt that the benefits of UTx outweighed the risks, 36.3% (33/91) were undecided, with 
8.8% (8/91) stating that in fact the risks outweighed the benefits. 13.2% (12/91) felt that development 
of UTx would not lead to greater patient happiness, but 31.9% were undecided (29/91). Therefore, 
76.9% (70/91) stated that clinical UTx would lead to greater human happiness. With respect to 
bringing benefit to medicine in general, over 60% of respondents thought that the development of 
UTx would also lead to a furthering of the medical, surgical and transplantation fields. 68.1% (62/91) 
felt that UTx is achievable, 29.7% (27/91) were not sure and 7.7% (7/91) thought that it should never 
take place. 53.8% (49/91) believed that UTx should take place as soon as possible. 
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Ranking issues 
 
The level of importance of a particular issue with regards to achieving a successful UTx as well as its 
relation to other such issues of relevance has been demonstrated in Box 4b.2. Figure 4b.1 is a more 
detailed and illustrative assessment of Group 1, ranked as the group containing seven general concepts 
thought to be the most relevant to UTx. Risks to fetal and child development together with 
maintaining pregnancy were the three areas considered the most important in bringing about a healthy 
pregnancy from a transplanted uterus.  
  
The scores all followed a normal distribution and were of statistical significance (p<0.05). The 
hypothesis score was defined as 5/10 (logical decision as 1=least important and 10=most important).  
 
Box 4b.2     Grading of UTx issues according to how important they are in relation to each other  
(1=least important; 10=most important). Scores were provided by all 528 participants.  
 
Group 1: Concepts specific to Uterine Transplantation 
Surgery (technique, time length, complications)     
Immunology (graft rejection/tolerance)                            
Immunosuppressants (role and side-effects)       
Achieving pregnancy post-transplantation     
Maintaining pregnancy         
Risks to fetus          
Risk to child development        
 
Group 2: Procedural issues 
Developing a specific designated uterine transplantation team   
(surgeon, anaesthetist, psychologist, obstetrician, immunologist)  
Close link of uterine transplant team with coordinators     
Educating professionals about the procedure      
Support for healthcare professionals         
Impact of uterine transplantation on theatre and ITU staff     
Exposure of healthcare professionals to press intrusion     
Mean Score 
8.58 
8.02 
8.42 
8.23 
8.68 
8.91 
8.98 
8.83 
 
7.94 
6.56 
 
7.41 
7.84 
7.62 
8.48 
8.86 
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Negative impact of uterine transplant on other transplant programs    
 
Group 3: Retrieval issues 
Development of donor/recipient criteria for Uterine Transplantation  
Donor organ retrieval / transplantation time length      
Interruption/delay of daily operating room time in host hospital   
Liaison between other organ retrieval teams       
Issues related to surgical technique        
Patient acceptance of donor uterus (psychological/emotional impact)  
Patient post-operative health status        
 
Group 4: Recipient issues 
Length of operation         
Post-operative complications       
Risk of rejection       
Side-effects of immunosuppressants     
Conception          
Pregnancy         
Risks to fetus/baby      
 
Group 5: Donor Issues 
Educating the donor family about the aim & benefits of uterine transplantation   
Discussing with the donor family the actual process behind uterine transplantation 
Procedure outcome - Likelihood of benefit for the recipient     
Consent and consent form issues        
Is there any relation between donor and recipient’s offspring?   
Exposure of donor family to press intrusion       
Opportunities to meet with the recipient and potential baby post-transplantation 
8.84 
 
7.05 
8.12 
7.65 
7.41 
7.07 
6.65 
6.06 
6.42 
 
7.57 
7.99 
7.48 
6.68 
7.35 
7.44 
7.93 
8.12 
 
7.05 
8.16 
7.72 
7.81 
7.90 
5.87 
6.28 
5.59 
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Figure 4b.1 Scoring (score: 1-10, y axis; 1=least important and 10=most important) of general UTx concepts (Group 1) according to how important each 
concept is (in relation to each other) with regards to achieving a successful UTx. Mean scores were provided by all participants. The concepts are shown on 
the x axis. Topics were permitted to be scored equally. 
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4b.4. Discussion 
 
Part of the process of ‘transferring’ UTx from the animal to the human setting is ensuring that it is 
scientifically and ethically acceptable to attempt UTx in a woman. Gauging the thoughts and feelings 
of health-care professionals towards UTx is part of ethical acceptance. The support of fellow 
colleagues is not a necessary but is definitely a useful tool when it comes to bringing about the 
acceptance of a new and innovative procedure. Constructive pointers can also be highlighted in a 
pressure-free environment; for example, how the research process can be improved, areas which need 
more focus and depth and more emphatic ways for the UK UTx team to get their message across. The 
528 participants surveyed fell into five major groups: obstetricians and gynaecologists, nurse and 
midwives, surgeons, donor co-ordinators and medical students. They all took a maximum of 15 
minutes to complete the survey. It was handed out to them at the end of a presentation on aspects of 
UTx, emailed as a link following such a presentation or posted in an envelope.  
 
The most important finding of the study is that a noticeable majority of the participants (>90%) 
support the development of the UTx research programme and believe that UTx should be performed 
in the near future if considered appropriate medically, surgically and ethically. Interestingly, the 
proportion of the surveyed population who believed that UTx should take palace ‘as soon as possible’ 
was significant - 43%. Exactly four years was the figure given as the average time by when UTx 
would be offered as an acceptable treatment procedure, if funding is in place. However, despite this 
apparent support for UTx, a smaller proportion - 57.2% - believed that UTx is an achievable 
objective. The second largest group, 39.2%, was not able to confidently decide, and declared 
themselves as ‘unsure’. These two results when analysed together with the above percentage of the 
population who felt that UTx should be performed immediately suggests that generally speaking, 
healthcare professionals can be neatly placed in two camps. Those that feel enough research has been 
done to date, and thus, there is a real need for application of UTx clinically (43%) and those that, even 
though they may be supportive and want UTx to be performed provided it passes the ethics review, 
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think or cannot decide on whether human application of UTx can ever achieved (also 43%). Overall, 
however UTx appears to be supported by healthcare professionals in the UK with 94% wanting its 
clinical application provided all the criteria has been met and 57% stating that the afore-mentioned is 
achievable. Therefore, there is no real objection to UTx in principle.  
 
The proportion of the surveyed population who reported that they were undecided regarding an 
answer to a particular question was substantial throughout. Exactly half the population were 
undecided as to whether the benefits exceeded the risks. Approximately 40% were likewise unsure as 
to whether UTx would increase patient happiness. These two results initially appear difficult to 
explain if one considers that over 90% of those surveyed believe that UTx should be attempted 
provided the procedure, the team and the institution meet medical, surgical and ethical criteria. It 
seems that generally the health-care profession are supportive of UTx as an idea to bring about the 
restoration of fertility but a significant proportion, 40-50%, are not confident that UTx will ever get to 
a clinical stage. Three reasons stood out: (a) belief that the risks of UTx to both the mother and fetus 
are significant enough to prevent human UTx; (b) conviction that transplantation and non-rejection of 
a uterine graft may be possible, yet the graft will not able to carry a term pregnancy; and (c) financial 
implications on an already cash strapped National Health Service. With respect to the first reason, the 
significance of the potential risks certainly cannot be underestimated. However, one needs to realise 
that human UTx can only occur when granted permission by both the (proposed) institution and ethics 
committees. This will only occur if those committees believe that the risks are minimal and 
substantially outweighed by the potential benefits of UTx to the woman and couple. It is understood 
that until then, a section of the health-care profession will believe that the risks outweigh the benefits. 
Nevertheless, if human UTx is approved, the number of those professionals who are undecided will 
greatly decrease, as they instead start to see the risks as minimal rather than significant and UTx as 
predominantly a procedure performed to bring about personal happiness. Until then, it is reassuring to 
see that, despite the ‘undecided’ population, only 13% of those surveyed actually think that the risks 
outweigh the benefits and only 12% feel that UTx will not bring about patient happiness if successful. 
The second reason is similar in that it constitutes an aspect which cannot be proven either way and in 
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fact, only actual human attempts will shed light onto whether a transplanted graft can become gravid. 
No set number of animal experiments that must be performed before human UTx is permitted exist 
because no objective standards or criteria exist to make such a determination. This is because 
ultimately animal models cannot fully predict how a clinical experience will play out. Whether a 
human UTx should be allowed here in the UK will depend on research and advances abroad but most 
crucially, on the judgment of the researcher and transplant teams, the review boards of the 
participating institution, and most importantly, the patient diagnosed with uterine factor infertility. 
Finally, financial shortcomings should never prevent medical research and especially, the trial of a 
novel and innovative procedure, whether that may be in surgery or medicine, as its real benefit will 
only become apparent following clinical trials.  
 
When analysing the results according to the sub-groups, no real difference was seen in the 
percentages when compared to the overall results discussed above. The three sub-groups that were 
chosen prior to the commencement of the study were transplant team members (surgeons and donor 
co-ordinators), obstetricians and gynaecologists and fellows of the Royal College of Obstetricians and 
Gynaecologists specifically. The proportion of those who were undecided as to whether the benefits 
outweighed the risks revolved around 50%. Around two thirds of those surveyed from groups I and II 
felt that UTx was achievable, and 40% believed that it should occur as soon as possible. These results 
are crucial to the UK UTx drive. They demonstrate a broad level of support for this procedure from 
potential future team members. Obstetricians, gynaecologists, transplant surgeons and donor co-
coordinators will all be part of the multi-disciplinary team looking after a UTx patient. Their belief in 
UTx is vital at the outset of a human attempt. Also, it will allow for any concerns and worries to be 
recognized before the procedure is officially approved. The results are also a strong indication that 
UTx research and the direction which the UK human attempt is heading towards have a strong base of 
support amongst colleagues which will eventually perform this operation and subsequently look after 
the patient and hopefully her fetus and baby. Group III, made up of fellows, and therefore more senior 
and experienced obstetricians and gynaecologists, was also overall supportive but definitely more 
cautious.  A small drop in the proportion of those fellows who felt that felt that UTx was achievable 
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was noticeable - 54.6% in comparison to 66-68% recorded from groups I and II. Also 12.3% thought 
that it should never take place, which is still a small proportion but definitely higher than what was 
recorded for groups I and II. However those who believed that UTx should take place as soon as 
possible numbered the same as in groups I and II (~40%) which is reassuring. The main reason for 
this slight but still significant shift lies in the age demographic of the sub-population. The seniority of 
the group means that the participants are more experienced and more knowledgeable yet also more 
conservative, set in their own practice and less likely to consider novel and innovative ideas. All 16 
fellows who stated that UTx should never take place cited ethics as their principle reason, i.e. UTx is 
an unethical procedure and its ‘promise’ should not be offered to ‘vulnerable’ patients. It is interesting 
that the same criticisms thrown towards our effort were also used in the 1960s and 1970s with the 
introduction of in-vitro fertilization. Fertility specialists have to date been the most supportive group 
towards UTx, both the research and the clinical effort, within the field of obstetrics and 
gynaecologists, most likely as they have faced similar arguments. Finally, in the same manner in 
which group III was less supportive, so group IV was more supportive than the general population, as 
well as groups I and II. Group IV was made of participants who have experienced infertility either 
personally or within a ‘couple’ setting. They have therefore individually felt the effects on infertility 
on their life as well as relationships. For this reason, their thoughts and ideas would be more empathic 
and understanding towards women who are experiencing a problem with their fertility - in this case a 
type of infertility caused by a uterine factor. Importantly, those familiar with problems that people 
with infertility encounter may find it easier to justify a radical and novel procedure. This was seen in 
the responses given. 54.9% felt that the benefits of UTx outweighed the risks, which was around 25% 
higher than the general population, including the other three groups. A smaller proportion was 
undecided. 76.9% stated that clinical UTx would lead to greater human happiness and over 60% of 
respondents thought that the development of UTx would also lead to a furthering of the medical, 
surgical and transplantation fields. In comparison to the overall proportion of 40%, in group IV, 
53.8% believed that UTx should take place as soon as possible. 
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It goes without saying that being aware of infertility may not automatically mean that the participants 
would select it over current and accepted non-surgical interventions i.e. surrogacy and adoption. 
These two options would always be offered first to a potential patient. Only if the patient proved to 
both medical and psychological teams that surrogacy and adoption would not suit them, would UTx 
be offered. Therefore, a more appropriate interpretation of the above relationship is that it justifies 
further more grants and research into the need for UTx. UTx should never be an automatic treatment 
choice; it will only ever treat a small number of AUFI patients.  
 
Ranking 
 
Participants were also asked to rank various issues related to UTx. These issues were divided into five 
main groups (Box 4b.2). Group 1 included seven issues which together explain the essence of UTx. 
Group 2 included issues related to the actual UTx procedure and transplant programme. Groups 3-5 
incorporated factors related to retrieval, recipient and donor aspects of UTx. The ranking process 
allowed for grading each issue according to its importance. The meaning of the word ‘importance’ in 
this case is as follows: importance with respect to UTx research, a future human UTx attempt and 
relative importance in comparison to other issues. Despite the number of participants who ranked all 
areas equally important, the actual ranking proved to be useful. Immunology and pregnancy issues 
were ranked as the most important, in particular maintaining pregnancy, risks to fetus and risks to 
development (Figure 4b.1). This would be as expected as these issues define the goal of UTx. It is 
only if they are researched and discussed properly, that one should move towards other issues. By this 
logic donor and procedure related issues are ranked last. Importantly, analysing the ranking separately 
for males and females, obstetricians and gynaecologists, fellows and transplant coordinators and 
surgeons did not alter the overall rank of the five groups.  
 
Of relevance to the UTx team is that despite the multi-factorial nature of UTx, it is still the main 
topics (group 1) which will decide whether this procedure goes ahead in the clinical setting. If the 
evidence shows that immunologically the graft will not be rejected in both its pregnant and non-
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pregnant states, and that conception, fetal growth and eventual delivery are statistically likely, then the 
other areas (groups 2-5) will not halt the trial of the procedure. Therefore, both the publicity and 
presentation of the research should focus on those topics. According to Figure 4b.1, conception, fetal 
progress and neonatal development are the key areas that score the highest rank with respect to 
importance, yet the only way to assess these areas is by allowing for human UTx in the first place. 
Also highlighted was the potential impact of UTx on theatre and ITU staff, negative impact of UTx on 
other transplant programmes and exposure of healthcare professionals to press intrusion   
  
The questionnaire also proved valuable in demonstrating how to approach different aspects of UTx. 
The optimal strategy would be to break up each issue into a number of manageable steps and 
approach each one separately. Each step of the UTx process (patient selection, embryo storage, 
surgery, embryo transfer, implantation, gestation) as well as issues related to the operation, recipient 
and donor ought to be tackled separately. Each set of issues falling under one of these categories 
(Groups 1-5) must have a clear management pathway developed. 
 
Strengths and Limitations 
 
The most important factor in favour of the results gathered is that 68% of those surveyed have been 
working within the medical profession for at least 5 years, which gives greater relevance to the 
answers provided, as they are based on a degree of experience. In addition, 75% of the participants 
were above the age of 30. 
 
All the conferences were generic ‘obstetrics and gynaecology’ conferences rather than specific 
conferences dedicated to fertility which should have minimised the risk of bias. However completing 
any type of survey poses the risk of ‘self-selecting’ individuals who will fill it in i.e. persons who are 
interested in some way or have a vested interest in the topic. 
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Conclusion 
 
It is clear from the topics addressed and sub-groups whose answers were analysed that for UTx to be 
successful and accepted, a broad level of support needs to be established from the outset. This will 
lead to a creation of an environment which shields form unnecessary stress but also one where 
concerns can be raised and addressed prior to the commencement of UTx. This study is the first in 
literature to try to sample the opinions and concerns of health-care professionals towards UTx. The 
most important finding of this study suggests that this ‘level of support’ is already there with regards 
to UTx. A substantial majority of the participants support the development of the UTx research 
programme and believe that UTx should be performed in the near future if considered appropriate 
medically, surgically and ethically. Those who believe that UTx should take palace ‘as soon as 
possible’ were almost half of the population, with a slightly higher proportion believing that UTx is an 
achievable objective. More effort is required to educate health care professionals about all aspects of 
UTx. Areas that need further developing and education are relationships of risks and benefits of UTx 
to the mother and fetus, as well as the likelihood of pregnancy following UTx. Greater exposure of 
UTx research is a necessity.  
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Summary 
 
This thesis represents a gradual addition to existing work done by the UK UTx team from 1997-2010. 
This has been the theme of UTx research since it began in the 1970s - always a steady, continuing 
accumulation of data towards the final goal of achieving pregnancy in a human transplant. Themes 
and areas which have been published on before have been added to and a number of novel ideas have 
been introduced.  
 
Study 1 
 
The two studies which were a continuation of previous research were the retrospective trachelectomy 
project and the rabbit allogeneic UTx. The point of the former study was to act as an introduction to 
UTx for this thesis. Trachelectomy is a fertility-preserving procedure and the origins of UTx lie in its 
discovery. There is an ultimate benefit with respect to UTx research. First, as a fertility-preserving 
procedure, it can raise awareness of other such procedures such as UTx Second, the surgical 
techniques required to carry out ART overlap significantly with the graft retrieval and anastomotic 
aspect of the UTx procedure. Finally, lessons learned from ART with regards to uterine perfusion can 
be applied to UTx. Namely, the fact that the uterus remains viable if supplied by two vessels out of 
the six that supply it (three pairs of ovarian, uterine and vaginal arteries). Post-ART, the uterus is most 
commonly supplied and drained by the left and right ovarian vessels only. 
  
Study 2a 
 
As mentioned the rabbit allogeneic UTx cased series was attempted previously by the UK team. This 
case series was the largest (nine as opposed to two previous sets of six and five). It highlighted some 
of the challenges with the choice of animal model and the complexity of the surgical procedure 
involved. The macrovascular patch technique involves aorto-aorta and veno-vena anastomoses which 
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would not be attempted in a human because of its highly risky strategy involving the most important 
blood vessels. The surgical survival rate (when including all 20 rabbit UTx performed by the team) 
was 80%, thus proving the feasibility of uterine allo-UTx using a macrovascular patch technique with 
respect to anatomical terms and surgical vascular achievability. Immunosuppression would follow 
kidney transplantation, with definite use of a steroid and CNI. 
 
The projects which were novel here were (a) IVF in the rabbit model; (b) autotransplantation in a 
sheep (solely to the UK team); (c) introduction of multi-spectral imaging and eLASCA to both the 
rabbit and sheep models in order to see if they could offer a better method of assessing uterine 
perfusion and blood flow and supply; and (d) the two human studies.  
 
The end result of the IVF experiment was a termination of pregnacy as a result of miscarriage. This 
may be seem rather disappointing but it is important to highlight that the study represents only the 
third example of conception and pregnacy following an allogeneic UTx, and the first such example in 
a rabbit model. The surgical anatomical macrovascular model was successful, with an appropriate 
level of perfusion attained. Post-operative recovery was uneventful, with no adverse effects recorded. 
The cause of fetal demise is most likely secondary to inadequate prevention of the immunological 
rejection response. Selecting the correct immunosuppression in a rabbit model proved difficult as a 
result of the paucity of data in the world literature as to what is deemed safe and appropriate in a 
rabbit allogeneic transplant model.  
 
Study 2b 
 
Considering the present sheep study, it should be emphasized that this was the ﬁrst time that the UK 
team attempted a macrovascular UTx large-animal model. In particular, internal to external iliac 
vessel anastomoses. The surgical technique was very similar to what would be used in a human 
model, with an obvious improvement with regards to procedure duration and skill. The final 
conclusion was that the external iliac vessels may definitely be used as recipients of the graft vessels 
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to allow for a secure blood flow because in three (out of five) ewes where grafting was possible, the 
grafted uteri demonstrated immediate perfusion. 
 
Study 3 
 
A multispectral imaging laparoscope has been demonstrated as a potentially useful tool during UTx. 
On comparison of its methodology with pulse oximetry, it appears to be more accurate and scientific. 
The advantages were the ability of the technique to monitor cornual O2Sat over the entire visible 
section of the organ in a fast and non-contact method. Furthermore, one does not have to ‘wrestle’ 
with the cornua to find a strong pulsatile signal. All these might be important for stages of the 
operation where time is critical. In the rabbit model, the most striking result was the level of perfusion 
in the one long-term surviving doe which was almost back to pre-operative levels when measured on 
day 89 post-UTx. This together with the pregnancy achieved in that particular uterus is a true proof of 
a successful UTx. Furthermore, the results demonstrated with the sheep model were extremely 
promising with no statistically significant difference between the pre-retrieval and post-UTx O2Sat 
values. Again the most obvious explanation lies in the anatomical similarity when comparing the 
pelvis of a sheep and a woman, and therefore a surgery with which the operators felt more at ease and 
more comfortable.  
 
The LASCA system is in principle a non-contact and real-time tool for the observation of flow, in this 
case blood, from which other parameters can be derived: heart rate, respiratory rate and oxygen 
saturation (level and map). Therefore its application is both qualitative and quantitative. Its strengths 
were revealed when applied to the sheep model. These preliminary results demonstrate vast potential 
of LASCA to surgery and importantly UTx. An accurate, real-time imaging modality, which uses a 
mathematical model to process the final results, is an improvement on current tools. Therefore, as a 
first attempt to trial an experimental technique in a previously untested area of medicine, the 
experience may be considered as useful. However, the eLASCA data acquired were limited and 
difficult to use in order to make any definitive conclusions. Therefore, this system currently remains a 
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prototype for further experimental investigation. Table D summarises the old and novel techniques 
input with regards to this thesis. 
 
Study 4 
 
The two human studies looked at the UTx conundrum from two different angles. The first study 
focused on potential UTx candidates and the second study on health-care professionals. The former 
study looked at attitudes and motivations of potential candidates to UTx. It was the first such study to 
demonstrate a qualitative relationship between AUFI patients and their curiosity and desire for UTx. 
In addition, it also formed the first part of what may be a psychological assessment of a potential 
patient. The health-care professional study is the first in literature to try to sample the opinions and 
concerns of health-care professionals towards UTx. It is clear from the topics addressed and sub-
groups whose answers were analysed that for UTx to be successful and accepted, a broad level of 
support needs to be established from the outset. This will lead to a creation of an environment which 
shields form unnecessary stress but also one where concerns can be raised and addressed prior to the 
commencement of UTx. The most important finding of this study suggests that this ‘level of support’ 
is already there with regards to UTx. A substantial majority of the participants support the 
development of the UTx research programme and believe that UTx should be performed in the near 
future if considered appropriate medically, surgically and ethically. Those who believe that UTx 
should take palace ‘as soon as possible’ were almost half of the population, with a slightly higher 
proportion believing that UTx is an achievable objective. 
 
Controls 
 
Controls were not used in this thesis as the concept of a control is not appropriate in this type of 
experimental approach. In the animal studies, the only situation whereby a control would have been 
suitable was the sole survivor (recipient #5). A pregnant non-transplanted doe would have acted as a 
control. In the immunology study, the white cell subset counts did have controls (unstained sample 
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and IgG1). As for the perfusion studies, the uterine graft prior to UTx in both the rabbit and sheep and 
the non-transplanted graft in the recipient prior to the hysterectomy acted as control-type points of 
reference. The issue of controls does not apply to the human studies.  
 
Further material relevant to the UTx story, but which was not part of this thesis, can be found under 
Appendix E. 
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Table D Summary of post-mortem, histopathology and perfusion results 
Uterine Transplant Post-Mortem Histopathology Perfusion 
Rabbit 
UTx #1 
dusky, firm, oedematous 
anastomotic breakdown 
total blood volume: 30ml 
Cavo-caval & aorto-aortic anastomosis breakdown 
leading to intraperitoneal haemorrhage 
PO: 87% 
MSI: N/A 
eLASCA: N/A 
UTx #2 
dusky, firm, oedematous 
anastomotic breakdown 
total blood volume: 20ml 
Cavo-caval & aorto-aortic anastomosis breakdown 
leading to intraperitoneal haemorrhage 
PO: 85% 
MSI: N/A 
eLASCA: N/A 
UTx #3 
pink, soft, normal size 
no anastomotic breakdown 
Respiratory compromise  
following blood aspiration 
PO: N/A 
eLASCA: N/A 
 
MSI: 
 
UTx #4 
pink, soft, normal size 
no anastomotic breakdown 
Cardiac damage 
(Left ventricular rupture) 
PO: N/A 
eLASCA: N/A 
 
MSI: 
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UTx #5 
pink, firm, large size 
no anastomotic breakdown 
Rabbit culled electively 
PO: 95% 
eLASCA: N/A 
 
MSI: 60% 
 
 
Gravid uterus 
 
PO: N/A 
eLASCA: N/A 
 
MSI: 83% 
 
UTx #6 
pink, soft, normal size 
no anastomotic breakdown 
Widespread pneumonia 
PO: N/A 
eLASCA: N/A 
 
MSI: 64% 
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UTx #7 
dusky, firm, oedematous 
anastomotic breakdown 
Shearing of the aorto-aortic and cavo-caval 
anastomosis leading to intraperitoneal haemorrhage  
PO: 93% 
eLASCA: N/A 
 
MSI: 25% 
 
UTx #8 
pink, soft, normal size 
no anastomotic breakdown 
Features in multiple organs of early 
ischaemia/hypoxia related injury, consistent with the 
history of hypovolaemic/haemorrhagic shock 
PO: 94% 
eLASCA: N/A 
 
MSI: 59% 
 
UTx #9 
dusky, hard oedematous 
no anastomotic breakdown 
Macroscopic features of a pulmonary embolism 
Features of early peritonitis which may represent a 
systemic inflammatory response to recent surgery or 
early infection 
PO: 86% 
eLASCA: N/A 
 
MSI: 59% 
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Sheep 
UTx #1 N/A N/A N/A 
UTx #2 
dusky, firm, oedematous 
elements of breakdown 
Uterus and oviduct show evidence of mild to 
moderate ischaemia. 
 
Thrombus in the left internal-external iliac 
anastomosis but the extent of the vessel lumen 
occlusion cannot be assessed. 
PO: 83% 
 
MSI: 57% 
 
 
eLASCA:  
 
UTx #3 
pink, soft, normal size 
no anastomotic breakdown 
Uterus and oviduct showing no significant 
abnormalities. 
 
No evidence of thrombus in the vascular 
anastomoses. 
PO: 83% 
 
MSI: 71% 
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eLASCA: 
 
UTx #4 N/A 
Features of myocarditis and an allergen induced 
bronchial hypersensitivity reaction. 
 
Both of these, alone or in combination would have 
affected the animal’s ability to withstand the 
physiological stress of anaesthesia. 
N/A 
 
UTx #5 
pink, soft, normal size 
elements of breakdown 
Possible thrombus in the right vascular anastomosis. 
 
Uterus and oviduct showing no significant 
abnormalities. 
 
No evidence of ischaemia. 
 
PO: 91% 
 
MSI: 60% 
 
 
eLASCA: 
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Epilogue 
 
A group of experts and other ‘stake holders’ gathered in London in November 2012 to assess the state 
of the art of human UTx and address any lingering concerns as women are identified for the next UTx 
surgeries. Experts involved in UTx research discussed the necessary steps, presented here as a set of 
‘way markers’, that must be considered in order to provide sufficient scientific and ethical 
justification for taking human UTx from a rare oddity, to a recognized and reasonable addition to the 
armamentarium of assisted reproductive technologies (ART). Speakers and participants represented 
areas of law, ethics, medicine, hospital administration, lay public and the social sciences. Specialists 
present included doctors of transplant medicine and surgery, infertility, gynecology, oncology, 
maternal-fetal medicine and others.  
 
History of uterine transplantation 
 
UTx was first performed in humans in 2000 on a 26 year old who had her uterus removed as a result 
of post-partum haemorrhage.61 The transplanted uterus failed after three months. Although 
controversial and appearing without precedent at the time, animal work had been performed for 
decades before. 
 
In the 1960s and 1970s, UTx and other female reproductive organ transplantations, were investigated 
as potential treatment for ovarian, tubal and uterine infertility.56 UTx was subsequently ignored for 
two decades following progress of alternative and modern ART, often equally controversial. UTx 
came back into focus at the beginning of this century secondary to the development of related 
fertility-preserving procedures 60 in gynaecological oncology and the realisation that a significant 
number of infertile women suffered from AUFI.3,4 
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Potential indications 
 
Causes of AUFI include congenital (absence or malformation) or acquired uterine factors (e.g. 
hysterectomy for uncontrollable haemorrhage) rendering a woman ‘unconditionally infertile’. Current 
estimates are that in USA, up to 7 million women, age 15-34 years, with AUFI may be appropriate 
candidates for UTx.3,4 As witnessed similarly with the advent of ART in the 1980s, the extent of the 
likely disease population enlarges at the introduction of any potential therapy. As a result of this 
realization, investigators have responded with publications demonstrating pregnancies in various 
autogeneic, syngeneic and allogeneic UTx animal models.104,163 
 
After more than a decade of published research from multiple independent institutions, it is now 
verifiably possible for a surgeon, with no significant prior research in the area, to successfully perform 
UTx as shown by a case in August 2011 from Turkey.261 
 
UTx may be safely performed today because of important developments in transplantation surgery 
including complex quality-of-life enhancing procedures. These are exemplified by multi-visceral, 
hand, larynx and face transplants.273,274 Unlike in these other non-vital transplants, the grafted uterus 
(and the necessary immunosuppressants) will only be in place for the 2-3 years that are necessary for 
pregnancy to be achieved. Early UTx recipients must agree to only one viable birth and no more than 
one year of attempted conception. This will avoid the risk of immune suppression related neoplasms 
such as HPV and other cancers. The natural history of HPV in other transplant recipients allows us to 
confidently counsel our patients in this specific short term, limited risk. Similarly, pregnancy in 
transplant recipients of every organ reassures us that the effects of local endometrial immune 
modulation on endometrial embryonic receptivity appears to be better than that before transplantation. 
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Surgery and alternatives to uterine transplantation 
 
UTx is therefore a ‘temporary’ treatment for AUFI only for women who cannot otherwise have a 
child either through adoption, surrogacy or any other method currently existing, or wish to undergo 
UTx in order to experience gestation. The patient who fits the criteria should be able to provide the 
team with informed consent under no coercion from partner or family and demonstrate all limitations 
provided by UTx.   
 
The UTx recipient must have produced an oocyte which has been fertilized in vitro resulting in 
normal cryopreserved embryos. These embryos will have to be successfully transferred into the uterus 
as the Fallopian tubes would not have been transplanted with the uterus. Excluding the Fallopian 
tubes from the transplant should eliminate the risk of pelvic inflammatory disease, ectopic pregnancy 
and potential infertility brought on by Fallopian tube pathology. Similarly, the donor uterus must be 
free of overt infection, gross anatomic abnormalities, know HPV or known infertility. 
 
The advantage of a live donor is that she could be a close relative, thus allowing for a better chance of 
a blood/tissue type match. Furthermore, the uterus and general well-being of the reproductive tract 
can be investigated extensively pre-operatively because of minimal time constraints. This would 
include imaging, as well as tests to rule out HPV infection, cervical dysplasia, leiomyoma, and 
endometrial polyps. On the other hand, the advantage of using a deceased donor lies with zero 
surgical risk to the donor and a more extensive dissection of the vascular tree on the uterine graft 
compared to a live donor. A more radical dissection would lead to recovery of larger arteries and 
veins, thus allowing for a technically easier vessel anastomosis. A disadvantage with using a deceased 
donor, compared with a live donor, is that graft survival may be negatively affected at brain death by 
major systemic inflammatory changes.275 
 
We envisage that following a successful pregnancy, a woman will decide either to proceed with 
another future pregnancy or will wish for her uterus to be removed. If it were the latter, a total 
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abdominal hysterectomy will be performed approximately six weeks post-delivery or at the time of 
Caesarean section. At the time of Caesarean section, preparation for emergency hysterectomy should 
be contemplated. There is a theoretical risk of abnormal placentation but this has not been seen in the 
numerous animal experiments that have addressed altered blood supply, impact of different 
anastomoses, various immunosuppression regimens and other variables. An alternative option would 
be to stop the immunosuppressants and simply allow the graft to atrophy within the pelvis with or 
without abnormal placental invasion. Potential obstetrical complications are not limited to the 
placenta. Specialist in high risk obstetrics will need to call upon all their experience in balancing the 
risk to the maternal-fetal UTx patient. 
 
Impaired quality-of-life, brought on by infertility, demands that UTx becomes safer and a more valid 
treatment option. Surrogacy and adoption will remain treatment alternatives of choice, but the risks 
associated with the former and the obstacles with the latter means they may not be satisfactory to 
everyone. Regardless, the majority of women with AUFI should be counselled and encouraged to 
pursue alternatives to UTx.   
 
Adoption is a worthwhile option but can be a challenging process where parents face substantial 
expenses and sometimes evolving dilemmas. A current debate in the UK is whether to encourage 
easier adoption of children from one ethnic background by adoptive parents from a different ethnic 
background. Surrogate births are mostly uncomplicated but the practice has faced controversy, with it 
being illegal in most of the world and many states in the USA. In the UK, the surrogate delivers and 
the genetic parents legally adopt, so there is scope for the surrogate to refuse to give up the baby. A 
need exists for additional relief options where surrogacy and adoption cannot suffice, in this case 
UTx. FIGO’s 2009 ethics statement advised against a premature move to human application.276 
However by 2012, other ethics groups were calling UTx ‘a good option’ under certain 
circumstances.277 UTx will be ethically acceptable whenever and wherever several recognized criteria 
are satisfied. We therefore treat the news of other successful UTx with cautious optimism, whilst 
awaiting news of long-term survival and successful pregnancy.277 
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Ethics of Uterine Transplantation 
 
UTx must satisfy, as any surgical innovation would, criteria as defined by FD Moore i.e. laboratory 
background, field strength, and institutional stability.278 Progress in multiple solid organ transplants 
has made UTx well within the technical capabilities of many transplant centres. For instance the 
uterus graft from a deceased donor may have only one large anastomosis (aorta/cava). However, even 
if multiple smaller anastomoses are used (never more than two), they are well within the experience of 
bowel and multi-visceral and certainly paediatric transplant centres. Paediatric transplant also 
provides reassurance regarding the vascular supply to the growing gravid uterus. Under physiologic 
control, paediatric anastomoses grow with the organ in a normal physiologic order. Animal 
transplants have confirmed that the fetus develops normally with no prematurity or growth restriction 
regardless of the vascular reconstitution. This is the case even in primates where Mihara et al 
underwent performed auto-UTx in non-human primate model (cynomolgous macaque) with 
anastomosis of two uterine arteries to the external iliac artery, and achieved pregnancy for the first 
time in this model.279 
 
Equally important, UTx must satisfy accepted bioethical principles (respect for autonomy, 
beneficence, non-maleficence and justice) and their application: informed consent, appropriate 
assessment of risk and benefit and fair selection of individuals. Whether seen as innovative surgery or 
a medical study, eventually the early decisions to proceed in any venue should depend on approval by 
a duly constituted ethics review committee, the participating institution, the local transplant team and 
most importantly, the patient to whom the transplant will be offered. 
 
Clearly, some institutions, and many surgeons, are capable and will proceed with UTx without any 
further research. However, it must be stated that a defined number of transplants should not be 
exceeded worldwide without a successful term delivery to minimize proceeding in futility using 
current techniques. From the above mentioned maternal and fetal complications, we have the 
obligation towards the patients and society, to closely monitor and registrar outcome of the procedure 
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and define satisfactory outcome no less than a live birth. If not achieved, the procedure should not be 
allowed to be instituted as treatment option. Towards this end, a registry should be maintained of all 
recipients and candidates much like the transplant waiting list which is updated for other organs. 
 
Further research 
 
The following research, most of it covered by this thesis (Figure J), is still required to allow 
application to an IRB for a human UTx: 
 
1) Additional pregnancies in a variety of large animal/primate models (to search for 
unanticipated consequences); 
2) Continuous assessment of women diagnosed with AUFI regarding UTx; 
3) Continuous assessment using “borrowed” psychological tools from transplant centres, 
adoption agencies and ART centres of potential recipients; 
4) Continuous careful ethical reflection, assessment and approval. 
 
Our group will continue to meet annually to address these areas and other special challenges that will 
arise. These challenges will require mature resources from institutions experienced in innovation now 
engaged in UTx. For instance appropriate ‘guaranteed’ funding levels will be impossible to ensure for 
the UTx recipient. Much of the expense, pregnancy, delivery and neonatal care, will be borne by the 
traditional payers. As best as possible, every contingency should be considered prior to UTx at any 
specific institution. Similarly, institutions with UTx capabilities must have had experience with 
appropriate pathways for media engagement for the recipient, her partner, and eventually, the child. 
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Figure J What must be done prior to proceeding with human UTx? 
 
 
 
Conclusion 
 
The second human UTx performed in 2011,261 as well as a series of 10 cases performed in Sweden in 
2012-13,280 one of which led to a healthy live birth means that UTx is now a recognised feasible 
procedure.281 Pregnancy following organ transplantation is complex but now commonplace. Closing 
on half a century of experience with pregnancy in solid organ recipients, an abundance of data has 
accumulated indicating satisfactory maternal and neonatal outcomes. Future UTx candidates, likely to 
represent a group not burdened by multiple co-morbidities, should be the beneficiaries of an even 
better prognosis.  
 
Further pregnancies after UTx will be challenging, but cannot be unexpected. As news of progress 
from the Turkish and Swedish cases and of any other human attempts is awaited, the belief is that 
UTx has become a matter of ‘when next’ rather than ‘if’. 
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Appendix A - Statistical analysis 
 
The analysis of data is described in the Methods section for each study. A brief overview is given 
here.  
 
Data related to O2Sat and PI was defined as non-parametric and Mann-Whitney U test was therefore 
carried out for comparison. Data related to the ‘Patient Assessment’ and ‘Health-care Professionals’ 
survey was also defined as non-parametric data and Mann-Whitney U test was therefore again carried 
out for comparison. Attitudes, motivations and feelings of UTx patients (Table 4a.2) and the sub-
group analysis (Table 4a.3) were analysed using Fisher’s exact test. The ranking data for the ‘Health-
care Professionals’ survey was analysed using a one-sample Kolmogorov-Smirnov test. A statistically 
significant difference was applied for a p-value <0.05. All statistical analysis was done using the 
Statistical Package for the Social Sciences version 19 (SPSS Inc, Chicago, Illinois, USA). 
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Appendix B - Study 4a: Interview 
 
INFORMED CONSENT FORM 
 
Title Study: Views on Womb Transplantation 
Version Number: 2 
Name of Principal Investigator: J. Richard Smith 
Date: 29/07/2011 
  
 
1. I confirm that I have read and understand the subject information sheet dated  .................  
version ............ for the above study and have had the  opportunity to ask questions which 
have been answered fully. 
⁯ 
2. I understand that my participation is voluntary and I am free to withdraw at any time, 
without giving any reason, without my medical care or legal rights being affected. 
⁯ 
3. I understand that my participation will involve a filling out of a questionnaire and also 
appreciate that my responses to questions will be taped. 
⁯ 
4. I understand that sections of any of my medical and/or research notes may be looked at by 
responsible individuals from Queen Charlotte's Hospital, Imperial College Healthcare NHS 
Trust, Imperial College London or regulatory agencies, where it is relevant to my taking part 
in this research.  I give permission for these individuals to access my records. 
⁯ 
 
5. The compensation arrangements have been discussed with me. 
⁯ 
 
 
6. I agree to take part in the above study. 
⁯ 
 
 
________________________                    ________________                    ________________ 
Name of Participant                                    Signature                                     Date 
 
 
 
 
________________________                    ________________                    ________________ 
Name of Person taking consent                  Signature                                     Date 
(if different from Principal Investigator) 
 
 
 
 
_______________________                      ________________                    ________________ 
Principal Investigator                                  Signature                                     Date 
 
 
 
 
  - 369 - 
Participant Information Sheet 
 
Dear Madam, 
 
Welcome. You are being invited to take part in a research study, organised and funded by Imperial 
College London. The research project has been reviewed and approved by an official panel involving 
3 professors based at our institution, as well as the Hospital’s Research Ethics Committee. 
 
We have decided to approach you in view of your history of medical problems related to your 
womb/uterus. Before you decide, it is important for you to understand why the research is being done 
and what it will involve. Please take time to read the following information carefully and discuss it 
with others if you wish. Please ask us if there is anything that is not clear or if you would like more 
information. Take time to decide whether or not you wish to take part. 
 
Background 
 
Our team has been looking into the area of uterine (womb) transplantation as a possible solution to 
womb factor infertility. This type of infertility describes many young women who were born without 
a womb or who have lost their womb because of illness. The only human attempt at womb 
transplantation occurred in 2000 in Saudi Arabia where the transplanted womb unfortunately had to 
be removed after 99 days. The belief in the scientific community was that this attempt was too early 
with a minimal amount of prior research. Since then research into womb transplantation 
(immunological, reproductive and technical aspects) has increased, with the various international 
teams aiming to arrive at a point where womb transplantation would be considered safe enough for a 
second human attempt. 
 
Our study 
 
This study is designed to learn more about the views of women with womb infertility and who may 
one day benefit from womb transplantation. It is important to note that this research is still very much 
at an experimental stage and is not available in medical practice. Therefore, there would be no direct 
benefit to you with regards to fertility if you take part in the study. 
 
If you decide to take part, we would like to ask you some questions using a pre-prepared 
questionnaire. Following this, we will show you a 10 minute video during which the issues related to 
womb transplantation are discussed. After the video finishes, we plan to talk about some of the issues 
raised. The whole process should take ~60 minutes. It will be recorded on tape to allow for the 
interview to flow more quickly and for us to analyse your responses later without worrying that we 
may have missed important information. There is a small chance that we may contact you again in the 
future for one further interview, and if this were to occur it would be done only once. In total we hope 
to interview 30-40 women from this particular clinic. 
 
Deciding to take part 
 
It is up to you to decide whether or not to take part. If you decide to take part you will be given this 
information sheet to keep and be asked to sign a consent form. We will then conduct the interview at a 
time that best suits you. Once the interview has begun, you are still free to withdraw at any time and 
without giving a reason. A decision to withdraw at any time, or a decision not to take part, will not 
affect the standard of care you receive. 
 
Questions/queries 
 
Please note that all data will be kept confidential and adhere to the Data Protection Act. Any 
information about you which leaves the hospital will have your name and address removed so that 
you cannot be recognised from it.  
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We cannot promise the study will help you but the information we get might help improve the 
treatment of people with Womb Factor Infertility in future. The results of study will made available to 
you, with the data published in a suitable medical journal. You will not be identified in any 
publication. 
 
If you have any questions or queries after the interview has finished, contact either Mr J. Richard 
Smith or Mr Srdjan Saso below who will happy to take your questions. In addition, if you are harmed 
by taking part in this research project, there are no special compensation arrangements. If you are 
harmed due to someone’s negligence, then you may have grounds for a legal action. Regardless of 
this, if you wish to complain, or have any concerns about any aspect of the way you have been treated 
during the course of this study then you should immediately inform the Investigator (Mr J. Richard 
Smith, see contact details below). The normal National Health Service complaint complaints 
mechanisms are also available to you. If you are still not satisfied with the response, you may contact 
the Imperial AHSC Joint Research Office.   
 
Thank you very much for reading about our project and considering taking part - your efforts are very 
much appreciated. 
 
 
With best wishes, 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
J. Richard Smith MD FRCOG 
Consultant Gynaecological Surgeon 
West London Gynaecological Cancer Centre 
Queen Charlotte’s Hospital 
Imperial College London 
Du Cane Road, London, W12 ONN 
Email: info@wombtransplantuk.org 
Tel: +44 (0)2077307077 
Srdjan Saso MBBS BSc MRCS 
Clinical Research Fellow  
Division of Surgery and Cancer 
Institute of Reproductive & Developmental Biology 
Imperial College London 
Hammersmith Hospital Campus 
Du Cane Road, London, W12 0NN 
Email: srdjan.saso@imperial.ac.uk  
Tel: +44 (0)7890795182 
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QUESTIONNAIRE 
 
Title Study: Views on Womb Transplantation 
Version Number: 5 
Name of Principal Investigator: J. Richard Smith 
Date: 28/10/2011 
 
 
Part 1: General Questions for Patients regarding Uterine Transplantation 
 
1. What is your profession? 
Administrative        ⁯ 
Advertising        ⁯ 
Art related        ⁯ 
Business/Entrepreneurship       ⁯ 
Catering industry       ⁯ 
Finance related       ⁯ 
General Industry       ⁯ 
Journalist/writer       ⁯ 
Lawyer        ⁯ 
Management Consultant     ⁯ 
Scientist        ⁯ 
Teacher/Academic       ⁯ 
Trade (builder/plumber/electrician/carpenter etc…)   ⁯ 
 
2. Please indicate your age? 
Age   …..  
 
3. How old were when you were diagnosed with Absolute Uterine Infertility?  
Age   ….. 
 
4. Would you like to have a child(ren) of your own? 
Yes     No 
 
5. To what extent would you want to have children (1 - not at all; 5 - very much)? 
.......... 
 
6. Do you currently have a partner with whom you would consider starting a family? 
Yes     No 
 
7. Prior to today, how much have you known about Uterine Transplantation? 
A lot  A fair amount        Heard it discussed only a few times Nothing 
 
8. How interesting do you find the field of Uterine Transplantation?  
A lot  A fair amount      Not that much  No interest whats-o-ever 
 
9. I do not understand the benefits of Uterine Transplantation. 
Strongly agree       Agree       Undecided       Disagree      Strongly Disagree 
If disagree/strongly disagree, why?    ………..………………………………………… 
 
10. I understand the risks of Uterine Transplantation.  
Strongly agree       Agree       Undecided       Disagree      Strongly Disagree 
If disagree/strongly disagree, why?    ………..………………………………………… 
 
  - 372 - 
11. I do not believe that the potential benefits of Uterine Transplantation outweigh the potential 
risks. 
Strongly agree       Agree       Undecided       Disagree      Strongly Disagree 
If disagree/strongly disagree, why?    ………..………………………………………… 
 
12. I believe that the development of uterine transplantation will generally benefit the fields of 
medicine and surgery. 
Strongly agree       Agree       Undecided       Disagree      Strongly Disagree 
If disagree/strongly disagree, why?    ………..………………………………………… 
 
13. I do not believe that the development of uterine transplantation will benefit the field of 
obstetrics and gynaecology. 
Strongly agree       Agree       Undecided       Disagree      Strongly Disagree 
If disagree/strongly disagree, why?    ………..………………………………………… 
 
14. Funds and grants should not be made available for novel and innovative fields such as 
uterine transplantation. 
Strongly agree       Agree       Undecided       Disagree      Strongly Disagree 
If disagree/strongly disagree, why?    ………..………………………………………… 
 
15. This question is hypothetical and we apologise if it causes any distress. You do not have to 
answer it. If you were to have a functioning uterus and uterine transplantation ever became a 
reality, would you give permission for your uterus to be added to the Organ Donation register? 
Yes   No   Not sure? 
If no, why not?   ……………………………………………………………………….. 
 
16. Provided the risks of uterine transplantation were negligible would you accept a uterus if it 
could lead to a healthy pregnancy? 
Yes   No   Not sure? 
If no, why not?   ……………………………………………………………………….. 
 
17. In your opinion, should Uterine Transplantation not take place? 
Never take place ⁯       Not yet                 Should take place as soon as possible If not yet, why 
not?   ………………………………………………………………….. 
If never, why not?   …………………………………………………………………… 
 
18. In your opinion, is Uterine Transplantation achievable? 
Yes     No 
If no, why not?   ……………………………………………………………………….. 
If yes, how many years?   ……………………………………………………………… 
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Patient Motivation and Uterine Transplantation 
 
Please give a GRADE from 1 to 10 
1 = ‘strongly disagree’ AND 10 = ‘strongly agree’ 
 
1. The ability to have a child of my own is important to me   ……………………... 
 
2. Surrogacy and/or adoption offer a valid solution to my infertility   …………….    
 
3. I have looked at all available options to have a child and feel that uterine transplantation 
would not suit me the most   ……………………………………… 
 
4. If uterine transplantation became a safe, tried and tested option, I would consider it as my 
first option i.e. ahead of both of surrogacy and adoption   ……….  
 
5. I do not find uterine transplantation extremely relevant to my quality of life   ……….. 
 
6. The development of uterine transplantation will lead to greater personal happiness   
………… 
 
7. If uterine transplantation became possible in humans, I would not undergo this procedure in 
order to have a child   ……………… 
 
8. If uterine transplantation became possible in humans, I would undergo this procedure, fully 
aware that adoption or surrogacy would be ultimately safer for my wellbeing   ……………… 
 
9. If uterine transplantation became possible in humans, I would not undergo this procedure, as 
I am fully aware that it could fail and the ultimate goal of achieving successful pregnancy would 
not be achieved   ……………… 
 
10. If uterine transplantation became possible in humans, I would undergo this procedure, fully 
aware of significant risks to my future baby   …………………… 
 
11. My desire to have a child is based solely on my own feelings and wishes and I am not 
influenced by anybody else   ……………………………………………….... 
 
12. I have a strong support system around me, including family and friends – I would therefore 
not be alone to go through this   …………………………………... 
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Issues surrounding Uterine Transplantation 
 
Please GRADE the following issues according to how important you feel they are in relation to each 
other 
 
Grade from 1-10 where 1=least important and 10=most important 
 
Issues can be given the same grade 
 
1. Concepts specific to Uterine Transplantation 
Surgery (technique, time length, complications)        ……….. 
Immunology (graft rejection/tolerance)         ……….. 
Immunosuppressants (role and side-effects)         ……….. 
Achieving pregnancy post-transplantation          ……….. 
Maintaining pregnancy            ……….. 
Risks to fetus                    ……….. 
Risk to child development          ……….. 
Donor family issues            ……….. 
 
2. Of all the issues covered, what do you think is the most important issue and why? 
……………………………………………………………………………………………………………
……………………………………………………………………………………………………………
……………………………………………………………………………………………………………
………………………………… 
 
 
Part 2: Discussion of topics relevant to UTx/Q&A Session 
 
 
Part 3: 20 minute video 
 
 
Part 4: Shortened questionnaire 
 
 
1. I understand the benefits of Uterine Transplantation. 
Strongly agree       Agree       Undecided       Disagree      Strongly Disagree 
If disagree/strongly disagree, why?    ………..………………………………………… 
 
2. I do not understand the risks of Uterine Transplantation.  
Strongly agree       Agree       Undecided       Disagree      Strongly Disagree 
If disagree/strongly disagree, why?    ………..………………………………………… 
 
3. I believe that the potential benefits of Uterine Transplantation outweigh the potential risks. 
Strongly agree       Agree       Undecided       Disagree      Strongly Disagree 
If disagree/strongly disagree, why?    ………..………………………………………… 
 
4. I do not believe that the development of uterine transplantation will generally benefit the 
fields of medicine and surgery. 
Strongly agree       Agree       Undecided       Disagree      Strongly Disagree 
If disagree/strongly disagree, why?    ………..………………………………………… 
 
5. I believe that the development of uterine transplantation will benefit the field of obstetrics 
and gynaecology. 
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Strongly agree       Agree       Undecided       Disagree      Strongly Disagree 
If disagree/strongly disagree, why?    ………..………………………………………… 
 
6. Funds and grants should not be made available for novel and innovative fields such as uterine 
transplantation. 
Strongly agree       Agree       Undecided       Disagree      Strongly Disagree 
If disagree/strongly disagree, why?    ………..………………………………………… 
 
7. This question is hypothetical and we apologise if it causes any distress. You do not have to 
answer it. If you were to have a functioning uterus and uterine transplantation ever became a 
reality, would you give permission for your uterus to be added to the Organ Donation register? 
Yes   No   Not sure? 
If no, why not?   ……………………………………………………………………….. 
 
8. Now that you have watched a video presentation where we discuss the potential risks to you 
and your baby would you accept a uterus if it could lead to a healthy pregnancy? 
Yes   No   Not sure? 
If no, why not?   ……………………………………………………………………….. 
 
9. In your opinion, should Uterine Transplantation not take place? 
Never take place ⁯       Not yet                 Should take place as soon as possible If not yet, why 
not?   ………………………………………………………………….. 
If never, why not?   …………………………………………………………………… 
 
10. In your opinion, is Uterine Transplantation achievable? 
Yes     No 
If no, why not?   ……………………………………………………………………….. 
If yes, how many years?   ……………………………………………………………… 
 
 
 
Patient Motivation and Uterine Transplantation 
 
Please give a GRADE from 1 to 10 
1 = ‘strongly disagree’ AND 10 = ‘strongly agree’ 
 
 
1. If uterine transplantation became possible in humans, I would undergo this procedure in 
order to have a child   ……………… 
 
2. If uterine transplantation became possible in humans, I would not undergo this procedure, as 
I am fully aware that adoption or surrogacy would be ultimately safer for my wellbeing   
……………… 
 
3. If uterine transplantation became possible in humans, I would undergo this procedure, fully 
aware that it could fail and the ultimate goal of achieving successful pregnancy would not be 
achieved   ……………… 
 
4. If uterine transplantation became possible in humans, I would not undergo this procedure, 
fully aware of significant risks to my future baby   ……………… 
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Issues surrounding Uterine Transplantation 
 
Please GRADE the following issues according to how important you feel they are in relation to each 
other  
 
Grade from 1-10 where 1=least important and 10=most important 
 
Issues can be given the same grade 
 
1. Concepts specific to Uterine Transplantation 
Surgery (technique, time length, complications)        ……….. 
Immunology (graft rejection/tolerance)         ……….. 
Immunosuppressants (role and side-effects)         ……….. 
Achieving pregnancy post-transplantation          ……….. 
Maintaining pregnancy            ……….. 
Risks to fetus                    ……….. 
Risk to child development          ……….. 
Donor family issues            ……….. 
 
2. Of all the issues covered, what do you think is the most important issue and why? 
……………………………………………………………………………………………………………
……………………………………………………………………………………………………………
…………………………………………………………………………………………………………… 
 
 
 
Part 5: Post-video interview 
 
 
a) How does the diagnosis of infertility affect your day-to-day life? 
 
 
b) Have you given any thought to having children in the future? If you have, which methods have you 
considered (surrogacy, adoption)? What are your thoughts about such options? 
 
 
c) Why is the idea of ‘having children’ important to you? 
 
 
d) In the questionnaire, you had to answer questions regarding uterine transplantation. Following that, 
you watched a video on this topic. Have you ever heard of this proposed procedure before and what 
are your thoughts regarding it? 
 
 
e) Do you feel that uterine transplantation can ever become a valid option? Can you explain your 
answer? 
 
 
f) Can you describe what the process of uterine transplantation might entail (e.g. patient selection, 
surgery, IVF, pregnancy, delivery, immunosuppression, support)? 
 
 
g) Do you have any other questions? Is there something regarding the questionnaire or this interview 
that you would like to discuss? 
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Appendix C Study 4b: The Healthcare Professionals Survey: Views on Uterine Transplantation 
 
1. What is your medical profession? 
Obstetrician/Gynaecologist      ⁯ 
Surgeon        ⁯ 
Physician         ⁯ 
Pathologist/Immunologist       ⁯ 
Paediatrician         ⁯ 
Psychiatrist         ⁯ 
Nurse         ⁯ 
Midwife         ⁯ 
Donor Co-ordinator       ⁯ 
Medical Student       ⁯ 
Others, please specify   ………………………………………………. 
 
2. Please indicate your age and gender? 
Age   …..   Gender   ….. 
 
3. Please indicate the length of time that you have been working/studying within the medical 
field (not including research): 
Less than 1 year        ⁯ 
Between 1 and 5 years       ⁯ 
Between 5 and 10 years      ⁯ 
More than 10 years        ⁯   
 
4. Have you ever experienced any personal issues with infertility? 
Yes  ⁯               No ⁯               Declined to comment    ⁯ 
 
5. Do you know anyone (woman or a couple) who has experienced problems with conceiving i.e. 
infertility? 
Yes  ⁯                    No ⁯ 
 
6. Prior to today, how much have you known about Uterine Transplantation? 
 A lot    ⁯   A fair amount ⁯        Heard it discussed only a few times ⁯   Nothing ⁯ 
 
7. How interesting do you find the field of Uterine Transplantation?  
A lot     ⁯   A fair amount    ⁯   Not that much   ⁯    No interest whats-o-ever ⁯ 
 
8. I understand the benefits of Uterine Transplantation. 
Strongly agree ⁯   Agree ⁯   Undecided ⁯   Disagree ⁯   Strongly Disagree ⁯ 
If disagree/strongly disagree, why?    ………..………………………………………… 
 
9. I do not understand the risks of Uterine Transplantation.  
Strongly agree ⁯   Agree ⁯   Undecided ⁯   Disagree ⁯   Strongly Disagree ⁯ 
If disagree/strongly disagree, why?    ………..………………………………………… 
 
10. I believe that the potential benefits of Uterine Transplantation outweigh the potential risks. 
Strongly agree ⁯   Agree ⁯   Undecided ⁯   Disagree ⁯   Strongly Disagree ⁯ 
If disagree/strongly disagree, why?    ………..………………………………………… 
 
11. I do not believe that the development of uterine transplantation will lead to greater patient 
happiness. 
Strongly agree ⁯   Agree ⁯   Undecided ⁯   Disagree ⁯   Strongly Disagree ⁯ 
If disagree/strongly disagree, why?    ………..………………………………………… 
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12. I believe that the development of uterine transplantation will generally benefit the fields of 
medicine and surgery. 
Strongly agree ⁯   Agree ⁯   Undecided ⁯   Disagree ⁯   Strongly Disagree ⁯ 
If disagree/strongly disagree, why?    ………..………………………………………… 
 
13. I do not believe that the development of uterine transplantation will benefit the field of 
obstetrics and gynaecology. 
Strongly agree ⁯   Agree ⁯   Undecided ⁯   Disagree ⁯   Strongly Disagree ⁯ 
If disagree/strongly disagree, why?    ………..………………………………………… 
 
14. I believe that the development of uterine transplantation will be a useful and welcome 
addition to the field of transplantation. 
Strongly agree ⁯   Agree ⁯   Undecided ⁯   Disagree ⁯   Strongly Disagree ⁯ 
If disagree/strongly disagree, why?    ………..………………………………………… 
 
15. Funds and grants should not be made available for novel and innovative fields such as 
uterine transplantation but should instead be focused on life saving research programmes e.g. 
cancer research. 
Strongly agree ⁯   Agree ⁯   Undecided ⁯   Disagree ⁯   Strongly Disagree ⁯ 
If disagree/strongly disagree, why?    ………..………………………………………… 
 
16. Would you give permission for your or your family member’s uterus to be donated after 
death? 
Yes, for both my uterus and a family member's uterus     ⁯ 
Yes, for my uterus only         ⁯ 
Yes, for my family member's uterus only       ⁯ 
No, not for either my uterus or a family member's uterus    ⁯ 
I cannot make a decision for my family member      ⁯ 
I do not have a uterus          ⁯ 
Not sure           ⁯ 
 
If no, why not?   ……………………………………………………………………….. 
 
17. In your opinion, should Uterine Transplantation not take place? 
Never take place   ⁯   Not yet   ⁯  Should take place as soon as possible  ⁯   
If not yet, why not?   ………………………………………………………………….. 
If never, why not?   …………………………………………………………………… 
 
18. In your opinion, is Uterine Transplantation achievable? 
Yes  ⁯               No ⁯   Not sure?  ⁯ 
If no, why not?   ……………………………………………………………………….. 
If yes, how many years?   ……………………………………………………………… 
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Issues surrounding Uterine Transplantation 
 
Please GRADE the following issues according to how important you feel they are in relation to each 
other 
 
Grade from 1-10 where 1=least important and 10=most important 
 
Issues can be given the same grade 
 
1. Concepts specific to Uterine Transplantation 
Surgery (technique, time length, complications)     ……….. 
Immunology (graft rejection/tolerance)       ……….. 
Immunosuppressants (role and side-effects)      ……….. 
Achieving pregnancy post-transplantation      ……….. 
Maintaining pregnancy         ……….. 
Risks to fetus         ……….. 
Risk to child development       ……….. 
 
2. Recipient issues 
Length of operation         ……….. 
Post-operative complications       ……….. 
Risk of rejection        ……….. 
Side-effects of immunosuppressants      ……….. 
Conception         ……….. 
Pregnancy         ……….. 
Risks to fetus/baby        ……….. 
 
3. Procedural issues 
Developing a specific designated uterine transplantation team   ………. 
(surgeon, anaesthetist, psychologist, obstetrician, immunologist) 
Close link of uterine transplant team with coordinators     ……….. 
Educating professionals about the procedure     ……….. 
Support for healthcare professionals       ………..  
Impact of uterine transplantation on theatre and ITU staff    ……….. 
Exposure of healthcare professionals to press intrusion     ……….. 
Negative impact of uterine transplant on other transplant programs   ……….. 
 
4. Retrieval issues 
Development of donor/recipient criteria for Uterine Transplantation   ……….. 
Donor organ retrieval / transplantation time length     ……….. 
Interruption/delay of daily operating room time in host hospital    ……….. 
Liaison between other organ retrieval teams      ……….. 
Issues related to surgical technique       ……….. 
Patient acceptance of donor uterus (psychological/emotional impact)   ……….. 
Patient post-operative health status       ……….. 
 
5. Donor Issues 
Educating the donor family about the aim & benefits of uterine transplantation          …. 
Discussing with the donor family the actual process behind uterine transplantation …. 
Procedure outcome - Likelihood of benefit for the recipient    ……….. 
Consent and consent form issues       ……….. 
Is there any genetic relation between donor and recipient’s offspring?  ……….. 
Exposure of donor family to press intrusion      ……….. 
Opportunities to meet with the recipient and potential baby post-transplantation      …  
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6. Of all the issues covered, what do you think is the most important issue and why? 
……………………………………………………………………………………………………………
……………………………………………………………………………………………………………
……………………………………………………………………………………………………………
………………………………… 
 
7. Are there any issues that we have not covered? What are they? 
……………………………………………………………………………………………………………
……………………………………………………………………………………………………………
……………………………………………………………………………………………………………
………………………………… 
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Appendix D – Letter to the Fellows of the Royal College of Obstetricians and Gynaecologists 
 
 
Dear Fellows of the Royal College of Obstetrics and Gynaecology, 
 
 
 Mr J. Richard Smith has been the UK lead into Uterine Transplantation for the past 10 years. 
We thought it was time to bring you up to date with progress and to tell you about the next phase of 
our research. 
 
 
Our team, based at The Lister Hospital in Chelsea and at Imperial College London, is about to begin 
several new projects.  We will very soon be carrying out a new series of operations on mammals to 
prove some new surgical techniques and hopefully to enable some of the animals to become pregnant.  
 
 
One of these new projects is designed to learn more about health-care professionals’ attitudes and 
importantly the views of our own colleagues regarding uterine transplantation. 
 
 
It is in connection with this project that we would very much appreciate your help. Dr Srdjan Saso is a 
clinical research fellow carrying out a PhD in uterine transplantation at Imperial College and has 
devised a questionnaire which attempts to assess the views of health care professionals  
 
 
Furthermore, a website is almost up and running. On it, one will be able to find out everything about 
the project - background, reasons for carrying out the research, future related projects and 
conferences, forthcoming events, information concerning members of our team and contact details if 
you wish to raise any issues. 
 
 
If you would like to help our research, please fill in the questionnaire and either post it back to one of 
the addresses below or drop it off at the College. 
 
 
Thank you once again for expressing an interest in our programme. We very much hope we will hear 
from you again in the near future. Please do not hesitate to contact us if you have any queries. 
 
 
With best wishes, 
 
 
 
Mr J. Richard Smith MD FRCOG  and  Mr Srdjan Saso MBBS BSc MRCS 
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Appendix E 
 
Uterine Transplantation in Primates 
 
This thesis has focused on two specific animal models, rabbit and sheep. Lately, UTx research has 
been focusing on experiments concerning non-human primates and it is worth describing in brief the 
progress in this area of UTx. The main advantage is the relatively large body size and the close 
resemblance to the anatomy and physiology of a human. The foremost similarity lies in the straight 
cervical canal enabling endometrial sampling, embryo-transfer and hysteroscopy. Several reviews and 
guidelines have stated that primate research should be mandatory before introduction of UTx in 
humans.4,64,282-284 Prior to the first ever human UTx in 2000, the only primate research was performed 
by Scott et al in the early 1970s.67 This was an original experiment, especially when considering the 
decade in which it was carried out, involving the transplantation of the both the uterus and Fallopian 
tube. As discussed previously, the transplantation performed was just one of the solutions put forward 
as a possible cure of infertility. Four rhesus monkeys had auto-transplants and four had cross-
transplants with each serving as a donor and a recipient in the latter. With respect to the auto-
transplants, following their removal, the uterus and Fallopian tubes were placed back into the same 
monkey after 20 minutes, with no dissection of vascular pedicles. The surgical technique involved 
omental wrapping and therefore the use of the omentum as the vascular supply. The blood flow was 
re-established by neo-agenesis from the omentum. Three out of four autotransplants maintained a 
normal sized uterus and resumed cyclical menstruation with clomiphene citrate stimulation. One 
monkey died three months following the operation from an unknown cause. The three surviving 
monkeys were placed with males for 10 months but no pregnancy occurred. Histopathology carried 
out one year following the transplants showed a normal secretory endometrium but non-patient 
Fallopian tubes, most probably caused by an ischaemic period of several days post-autoUTx. This 
most likely explained the absence of a gravid uterus. In a human UTx, the Fallopian tubes would not 
be transplanted as conception would occur via embryo transfer and would therefore, not be natural. 
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The allotransplants underwent regular post-operative biopsies of their internal genital organs. The 
usual rejection signs were elucidated - oedema and progressive mononuclear infiltration which 
appeared initially in the endometrium and after 14 days full rejection was present. The endometrium 
was rejected more rapidly than the myometrium as seen with small-animal studies. Weekly white cell 
counts and haematocrit levels were no different between the groups. It is worth highlighting that a one 
year follow-up period in this study is to be commended as that exact period would be applied in 
human UTx. The omentum technique is today obsolete and would not be practised in a woman. 
However from the results above it seems that the omentopexy technique may indeed bring about 
uterine graft re-vascularisation if the uterus is of a smaller size such as in the rhesus monkey. The 
allotransplants in the above study were not administered any immunosuppression.67 Despite extensive 
use of immunosuppression in primate research, results cannot be directly extrapolated.285 What may 
be therapeutic in humans i.e. hand transplantation, may be sub-therapeutic in composite tissue 
allotransplantation in monkeys.4,286,287 
 
The next of set primate experiments was performed by Fageeh et al as part of preparation for human 
UTx.61 These experiments were described only briefly. Hysterectomies followed by auto-
transplantations were performed in 16 baboons. Tissue and vascular integrity was preserved. The uteri 
were flushed with cold Euro-Collins solution. Ischaemic times were not reported. Inspection of tissue 
texture and colour at exploration 6–12 weeks post-operatively indicated viability. Two types of 
anastomosis were tried out, first end-to-end uterine vessel anastomosis and subsequently a 
modification to end-to-side anastomosis to the internal iliac vessels. Occlusion was 75% and 90% 
respectively. The primate studies demonstrated survival of the uterine graft and indicated that good 
mid- and long-term vessel patency could be achieved using particular microvascular techniques for 
uterine arterial and venous anastomosis in an end-to-side fashion.61 
 
Since then six further studies have been performed on non-human primates. It is interesting that they 
have all been published from 2010-2013 as primate research is a very novel addition to the long-
standing body of UTx research. Enskog et al performed an original experiment whereby basic surgical 
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techniques were developed in a case series of baboon uterine transplants. Five animals were used for 
studies of pelvic vascular anatomy.173 Ten underwent actual surgery - a uterine autotransplant. The 
graft was utero-tubal-ovarian, with the recovery surgery including bilateral dissection of the uterine 
arteries and the anterior portions of the internal iliac arteries, and for venous outflow bilateral ovarian 
veins. The ovaries and the oviducts were kept with the graft as the hormones produced resulted in 
typical cyclic perineal skin changes of the female baboon which is an easy and non-invasive method 
to assess graft function.288 The graft was removed, flushed and kept ex vivo for two hours when the 
two arterial ends and two venous ends were anastomosed side-to-side to construct one arterial and one 
venous end. The single arterial and venous ends were anastomosed unilaterally to the external iliac 
vessels. The animals (n=10) were evaluated concerning cyclicity and later by laparoscopy/laparotomy. 
The total duration of organ retrieval, and transplantation was recorded by the authors and came to 
around six hours with an overall ischaemic time of the specimen of about three hours. Nine animals 
survived with one animal dying from cardiomyopathy. Five out of the nine surviving animals resumed 
cyclicity which suggested re-established ovarian function. Only two out of these five animals 
exhibited resumed menstruation, indicating re-established both ovarian and uterine function. Normal-
sized uteri were confirmed in these two animals. The conclusions of the authors were apposite. The 
feasibility of UTx by vascular anastomosis in a non-human primate species was demonstrated in this 
study. However, as only 20% of the uteri resumed menstruation, it was concluded that UTx is a 
complex procedure and thus, modifications of the surgical method would be required.173 
 
The follow-up study was also performed by the Brannstrom team.289 The animal model was again a 
baboon and the transplantation was autogeneic. The authors modified the surgical technique and 
extensively dissected the ovarian veins to include their inlets into the inferior caval vein and the left 
kidney vein. This was done so as to achieve a vascular anastomosis with venous walls that are thicker. 
With respect to anastomosis, the modification was such that the anastomosis was unilateral and end-
to-end to the internal iliac artery. The anastomosis surgery was also performed by a transplant 
surgeon. Ten baboons were operated on using the modified technique whereas six underwent a 
technique like that described in the previous study.173 Overall short-time survival of the animals was 
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88%. Out of the surviving animals, 75 % (80% in the modified group and 66% in the original group) 
resumed ovarian cyclicity. Regular menstruation after UTx was only demonstrated in the modified 
group; it was 60 % which is an increase on the previous study (20%). The authors tried to achieve 
both conception and pregnancy by exposing the menstruating animals (n=6) to timed mating for >5 
menstrual cycles. However pregnancy did not occur. This was most likely because of adhesions and 
tubal blockage seen in the post-mortem analysis. This conclusion is yet another which adds to the 
growing evidence that conception should be attempted in a woman via IVF and embryo transfer. The 
final conclusion of the authors is suitable, that the modified anastomosis technique is a safe procedure 
and leads to resumed long-term uterine function in a majority of the animals.289 
 
Longer term non-human primate UTx survival has also been reported with successful 
immunosuppression. Using rhesus macaques, three uterine allograft transplants were performed. Two 
animals expired post-UTx but the third transplant was successfully accomplished and maintained for 
approximately one year.283 This primate data was also important for demonstrating that acute rejection 
could be treated with commonly available immunosuppressants that are compatible with human 
pregnancy. Specifically, immunosuppression of the primate uterus was maintained with CsA targeting 
serum levels (target CsA trough was 150ng/mL) typically found in other successful human solid 
organ transplantations. The diagnosis of acute rejection was made based on clinical grounds (i.e. 
watery vaginal discharge), confirmed by sonogram (oedematous UTx graft) and managed based on 
clinical human transplant medicine protocols i.e. steroids, CsA dose adjustment and adding other 
agents such as tacrolimus. These results were important in confirming the potential for robust survival 
of the human uterus graft under a variety of situations.104 
 
A team in Japan has furthered primate UTx research by carrying out two original and highly valuable 
studies. First, Mihara et al evaluated the intra- and post-operative blood flow in the vascular 
anastomosed regions and the blood-perfused area of the transplanted uterus in a cynomolgus macaque 
model of uterus autotransplantation.290 Investigations used were indocyanine green (ICG) 
fluorescence angiography and Doppler ultrasonography. The former was used during surgery to assess 
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blood perfusion in the vascular anastomosed region and uterine area. The latter evaluated post-
operatively the uterine size, presence or absence of the endometrium and blood flow rates in the 
uterine artery and vein. Six female cynomolgus monkeys underwent surgery. The first two animals 
were used to study the pelvic vascular anatomy and the remaining four animals were used for uterus 
autotransplantation. Uterine arterial and venous anastomoses to the external iliac artery and vein 
respectively succeeded in all four animals that underwent autotransplantation. Intraoperative ICG 
fluorescence angiography showed appropriate blood flow in the vascular anastomosed regions. 
Interestingly, and demonstrated for the first time in large animal and specifically primate research, the 
entire uterus received sufficient blood supply from a single uterine artery. Doppler studies 
demonstrated favourable blood flow in the uterine artery and vein immediately after surgery. The 75% 
mortality rate was not because of poor anastomosis or surgical complications. The animals died within 
three months because of reduced feeding and loss of body strength. Importantly, the authors’ 
conclusion that ICG fluorescence angiography can be used for simple evaluation of real-time blood 
flow conditions in the anastomosed uterine artery, vein and uterine area is important as it can bring 
about a greater chance of successful uterus transplantation.290 
 
The second study by the same team again utilized a UTx primate auto-model and evaluated the 
patency of the microsurgical anastomoses and the perfusion of the transplanted uterus with the aim of 
achieving pregnancy.279 Two female cynomolgus monkeys underwent surgery. For the anastomosis, 
the arteries used were the uterine arteries which were joined in an end-to-side fashion to the external 
iliac artery. For the first case, two arteries and one vein were anastomosed and for the second, two 
arteries and two veins. As with the previous study, uterine arterial blood flow and uterine size were 
determined by intraoperative ICG angiography and ultrasonography. The biopsy of the uterine cervix 
was taken post-operatively. In the first case, ICG angiography demonstrated the occlusion of one of 
the anastomosed arteries during the operation and the uterus atrophied two months post-UTx. In the 
second case however, the transplanted uterus survived and normal menstruation occurred. The animal 
achieved a natural pregnancy and was delivered via an emergency Caesarean section as a result of 
early placental separation. The newborn suffered fetal distress. Importantly, this is the first report of a 
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natural pregnancy in a primate following uterine autotransplantation. It seems that in this study, 
bilateral uterine arteries and the unilateral ovarian vein are required for a successful UTx. However 
drawing a conclusion is difficult as a result of only two primates used in the research.279 
 
The final study in the primate series is also the most recent and of the highest quality.291 It mimicked 
what would happen in a human attempt in Sweden. The plan put forward by the Brannstrom team is to 
use a live donor as a result of a paucity of suitable heart-beating brain stem dead donors. 18 female 
baboons were used as uterus donors and as uterus recipients, thus making up a total of 36 female 
baboons. Donation was live for the reason explained above. The actual transplant was allogeneic. 
Blood type was investigated by the authors; out of all the donor/recipient combinations, 55% were 
ABO identical and additionally 45% were ABO compatible. The follow-up time was between five and 
eight weeks. The uterine graft retrieved included (bilaterally) the main trunk of the internal iliac artery 
with the largest branch on each side and ovarian veins dissected all the way to their inlets into the IVC 
and the left kidney vein. Anastomoses were unilateral to the left external iliac artery and vein. The 
round ligaments of the uterine graft were attached to the corresponding ligaments of the recipient for 
graft fixation and the vagina was re-anastomosed by continuous suture. With respect to 
immunosuppression, the baboon recipients were placed in one of the following groups: (a) no 
immunosuppression (n=4); (b) monotherapy (oral slow release tacrolimus; n=4); and (c) induction 
therapy (antithymocyte globulin) followed by triple therapy (tacrolimus, mycophenolate, 
corticosteroids; n=10). Variables that were measured included surgical parameters, survival, 
immunosuppression and rejection patterns. The durations of uterus retrieval and recipient surgery 
were acceptable and would be considered ‘normal’ in humans. They were around three and three and 
a half hours respectively. The total ischaemic time was around three hours. Importantly, all the 
recipients and the donors survived the surgery. Rejection was seen in all recipients to varying degrees, 
with only one baboon displaying a uterus of normal appearance at the end of the study period. High 
blood levels of tacrolimus (.60 ng/ml) were recorded but interestingly, no evidence of nephrotoxicity. 
In summary, the study is the most important to date. It used the biggest number of non-human 
primates, it described an allogeneic transplant, and donation was of a live nature. The transplants were 
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surgically successful, with allogeneic UTx in the baboon demonstrated as a donor- and recipient-safe 
and thus feasible surgical procedure. The immunosuppression protocol that should be applied must 
involve induction therapy and a triple protocol. Further research is needed however to optimize 
immunosuppression protocols in order to avoid uterine rejection.291 
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Human Uterine Transplantation  
 
The first ever UTx performed in a woman occurred in 2000 in Saudi Arabia as outlined in detail in 
Chapter 1. In a fair comparison with other firsts in transplantation history, the first human uterus 
transplant was a relative success.61 In summary, UTx was carried out on a 26-year-old female who 
lost her uterus at the age of 20 as a result of a post-partum haemorrhage. The donor was a 46-year-old 
patient diagnosed with multi-loculated ovarian cysts. She had undergone a modified hysterectomy, 
performed in such a way to preserve tissue and vascular integrity. Surgically, the uterine graft was 
connected in an orthotopic position to the recipient's vaginal vault. The uterosacral ligament was 
shortened in order to achieve additional fixation. The immunosuppression regimen was oral 
cyclosporine A, azathioprine and prednisolone. Allograft rejection was monitored by Echo-Doppler 
studies, magnetic resonance imaging and measurement of the CD4/CD8 ratio in peripheral blood by 
fluorescence activated cell sorter. Immunologically, the trial was controlled - an episode of acute 
rejection was treated on the ninth day with anti-thymocytic globulin. The transplanted uterus 
responded well to combined estrogen-progesterone therapy. It caused endometrial proliferation up to 
18mm. The patient had two episodes of withdrawal bleeding upon cessation of the hormonal therapy. 
The main issue centred around the uterine arteries and veins. They were extended using reversed 
segments of the great saphenous vein, then connected to the external iliac arteries and veins, 
respectively. The double anastomosis as well as inadequate uterine structure support unfortunately led 
to acute vascular thrombosis 99 days after transplantation secondary to probable tension, torsion, or 
kinking of the connected vascular uterine grafts. The necrosed uterus was removed via hysterectomy. 
Macro- and microscopic histopathological examination revealed acute thrombosis in the vessels of the 
uterine body, with resulting infarction. Both Fallopian tubes remained viable, however, with no 
evidence of rejection.61 
 
At the time of writing of this thesis, the second human UTx had been carried out unexpectedly.261 
Unexpectedly as it was by a team of plastic surgeons in Turkey led by Professor Omer Ozkan with no 
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previous record or publications on the topic of UTx. However it is an exciting and well planned study, 
promising a first real breakthrough in the human application of UTx since the Saudi case. Ozkan et al 
describe the first-year results of the first human uterus transplantation case from a multi-organ donor 
(and second human case historically). After approval from the local transplantation committee and the 
institutional review board, three candidates out of 10 patients with MRKH syndrome who had 
previously undergone vaginal reconstruction surgery were initially selected over a two year period.261  
 
The AUFI patient was a 21-year-old woman with complete Mullerian agenesis who had been 
previously operated on for vaginal reconstruction. The patient underwent two IVF cycles, which 
yielded eight grade-1 embryos. The deceased donor was a nullipara, 22-year-old, braindead woman 
who had incurred cerebral trauma in a traffic accident. Uterus and proximal vagina retrieval with 
preservation of the bilateral ovarian and common iliac artery and vein tracts was achieved with wide 
excision of the broad ligament, round ligament, and vesicouterine and sacrouterine peritoneal sheets.  
The graft was perfused with University of Wisconsin (UW) solution at 4◦C to ensure removal of all 
blood cells and fibrin and to induce central core cooling for tissue preservation until revascularization. 
She underwent the UTx procedure consisting of orthotopic replacement and fixation of the retrieved 
uterus, revascularization, and end-to-site anastomoses of bilateral hypogastric arteries and veins to 
bilateral external iliac arteries and veins (Figure 1).261 
 
The authors described their immunosupression regimen in detail. Immunosuppression induction with 
a 2.0 mg/dL daily dose of Thymoglobulin was administered intra-operatively, adjusted based on the 
CD3 levels, and stopped on day 10. An initial intraoperative dose of 1000mg of prednisolone was 
administered and then reduced to 20mg at 1 week after surgery. Tacrolimus (0.2 mg/kg) was not 
started simultaneously but rather on day 7 to decrease the rate of complication s related to 
immunosuppressive therapy. Maintenance immunosuppression therapy consisted of tacrolimus (0.2 
mg/kg with plasma levels 15–20 ng/mL), mycophenolate mofetil (2 g/day), and prednisolone (20 
mg/day). Cotrimoxazole (2.5 mg/kg per day orally) was administered for the first 6 months. 
Subcutaneous heparin was administered for antithrombotic prophylaxis.261 
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Figure 1 Schematic representation of the surgical procedure (Courtesy of Ozkan et al) 261 
 
 
 
 
Key: EIA, recipient external iliac artery; EIV, recipient external iliac vein; HA, donor hypogastric 
artery; HV, donor hypogastric vein; O, recipient ovary; U, donor uterus; V/V, recipient and donor 
vaginas. Note bilateral salpingeal tubes were ligated.  
 
 
The patient recovered well following the surgery and did not experience any complications. She was 
discharged at the end of the first month. Her menstrual cycles resumed, with menarche 20 days after 
transplant surgery. Her menstruation was irregular for the next two menstrual cycles after the first 
menstrual cycle, and her endometrial thickness reached 21mm. She has had 12 menstrual cycles since 
the operation. Vaginal biopsy samples were taken every two weeks for the first three months, whereas 
endometrial biopsy were obtained every three months. The mucosa of the transplanted vagina at 
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month six demonstrated a few lymphocytes around the capillaries, but there was no fibrinoid necrosis. 
The endometrial biopsy at 6 months revealed vacuolization of the glandular epithelium and 
oedematous stroma. 
 
Significantly this is the longest-lived transplanted human uterus to date with acquirement of menstrual 
cycles. The authors performed a planned and well-thought out experiment, with the necessary 
attention paid to all aspects - surgery, immunology, IVF and post-operative assessment. The authors 
provide detailed information on the first 12 months of the longest-lived transplanted human uterus to 
date, which subsequently achieved menstrual cycles. They also add a caveat of their awareness that 
the actual success will be the delivery of a single healthy fetus from the uterus transplant.261 
 
UTx in the United Kingdom 
 
The completion of this PhD will signal the commencement of the UK team’s efforts to perform the 
first UK case series of five human uterine transplants in 2015. Therefore, future work will entail:  
 
(a) Application and approval from the necessary national and local ethics committees for the 
commencement of the first five human uterine transplants; 
(b) Raising of the necessary funds; 
(c) Drawing up of scientific protocols (four will be required: surgical, immunological, fertility, 
obstetric)  
 
The scientific protocols will be based on information derived from the first two human cases and all 
animal experiments to date. The UTx team will consist of gynaecological and transplant surgeons, 
immunologists, obstetricians and fertility specialists. As stated by Brannstrom et al, the introduction 
of human UTx should be performed and assessed under the newly formed IDEAL guidelines for a 
science-based approach to the application of surgical innovations.292 They are based on five 
principles: Innovation, Development, Exploration, Assessment, and Long-term study, which were 
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developed by an international group of surgeons, researchers, journal editors, methodologists, 
statisticians, and other people who are committed to producing, disseminating, and evaluating quality 
research in surgery. 
 
Table 1 describes the UTx process once the five patients are selected in the first half of 2014, using 
the selection criteria describe above. We predict that, provided there is either no failure of the graft or 
miscarriage following the first embryo transfer, it may require 2-2.5 years until the birth of the first 
baby, and 5 years until the birth of the second. This does not differ from the duration involved with 
normal conception, surrogacy or adoption. Depending on the patient’s wishes as to the timing, the 
uterus will be removed following a completion Caesarean hysterectomy. An elective Caesarean 
section should be the mode of delivery in order to prevent any damage to the uterine graft fixation 
points which may occur with a natural delivery. IVF treatment should be performed prior to UTx. 
This is so that the couple’s fertility may be confirmed and also that the embryos may be stored for 
future transfer around 9-12 months post-transplantation as postulated by the international 
recommendations for transplant patients. 
 
The donor graft can come from two potential two sources, either a live-related or brain-stem dead 
heart-beating donor. This debate is currently still on-going, with the UK and USA teams planning to 
use the latter as they feel that the optimum graft is obtained from a multi-organ donor, with the 
application of the usual criteria for all organ donations. The Swedish team feel that a living donor 
would suit them better. The advantages of using a brain-stem dead, heart-beating organ donor are as 
follows. First, there is no surgical risk imposed on the donor as would be with a live donor. Also, with 
a live donor, she would have to be in good general health to minimize the surgical risk at 
hysterectomy, which is not at all a factor of importance with a deceased donor. Second, long-term 
survival and graft function is more likely with our chosen method. This is because as concluded 
following the first human UTx case in 2000, the uterus necessitates a tension-free and large diameter 
vascular anastomosis only possible when retrieving the larger pelvic vessels. Such a procedure, 
whereby the vascular tree may be more extensive, can only be performed in a deceased donor where 
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there is no future need for these vessels. This would allow recovery of the larger pelvic arteries and 
veins, thus ensuring easier anastomosis at transplantation. Joining transplantation retrieval teams is a 
good pointer as to where this theory is in fact applicable in practice. Del Priore et al participated in a 
local organ donor network retrieval team for over six months in order to determine if a uterus can be 
retrieved for reproductive organ transplantation and to describe the surgical technique.293 1800 heart-
beating, brain-dead multi-organ donors were identified through an existing donor network following 
routine protocols, with multi-organ procurement surgery taking place in approximately 150 of these.  
Nine were specifically consented for uterine retrieval following institutional review board and organ 
donor network approval of the UTx project. This occurred in eight donors, with uterine retrievals 
performed by experienced gynaecologic surgeons. All were parous females, aged 30-45 years, with 
one to three deliveries of healthy children. Additional operating time ranged from 30 to 100 minutes, 
with the actual time decreasing down to 15 minutes eventually. Estimated blood loss was 10-20ml; 
this does not include one case which had a 250ml loss due to a lacerated internal iliac vein. The 
complete and bilateral internal, external and common iliac arteries and veins were recovered in two 
grafts, and the vascular pedicle included the vessels up to the anterior portions of the iliacs in five 
grafts. However unilateral loss of uterine vessels was demonstrated in two out of these. After 
retrieval, serial histology sections throughout the period of cold ischaemia, taken every 15-30 
minutes, showed no signs of morphological change in the myometrium and endometrium over 12 
hours of cold ischaemia. This was a useful experiment for its main finding that the human uterus can 
be obtained from local organ donor networks using existing protocols and minimal impact on the life-
saving organ retrievals. Furthermore, it also demonstrated that separate flushing is necessary for the 
uterus, with femoral arties preferred for flush cannulation because they do not interfere with existing 
retrieval protocols.293 Brannstrom et al also report that in their collaborative group, transplant 
surgeons have recovered uteri from seven multi-organ donors.294 In these trials vascular pedicles 
including the complete uterine vessels, internal iliac vessels, common iliac vessels, and lower part of 
the aorta and vena cava were recovered.275,294 
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Table 1 UK Uterine Transplantation process 
 
Stage Cumulative Time 
1st Clinic Appointment Day 0 
Medical and Psychological Evaluation  Day 0 - Month 3 
Embryo Harvest Month 3 
Embryo Storage 
Donor Location 
Months 3-6 
UTx Month 6 
Embryo Transfer Month 15-18 
Delivery via Caesarean Section Month 24-27 
 
 
The main disadvantage with use of an organ from a deceased donor is the lack of time that can be 
spent investigating the donor because of the two/three day window prior to organ harvest. This 
‘investigation’ is necessary to obtain an accurate and complete medical, surgical and gynaecological 
history regarding the patient, to rule out several uterine-associated pathological conditions before 
transplantation, to diagnose any gynaecological pathology such as neoplasia and leiomyomas and rule 
out any microbiological or oncological pathology. The uterus donated by a live donor would also be 
investigated pre-operatively, as a result of this extra time, by magnetic resonance imaging to diagnose 
vascular anomalies or atherosclerosis of uterine vessels. In addition, the negative effect of the major 
systemic inflammatory changes on graft survival.275,295 This negative effect is directly related to the 
time interval between brain death and organ recovery. Finally, by using a live donor, one can opt for a 
relative as the donor i.e. an older sister, the mother, or an aunt because the chance of matching 
blood/tissue type would be high. Johannesson et al performed a study assessing the practicality of 
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uterine retrieval from a live donor for the purpose of subsequent transplantation.294 The main aim was 
to see whether the uterine graft had long and wide enough vascular pedicles for direct vascular 
anastomosis bilaterally to the external iliacs. This would mean that extensions with saphenous grafts 
would not be required. The experiment involved vascular dissection of the uterine arteries and veins at 
radical hysterectomy in 19 patients diagnosed with cervical cancer. The uterine arteries and veins 
were dissected separately from the anterior divisions of the internal iliacs. The lengths (median) of the 
free portions of the left uterine artery and vein were 68 mm and 55 mm, and the right uterine artery 
and vein were 65 mm and 50 mm, respectively. The inter-external iliac artery distance (median) was 
90 mm. The inter-external iliac artery distance, corresponding to distance between proposed bilateral 
anastomosis sites, was 90mm. All these measurements demonstrate precisely what would be sufficient 
for direct bilateral anastomosis to the external iliacs. Peri-operative and postoperative outcomes were 
compared with 76 patients (control group) undergoing standard radical hysterectomy without 
particular uterine vessel dissection, with no statistical difference between those outcomes. In 
conclusion, the study demonstrates two points. First, that long vascular pedicles can be obtained after 
selective dissections of the uterine arteries and veins from a live donor and second, that post-operative 
recovery of a live donor is not compromised.294 
 
Thus the decision on which kind of donor to use would be left to the individual teams to decide. Other 
donor as well as recipient criteria is more certain. The recipient should be a genetic female of an age 
between 18 and 38 to ensure an appropriate ovarian reserve. The reserve should be evaluated by 
ultrasound and by measuring a patient's levels of follicle-stimulating hormone, oestradiol, and anti-
Mullerian hormone, as well as the patient's antral follicle count and karyotype (normal female 
46,XX). She should also be in good medical and psychological health, with no significant medical, 
surgical or gynaecological history and a BMI<25 kg/m2. In particular, a cancer-free patient is desired; 
if she had been diagnosed with cancer previously, five years at least should pass after cancer surgery 
to ensure that there is no risk for recurrence of the disease. Finally, the recipient must have a long-
term partner and a good support network involving family and friends. 
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With regards to the donor, the following are paramount: she or her family have signed an advanced 
directive for post-mortem organ-donation; negative human papilloma virus status; normal endometrial 
cavity on ultrasound (no leiomyomas or endometrial polyps); normal Pap smear history (no cervical 
dysplasia); and age between 18 and 50 years. Above the age of 50, the donor is likely to be peri-/post-
menopausal with a risk of atherosclerosis of the vessels required for anastomosis. Ideally, the uterus 
should come from a donor with proven fertility, with no previous gynaecological history. Finally, a 
blood type and tissue match has to be performed with the latter being of less importance, according to 
modern transplantation standards.296 
 
Also in need of consideration by the UK team is what may be the best method to fix the uterine graft 
into the pelvis. With respect the first human UTx case, uterine prolapse did occur and this must be 
prevented with future cases. The vaginal rim of the graft will naturally be anastomosed to the vaginal 
vault of the recipient. The lengthy round ligaments recovered during retrieval should  fixed to the 
pelvic sidewalls and the uterosacral ligaments, which are nearly always preserved in women 
diagnosed with AUFI, should be fixed to the lower posterior part of the uterus. They would also 
support the cervix and ensure prevention of displacement and prolapse, especially of a gravid uterus. 
Brannstrom et al also believe that part of the bladder peritoneum should be sutured on top of the 
uterus as extra fixation.4,275 
 
Finally, with respect to the immunosuppression protocol, the UK team will use a standard regimen 
protocol, involving induction and maintenance therapy that is used for kidney transplantation at 
Hammersmith Hospital. Induction therapy would involve a steroid, monoclonal antibody and possibly 
an antithymocyte globulin to lower the numbers of circulating T cells. Maintenance therapy would be 
the standard triple immunosuppression (tacrolimus/CsA, corticosteroids, anti-proliferative agent). 
Interestingly, the above proposed immunosuppression protocol has led to 100% graft survival of 
highly immunogenic composite tissues such as the hand and the face.275,297  
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Applications, Ethics and Originality 
 
From the on-going research work over the last 10 years, one can conclude that in terms of progress, 
UTx is close to moving to the human setting. The aim is to apply future results achieved from the 
above research in order to allow the ‘perfect’ setting for the commencement of human transplantation. 
With regards to our UK-based work, over a hundred women have submitted written requests to our 
department wishing to undergo a uterine transplant. FIGO Committee for the Ethical Aspects of 
Human Reproduction and Women’s Health recently brought forward such ethical considerations 
which touch on fundamental issues concerning perception of procreation and parenthood as well as 
those of medical advancements.276 These perceptions differ globally and as described by Brannstrom 
et al, this diversity is moral, religious and philosophical. Values in dissimilar societies will most likely 
render UTx acceptable in some societies and unacceptable in others.65,177  
 
It is important to distinguish between the ethics of UTx research and the ethics of the UTx procedure. 
That carrying out UTx research over the past 50 years has been ethical is confirmed by the permission 
granted by various Animal Research bodies to perform the animal experiments. Furthermore, the 
greater technical precision gained from a better understanding of pelvic anatomy advanced our 
existing knowledge of operative gynaecological oncology procedures. There have already been a 
number of ‘spin-offs’ directly related to gynaecological practice which have arisen from our previous 
research. They include the first case of fertility sparing surgery for a giant adenomatoid tumour of the 
uterus226, a tumour previously managed by hysterectomy and a successful cessation of haemorrhage in 
a patient with a ruptured cornual ectopic pregnancy without recourse to hysterectomy.175 Also, some 
of the techniques have proved useful in the surgical management of Gestational Trophoblastic 
Disease, 156,174,298 as well as the treatment of uterine arterio-venous malformation 227 where selective 
temporary ligation of the uterine and ovarian vessels was applied. Finally, the idea of ART, as 
described previously, has demonstrated that the uterus is capable of sustaining a term pregnancy with 
only one of its redundant vascular pedicles intact. Similarly, knowledge gained from the 
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immunological aspects of UTx can be shared with other transplant fields. Benefits may also come 
from the ability to study perfusion in a smooth muscle organ transplant, how a transplanted organ 
adapts to the change in its vascular environment during pregnancy, and the proliferation of functional 
muscle mass. 
 
With respect to the ethics of the actual UTx procedure, the main debate focuses on whether a radical 
procedure such as UTx is needed. And if so, whether the benefits of it outweigh the intra-operative 
and post-operative risks to the mother and fetus. Need is a difficult topic to judge. If looking at 
numbers, around 100,000 women between the ages of 16-42 suffer from AUFI, whereas in America 
that number is most likely close to seven million. The figures are staggering and that is simply when 
looking at two countries in the Western hemisphere. This is not a life-saving transplant yet neither is 
kidney, and more recently, hand, larynx and face which are now offered in selected centres. The area 
of transplantation has been expanding over the recent years and does now include qualify-of-life 
improving transplants. UTx is most certainly offered as a quality-of-life improving procedure i.e. to 
improve the situation of a woman and couple who are unable to have their own genetic child by any 
other method. The importance of infertility to a couple is not for anyone else to determine - to some it 
may appear irrelevant yet to others it is of a vital importance. When IVF was first introduced it also 
had to face similar criticisms and challenges, both religious and scientific. Yet if UTx remains the 
only option for a couple to who are unable to conceive a genetic child (and surrogacy and adoption 
are not possible as a result of legal, ethical or moral reasons), then surely the decision on whether to 
carry out such a procedure lies with the feet of the patient and the medical team. For most of the 
world, including much of western Europe, surrogacy is considered illegal for these reasons. 
 
The important ethical principle of dominance of benefits over risks should thoroughly be analyzed 
where four subjects may be involved; the donor (living or deceased) with immediate family, the 
recipient, the partner of the recipient who is also the prospective father, and the future child. The 
ethics of the last subject, i.e. the offspring, as a fetus, neonate and independent person, are the most 
controversial. Maternal immunosuppression does not seem to increase perinatal risk 152 but long-term 
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effects of fetal exposure to immunosuppressants may exist.299,300 In addition, how does one assess the 
right of an unborn child to choose treatment i.e. immunosuppressants that may result in a higher 
incidence of preterm deliveries, low birth weights, intra-uterine growth restrictions yet it is that 
specific treatment that allows it to be born? 141-143 Although non-existent in the UK, a concept termed 
‘wrongful birth’ has been used in the US justice system whereby a person can sue his/her parents or 
the medical profession for allowing their birth and ensuing (difficult) life experience. All this must be 
considered yet the most significant rule of obstetrics remains, `that the life of the mother is a priority 
and should be treated as such if the post-UTx pregnancy takes an unexpected turn. 
 
Interestingly, the concept of UTx covers all aspects of human ethics: primum non nocere (non-
maleficence), autonomy, beneficence, justice and dignity. UTx offers all of the last four qualities to a 
patient suffering from AUFI. Further research proposed earlier will allow us to meet the criteria for 
ethical analysis of a surgical innovation, as proposed by Moore:278 sound research foundation, 
adequate combination of knowledge and expertise from all fields related to the procedure, and 
internationally recognised proficiency in the institution in which the procedure is performed.3 It is 
only the application of such a thorough approach which will lead to compliance with the first and 
most important pillar of medical ethics: primum non nocere.65,278 And most importantly, that ever-
elusive life goal of eudaimonia (human flourishing), an Ancient Greek concept of the highest form of 
human goodness and happiness, can be attained by couples for whom the concept of family was 
always an impossibility. 
 
With regards to our group of women, they are mostly non-cancer patients. We believe that cancer 
patients are inappropriate at this initial stage of human UTx until anti-rejection protocols are fully 
worked out. Instead, preferred patients for this initial step are women who have been born without a 
uterus or those who have had a hysterectomy, but not as part of a curative cancer treatment. In 
addition, 50-70 women per year undergo surrogacy in the UK. 
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Research into UTx has flourished over the past 15 years, with the procedure performed in small and 
large animal models, primates, autogeneic and allogeneic models, and most importantly with 
pregnancies now being demonstrated. A point is now being reached, whereby human UTx is 
attempted secondary to various ethics bodies around the globe realising that performing more animal 
research as opposed to attempting human transplants would not be advancing the field further. No 
animal model can ever predict the actual clinical experience. Therefore, the ultimate decision will be 
influenced by the judgment of the UTx team, the IRB of the participating institution, and most 
importantly, the patient to whom the transplant will be offered.3 
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